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A AB BS ST TR RA AC CT T   
 
       Migraine, a neurovascular disorder, is associated with disturbances in brain stem 
activity during attacks.    Interictal persistence of these disturbances might increase 
vulnerability to recurrent attacks of migraine.   To explore this possibility, effects of 
motion sickness and pain on migrainous symptoms and extracranial vascular reponses 
were  investigated  in  27  migraine  sufferers  in  the  headache-free  interval,  and  23 
healthy age/sex matched controls.    
      Symptoms  of  migraine  and  motion  sickness  are  remarkably  similar.    As  both 
maladies involve reflexes that relay in the brain stem, they most probably share the 
same neural circuitry.  Furthermore, migraineurs are usually susceptible to motion 
sickness  and,  conversely,  motion  sickness-prone  individuals  commonly  experience 
migraine.   Participants in the present study were exposed to optokinetic stimulation 
(OKS),  a  well-established  way  of  inducing  symptoms  of  motion  sickness  in 
susceptible individuals.    
      Sensitivity to painful stimulation of the head and hand was also explored.  Head 
pain is a hallmark of a migraine attack and cutaneous allodynia has been observed 
elsewhere in the body during attacks.  The trigeminal nerve is associated with head 
pain in migraine, and trigeminal activity evokes reflexes that relay in the brain stem.  
To  stimulate  the  trigeminal  nerve,  ice  was  applied  to  the  temple.    To  stimulate 
nociceptors elsewhere in the body the participant immersed their fingers and palm in 
ice-water. 
      Procedures  used  in  this  study  were  physically  stressful  and  probably 
psychologically stressful.    The impact of stress in relation to the development of   iv
symptomatic and vascular responses, particularly anticipatory stress-responses, was 
explored.  
     This research involved one central experiment that consisted of six experimental 
conditions.  On  separate  occasions  participants  were  exposed  to  optokinetic 
stimulation  and  painful  stimulation  of  the  head  or  limb,  individually  and  in 
combination.   
      In  migraine  sufferers,  symptomatic  responses  were  enhanced  during  all 
procedures  involving  OKS  and  during  temple  pain  after  OKS,  in  the  presence  of 
residual  motion  sickness.    During  trigeminal  stimulation  independent  of  OKS, 
headache  initially  developed  followed  by  nausea  as  the  procedure  progressed.    In 
contrast,  symptoms  barely  developed  in  controls  during  any  of  the  six procedures 
except for slight dizziness, self-motion and visual-illusion during conditions involving 
OKS, and slight nausea when the temple was painfully stimulated during OKS and 
during  OKS  alone.    Trigeminal  stimulation  during  OKS  intensified  nausea  and 
headache in migraine sufferers compared to during OKS alone or limb pain during 
OKS.  However, the remaining symptomatic ratings were not affected by temple pain 
during OKS, suggesting a specific association between nausea and head pain.  It may 
be  that  these  cardinal  symptoms  compound  one  another  during  a  migraine  attack.    
Enhanced symptomatic responses in migraine sufferers during the headache interval 
may indicate activation of hypersensitive neural pathways that mediate symptoms of 
motion  sickness  or  migraine.    Migraineurs  found  procedures  generally  more 
unpleasant, and ice-induced pain ratings more intense and unpleasant, than controls, 
which may further indicate hyperexcitable nociception in this group, or a difference in 
their criterion of discomfort.   v 
        Vascular  responses,  particularly  during  OKS  alone,  and  during  painful 
stimulation independent of OKS, were greater in migraine sufferers than in controls.   
The added stress of painful stimulation during OKS appeared to boost facial blood 
flow  in  controls  to  approach  levels  obtained  in  migraine  sufferers.      Enhanced 
vasodilatation was observed in migraineurs prior to painful stimulation, presumably 
due to anticipatory anxiety.              
       For  both  groups  ipsilateral  vascular  responses  were  greater  than  contralateral 
responses when the hand was painfully stimulated.    During limb pain before OKS 
asymmetry  was  minimal  in migraine sufferers but more apparent in controls.  An 
enhanced stress response in migraineurs may have drawn ipsilateral and contralateral 
responses closer together. 
        The development of symptoms during the procedures of this study provides an 
insight into how symptoms might develop sequentially in a migraine attack.  Once the 
headache is in motion, nausea and headache may mutually exacerbate one another.  In 
turn,  trigemino-vascular  responses  and  stress  appear  to  be  associated  with  the 
migraine  crisis.    Given  the  interactive  nature of symptomatic, vascular, and stress 
responses,  it  may  be  more  effective  to  target  multiple,  rather  than  individual, 
symptoms, in prophylactic or acute chemical and psychological interventions.   
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CHAPTER 1 
 
INTRODUCTION 
 
 
 
Living with migraine   (Maree, 2002: personal account of a chronic migraine sufferer) 
                 
“Migraine  has  been  my  ultimate  foe,  merciless  and  efficient.    It  has  destroyed  my 
friendships, relationships, spontaneity, career, hobbies, social life, recreation, and my 
reliability as a person.  It has derailed my dreams and goals.  It has stolen from me over 
time – days, months, and now years. It has all but taken my life, not quite.  Even when 
headache-free I live a constant nightmare that no day seems to follow ... in dread of that 
next attack.” 
 
 
 
 
The burden of migraine 
 
 
Individual and community costs 
 
 
      Migraine  is  a  common,  chronic,  sometimes  progressive,  and  often  incapacitating, 
neurovascular  disorder  (Lipton  and  Bigal,  2005;  Goadsby,  2003;  Silberstein,  2003).       
The above extract of a personal account from a chronic migraine sufferer demonstrates 
the extent to which migraine can disrupt an individual’s life.  Indeed the personal burden 
of  this  disease  has  been  widely  acknowledged  (Lipton  and  Bigal,  2005;  Holmes, 
MacGregor and Dodick, 2001).  It is also accepted that many headache sufferers live with 
a fear of the next attack, which restricts their daily lives, and sometimes their ability to 
meet social commitments (Rasmussen, 2001).   Even between attacks many migraine 
sufferers  do  not  fully  recover,  reporting  reduced  general  well  being  and  negative 
repercussions  on their quality  of life  (Linde,  2006; Linde  and  Dahlöf,  2004).    As Jo 
Liddal, past director of the Migraine Action Association (previously the British Migraine                   
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Association) aptly  commented: “Migraine may not be life-threatening but it is certainly 
quality-of-life-threatening” ( MacGregor, 1999, p.1). 
        Substantial  socio-economic  costs  to  the  community  are  also  well  documented 
(Bigal,  Rapoport,  Bordini,  Tepper, Sheftell  and  Speciali, 2003; Lafata, Moon, Leotta, 
Kolodner, Poisson and Lipton, 2004; Lipton and Bigal, 2005; Holmes, MacGregor and 
Dodick, 2001).   Lost days because of severe headache can lead to both direct (e.g., lost 
wages, medical costs) and indirect (e.g., reduced productivity) costs.   A large community 
based self-report survey in the United States in 1999 (29,727 respondents) indicated 53% 
of sufferers found that migraine headache either substantially disrupted routines/activities 
or required bed rest.  Thirty-one percent missed at least 1 day of work or school because 
of migraine in a 3 month period, and productivity was decreased by about 50% in 51% of 
respondents  (Lipton,  Stewart,  Diamond,  Diamond  and  Reed,  2001).    More  recently, 
another large community-based survey in Norway (38,192 respondents) asked questions 
about  headache  (migraine  and  non-migrainous)  and  sick  leave  in  the  previous  year 
(Fiane, Haugland, Stover, Zwart, Bovim and Hagen, 2006).  The incidence of sick leave  
>8 weeks was greater than 3 times higher among those with headaches - more than 14 
days per month (20%), compared to those without headache (6%).  Elsewhere, a review 
of the literature (Celik, Ekuklu, Tokuc and Utku, 2005) confirmed that globally days of 
work lost because of migraine are substantial, ranging from 3.8 to 5.6 per year for every 
migraine sufferer.  Not surprisingly, the financial cost of reduced productivity associated 
with migraine is substantial.   Additionally, migraineurs have been found to use more 
medical  care  services  and  incur  more  associated  medical  costs  than  non-migraineurs 
(Edmeads and Mackell, 2002; Hu, Markson, Lipton, Stewart and Berger, 1999).  Celik et 
al. (2005) point out that in the United States alone direct costs associated with migraine 
are approximately one billion dollars per year.   
      Furthermore,  the  persistent  strain  on  interpersonal  relationships,  disruption  to 
social/recreational  activities,  and  the  financial  burdens  (healthcare  costs,  lost  wages), 
particularly  incurred  by  chronic  migraine  sufferers,  is  also  shared  by  significant 
others/carers (Liberman and Steiner, 2003).   Additionally, they probably share to some 
degree the sense of helplessness that sufferers experience. 
                                 
                                                                     3 
 
                                                                          
 
Prevalence 
 
        Migraine is the most prevalent of the headache disorders:  worldwide, 46% of the 
adult population experience an active headache disorder, and of those 42% suffer with 
migraine (Stovner, Hagen, Jensen, Katsarava, Lipton, Scher, Steiner and Zwart, 2007).   
The  World  Health Organization ranks  headache disorders in  general  as the 10
th most 
disabling condition in comparison to other illnesses, for both genders, and the 5
th  most 
disabling for women (Stovner et al., 2007).    Migraine specifically, in comparison to 
other illnesses,  is a common, painful and disabling illness throughout the world, ranked 
19
th  among  all  causes  of  years  lived  with  disability  (ICHD,  2004;  Lipton,  Bigal, 
Amatniek and Stewart, 2004; WHO, 2002, 2004).   
          The  estimated  prevalence  of  migraine  across  various  European  populations  is 
variable but all agree with a female preponderance between 15-35% compared to 3-15% 
of males (Celic, Ekuklu, Tokuc and Utku, 2005; Rasmussen, 1995).  American studies 
concur  that  migraine  is  a  common  disorder  with  a  female  predominance  (Morillo, 
Alarcon,  Aranaga,  Aulet,  Chapman,  Conterno,  Estevez,  Garcia-Pedroza,  Garrido, 
Macias-Islas,  Monzillo,  Nunez,  Plascencia,  Rodriguez  and  Takeuchi,  2005;  Lipton, 
Stewart, Diamond, Diamond, and Reed, 2001; Lipton, Stewart and Simon, 1998).  The 
female preponderance may be due to factors related to female hormones (Rasmussen, 
1995).  The implications of hormonal factors in relation to migraine susceptibility are 
considered  later  in  this  chapter.    A  population-based  survey  in  the  United  States 
conducted in 1999 estimated that the prevalence of migraine was 18.2% among females 
and  6.5%  among  males  (Lipton  et  al.,  2001).    These  findings  were  compared  to  an 
identical national survey conducted a decade earlier and it was found that the prevalence 
and distribution of migraine had remained constant over time, proportionate to the growth 
of the population.  This indicates that migraine is a consistently highly prevalent disorder.               
          Migraine usually peaks in the twenties or thirties,  generally the most demanding 
years of life when family and career paths are being established, and starts to wane by 
age 50 (WHO, 2000; Gressor, 1992).   Children and adolescents are also vulnerable and, 
depending on the frequency and severity of attacks, academic and social development 
may  be  hindered  (Laurell,  Larsson,  Mattsson,  and  Eeg-Olofsson,  2006;  Karwautz,                   
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Wöber, Lang, Bock, Wagner-Ennsgraber, Vesely, Kienbacher and Wöber-Bingöl, 1999; 
Lipton, Stewart, Diamond, Diamond and Reed, 2001; Mazzone, Vitiello, Incorpora and 
Mazzone, 2005; Passchier and Orlebeke, 1985; Riva, Aggio, Vago, Nichelli, Andreucci, 
Paruta, Arrigo, Pantaleoni and Bulgheroni, 2006; Rossi, Cortinovis, Menegazzo, Menini 
and Carnelli, 2005; WHO, 2000), and perhaps self-confidence undermined.     
            The high prevalence and disabling consequences of migraine suggest it is indeed 
an important target for public health interventions (Lipton et al., 2001).   
 
Other health related concerns 
 
        Needless to say, the personal burden of migraine and the toll of the accompanying 
mental/physical stress may render some individuals increasingly vulnerable to developing 
various  stress  related  illnesses.    Indeed,  migraine  has  been  linked  with  a  number  of 
psychiatric disorders including general anxiety, depression, bipolar disorder and social 
phobia (Dowson and Cady, 2002).    
        Physical health can also be threatened  in  cases of  migraine-related stroke, with  
potentially  lethal  or  permanently  disabling  consequences  (Lampl  and  Marecek,  2006; 
Tietjen,  Al-Qasmi,  Gunda  and  Herial,  2005;  Merikangas,  Fenton,  Cheng,  Stolar  and 
Risch, 1997; Buring, Herbert, Romero, Kittross, Cook, Manson, Peto and Hennekens, 
1995).   Some studies suggest that migraine may account for 10-27%  of the probable 
causes  of  stroke  in  those  under  the  age  of  40  for  both  sexes  combined  (Sacquegna, 
Andreoli,  Baldrati,  Lamieri,  Guttmann,  de  Carolis,  Di  Pasquale,  Pinelli,  Testa  and 
Lugaresi, 1989; Spaccavento and Solomon, 1984), and up to 30-60% for women younger 
than 45, particularly those with migraine with aura who smoke or use oral contraceptives 
(Kurth,  2007;  MacClellen,  Giles,  Cole,  Wozniak,  Stern,  Mitchell  and  Kittner,  2007; 
Lampl and Marecek, 2006).   The risk of comorbid stroke is clearly increased in migraine 
sufferers, particularly in certain subgroups.    
         Consistent with this, Welch, Brandes, Salerno and Brandes (2006) found that C-
reactive protein, a sign of oxidative stress, inflammation, and stroke risk, were increased                   
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in migraine sufferers with atypical (e.g., aura with complex features occurring late in the 
headache  phase,  marked  hemiplegic  or  aphasic  symptoms)  and  severe  attacks.              
Furthermore,  magnetic  resonance  imaging  studies  indicate  that  subclinical  posterior 
circulation  stroke,  and  diffuse  white  matter  lesion  loads,  increase  with  regularity  of 
migraine (Lampl and Marecek, 2006).   Both types of brain injury: infarct (including 
subclinical  posterior  circulation  stroke)  and  white  matter  lesions,  are  linked  with 
increased risk of clinical stroke, physical limitations and cognitive impairment, including 
dementia (Longstreth, Manolio, Arnold, Burke, Bryan, Jungreis, Enright, O’Leary and 
Freid,  1996).        Lampl  and  Marecek  (2006)  suggest  that  migraine  may  contribute  to  
progressive damage to the brain; hence, it could be viewed as a chronic episodic and 
sometimes chronic progressive disorder.  Evidence certainly suggests that migraine is a 
chronic episodic disorder that progresses in some individuals.  Progression of migraine is 
characterized by gradual increase in migraine attack frequency, and sometimes constant 
pain (Bigal and Lipton, 2006; Lipton and Pan, 2004).   This state is variously referred to 
as chronic migraine, a subtype of the chronic daily headaches (Bigal and Lipton, 2006; 
Silberstein,  Lipton  and  Sliwinski,  1996),  malignant  migraine,  transformed  migraine 
(Lipton and Bigal, 2007) or probable chronic migraine with probable medication overuse 
(ICDH, 2004).  Given the high prevalence of migraine, Lampl and Marecek (2006) thus 
recognize the importance of confirming whether migraine is indeed a possible risk factor 
for  cerebral  infarct  or  white  matter  lesions.      Additionally,  Lampl  and  Marecek 
recommend that a major goal of treatment should include preventing the accumulation of 
brain lesions, in addition to relieving pain and restoring the patient’s ability to function 
(Diamond, Bigal, Silberstein, Loder, Reed and Lipton, 2006;  Edwards, 2001).    
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Migraine  has  a  long  history  with  many  questions  that  remain 
unanswered  
 
       Headache has troubled humankind since ancient times (Zayas, Mainardi, Maggioni 
and  Zanchin,  2006;  Rapoport  and  Edmeads,  2001;  MacGregor,  1999).    This  long-
association of headache and the human condition was accordingly encapsulated by John 
Ruskin  Graham,  MD,  MACP  (1909-1990)  with  his  glib  comment    “Homo  Sapiens 
Erectus has a headache” (cited in Spierings, 2001, p. 910).  Headache generally, and 
migraineous type headache particularly, has been described in ancient literature along 
with  an  archaic  understanding  of  head  pain  and  associated  treatments.    Neolithic 
ancestors dating from 7000-BC apparently believed evil spirits were responsible for the 
pain  of  headache.    Treatment  included  a  primitive  brain  surgery  referred  to  as 
‘trepanning’, which involved removal of circular chunks of the skull thought to release 
evil spirits, which in turn cured the headache.  Surprisingly many survived this operation 
as shown by bone regrowth around the holes of these skulls.    
          Migraine has also been mentioned in one of the oldest known medical manuscripts, 
the Ebers papyrus, discovered at Thebes, Egypt in the 1800’s.   It was described here as a 
“sickness of half of the head”.  Treatment  from around 1200-BC involved the application 
of a ceramic crocodile, with herbs stuffed in the mouth, to the head of the patient which 
was  believed  to  somehow  cure  the  condition.    Historians  however,  suggest  that 
compression of the temples by the tie and/or the medicinal effect of the herbs may have 
helped relieve the pain (Lance and Goadsby, 2002; MacGregor, 1999).  Clearly, migraine 
is an old and baffling condition.   
       The  understanding  of  migraine  today  is  thankfully  more  sophisticated  but 
nonetheless  the  pathophysiology  of  the  condition  is  still  not  completely  understood 
(Knight, 2005).   Current pharmacological treatment of migraine is aimed at relieving the 
acute attack and in some cases prophylactic medication is also required (Silberstein and 
Rosenerg,  2000).      Non-pharmacological  approaches  to  treatment  include  trigger 
avoidance,  acupuncture,  biofeedback,  and  stress  management  strategies,  which  may 
involve relaxation/meditation therapy and/or cognitive behaviour therapy (Linde, 2006; 
Rains, Penzien and Lipchik, 2006).   Regular and frequent aerobic exercise has also been                   
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suggested in the management of migraine (Köseoglu, Akboyraz, Soyuer and Ersoy, 2003; 
Locket and Campbell, 1992). 
         There  is  a  paucity  of  treatment  aimed  at  reducing  the  likelihood  of  recurring 
migraine attacks.  Perhaps this is because attention to those migraineurs who may require  
preventive  treatment  is  generally  lacking  (Diamond  et  al.,  2006).    In  addition,  little 
evidence is available on the effects of preventive treatments on the impact of migraine 
with  regards  to  quality  of  life  and  activity  limitations;  whereas  outcomes  of  acute 
treatments, particularly pharmacological, are more often explored (e.g., Amico, Solari, 
Usai,  Santoro,  Bernardoni,  Frediani,  De  Marco,  Massetto  and  Bussone,  2006;  Linde, 
Mellberg  and  Dahlöf,  2006;  Mushet,  Miller,  Clements,  Pait  and  Gutterman,  1996; 
Santanello,  Polis,  Hartmaier,  Kramer,  Block  and  Silberstein,  1997;  Dasbach,  Carides, 
Gerth, Santanello, Pigeon and Kramer, 2000).    If repeated attacks of migraine are to be 
reliably managed/treated, mechanisms underlying susceptibility to migraine need to be 
better  understood  in  the  first  place.      Therefore,  more  research  aimed  at  deciphering 
mechanisms underlying susceptibility to migraine and associated preventative treatments 
is required. 
         Outcomes of treatments are variable in terms of relieving or reducing the frequency 
of  attacks,  and  not  all  treatments  are  entirely  harmless,  particularly  pharmacological 
interventions where adverse side effects are possible.  Furthermore,  if migraine headache 
is  misdiagnosed  and  consequently  mismanaged,  inappropriate  and  unnecessary 
medication is likely to be administered.  In turn, the haphazard use of medication may 
lead to overuse, which can exacerbate and complicate the clinical picture of headache 
(Rains, Lipchik and Penzien, 2006; Boes and Capobianco, 2005).   
 
 
 
 
 
 
                   
                                                                     8 
 
                                                                          
 
 
Aim of the book 
 
 
      Contemporary  research  indicates  that  migraine  headache  and associated symptoms 
are  directly  related  to  a  disturbance  in  brain  stem  nuclei  (Weiller,  May,  Limmroth, 
Jǔptner,  Kaube,  Schayck,  Coenen  and  Diener,  1995).    The  present  book  aims  to 
investigate whether this disturbance persists covertly interictally in migraine sufferers.  
To investigate this possibility people who suffer with recurring attacks of migraine were 
exposed to various sensory stimuli during the headache-free interval.  Specifically, causal 
relationships  between  symptoms  of  migraine  and  extracranial  vascular  reactivity  to 
various  stimuli  were  explored.    On  separate  occasions  participants  were  exposed  to 
optokinetic  stimulation  and  painful  stimulation  of the head or limb, discretely and in 
combination.   
        Of  further  interest  was  the  impact  of  stress  in  relation  to  the  development  of 
symptomatic  and  vascular  responses.    Procedures  used  in  this  study  were  physically 
stressful  and  most  probably  psychologically  stressful.    Hence, evidence  of  the  stress-
response, particularly anticipatory stress-responses, was explored.  
        In  the  susceptible  individual  it  may  be  that  brain  stem  nuclei  are  either 
hyperexcitable to sensory or trigeminal stimuli, or that neural mechanisms that normally 
inhibit the development of symptoms are compromised, which may increase vulnerability 
to  attacks.    Additionally,  as  stress  is  a  commonly  recognized  trigger  of  migraine 
(Passchier, 1994; Reynolds and Hovanitz, 2000) it may be that an exaggerated stress-
response  influences the  initiation  and  the  development  of  attacks.    It  was hoped that 
findings  might  help  clarify  mechanisms  that  initiate  migraine,  and  that  these  insights 
would assist the development of approaches to reduce susceptibility to recurring attacks 
of migraine.  
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Chapter outline 
 
 
       This chapter introduces migraine headache.  The condition is defined, and  physical 
and  psychological  changes  that  occur  in  the  progression  of  a  migraine  attack  are 
explained.  The natural life course of migraine is also described.  Triggers and risk factors 
linked with migraine, which may increase vulnerability to the condition, are discussed 
next.  General characteristics that appear to be linked with vulnerability to migraine are 
described,  including  a  possible  genetic  predisposition,  biochemical  and  metabolic 
dysfunction,  hormonal  cycles,  tendency  to  vestibular  and  autonomic  instability, 
susceptiblility to motion sickness, and psychological ill-health/personality characteristics.  
Vascular, sensory and trigeminal responses of migraine sufferers between headaches are 
also  reviewed.      Stress,  a  commonly  recognized  migraine  trigger,  is  also  discussed.   
Following this, theories explaining mechanisms of a migraine attack are presented.   In 
light  of  this  knowledge,  and  the  recognized  characteristics  peculiar  to  individuals 
vulnerable to migraine, proposed mechanisms that may increase vulnerablity to repeated 
migraine attacks are considered.   This chapter concludes with a general overview of the 
book, and a list of key assumptions and hypotheses. 
 
 
 
 
Diagnosis    
 
 
       Headache, per se, is a common symptom that signals numerous complaints.  It may 
be a secondary symptom to an underlying complaint, e.g., sinusitis, hangover, fatigue, 
toothache, or illness (including flu, stroke, meningitis).  Alternatively, headache may be 
the  primary  symptom  of  a  headache  disorder.      Almost  the  entire  population,  96% 
according to Dowson and Cady (2002), will experience headache at least some time in                   
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their lives.   In fact, MacGregor (1999) claims that fewer than 2% of individuals have 
never experienced a headache.   The bulk of these complaints are primary headaches that 
resolve without the need of treatment.  Only very few are  sinister secondary headaches, 
e.g., those signaling brain tumor or stroke.  Most  of the headaches that present in primary 
care  settings  include  migraine,  tension-type  headache,  short,  sharp  headache,  cluster 
headache, chronic daily headache, and sinus headache and other causes of facial pain 
(Dowson and Cady, 2002).   Clear guidelines for the differential diagnosis of migraine 
and other headaches is crucial if headache is to be managed efficiently.    
            The  International  Headache  Society  (IHS)  originally  published  standard 
diagnostic guidelines for migraine and other headache types in 1988 and updated these 
guidelines in 2002 (ICHD, 2004).  The IHS classification system, initiated by Professor 
Jes Olesen,  is a landmark in the scientific study of headaches.   Prior to the introduction 
of these guidelines there was no basis for classifying headaches until the early 1960’s.   
In 1962  the Ad-Hoc Committee of the National Institutes of Health published a glossary 
of definitions to help classify headache syndromes (Boes and Capobianco, 2005; Göbel, 
2001).  However, Göbel pointed out that from the start this glossary was not particularly 
reliable - it was not based on empirical findings and required subjective interpretation.   
In contrast, the IHS classification is empirically based.  Furthermore, it is one of the most 
frequently cited texts and, since its introduction almost 2 decades ago, has inspired a 
surge of pathophysiological and epidemiological research into headache disorders.  The 
World  Health  Organization  (WHO),  in  recognition  of  the  global  burden  of  headache 
disorders, included the IHS classifications of headaches in its international classification 
ICD-10NA  publication.    The  ICD-10NA  codes  and  classifications  are  particularly 
important in clinical practice as all diseases are uniformly recorded using this system 
(Göbel, 2001).   
              Migraine manifests differently between individuals and also sometimes within 
individuals  from  attack  to  attack  (Lance,  2000;  Lance  and  Goadsby,  2002;  Linde, 
Mellberg  and  Dahlöf,  2006;  Lipton,  Cady,  Stewart,  Wilks  and  Hall,  2002).      Most 
migraine sufferers suffer from attacks without aura, one-third  experience attacks with 
aura (Lance, 2000).    Elsewhere the estimate of migraineurs with aura is even less, at 
most, one-fifth of migraine sufferers (Goadsby, 2001).   Many of those who suffer attacks                   
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with aura also experience attacks without aura (ICHD, 2004).   The ICHD-II diagnostic 
criteria  for  migraine  attacks  with/without  aura  are  presented  in  Tables  1.1  and  1.2, 
respectively.    
         Furthermore,  migraine  itself  is  not  a  homogenous  condition,  but  instead 
encompasses  a  group  of  syndromes  with specific aura features or uncommon courses 
(Evers, Áfra, Frese, Goadsby, Linde, May and Sándor, 2006; Linde, 2006).  The ICHD-II 
diagnostic criteria of subclassifications of migraine and the WHO ICD-10NA codes are 
presented in Table 1.3. 
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Table 1.1.  ICHD-II diagnostic criteria for migraine with aura  
 
________________________________________________________________________  
 
Typical aura with migraine headache 
A.  At least two attacks fulfilling criteria B-D 
B.  Aura consisting of at least one of the following, but no motor weakness: 
1.  Fully reversible visual symptoms including positive features (e.g.,    
     flickering lights, spots or lines) and/or negative features (i.e., loss of    
     vision) 
2.  Fully reversible sensory symptoms including positive features (e.g., pins  
     and needles) and/or negative features (i.e., numbness) 
3.  Fully reversible dysphasic speech disturbance 
 
C.  At least two of the following: 
1.  Homonymous visual symptoms and/or unilateral sensory 
2.  At least one aura symptom develops gradually over >5 min and/or different  
      aura symptoms occur in succession over >5 min 
3.   Each symptom lasts >5 min and <60 min 
 
D.  Headache fulfilling criteria B-D for migraine without aura begins during the 
aura or follows aura within 60 min 
 
E.  Not attributed to another disorder. 
________________________________________________________________________ 
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Table 1.2.  ICHD-II diagnostic criteria for migraine without aura  
 
________________________________________________________________________  
 
A.  At least five attacks fulfilling B-D 
B.  Headache attacks lasting 4-72 hours (untreated or unsuccessfully treated) 
C.  Headache has at least two of the following characteristics: 
1.  Unilateral location 
2.  Pulsating quality 
3.  Moderate or severe pain intensity 
 
D.  During headache at least one of the following: 
1.  Nausea and/or vomiting 
2.  Photophobia and phonophobia 
 
E.  Not attributed to another disorder 
________________________________________________________________________ 
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Table 1.3.  ICHD-II diagnostic criteria of subclassifications of migraine and ICD-10NA 
codes  
________________________________________________________________________  
   IHS              WHO                                         Diagnosis 
ICHD-II      ICD-10NA 
  code              code                   
 
1.                    G43                     Migraine  
 
1.1                  G43.0                  Migraine without aura 
 
1.2                  G43.1                  Migraine with aura 
    1.2.1           G43.10                      Typical aura with migraine headache 
    1.2.2           G43.10                       Typical aura with non-migraine headache 
    1.2.3           G43.104                     Typical aura without headache 
    1.2.4           G43.105                     Familial hemiplegic migraine (FHM) 
    1.2.5           G43.105                     Sporadic hemiplegic migraine  
    1.2.6           G43.103                     Basilar-type migraine 
 
1.3                  G43.82                 Childhood    periodic   syndromes  that   are   commonly   
                                                    precursors of migraine 
    1.3.1           G43.82                       Cyclical vomiting 
    1.3.2           G43.820                     Abdominal migraine 
    1.3.3           G43.821                     Benign paroxysmal vertigo of childhood 
 
1.4                  G43.81                 Retinal migraine 
 
1.5                  G43.3                   Complications of migraine 
    1.5.1           G43.3                          Chronic migraine 
    1.5.2           G43.2                          Status migrainosus 
    1.5.3           G43.3                          Persistent aura without infarction 
    1.5.4           G43.3                          Migrainous infarction 
    1.5.5           G43.3 +                 Migraine-triggered seizure 
                       G40.x or G41.x
1     
 
1.6                  G43.83                  Probable migraine 
    1.6.1           G43.83                         Probable migraine without aura 
    1.6.2           G43.83                         Probable migraine with aura 
    1.6.5           G43.83                         Probable chronic migraine    
 
________________________________________________________________________             
1  The additional code specifies the type of seizure                   
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          Any individual may experience an isolated migrainous-like headache or even a few 
in a lifetime (Linde, 2006) but at least 5 lifetime attacks of migraine are required before it 
is regarded as a pathological disorder and a diagnosis of migraine is given.   A cardinal 
feature of migraine,  differentiating it  from the majority of other headache syndromes, is 
prolonged (4-72 hours) often excruitiatingly painful headache.  Another hallmark of an 
attack is nausea; around 90% experience nausea and 75% vomit (Lance and Goadsby, 
2000).    Nausea  may  be  experienced  at  any  point  during  the  attack,  and  sometimes 
preceeds the headache by an hour or more (Lance, 1999; Lance and Goadsby, 2000), so 
understandably migraines are sometimes referred to as ‘sick headaches’ (Gressor, 1999; 
MacGregor,  1999).    Dizziness/vertigo  (Marano,  Marcelli,  Di  Stasio,  Bonuso,  Vacca, 
Manganelli,  Marciano  and  Perretti,  2005;  Baloh,  1997;  Cutrer  and  Baloh,  1992), 
drowsiness, and body temperature changes (fever, chills) are also commonly experienced 
during a typical attack (Gressor, 1999; Lance and Goadsby, 2000).  In addition, intra- and 
extracranial vasodilatation is sometimes observed during attacks (Lance and Goadsby, 
2000).   
        Clearly,  symptomatic  and  vascular  responses  during  attacks  of  migraine  are 
pronounced and exposure to sensory stimuli have been found to accentuate responses, 
particularly  headache  (Linde,  2006; Linde, Mellberg andDahlöf, 2006).   Linde et al. 
(2006) point out that hypersensitivity has also been demonstrated interictally and during 
the premonitory phase of an attack, i.e., photo- and phonophobia.  Whether symptomatic 
and vascular responses to sensory stimuli are particularly reactive in migraine sufferers 
interictally, suggesting neural hypersensitivity which perhaps renders sufferers vulnerable 
to recurring migraine attacks, is the subject of this book.   Specifically, the relationship 
between  symptomatic  and  vascular  changes  in  individuals  vulnerable  to  migraine, 
following the activation of brainstem nuclei via stimulation of trigeminal nerve pathways, 
vestibular pathways, and painful stimulation away from the head, is investigated between 
headaches. 
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The  natural  life  history  of  migraine  and  progression  of  a  migraine 
attack 
 
 
 
Natural history of migraine/prognosis 
 
       Migraine may first appear at any stage of life.   However, for most individuals onset 
of migraine occurs between age 20-30.  For some, the first signs of migrainous symptoms 
develop  in  childhood.      Research  suggests  that  10-30%  of  children  and  adolescents 
experience  weekly  or  daily  headache,  with  migraine  occurring  in  3-15%  of  children 
(Mazzone et al., 2005).  A long-term follow-up study found that 48.6% of adolescent 
females  still  had  migraine  after  6.6  +  1.6  years  (Kienbacher,  Wöber,  Zesch,  Hafferl-
Gattermayer,  Posch,  Karwautz,  Zormann,  Berger,  Zebenholzer,  Konrad  and  Wöber-
Bingöl, 2006).   Keinbacher et al. found that poor prognosis was partly related to delayed 
time  between  headache  onset  and  first  presentation/diagnosis,  prompting  the  question 
whether  early  therapeutic  intervention  in children  and adolescents  with  migraine may 
have a more favourable effect on the long-term prognosis.   
        Migrainous symptoms in very young children generally involve nausea, abdominal 
pain and vomiting, without headache.   As the vulnerable child matures headache may 
accompany  the  gastrointestinal  symptoms.    Then  at  puberty,  the  headache  may  be 
announced  by  visual  symptoms  (aura).    Most  agree  that  during  childhood  males  are 
equally  as  vulnerable  to  migrainous  symptoms  as  females  (Gressor,  1999;  Lance  and 
Goadsby, 2000; Lance, 1999; MacGregor, 1999).   However, Lipton and Bigal (2005) in 
a review of the literature found that prior to puberty migraine is actually more common 
among  boys  than  girls.      The  reverse  is  the  case  at  puberty  whereby  females  are 
predominantly  more  affected  than  males  (Gressor,  1999;  Lance  and  Goadsby,  2000; 
Lance, 1999; MacGregor, 1999).  MacGregor (1999) points out that boys with childhood 
migraine are more likely to “grow out of migraine but girls grow into it”, often worsening                   
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during the menopause due to erratic oestrogen secretions.    For some females (one-sixth), 
menarche heralds the onset of migraine attacks (Zacur, 2006).   By adulthood three times 
as many females suffer migraine as males (Kemper, 2006).  The influence of hormonal 
factors in relation to susceptibility to develop migraine is discussed later in this chapter 
(pages 46-47). 
          Prognostically, most individuals diagnosed with migraine will continue to suffer 
attacks throughout life to some degree.  Bille (1981) found that 60% of a group of 73 
children (age 7-13) with migraine went into remission by adolescence, but attacks started 
again in one-third of the remitters.  When followed up some years later, Bille found that 
60% of this original group of affected children were still suffering migraine attacks at age 
30.  A series of longitudinal studies related to Bille’s 1981 study (including Bille, 1997) 
monitiored  these  migraine  sufferers  over  40  years.    Bille  found  that  the  majority  of 
sufferers (51%) still experienced migraine at the 40 year follow-up, then aged between 
47-53 (Bille, 1997).   Twenty-nine percent of these individuals suffered repeated attacks, 
at least annually without remission, 22% had migraine-free periods from 2 years up to 10 
years on average.  Forty-six percent were free of migraine, 23% free since puberty.   The 
prognosis was poorer for females.     
        The frequency and intensity of migraine attacks in most cases wanes from around 
age 50 (Gressor, 1999; Lance, 1999).  In one particular study (Whitty and Hockaday, 
1968) occasional attacks were found to persist in 50% of adult migraine patients at 65 
years of age.  It was pointed out by  Martins, Bordini, Bigal and Speciali (2006) that the 
incidence of migraine in the elderly may in actual fact be under recognized as symptoms 
in this cohort are less typical; consequently many seniors may be misdiagnosed.   
       These  studies  suggest  that  most  individuals  vulnerable  to  migraine  can  expect, 
following onset, to suffer with recurring attacks throughout life in differing forms and to 
differing degrees.   
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Natural progression of a migraine attack 
  
       A  migraine  attack  involves  a  cascade  of  complex  neurological  changes  that 
frequently start before and continue after the symptom of headache (Cady, Schreiber, 
Farmer  and  Sheftell,  2002).      Blau  in  the  1990’s  established  the  terminology  of  the 
various  stages  of  a  migraine  attack,  identifying  five  distinct  stages:  the  premonitory 
phase, aura,  headache, resolution and postdrome - also sometimes referred to as recovery 
(Blau, 1992).  Sometimes the resolution phase of an attack  is not recognized as a phase 
in itself but is considered as the transition or bridge between the headache phase and 
postdrome of the attack (Linde, 2006; Griffin, Ruggiero, Lipton, Silberstein, Tvedskov, 
Olesen,  Altman,  Goadsby  and  Macrae,  2003;  Quintela,  Castillo,  Muñoz  and  Pascual, 
2006).   Stages are fairly methodical but may vary for each migraine sufferer.  Some 
phases may not necessarily occur and there is no distinct onset or end of each stage, apart 
from  the  aura.    Commonly  experienced  symptoms  during  the  progression  of  a  
complete/typical migraine attack are shown in figure 1.1.   Figure 1.2 shows the average 
duration of each phase of a migraine attack.    
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Migraine interval 
   
Figure 1.2.   Average duration of each phase of a migraine attack (Adapted from 
ICHD, 2004; MacGregor, 1999; Lance and Goadsby, 2000)    
 
 
 
 
      The  average  duration  of  the  headache  phase  of  a  migraine  attack  is  variable 
(Stewart, Shechter and  Lipton, 1994).    The IHS estimate a migraine attack may last 
anywhere between 4-72 hours (see Table 1.2).   However, in a review of the literature 
Stewart  et  al.  found  that  the  average  duration  of  an  attack  varied  depending  on 
whether participants were IHS diagnostically categorized with migraine or were less 
strictly categorized.  Studies based on IHS  criteria indicated that the median duration 
of  attacks  ranged  from  9-24  hours.    In  contrast,  the  usual  duration  of  migraine 
headache tended to be shorter (<4 hours) in studies that had less strict diagnostic 
criteria that measured younger sufferers, particularly children and men.   
           The  interval  between  attacks  varies  for  each  individual  depending  on  the 
frequency  of  their  attacks.    Stewart  et  al.  (1994)  reviewed  a  number  of  studies 
measuring the frequency of migraine attacks.  Comparing data between studies was 
               4-72hrs 
 
 
 
 
 
 
20-60  
     mins                                
 
 
1-2days                    1-2 days   21 
difficult as categories used to report frequency of attacks were variable,  e.g., several 
per month vs one per month, <5-10 per year vs 0-52 per year.  However, Stewart et al 
estimated, from studies where categories were mutually exclusive, the median number 
of attacks per month ranged between 0.4 per month to 1.5 per month.   The median 
attack rate was greater for females than for males.    
           Dahlem and Podoll (2007) point out that the migraine interval is not seen as a 
phase  itself.    However,    as  cortical  excitability  has  been  observed  interictally, 
suggesting  migraine  may  be  secondary  to  a  genetic  predisposition,  the  migraine 
interval should also be recognized as a distinct phase.   This book further explores the 
possibility of an underlying persistent systemic vulnerablility to migraine. 
 
      
 
Premonitory period 
 
 
       Most  migraine  sufferers  experience  premonitory  symptoms  (Amery,  Waelkens 
and Vandenbergh, 1986; Dowson and Cady, 2002; Linde, 2006; Schoonman, Evers, 
Terwindt,  van  Dijk  and  Ferrari,  2006).    Griffen  et  al.  (2003)  demonstrated  that 
migraineurs,  using  an  electronic  diary  system  to  record  premonitory  symptoms, 
successfully predicted the impending migraine headache with up to 72% accuracy.   
Dahlöf and Linde (2001) similarly found that patients were able to predict migraine 
headache from premonitory symptoms hours to days beforehand.   Some premonitory 
symptoms, e.g., food cravings, heightened sensory acuity, and muscle tension, may be 
mistaken for migraine triggers.  These misconceptions are probably, in part at least, a 
conditioned association due to the close proximity of the symptom to the headache 
phase of the attack.  In reality exposure to supposed triggers does not always result in 
an attack.  For some individuals certain triggers may play a role in the development of 
attacks but in general there is little evidence to support the claim that trigger factors, 
particularly foods, induce migraine.   By and large research indicates that headache 
frequency is not different between those on restricted or normal diets (Dowson and 
Cady, 2002; Lance, 1999; MacGregor, 1999; Medina and Diamond, 1978).  Trigger 
factors associated with migraine are reviewed later in this chapter (pages 62-69).  In   22 
fact most migraine attacks occur spontaneously.   Therefore, premonitory symptoms 
are more likely part of the attack rather than triggers of the attack (Dowson and Cady, 
2002).  
         Quintel et al. (2006) found that 83% of migraine sufferers reported experiencing 
premonitory  symptoms,  particularly  anxiety,  phono-/photophobia,  irritability, 
unhappiness, yawning and concentration difficulties.   Griffen et al. (2003) similarly 
demonstrated that migraineurs reported warning features prior to migraine headache 
including  feeling  weary  (72%),  experiencing  impaired  concentration  (51%),  neck 
stiffness  (50%)  photophobia  (49%),  phonophobia  (38%),  intolerance/irritablility 
(39%), yawning (28%) and feeling emotional (24%).   Quintel et al. (2006) did not 
give  participants  the  opportunity  to  report  on  the  presence  of  muscular  or  neck 
tension/stiffness prior to an attack, which obviously accounted for the absence of this 
dimension as a potential premonitory symptom in their study.  
         Yawning  can  precede  migraine  or  follow  the  attack,  sometimes  for  hours  
(Drummond and Lance, 1984; Rasmussen and Olesen, 1992) and may well be related 
to tiredness also commonly reported during the premonitory period.   Yawning is a 
motor response coordinated in the brainstem that generally signifies drowsiness and 
fatigue, but can also signal hunger or boredom (Argiolas, Melis and Gessa, 1987).    
Yawning in the premonitory phase of a migraine attack has been linked to dopamine 
release  possibly  involving  brain  stem  nuclei  (Griffen  et  al.,  2003;  Jacome,  2001).   
Interestingly,  Jacome  (2001)  presented  3  case  studies  of  migraine  sufferers  with 
persistent, isolated yawning in the absence of drowsiness prior to migraine headache.  
Perhaps  the  yawning  in  these  cases  was  related  to  premonitory  symptoms  of 
hunger/craving, indicating hypothalamic disturbance (Waxman, 2003).    
            During  the  headache  phase  of  an  attack,  drowsiness  develops  further, 
culminating in the urge to sleep (Jacome, 2001).  Sleep and wakefulness, and degrees 
of tiredness/drowsiness between these levels of alertness, are regulated by reticular 
formation structures in the hypothalamus and brain stem.  Nerve cells in the reticular 
formation of the pons begin to discharge just before sleep (Waxman, 2003).          
          Clearly,  a  number  of  cognitive  and  physical  prodromal  symptoms  are 
experienced, suggesting that neurological changes start before the headache, perhaps 
mediated  via  hypothalamic  and  brain  stem  structures.    Furthermore,  as  many 
prodromal symptoms continue throughout all three phases of a migraine attack (see 
figure 1.1), it appears that ongoing activity in these subcortical centers is somehow   23 
involved in migraine.  Therefore, headache is just one feature of the entire attack.  
These findings perhaps implicate migraine as an intermittent or episodic dysfunction 
of trigeminovascular regulation (Griffen et al., 2006), most likely mediated via brain 
stem structures (Weiller et al., 1995).  In any case, prodromal symptoms are generally 
believed  to  arise  from  hypothalamic  disturbance  (Cady  et  al.,  2002;  Lance  and 
Goadsby,  2000;  MacGregor,  1999).    The  gradual  development  of  prodromal 
symptoms  most  probably  reflects  neurochemical  disruption  (Dowson  and  Cady, 
2002), as Lance and Goadsby (2000) propose, involving monoaminergic transmission 
in the hypothalamus culminating in migraine headache with/without aura.  Cady et al. 
(2002)  suggest  that  diffuse,  non-specific  alterations  of  supratentorial  brain activity 
during the premonitory phase may underlie subsequent neural changes at the level of 
the brain stem. 
        The link between the prodromal and headache phases of a migraine attack may, 
in turn, have therapeutic potential for intervention in the management of migraine in 
the prodromal phase (Griffen et al., 2003).   Most migraine sufferers, however, regard 
the headache phase as the worst feature of the attack (Linde et al., 2006).  Hence, 
intervention,  whether  acute  or  preventative,  is  primarily  focused  on  treating  or 
diverting  the  headache  phase  (Griffen,  2003).    In  particular,  pharmacological 
management  of  migraine  involves  treating  the  acute  headache  (medication  may 
extend for days) or prophylactic daily treatment is taken.  In either case, treatment 
does not always deflect attacks.   
         However,  the  frequency  of  attacks  including  premonitory  symptoms  may 
decrease  in  individuals  on  prophylactic  anti-migraine  medications.    Also,  in  some 
cases  premonitory  symptoms  following  an  attack  have  been  found  to  be  less 
prominent  in  those  on  preventatives.    These  findings  imply  that  prophylactic 
medication not only reduces the headache phase of an attack but can also reduce the 
CNS activation occurring before the headache phase (Quintela et al., 2006). 
         Early adminstration of medication, preferably before the headache starts, is a 
key factor in migraine prevention (Waelkens, 1984).   Griffen (2003) suggests that 
pre-emptive treatment during the premonitory period, at the brink of the headache 
phase, may not only more efficiently control the attack but also limit the amount of 
medication required.   Pradel, Subedi, Varghese, Mullins and Weis (2005) confirm 
that early headache response/relief to eletriptan and sumatriptan in the acute treatment 
of  migraine  (by  0.5  hours)  was  associated  with  more  rapid  return  to  functioning   24 
compared  with  patients  who  did  not  attain  a  headache  response  at  0.5  hours.   
However, as Linde et al. (2006) demonstrated, regardless of whether or not the acute 
attack  was  treated  with  various  anti-migraine  medications  including  sumatriptan, 
recurrence  of  headache  was  common  (at  least  1  in  3  attacks),  necessitating  re-
medicating to manage symptoms.   
         It is noteworthy that 28% of attacks are not preceded by premonitory symptoms  
(Griffen, 2003),  so it appears that the nervous system sometimes recovers from the 
physiological process of migraine before the development of headache (Cady et al., 
2002).   In these instances pre-emptive medication may therefore be unnecessary.  
        Alternatively, it may be helpful to intervene prior to the premonitory phase as 
neurophysiological abnormalities have been observed interically (Judit, Sándor. and 
Schoenen,  2000;  Evers,  Quibeldey,  Grotemeyer,  Suhr  and  Husstedt,  1999).  
Electrophysiological  studies  measuring  event-related  potentials  have  demonstrated 
gradual  reduction  of  cognitive  habituation  during  the  migraine  interval,  which 
abruptly normalizes on the first day of the attack, and is inversely related to levels of 
platelet serotonin (Evers et al., 1999).   Other studies have shown normalization of 
visual  and  auditory  evoked  potentials  just  before  and  during  migraine  attacks  in 
contrast  to  increasingly  depressed  interictal  responses  (Judit  et  al.,  2000).    The 
interictal abnormalities of cortical hyperexcitability demonstrated in these studies may 
be a neurophysiological sign of an impending attack and the increasing vulnerablity of 
the migrainous brain to precipitating stimuli (Griffen et al., 2003).   As most migraine 
attacks occur spontaneously (Dowson and Cady, 2002), perhaps that ‘next attack’ is a 
time-bomb waiting to happen in a vulnerable system.   It may be relevant to consider  
the premonitory phase as actually the earliest part of the entire attack, rather than a 
distinct phase in itself; headache would then represent the pinnacle of the temporal 
course of the attack.   This being the case, it may be wiser to aim intervention at the 
migraine interval; hence, suppressing the premonitory phase altogether, before this 
earliest part of the attack is in motion.     
       The  hypothalamus  and  brainstem  may  be  involved  in  the  generation  of 
premonitory symptoms in migraine attacks (Cady et al., 2002; Lance and Goadsby, 
2000;  MacGregor,  1999)  but  whether  these  areas,  particularly  the  hypothalamus, 
should be targeted in the development of prophylactic drug treatment, needs to be 
carefully  considered.      The  hypothalamus  is  the  chief  region  for  the  control  and 
regulation  of  numerous  bodily  functions  including  endocrinal,  cardiovascular,   25 
respiratory, temperature, appetite and thirst. The hypothalamus also acts as a mediator 
of stressful, emotional and environmental influences on endocrine glands including 
the  release  of  pituitary  hormones.      Hypothalamic  mechanisms  are  complex, 
specialized and often interrelated (Venes, 2001; Bray et al., 1999).   Hence, attempts 
to chemically manipulate this part of the brain may be problematic, bearing the risk of 
interfering with bodily homeostasis.   
 
 
 
 Prodrome/aura 
 
       Aura  typically  precedes  the  headache  phase  of  an  attack  but  can  also  occur 
simultaneously with the headache.   In rare cases aura may appear hours or days after 
the  onset  of  headache  (Goadsby,  2001;  Russell  and  Olesen,  1996).    Many  who 
experience migraine with aura commonly have attacks without aura but only a few 
patients have aura exclusively without headache (ICHD II, 2004).    Migraine aura 
involves the gradual development of reversible neurological disturbances, e.g., visual 
(99% of auras), sensory (31% of auras), speech (18% of auras), and motor (6% of 
auras), discretely or in combination (Russell and Olesen, 1996).   Symptoms of aura 
can take around  5-20 minutes to develop and can last up to 1 hour (Goadsby, 2001; 
Linde, 2006).    There is generally an  interval between the resolution of the aura and 
the onset of headache of up to 1 hour, in which disturbances similar to premonitory 
symptoms  may  be  experienced,  e.g.,  alterations  of  mood,  speech,  or  a  sense  of 
detachment from the environment (MacGregor, 1999).  
      Aura  symptoms  can  arise  from  anywhere  in  the  cerebral  cortex  or  brain  stem 
(MacGregor, 1999).   However, as visual symptoms are commonly experienced, the 
migraine aura is generally localized in the visual cortex of the occipital lobe (Lance 
and Goadsby, 2000).    During the aura a transient oligemia spreads across the cortex 
(Lauritzen, 1994; Olesen, Larsen and Lauritzen, 1981).   The underlying mechanism 
of the migraine aura is thought to be cortical spreading depression (CSD) as aura 
symptoms, particularly  visual hallucinations, develop at a similar pace to the cortical 
spreading depression (Lauritzen, 1994; Russell and Olesen, 1996).     
       It has been suggested that the aura of migraine somehow generates the complete 
attack, particularly the component of pain (Goadsby, 2001).  Goadsby explored this   26 
premise, pointing out, that as only the minority of migraineurs experience aura, it 
seems unlikely that aura can account for headache in the majority of sufferers.   In 
addition,  aura  does  not  necessarily  precede  an  attack  but  can  appear  well  after 
headache is established.   Those convinced that aura may underly head pain suggest 
that ‘clinically silent aura’ may occur in migraine sufferers without aura (Goadsby, 
2001; Ramadan and Welch, 1995).   However, in attacks with aura in the absence of 
headache, implying that aura is independent of pain, the possiblility of a clinically 
silent aura underlying headache is challenged (Goadsby, 2001).  Or, as Cady et al. 
(2002)  suggest,  as  with  the  premonitory  symptoms  appearing  independent  of 
headache, it may be that the nervous system sometimes recuperates or aborts from the 
physiological process of migraine before the development of headache. 
         In  an  attempt  to  clarify  the  link  between  CSD  and  nociceptive  activity, 
Ebersberger,  Schaible,  Averbeck  and  Richter  (2001)  recorded  neuronal  activity  in 
anesthetized rats, from secondary sensory neurons in the trigeminal nucleus caudalis 
with input from  the meninges and tested whether nociceptive neurons at this location 
could  be  activated  as  a  consequence  of  cortical  spreading  depression.    CSD  was 
induced by the application of potassium chloride to the dura mater at levels normally 
seen during CSD.   Plasma extravasation in the dura mater as a consequence of CSD 
was also explored.  Ebersberger’s findings suggest that CSD did not initiate headache 
(nociception) via neurogenic inflammation, at least in deeply located neurons of the 
trigeminal nucleus.  Specifically, cortical spreading depression did not evoke plasma 
extravasation,  and  potassium  levels  seen  during  CSD  did  not  alter  the  release  of 
calcitonin gene-related peptide and prostaglandin E2 from the dura. 
        In  contrast  to  Ebersberger’s  findings,  Supornsilpchai,  Sanguanrangsirikul, 
Maneesri  and  Srikiatkhachorn  (2006)  discovered  that  CSD  was  indeed  related  to 
increased trigeminal nociceptive discharge.   Specifically, serotonin depletion in rats 
enhanced  CSD-induced  trigeminal  nociceptive  discharge,  cortical  excitability 
increased, and trigeminal niociceptive sensitivity was enhanced.  CSD was induced by 
the topical application of potassium chloride on the parietal cortex of anesthetized rats 
and  serotonin depletion was achieved via administration of para-chlorophenylalanine, 
a  tryptophan  hydroxylase  inhibitor.    Cortical  activity  was  monitored  by 
electrocorticography.    Trigeminal  nociceptive  activity  was  determined  from  the 
examination of concentrations of Fos-IR in various sites of the trigeminal nucleus   27 
caudalis, the cervical spinal cord and from the caudal medulla.  The concentrations of 
Fos-IR were greater in the low 5-HT group than in control rats.   
        According  to  Supornsilpchai  et  al.,  the  effects  of  serotonin  depletion  on  the 
development  of  CSD  and  trigeminal  nociceptive  activity  has  not  previously  been 
studied.    On the other hand, it is widely accepted that pain modulation in a migraine 
attack  is  associated  with  low  platelet/plasma  serotonin  levels  (Ferrari,  Odink, 
Tapparelli,  van  Kempen,  Pennings  and  Bruyn,  1989;  Lance  and  Goadsby,  2000; 
MacGregor, 1999).  Other behaviours (e.g., sleep, feeding) are also linked to altered 
serotonin levels (Supornsilpchai et al., 2006).   Supornsilpchai’s recent novel findings 
shed light on the role that serotonin may play in the aura stage of a migraine attack 
which, in turn, may help to clarify the relationship between aura and head pain in 
migraine.  
        However, the literature generally asserts that CSD, or the aura of migraine, is not 
necessarily  linked  to  trigeminovascular  nociceptive  activation  (Goadsby,  2001).   
Instead,  migraine  aura  and  trigeminovascular  nociceptive  activity  are  more  likely 
parallel processes (Goadsby, 2001; Silberstein, 1994).  The pain of migraine may be 
more  to  do  with  ‘the  abnormal  perception  of    the  normal  than  the  activation  of 
nociceptive pathways in the classical way that pain is generated’ (Goadsby, 2001, p.5) 
(e.g.,  photophobia  is  the  exaggeration  of  normal  light  and  phonophobia  the 
exaggeration of normal sound, by the brain).   Migraine may, in effect, be ‘an episodic 
disorder  of  sensory  sensitivity  whose  basic  understanding  and  generation  will  be 
found in the brain and whose pathophysiological behaviour will not respect classical 
pain physiology’ (Goadsby, 2001, p. 5.).  Indeed, electrophysiological studies using 
evoked and event-related potentials demonstrate lack of habituation interictally, which 
normalizes during the headache stage of the attack (Gantenbein and Sándor, 2006; 
Evers  et  al.,  1999;  Judit  et  al.,  2000;  Wang  and  Schoenen,  1998),  implying  that 
abnormal cortical activity is ongoing.    
         It is clearly undecided whether CSD, the well-acknowledged neuronal process 
underlying visual aura, is required for migraine headache to develop (Wolthausen, 
Sternberg,  Gerloff  and  May,  2009).        Interestingly,  findings  from  a  recent  study 
conducted  by  Wolthausen  et  al.    may  help  resolve  this  intellectual  stalemate.   
Wolthausen  et  al.  treated  3  patients  suffering  migraine  with  (visual)  aura  with 
flunarize or topiramate for 4 months.   Aura symptoms resolved completely in each 
case whereas headache persisted.  For 1 patient, attack frequency increased.  In all   28 
patients  aura  returned  once  treatment  ceased.      Findings  indicated  that  for  these 
individuals  at  least,  migraine  headache  developed  without  aura  and  presumably 
without CSD (the neurophysiological correlate of visual aura) – whether silent or not.    
      The  Wolthausen  group  proposed  that  CSD,  which  involves  cortical  neuronal 
depolarization waves, single-handedly may not be prerequisite for migraine headache 
to  develop,  but  instead  CSD-related  processes,  occurring  in  isolation  or  together, 
could be to blame.  CSD-related processes include haemodynamic changes, which 
involve the spread of vasodilatation along arterioles extending beyond CSD areas.   
Extensive  intercellular  changes  are  also  associated  with  CSD  involving  astrocyte 
calcium waves associated with the release of neuromodulators of pain transmission.   
Wolthausen et al. suggest that these associated processes of CSD - haemodynamic 
changes and astrocyte calcium waves - rather than CSD itself, more likely determine 
whether  headache  develops  together  with  aura  or  if  aura  develops  in  isolation  of 
headache.      With  this  in  mind  Wolthausen et al. speculated that cortical neuronal 
depolarization  waves  might  not  develop  in  migraine  without  aura,  whereas  aura 
without  headache  may  be  due  to  isolated cortical neuronal waves.   However, all 
CSD-related processes may be involved in migraine with aura.   
         If this is the case it may shed light on why some drugs, as seen in Wolthausen’s 
study, inhibit CSD without relieving headache (Wolthausen et al., 2009).  Wolthausen 
recommends that future research exploring CSD-like phenomena in migraine without 
aura should investigate attacks as early as possible to avoid missing sometimes short-
lasting  early  cortical  propagating  activity,  to confirm or reject results.   This may 
clarify whether a link does indeed exist between aura (silent or not) and the headache 
of migraine.   However, if migraine with aura and aura without headache are derived 
from  the  interplay  of  CSD-related  neural  activity  (Wolthausen  et  al.,  2009),  a 
neurophysiological relationship between aura (CSD) and headache might very well 
exist.   
      On the other hand aura may purely be part of the migraine process but is not 
necessarily linked to the pain of the condition.   Headache sometimes follows, or is 
concomitant with aura, but is not necessarily part of the episodic-course of the attack.   
          Interestingly, Cady et al. (2002) challenged the view that aura is soley linked to 
migraine headache in the first place, which may have implications for early detection, 
diagnosis and management of migraine.   In particular, when mild headache follows 
aura in the absence of associated  migrainous symptoms (see Figure 1.1), the actual   29 
headache resembles tension type headache rather than migraine headache (ICDH II, 
2004).   Also, curiously, aura has been described prior to the onset of cluster headache 
(Silberstein,  Niknam,  Rozen  and  Young,  2000).    Cady  et  al.  (2002)  advise  that 
atypical  observations  with  regard  to  aura  may  require  further  investigation  and 
revision.  Nevertheless, these observations may indicate that primary headaches are 
more closely linked than otherwise supposed.  Cady et al.  proposed a “convergence 
hypothesis”  of  primary  headaches,  in  contrast  to  the  distinct  diagnostic  headache 
syndromes endorsed by the IHS, particularly with respect to a continuum for tension-
type headache to migrainous headache to migraine headache.   Furthermore, sinus 
headaches  sometimes  evolve  to  become  migraine,  suggesting  that  this  headache 
syndrome may also be more closely associated that assumed.   In an earlier study 
Drummond (1985) explored precipating, aggravating and relieving factors in different 
categories of headache, and similar to Cady et al. (2002), concluded that there may be 
a continuum between migraine, tension-vascular and tension headache.   However, 
Drummond  found  that  cluster  headache  emerged  as  a  distinct  entity  with  its  own 
etiology.   
 
 
 
Headache and Resolution 
 
        The first indication of migraine headache is typically a mild, dull, diffuse ache 
(Dowson  and  Cady,  2002;  Lance  and  Goadsby,  2000;  Lance,  2000;  MacGregor, 
1999).      In  about  two-thirds  of  sufferers  the  pain  is  felt  unilaterally  and  for  the 
remainder, bilaterally.  Pain may initially be felt deep behind the eye or can involve 
the frontotemporal region of the head, sometimes radiating to the back of the head and 
upper neck.  Alternatively, the pain may begin at the occiput and/or upper neck, and 
radiate forward, developing into a band of pain surrounding the forehead and neck.  In 
a few sufferers the pain is felt in the lower part of the face, typically unilaterally, 
involving  the  nostril,  cheek  and  jaw/teeth,  i.e.,  lower  half  head  migraine,  facial 
migraine (Lance and Goadsby, 2000).     
         The anatomical location of  pain during migraine headache may indicate how 
pain is generated neurally in an attack.   Neck pain in particular is a common feature 
of migraine so may be an important clue  (Kaniecke, 2004).   Kaniecke found that   30 
neck pain, within an hour of the attack, was reported as frequently as was nausea or 
phono/photophobia  (75%).      Neck  pain  late  in  an  attack,  after  headache  has 
developed, may indicate central sensitization and cutaneous allodynia (Burstein, Cutre 
and Yarnitsky, 2000).   It is less clear what the neck pain indicates earlier on in an 
attack.  Kaniecke explored early and late onset of neck pain in relation to headache in 
an attack.  Treating an attack with triptans at the first sign of neck pain in 50 sufferers 
who experienced neck pain first then headache, resulted in a better response rate than 
treating an attack when neck pain developed after headache in another 50 sufferers.  
Kaniecke  suggested  that  early  neck  pain  may  represent  referred  pain,  a  trigger  or 
premonitory  symptoms.    Perhaps  treating  the  attack  at  the  first  sign  of  neck  pain 
rather  than  headache  (Kaniecke,  2004)  aborts  the  migraine  process  before  the 
sensitization  of  peripheral  trigeminovascular  neurons  associated  with  headache 
(Burstein, 2004).   
     Within  hours  the  initial  dull  headache  intensifies  to  a  throbbing  quality  of 
moderate to severe intensity (Lance and Goadsby, 2000).  For some the pain has a 
different  quality,  in  particular  it  is  described  as  pressing  or  tightening  (Kaniecke, 
2004; Olesen, 1978).  A state of constant pain may ensue, or alternatively pain may 
fluctuate between moderate to severe until the headache eventually resolves, in most 
cases,  following  sleep  or  vomiting  (Blau,  1991,  1992;  Lance  and  Goadsby,  2000; 
Linde et al., 2006; Olesen, 1978 and Quintela et al., 2006).   Linde et al. (2006) found 
that  the  time  of  vomiting  in  relation  to  pain  intensity  influenced  whether  or  not 
headache  improved  followed  vomiting.    When  vomiting  occurred  before headache 
reached  maximum  intensity,  improvement  in  headache  followed.      However,  if 
vomiting  appeared  at  the  peak  of  pain  intensity,  headache  did  not  necessarily 
decrease. 
     Migraine headache can manifest at any time of the day or night but its debut is 
commonly experienced as a mild headache on awakening  (Linde, 2006; Linde et al., 
2006).  Sometimes the sufferer may awaken with a full-blown attack (see Table 1.2).   
In these cases the characteristic introductory mild head pain may have developed and 
progressed before the sufferer awakens (Olesen, 1978).   Perhaps the premonitory and 
aura phases of the attack similarly develop unnoticed prior to awakening for some 
sufferers.    
      Symptoms typical of migraine headache (refer to Table 1.2) vary widely between 
sufferers, and even within sufferers from one attack to another (Linde et al., 2006).     31 
However, in most cases symptoms other than headache progressively appear as head 
pain  worsens.      In  turn,  the  headache  may  then  become  throbbing  in  quality  as 
associated symptoms intensify (Olesen, 1978).   More recently, Linde et al. (2006) 
charted the natural course of migraine attacks, treated and untreated.  Linde et al. 
analysed data based on the hourly self-reports of 30 migraine sufferers during attacks, 
using  a  100-point  visual  analogue  scale.      Despite  inter-  and  intra-individual 
variability during attacks, or whether or not treatment was administered, symptoms of 
each  attack  generally  followed  the  same  temporal  course  –  albeit  with  moderate 
variations.      Acute  medication,  although  effective,  by  and  large  only  temporarily 
influenced the course of the attack.   Headache recurred within 24 hours at least once 
in three attacks in 78% of sufferers, irrespective of whether attacks were treated with 
rizatriptan  or  left  untreated.    Usually  a  synchronized  time-intensity  course  of 
phono/photophobia in proportion to headache intensity was observed.  Compatible 
time-intensity  courses  between  phono/photophobia  and  nausea  were  also  seen.   
However, sometimes phono/photophobia did not develop at any stage, despite severe 
pain and nausea.   Furthermore, nausea was sometimes absent despite severe pain and 
phono/photophobia.  These observations demonstrate that IHS criteria for migraine 
are not always satisfied in each attack, particularly if the attack is treated early (Linde 
et al., 2006). 
       When  typical  features  of  attacks  such as nausea or phono/photophobia appear 
before the pain, the notion that symptoms of migraine follows a predictable temporal 
course  with  head  pain  as  the  forerunner,  is  further  challenged.      Under  these 
circumstances it appears that the attack as such may have started in the premonitory 
phase,  implying  that  the  driving  force  of  the  attack  may  take  place  in  the 
hypothalamus or cerebral cortex rather than, as generally supposed, the trigeminal-
somatosensory system (Griffen et al., 2003; Kelman, 2004; Schoonman, Evers, van 
Dijik and Ferrari, 2003).    
       This book is particularly interested in teasing-out causal relationships between 
symptoms of migraine.  Specifically, symptoms normally experienced in a migraine 
attack were evoked in migraine sufferers interictally, in a sense simulating an attack.   
It was anticipated that experimentally controlled observations during the headache-
free  interval,  of  symptoms  usually  seen  during  an  attack,  may  help  clarify  the 
contribution of a vulnerable nervous system in the manifestation of an attack; hence, 
providing further insights into understanding the pathophysiology of migraine.   32 
 
 
Postdrome/Recovery  
 
     The postdrome refers to the period of symptoms experienced directly following the 
acute headache of a migraine attack, affecting some 68-94% of migraineurs (Blau, 
1991;  Kelman,  2005;  Quintela  et  al.,  2006).        Symptoms  commonly  experienced 
include physical/mental tiredness, concentration difficulties, low-grade headache/head 
tenderness,  and  subdued  or  depressed  mood,  but  a  few  individuals  report  feeling 
euphoria or relief.    Gastrointestinal symptoms (e.g., anorexia), sensory hyperacuity 
(e.g.,  phono/photophobia)  and  neck  pain/stiffness  are  occasionally  reported.   
Symptoms  generally  last  for  around  24  hours  but  occasionally  exhaustion  and 
lethargy will linger for several days.   Postdrome symptoms are more likely to occur 
following  severe  or  more  typical  full-blown  migraine  attacks,  i.e.,  those involving 
aura, headache, nausea, photo/phonophobia (Blau, 1991; Kelman, 2005; Quintela et 
al., 2006).     
      Curiously, pro- and postdrome symptoms affect more individuals, and last longer, 
than do aura symptoms, yet notably less attention has been paid to the early and late 
stages of the attack compared to the aura in terms of research (Blau, 1991; Quintela et 
al., 2006).  This may be because the aura is so spectacular and, although debated, has 
been assumed to be the driving force of the entire attack (Goadsby, 2001).  The dearth 
of  attention  given  to  the  pro-  and  postdrome  may  also  be  because  each  of  these 
phenomena is overshadowed by the headache phase of the attack, generally regarded 
as the worst feature of the condition (Linde et al., 2006).    
        Marginally more attention has been given to the prodrome than the postdrome, 
possibly because premonitory symptoms signal an unwelcome impending attack, so 
need to be taken seriously.   On the other hand, the postdrome, despite uncomfortable 
and  sometimes  disabling  symptoms,  remains  almost  unstudied  (Kelman,  2005; 
Quintela et al., 2006).   It has been suggested that postdromal symptoms are merely 
after effects of the main attack, e.g., medications taken, extra time spent in bed, lack 
of food (Blau, 1991).   However, Blau points out that analgesics typically do not have 
such prolonged effects and not all patients miss meals or remain in bed during attacks.   
Alternatively, the postdrome may be welcomed as a ‘relative calm after the headache-
storm’,  hence  could  be  overlooked  in  terms  of  research  as  being  somehow  less   33 
important than the acute headache.    However, Selby (sited in Blau, 1991) referred to 
the postdrome as “the third act in the drama” of migraine episodes - an integral part of 
the condition.   As headache recurrence is common within the first 24 hours following 
the acute headache (Linde et al., 2006), implying continued activation or disinhibition 
of neural pathways during the postdrome, the postdrome might indeed be considered 
part  of  the  one  process  in  the  production  of  migraine  headache.    Therefore,  the 
postdrome probably warrants as much attention as that given to the more prominent 
headache phase of the condition.     
      Consistent with the notion that the postdrome is an integral part of the migraine 
process, Shibata, Osawa and Iwata (1998) found abnormal visual evoked potentials to 
pattern reversals for several days after migraine attacks in migraineurs with aura and 
migraine  without  headache,  indicating  that  hyperexcitability  in  visual  pathways 
persists  beyond  the  aura/headache  phase  of  an  attack.      This  abnormal 
electrophysiological  dysfunction  was  found  to  gradually  decrease  but  continued  to 
some extent interictally, implying constant neural inhibitory deficits, which in turn 
may leave the individual vulnerable to the next attack.    
        The range of symptoms during the postdrome suggests that the entire brain is 
involved  in  the  aftermath  of  a  migraine  attack  (Kelman,  2005;  Blau,  1991).  
Furthermore,  given  the  striking  similarity  between  symptoms  of  the  pro-  and 
postdrome,  similar  neural  pathways  or  mechanisms  may  be  common  in  the 
manifestation of both.  Kelman (2005) described the pro- and postdrome as separate 
parts  of  the  one  process,  interrupted  or  camouflaged  by  headache  and  associated 
symptoms.   Perhaps then the driving force of the headache starts with generalized 
neural activity as seen in the prodrome stage of the attack.  In turn, headache develops 
following subsequent trigeminovascular system involvement.  Then, as Blau (1991) 
suggests,  as  the  headache  resolves  postdromal  symptoms  may  represent  the  slow 
decline of the migraine process involving the whole brain and associated abnormal 
neurotransmission or neural metabolic disturbances (Blau, 1991).    
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Headache interval 
 
        Abnormal  brain  activity  has  been  detected  in  migraine  sufferers  during  the 
interictal  period  (Gantenbein  and  Sándor,  2006;  Aurora,  Cao, Bowyer and Welch, 
1999; Auror, Ahmad, Welch, Bhardhwaj and Ramadan, 1998; Wray, Mijovic-Prelec 
and  Kosslyn, 1995; Dahlem and Podoll, 2007; Evers, Quibeldey, Grotemeyer, Suhr 
and  Husstedt,  1999;  Grosser,  Oelkers,  Hummei,  Geisslinger,  Brune,  Kobal  and 
Lıtsch,  2000;  Judit,  Sándor  and  Schoenen,  2000;  Schoenen,  1996;  Siniatchkin, 
Gerber, Kropp, Voznesenskaya and Vein, 2000; Wang and Schoenen, 1998).  The 
abrupt normalization of interictal lack of habituation observed during an attack, using 
evoked  and  event-related  potentials,  suggests  a  possible  role  of  increasing  energy 
reserves in attack generation (Gantenbein and Sándor, 2006).    Furthermore, migraine 
sufferers  are  more  sensitive  to  sensory  stimulation  (light,  sound,  smell,  pain) 
interictally  than  are  healthy  controls  (Drummond,  1987;  Drummond,  1986; 
Drummond  and  Woodhouse,  1993;  Main,  Dowson  and  Gross,  1997;  Snyder  and 
Drummond, 1997), which suggests that the nervous system in migraineurs is either 
constantly vigilant to incoming sensory stimuli or perhaps never fully recovers from 
persistent attacks.   Whatever the case, the headache-free interval appears to be a 
vulnerable  period.      Certainly,  migraine  sufferers  develop  headache  following 
stimulation  of  trigeminal  and  nociceptive  pathways  interictally  (see  publications 
related to this book, Granston and Drummond).   Provocative visual stimuli during the 
headache-free  interval  also  induced  subsequent  headache  in  migraine  sufferers 
(Aurora et al., 1999; Cao, Welch, Aurora and Vikingstad, 1999). 
         The  aim  of  preventative  treatment,  typically  prophylactic  medication,  is  to 
deflect the acute attack.   Perhaps if the focus of preventative treatment was shifted to 
normalizing  interictal  malfunction,  the  threshold  of  the  migrainous  brain  to 
provocative  incoming  stimuli  may  increase;  hence,  more  robustly  protecting  the 
susceptible individual from attacks.   Clearly, anti-nociceptive drugs act differently on 
trigeminal  pain  processing  during  and  outside  attacks.      As  Katsarava,  Limmroth, 
Baykal,  Akguen,  Diener  and  Kaube  (2004)  demonstrated,  anti-nocipetive  drugs 
commonly  used  to  treat  acute  migraine  headache,  i.e.,  acetylsalicylic  acid  and 
zolmitriptan,  are  more  effective  in  suppressing  nociceptive  blink  reflexes  when 
administered  during  migraine  attacks  than  interictally  (Katsarava  et  al.,  2004).     35 
Therefore, use of pharmacological treatment interictally needs to be customized for 
optimal effect. 
        This book explored symptomatic and vascular responses in migraine sufferers 
between headaches.    It was anticipated that observations during this particularly 
sensitive period might help further clarify the extent of interictal hypersensitivity in 
migraineurs.   In turn, ways to more efficiently manage this common, relentless and 
unpredictable condition, may be realized.   
 
 
 
 
Risk factors associated with increased vulnerability to migraine 
 
 
       Certain risk factors are thought to predispose the individual to migraine.   This 
vulnerability  in  conjunction  with  some  internal  and/or  external  stimuli  may  then 
precipitate a migraine attack (Dowson and Cady, 2002; Lance and Goadsby, 2000; 
MacGregor, 1999).   Numerous studies acknowledge the importance of identifying 
risk factors in order to control the progression of migraine, a well-recognized chronic-
recurrent disorder, from evolving into transformed migraine, a subtype of the chronic 
daily headaches – a state sometimes leading to nearly constant pain (Bigal and Lipton, 
2006; Lipton and Bigal, 2007).  Bigal and Lipton (2006) categorized risk factors for 
migraine progression into two groups, non-remedial and remedial.   Non-remedial or 
not readily modifiable risk factors include gender, age, race, head injury, and low 
education/socioeconomic status.  Remedial or modifiable risk factors include attack 
frequency,  obesity,  medication  overuse,  stressful  life  events,  caffeine  overuse,  and 
snoring.  Bigal and Lipton also suggest that allodynia, pro-inflammatory states, other 
pain syndromes and pro-thrombotic states, render the individual more vulnerable for 
migraine progression.  
       The threshold of susceptibility probably depends on the degree of predisposition 
in  conjunction with various triggering factors (Bigal and Lipton, 2006; Lance and 
Goadsby, 2000; MacGregor, 1999), which may explain why one particular trigger, 
e.g., missing a meal, flickering sunlight or lack of sleep, may not always trigger an   36 
attack from one individual to the next or from one attack to another (MacGregor, 
1999).   MacGregor points out that if a potential trigger happens to coincide with 
hormonal  changes  during  menstruation  and/or  a  period  of  stressful  life  events,  an 
attack is more likely to ensue than when exposure to triggers are in isolation.   
         Martin  (2001)  suggested  that  the  tendency  for  migraine  sufferers  to  avoid 
suspected  triggers  such  as  light  might  lead  to  the  development  of  an  insidious 
hypersensitivity to such stimuli, thus increasing headache frequency.    Consistent 
with this idea Martin found that prolonged exposure to intense light was associated 
with a subsequent decrease in pain ratings in response to this stimulus.    This reaction 
was not as clear for graded exposure to noise (Martin, Reese and Forsyth, 2006).   
        Dowson  and  Cady  (2002)  point  out  that  proposed  risk  factors  thought  to 
predispose  or  precipitate  migraine  sufferers  to  migraine  should  be  considered 
carefully as they may merely coexist coincidently.   Nevertheless, research to date has 
produced  some  encouraging  results  with  respect  to  the  various  contributing 
mechanisms that may render some individuals more likely to develop migraine than 
others.  Predisposing and precipitating factors which may determine the migrainous 
threshold are discussed next. 
 
 
 
Predisposing factors 
  
 
 Genetics 
 
 
       The  majority  of  migraine  sufferers  participating  in  the  research  for  this  book 
reported a family history of migraine – 23 out of 27 participants (85.7%).   In contrast, 
only 5 out of 23 healthy controls (21.7%) reported a similar history.    The strong 
familial link with migraine suggests that migraine has a genetic link.   There is 50% 
likelihood that a child will develop migraine if one parent is a migraine sufferer; 75% 
if  both  parents  have  the  condition,  and  20%  if  an  extended  family  member  has 
migraine (Larkin, 1997).  Twin studies indicate a consistently greater co-incidence of 
migraine  among  monozygotic  (identical)  twins  compared with dizygotic (fraternal)   37 
twins, further suggesting that a genetic component underlies the disorder  (Larkin, 
1997; Svensson, Larsson, Waldenlind and Pedersen, 2003; Ziegler, Hur, Bouchard, 
Hassanein  and  Barter,  1998).      The  higher  concurrent  rates  for  migraine  among 
monozygotic twins were found even among twins raised apart (Svensson et al., 2003; 
Ziegler  et  al.,  1998),  implying  that  genetic  factors  have  more  influence  than 
environmental factors in determining who is likely to develop this disease. 
       In a large population based study of Finnish twins (monozygotic and dizygotic), 
structural equation techniques identified a strong genetic component in the etiology of 
migraine  (Honkasalo,  Kaprio,Winter,  Heikkilä,  Sillanpää  and  Koskenvuo,  1995).    
However, unshared environmental factors for twins raised apart were also found to 
play a role in the etiology of migraine.  Honkasalo et al. suggested that environmental 
factors might account for much of the variability observed in migraine occurrence.    
     Understanding  the  basis  for  possible  hereditary  aspects of migraine is far from 
straightforward.    There is no single gene that causes the disorder and only familial 
hemiplegic  migraine has been found to have a strong genetic tendency  (Gardner, 
1999, 2006; Larkin, 1997; Peroutka, Wilhoit and Jones, 1997).  This rare form of 
migraine appears to be transmitted by an autosomal dominant mode of inheritance 
linked to mutations in the calcium channel gene CACNA1A assigned to chromosome 
19.   This mutated calcium channel gene accounts for 50-55% of cases of familial 
hemiplegic migraine (Gardner, 1999, 2006; Ophoff, Terwindt, Vergouwe, van Eijk, 
Oefner, Hoffman,  Lamerdin, Mohrenweiser,  Bulman,  Ferrari,  Haan, Lindhout, van 
Ommen,  Hofker, Ferrari and Frants, 1996; May, Ophoff, Terwindt, Urban, van Eijk, 
Haan,  Diener,  Lindhout,  Frants,  Sandkuijl  and  Ferrari,  1995).      In  some  cases 
abnormalities  have  also  been  located  on  chromosome  1,  in  the  sodium/potassium 
pump gene ATP1A2  (Ducros, Joutel, Vahedi, Cecillon, Ferreira, Bernard, Verier, 
Echenne,  Demunain,  Bousser  and  Tournierlasserve,  1997;  Gardner,  1999,  2006).   
Mutations in CACNA1A lead to alterations of calcium activity in brain cells and, in 
turn,  neurotransmission,  which  may  explain  brain  excitability  in  individuals  with 
migraine (Gardner, 2006).   Furthermore, it is suggested that mutations in CACNA1A 
function  may  depress  levels  of  serotonin  via  effects  on  ion  homeostasis  and  gene 
expression (Estevez, 2006).   Recent studies (Dichgans, Freilinger, Eckstein, Babinin, 
Lorenz-Depiereuz, Biskup, Ferrari, Herzog, van den Maagdenberg, Pusch and Strom, 
2005;  Jen,  Wan,  Palos,  Howard  and  Baloh,  2005)  have  identified  additional  gene 
mutations linked to familial hemiplegic migraine in the genes SLC1A3 and SCN1A.    38 
The latter gene has also been associated with epilepsy, suggesting molecular links 
between migraine and epilepsy (Dichgans et al., 2005).  
        It is thought that mutations on chromosome 19 may underlie susceptibility for 
the more usual forms of migraine including migraine with and without aura (May et 
al., 1995), but a genetic link has not been confirmed (Larkin, 1997).   However, other 
susceptibility loci have recently been identified for common forms of migraine, in 
genome-wide screens and candidate-locus studies (Gardner, 2006).  Data elsewhere 
has suggested the involvement of dopamine receptor and synthesis pathways in the 
manifestation of migraine, particularly migraine with aura (Peroutka et al., 1997).   
         Clearly the research demonstrates that migraine has a genetic component, but 
environmental factors also appear to play an important role in the etiology of this 
condition.   All things considered, perhaps migraine results from the interaction of 
several genes with each other and/or environment factors.  It may be that those who 
inherit a low threshold to migraine attacks are more vulnerable to migraine triggers 
(Larkin, 1997; MacGregor, 1999).   
    
 
Dysfunction of the autonomic nervous system 
 
 
        Vascular  and  symptomatic  responses  of  migraine  sufferers  to  various  stimuli 
including optokinetic stimulation and painful stimulation of the head and limbs were 
explored  in  this  book.      Presumably these stimuli would be considered stressful; 
hence activation of the autonomic nervous system might be expected.   Research has 
shown instability of autonomic nervous system function in migraine sufferers during 
and  outside  migraine  attacks,  which  has  been  hypothesized  to  predispose  them  to 
migraine  (Dowson  and  Cady,  2002).    It  has  been  suggested  that  sympathovagal 
imbalance could explain systemic and central migraine phenomena including cranial 
vasculature  changes  and  bowel  motility.    Also,  associated  symptoms  of  migraine, 
such as nausea and vomiting, as well as symptoms commonly experienced during the 
premonitory  period  including  sensitivity  to  light,  sound  and  smell,  and  irritability, 
could have an autonomic basis (Blau, 1992; Mosek, Novak,Opfer-Gehrking, Swanson 
and Low, 1999; Pogacnik, Sega, Pecnik and Klauta, 1993).     39 
       Autonomic dysfunction in migraine sufferers is well recognized but findings are 
inconsistent across studies as to the division of the autonomic nervous system affected 
and the direction and degree of instability.    Autonomic impairment has mostly been 
attributed to sympathetic hypofunction (Havanka-Kanniainenm Tolonen and Myllylä, 
1986, 1988; Fanciullacci, 1979; Mosek et al., 1999; Peroutka, 2004; Pogacnik, Sega, 
Pecnik  and  Klauta,  1993).    However,  sympathetic  hyperfunction  (Peroutka,  2004; 
Appel,Kuritzky,Zahavi,  Zigelman  and  Askeirod,  1992;  Zigelman,  Appel, 
Davidovitch, Kuritzky, Zahave and Akseirod, 1994) has also been reported.    
            Unilateral  autonomic  symptoms  such  as  lacrimation,  conjunctival  injection, 
eyelid oedema and nasal congestion - normally characteristic of trigeminal autonomic 
cephalalgias (e.g., cluster headache) - have been observed in up to almost 50% of  
migraineurs during attacks (Barbanti et al., 2002).   The headache was more intense in 
migraine sufferers with unilateral autonomic symptoms than in those without.   The 
presence  of   these  symptoms  suggests activation of the cranial parasympathetic 
system, specifically the activation of the trigeminal-autonomic reflex (Al-Din et al., 
2005; Barbanti et al., 2002).   Interestingly, Frese, Evers and May (2003) observed 
that  autonomic  activation  such  as  lacrimation,  conjunctival  injection  and  nasal 
congestion  was  evoked  in  healthy  controls  following  subcutaneous  injection  of 
capsaicin to the forehead, suggesting a normal response to trigeminal pain. 
       Consistent  with  parasympathetic  involvement  in  migraine  sufferers,  during 
attacks  with  cranial autonomic symptoms, Goadsby, Edvinsson and Ekman (1990) 
found  high  levels  of  vasoactive  intestinal  polypeptide  in  the  cranial  venous 
circulation.    Outside the cranial circulation, parasympathetic function in migraine 
sufferers was found to be normal compared to healthy controls when exposed to a 
battery of well-validated tests of autonomic function (Mosek et al., 1999).   
      An imbalance of the autonomic nervous system may indeed explain many of the 
clinical manifestations of migraine.  Furthermore, autonomic instability may render 
the  individual  more  vulnerable  to  the  impact  of  external  triggers  in  the  migraine 
interval.   
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Moleculecular basis of migraine susceptibility  
 
      It  has  been  suggested  that  migraine  belongs  to  a  functional,  as  opposed  to 
structural, pathology (Bryn, 1980).  A typical attack involves, with rare exceptions, 
reversible and transient autonomic, vascular and nociceptive dysfunction or changes.  
The  absence  of  physical  or  structural  changes  (e.g.,  which  may  follow  stroke  or 
myocardial infartion) suggests that a migraine attack may be chemically induced.    
        Key molecular targets implicated in migraine pathophysiology which have been 
extensively studied, include:  
•  Mitochondria and magnesium (Barbirolli, Montagna, Cortelli, Fanicello, Iotti, 
Munari,  Pierangeli,  Zaniol  and  Lugarisi,  1992;  Bigal,  Bordini,  Tepper  and 
Speciali,  2002;  Demirkaya,  Vural,  Dora  and  Topçuoğlu,  2001;  Peikert, 
Wilimzig and Köhne-Volland, 1996; Schoenen, 1996; Welch and Ramadam, 
1995; )  
•  Amino  acids  (Rajda,  Tajti,  Komoróczy,  Seres,  Klivényi  and  Vécsei,  1999;  
Martinez, Castillo, Rodriguez, Leira and Noya, 1993; Welch, Barkley, Tepley 
and  Ramadam,  1993;  Garlick,  2004;  Schaumburg,  Byck,  Gerstl  and 
Marshman,  1969;  D’Andrea,  Cananze,  Joseph,  Morra,  Zamberlan,  Milone, 
Grunfeld and Welch, 1991; Cananzi, D’Andrea, Perini, Zamberlan and Welch, 
1995; Ferrari, Odink, Bos, Malessy and Bruyn, 1990) 
•  Calcitonin  gene-related  peptide  (Ashina,  Bendtsen,  Jensen,  Schifter  and 
Olesen, 2000; Goadsby and Edvinsson, 1993; Kawasake, et al, 1988; Lassen, 
Haderslev, Jacobsen, Iversen, Sperling and Olesen, 2002; Moskowitz, 1993; 
Peitrobon, 2005)  
•  Endogenous  opioids  (Anselmi,  Baldi,  Casacci  and  Salmon,  1980;  Bach, 
Jensen, Blegvad, Fenger, Jordal and Olesen, 1985; Baldi, Salmon, Anselmi, 
Spillantini,  Cappelli,  Brocchi  and  Sicuteri,  1982;  Baskin  and  Hosobuchi, 
1981;  Facchinetti,  Nappi,  Savoldi  and  Genazzani,  1981;    Fettes,  Gawel, 
Kuzniak and Edmeads, 1985; ; Mosnaim, Diamond, Wolf, Puente and Freitag, 
1989;  Mosnaim,  Wolf,  Chevesich,  Callaghan  and  Diamond, 1984; Sicuteri, 
1981).   
   41 
These findings are not directly related to the present study; hence their discussion is 
beyond  the  scope  of  this  book.      The  reader  is  instead  directed  to  the  relevant 
bracketed  references  for  more  detailed  debate.    However,  as  physiological  and 
symptomatic  responses  to  stressful  stimuli  are  of  interest  in  the  present  study, 
biochemical aspects of migraine in relation to stress are discussed next.   Stress is 
further  discussed  later  in  this  chapter  in  the  context  of  general  migraine  triggers 
(pages  62-69). 
 
 
 
Stress and biochemical responses 
 
 
        Mitochondria and magnesium 
 
        Various biochemical and metabolic irregularities have been linked with migraine 
(Wang  and  Schoenen,  1998;  Welch  and  Ramadam,  1995).      Reduced  levels  of 
magnesium  in  the  blood  stream  of  migraine  sufferers  are  proposed  to  alter 
mitochondrial  energy  metabolism  (Welch  and  Ramadam,  1995).    Subsequent 
biochemical/metabolic  imbalance  could  culminate  in  a  migraine  attack.  
Mitochondrial  irregularities  may  be  directly  due  to  low  magnesium  caused  by 
systemic  magnesium  deficiency.    Low  systemic  magnesium  may  be  compromised 
further  during  acute stress, leading to additional decreases in systemic magnesium 
levels; thus tipping a threshold resulting in depleted brain magnesium (Welch and 
Ramadam,  1995).        As  procedures  used  in  this  study  were  stressful,  the  stress-
response  may  potentially  have  compromised  magnesium  levels  of  participants  and 
consequently influenced responses at a cellular level. 
        Magnesium is required for the aerobic stages of mitochondrial cell respiration, in 
particular  for  the  synthesis  of  adenosine  triphosphate  (Venes,  2001).    Adenosine 
triphosphate  is  the  main  source  of  cellular  energy  used  for  a  host  of  metabolic 
processes,  including  transmission  of  nociceptive  information  within  dorsal  root 
ganglion  neurons  and  the  spinal  cord  (Hains,  2004).    High  brain  adenosine 
triphosphate concentration was observed in migraine sufferers between attacks, which 
indicates unstable cerebral energy metabolism, most probably a sign of mitochondrial   42 
dysfunction  (Barbirolli,  Montagna,  Cortelli,  Fanicello,  Iotti,  Munari,  Pierangeli, 
Zaniol and Lugarisi, 1992).  Magnesium deficit leads to increased cellular respiration 
and, in turn, decreased mitochondrial energy reserves (Welch and Ramadam, 1995).   
         Disruption of metabolic homeostasis and biochemical shifts are postulated to 
underlie activation of the trigeminovascular system, thus enabling the production of a 
migraine attack (Schoenen, 1996).   Indeed, many migraine sufferers in the present 
thesis developed full-blown attacks following certain procedures (refer to publications 
related  to  book,  Granston  and  Drummond,  2005),  suggesting  activation  of 
trigeminovascular nuclei, possibly secondary to disrupted metabolic processes.  It is 
not certain whether altered mitochondrial function is secondary to decreased brain 
magnesium or a primary fault.  However, Welch and Ramadam (1995) suggest that 
magnesium  deficiency  or  defects  in  mitochondrial  metabolism,  or  both,  may 
predispose the brain to spontaneous spreading depression, or at least its activation by 
migraine triggers. 
          The therapeutic benefits of magnesium supplementation (Bigal, Bordini, Tepper 
and Speciali, 2002; Demirkaya, Vural, Dora and Topçuoğlu, 2001; Peikert, Wilimzig 
and Köhne-Volland, 1996) support the idea that depleted magnesium plays a role in 
the pathogenesis of migraine.  Administration of magnesium sulphate intravenously in 
the  acute  treatment  of  migraine  (Bigal,  Bordini,  Tepper  and  Speciali,  2002; 
Demirkaya, Vural, Dora and Topçuoğlu, 2001), and oral magnesium prophylactically 
(Peikert,  Wilimzig  and  Köhne-Volland,  1996),  alleviates  symptoms  of  migraine 
including aura, head pain, nausea, and phono/photophobia.  
 
 
 
       Endogenous Opioid peptides 
 
         Stress  may  be  associated  with  fluctuating  opioid  levels  observed  during  the 
migraine crisis (Anselmi et al., 1980).  Anselmi et al. noted a decrease in cerebral 
spinal fluid enkephalin levels during migraine attacks and an increase in serum β-
endorphin-like-immunoreactivity at the end of an attack.   Hyperendorphinaemia at 
the end of an attack was thought to reflect the stress provoked by the attack.   As 
stress  has  been  shown  to  induce  pituitary  release  of  β-endorphins  (among  other 
related peptides and hormones), by implication, pituitary β-endorphin may play a role   43 
in resolving migraine headache (a well acknowledged stressful event) and restoring a 
state of well-being. 
       It may be that lowered pain thresholds observed in migraine sufferers (Fernández-
de-las-Peñas,  Cuadrado,  Arendt-Nielsen  and  Pareja,  2008;  Giamberardino,  Tafuri, 
Savini,  Fabrizio,  Affaitati,  Lerza,  Di  lanni,  Lapenna  and  Mezzetti,  2007;  Kowacs, 
Piovesan,  Werneck,  Tatsui,  Lange,  Ribas  and  da  Silva,  2001;  Langemark,  Jensen, 
Jensen  and  Olesen,  1989)  may  be,  at  least  in  part,  due  to  a  failure  of  the  opiate 
receptor system to modulate sensitivity to pain (Mosnaim, Diamond, Wolf, Puente 
and  Freitag,  1989;  Sicuteri,  1981).      In  contrast,  in  schizophrenia,  biochemical 
conditions compared to migraineurs are the reverse: cerebral spinal fluid is rich in 
enkephalins and endorphins.   In these patients the pain threshold is particularly high, 
headache complaints are infrequent and monoamine receptor sensitivity is lowered.   
Hyperendorphinaemia is also seen during pregnancy which may explain the remission 
of  pre-existent  idiopathic  headache,  the  increased  pain  threshold  and  the  euphoric 
mood often reported in women during pregnancy (Anselmi et al., 1980).   
           Dysfunction of opiate receptor sites in the pain pathway of migraine sufferers 
may  predispose  them  to  migraine  (Dowson  and  Cady,  2002;  Lance  and  Goadsby, 
2000).   Endogenous opioid peptides are compounds made up of two or more linked 
amino acids found naturally in the body - in the brain, certain endocrine glands and 
the  gastrointestinal  tract.    They  have  morphine-like  analgesic  properties, 
neurotransmitter and neuromodulator functions, and can influence behaviour (Venes, 
2001), i.e, opioid-induced state of well-being (Anselmi, Baldi, Casacci and Salmon, 
1980).          Opioids  that  are  produced  exclusively  in  the  brain  include  endorphins 
(polypeptides),  enkephalins  (pentapetides)  and  dynorphins.    These  inhibitory 
neurotransmitters interfere with the transmission of pain signals by binding to opiate 
receptor sites, preventing the release of substance P, thereby blocking the perception, 
transmission and sensation of pain (Venes, 2001).   Other chemical substances such as 
gamma-aminobutyric acid cooperate with enkephalin to inhibit the response to pain.   
Enkephalin  and  gamma-aminobutyric  acid  help  guard  the  nervous  system  from 
painful  stimuli  in  accordance  with  information  received  from  nerve  pathways  that 
descend  from  the  midbrain  to  brain  stem  and  spinal  cord.    In  particular,  the 
periaqueductal grey matter as well as the locus coeruleus, located in the brain stem, 
are  important  areas  involved  in  modifying  information  transmitted  through  pain 
pathways.   Descending pain control pathways regulate nociceptive impulses so that   44 
the brain receives inhibitory or excitatory pain information, as required.   The release 
of certain monoamines assists in the mediation of impulses from interneurons in the 
pain  pathway,  particularly  serotonin  from  the  periaqueductal  grey  matter  and 
noradrenaline (also known as norepinephrine) from the locus coeruleus (Lance, 2000).   
           Sicuteri (1981) hypothesized that an opioid receptor hypofunction in migraine 
sufferers accounted for the absence of pain relief observed following morphine during 
a migraine attack, and the weak inhibition of the spasmogenic effect of serotonin on 
the  dorsal  vein  in  the  hand.      However,  scientists  are  not  all  in  agreement  about 
plasma, cerebral spinal fluid or platelet methionine enkephalin and β-endorphin levels 
in migraine during or outside attacks (Anselmi et al., 1980; Bach, Jensen, Blegvad, 
Fenger,  Jordal  and  Olesen,  1985;  Baldi,  Salmon,  Anselmi,  Spillantini,  Cappelli, 
Brocchi and Sicuteri, 1982; Facchinetti, Nappi, Savoldi and Genazzani, 1981;  Fettes, 
Gawel,  Kuzniak  and  Edmeads,  1985;    Mosnaim  et  al.,  1989;  Mosnaim,  Wolf, 
Chevesich, Callaghan and Diamond, 1984).  Bach et al. (1985) reported that plasma 
β-endorphins were comparable during and outside attacks.  In contrast, Baldi et al. 
(1982)  found  that  plasma  β-endorphin  levels  were  lower  during  attacks  compared 
with the headache-free interval, and with controls.  Additionally, plasma β-endorphin 
levels were significantly lower in daily headache sufferers than in controls.   Another 
study (Fettes et al., 1985) found a difference in plasma β-endorphin levels between 
headache  types.    β-endorphin  levels  were  found  to  be  lower  in  classical  migraine 
sufferers than in those with common migraine or chronic daily vascular headache, or 
the control group.  Fettes et al. suggested that low levels of β-endorphin may play a 
role in the manifestation of the neurological dysfunction seen in the migraine aura. 
Interestingly, administration of naloxone, an opioid receptor antagonist used to treat 
addiction to opium-derived drugs (Venes, 2001), has been demonstrated to reverse 
migraine  aura  (Baskin  and  Hosobuchi,  1981)  and  cerebral  ischaemia  (Sicuteri, 
Boccuni,  Fanciullacci  and  Gatto,  1983).    These  findings  suggest  that  high  opioid 
turnover is linked with migraine aura. 
          In the present study, exposure to stressful procedures during the headache-free 
interval most likely influenced physiological (Drummond,  1984, 1985b; Passchier, 
1994;  Peroutka  et  al.,  1997)  and  symptomatic  (Kowacs  et  al,  2001)  responses.   
However,  the  influence  of  stress  on  circulating  opiates  in  migraine  sufferers 
interictally,  and  associated  psychopyhsiological  symptom  development,  was  not 
explored in this book.    Stress is clearly associated with fluctuating opioid levels   45 
during the migraine crisis (Anselmi et al., 1980).  Additionally, lowered opioid levels 
(Fettes  et  al.,  1985),  and  atypical  responses  to  stress  have  been  observed  during 
(Anselmi et al., 1980) and outside of attacks (Fettes et al., 1985).  Perhaps opioid 
receptor sites in migraineurs are also insensitive to opioids released during stressful 
stimuli interictally.  It may be that an exceptionally high level of stress is required to 
boost circulating opioids sufficiently for an impending attack to be aborted.  This may 
be the case where migraine headache follows a period of intense stress (Kohler and 
Haimer, 1990; Levor, Cohen, Naliboff, McArthur and Heuser, 1986).   Once the stress 
passes, opioid stores may drop to baseline levels, no longer sufficient to keep at bay 
the  headache  generated  during  the  stressful  period.    In  contrast  the  reverse  may 
happen during the attack - hyperendorphinaemia as the headache subsides is thought 
to reflect the stress provoked by the attack, which may help to resolve the headache 
(Anselmi et al., 1980).    Persistent dysfunction of opioid receptor sites may, to some 
degree, underlie susceptibility to migraine. 
 
 
 
 
The migraine predisposition, biochemical and metabolic dysfunction, and  stress: 
a synthesis 
 
 
         Genetic,  biochemical  and  mitochondrial  factors  have  been  suggested  to  play 
important roles in the etiology of migraine.  However, irrespective of any proposed 
candidate vying for the origin of migraine, it seems logical that responses to stress 
may variously, at least in part, explain why some individuals are more susceptible to 
developing a migraine attack than others.    Indeed, stress is a commonly reported 
migraine trigger  (Passcheir, 1994; Reynolds and Hovanitz, 2000).  Stress is further 
discussed later in this chapter in the context of general migraine triggers (pages  62-
69). 
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Hormones 
 
       Fifty  to  68  percent  of  women  migraineurs  experience  attacks  associated  with 
menstruation (Dzoljic, Sipetic, Vlajinac, Marinkovic, Brzakovic, Pokrajac and Kostic, 
2002; Lance and Goadsby, 2000; MacGregor, 1999; Zacur, 2006), which suggests 
that  hormonal factors may underlie the disorder.   Additionally, the predominance of 
female  migraine sufferers compared to male (3:1) (Kemper, 2006), further implicates 
female  hormones,  at  least  in  part,  in  the  etiology  of migraine (Rasmussen, 1995).    
Female participants in the present study were tested between menstruation and outside 
the premenstrual phase, to minimize any hormonal influences. 
       The  female  life cycle involves a sequence of hormonal milestones: menarche, 
peri-menopause and menopause.  Also, pregnancy, lactation, contraceptive use and 
the use of replacement sex hormones may be met in the course of the female lifespan 
(Fettes, 1999; Lipton, Stewart, Diamond, Diamond and Reed, 2001; Sances, Granella, 
Nappi,  Fignon,  Ghiotto,  Polatti  and  Nappi,  2003;  Silberstein  and  Merriam,  1999, 
2000;  Zacur,  2006).      Cyclic  sex  hormone  production  over  the  female  life  span, 
including at different stages of the menstrual cycle, affects the clinical expression of 
migraine (Herzog, 2007; Loder, Rizzoli and Golub, 2007; MacGregor, Chia, Vohrah 
and Wilkinson, 1990; Martin, Wernke, Mandell, Ramadan, Kao, Bean, Liu, Zoma and 
Rebar, 2005; Newman, 2007).     
        A  sudden  decline  in  oestrogen  and  progesterone  levels  marks  the  onset  of 
menstruation,  the  most  vulnerable  time  for  a  migraine  attack  to  develop.      Some 
individuals are prone to migraine attacks mid-cycle (at ovulation), which is similarly 
marked by a sudden decline in oestrogen levels.   The drop in oestrogen mid-cycle is 
followed by rapid restoration during the luteal phase in conjunction with an increase 
in  progesterone  levels  (Silberstein  and  Merriam,  1999,  2000;  Zacur,  2006).    One 
migraine sufferer in the present study reported that in addition to premenstrual and 
menstrual migraine, an attack was also more likely at ovulation.  Accordingly, this 
participant was tested during less vulnerable times of her cycle.    
        Studies confirm that hormone levels during the menstrual cycle in women who 
suffer menstrual migraine are comparable to those of controls (MacGregor, 1999).  
Evidently,  migraineurs  are  more  sensitive  to  the  effects  of  normal  hormonal 
fluctuations (Dzoljic et al., 2002; MacGregor, 1999).       47 
       Ovarian  hormones  have  a  major  effect  on  the  central  nervous  system  and 
modulate  several  neurotransmitter  systems  including  serotonergic,  glutamatergic, 
gamma-aminobutyric acid (GABA)ergic; and opiatergic (Herzog, 2007; Martin and 
Behbehani, 2006a; Silberstein and Martin, 2000; Veith, Anderson, Slade, Thompson, 
Laugel and Getzlaf, 1984).  All of these systems play a role in the pathophysiology of 
migraine headache, particularly in the pain modulation of this disorder (Herzog, 2007; 
Martin and Behbehani, 2006a; Silberstein and Martin, 2000).  The risk for migraine 
headache  during  different  phases  of  the  menstrual  cycle  may  therefore  be  due  to 
changes in the balance of neurotransmitter systems (Martin and Behbehani, 2006a).  
         However, sex hormones may only be one of several factors acting together to 
trigger migraine in susceptible women (Gupta, 2004; Martin and Behbehani, 2006b; 
Zacur, 2006), or merely circumstantial (Gupta, 1994).   Indeed, menstrual migraine is 
more likely to occur when hormonal triggers co-occur with other triggers, e.g., missed 
meals, physical or emotional stress, late nights (MacGregor, 1999).   Nevertheless, in 
order to control for a possibly confounding variable, participants in this study were 
not  tested  during  those  times  of  the  menstrual  cycle  when  they  were  considered 
vulnerable to developing an attack.  
 
 
 
 
The association  between gastrointestinal disturbances  and migraine 
 
 
 
      Early signs of gastrointestinal hypersensitivity  
 
      Eighty-two  percent  of  children  identified  as  having  cyclic  vomiting  syndrome 
manifest  symptoms  typical  of  migraine.    Interestingly,  in  children  susceptible  to 
migraine-associated  cyclic  vomiting,  motion  sickness  was  more  likely  to  trigger 
vomiting/migrainous symptoms than in children with non-migraine cyclic vomiting - 
10% vs 0% (Li, Murray, Heitlinger, Robbins and Hayes, 1999).   Longitudinal studies 
found that children with a history of recurrent vomiting of unknown causes were at   48 
increased risk of migraine in adulthood.   Furthermore, children with a history of 
motion sickness, migraine/family history of migraine, were more likely to vomit after 
mild  head  injury  (Jan,  1998;  Jan,  Camfield,  Gordon  and  Camfield,  1997).    The 
overlap  between  vomiting/migraine/motion  sickness  seen  in  childhood  suggests 
hypersensitive gastrointestinal responses from an early age in vulnerable individuals.  
Perhaps  these  overlapping  signs  of  vulnerability  may  be  associated  with  inherited 
factors given that a family history of migraine is common in children prone to cyclic 
vomiting or vomiting after mild head injury.  
 
 
 
 
The association  between motion sickness and migraine  
 
 
         Motion  sickness  is  associated  with  migraine  in  children  (Barabas,  Schempp 
Matthews and Ferrari, 1983; Jan, 1998) and adults (Cutre and Baloh, 1992; Kuritzky, 
Ziegler and Hassanein, 1981).   Most migraine sufferers (about two-thirds) are prone 
to  motion  sickness  (Baloh,  1997).    Genetic  factors  may  underlie  the  tendency  to 
motion  sickness  (Reavley,  Golding,  Cherkas,  Spector,  MacGregor,  2006),  just  as 
neuro-otological  symptoms  common  to  migraine,  have  been  linked  to  possible 
candidate genes (Baloh, 1997).   
          Bijveld, Bronstein, Golding and Gresty (2008) found that subjects exposed to 
visual motion while stationary developed headache more frequently than during off-
vertical axis rotation with their eyes open or closed.  Bijveld and colleagues suggested 
that mechanisms responsible for headache during visual motion alone may be similar 
to those of migraine. 
       Females are generally more prone to motion sickness (Golding, 2006; Grunfeld 
and  Gresty,  1999),  and  are  especially  vulnerable  during  menstruation  (Golding, 
Kadzere and Gresty 2005).  Curiously, female predominance also applies to migraine 
(Celic, Ekuklu, Tokuc and Utku, 2005; Rasmussen, 1995; Lipton, Stewart, Diamond, 
Diamond,  and  Reed,  2001).        Grunfeld  and  Gresty  (1999)  found  an  association 
between  these  female  weighted  maladies.      Female  yacht  crew  members  who   49 
experienced  migraine  reported  greater  susceptiblity  to  motion  sickness  than  other 
crew members.   Additionally, motion sickness and headache peaked during ovulatory 
or menstrual phases of the menstrual cycle, though migraine and motion sickness did 
not  always  occur  together.      Grunfeld  and  Gresty  commented  that  as  symptoms 
common to both of these disorders are remarkably similar, it is conceivable that some 
subjects may not have distinguished their symptoms.     
        Female sex hormones may, at least in part, predispose the susceptible individual 
to  motion  sickness (Golding, 2006) and migraine (Rasmussen, 1995).   Hormonal 
influences in relation to migraine susceptibility were discussed earlier (pages 46-47).    
With respect to motion sickness, susceptibility onset commonly occurs in childhood 
around age seven.  The appearance of motion sickness prior to puberty implies that 
sex  hormones  alone  are  not  an  explanation  for  the  onset  of  the  disorder.   
Additionally,  susceptibility  to  motion  sickness  gradually  declines  into  adulthood, 
which may indicate habituation to the ill-effects of motion over time (Golding, 2006).   
        Most  individuals  would  probably  find  the  disconcerting  nature  of  motion 
sickness  a  stressful  experience.      Therefore,  as  Graaf  and  Gresty  (1998)  propose, 
stress  and  motion  sickness  may  go  hand  in  hand.    Stress  may  influence  the 
neurochemistry  of  motion  sickness,  and  contribute  to  aspects  of  individual 
susceptibility  to  motion  sickness.    Stress  is  also  a  well-acknowledged  trigger  of 
migraine.  
 
 
 
         Vestibular instability 
 
 
          The essential mediator for motion sickness is the vestibular apparatus.  This is 
indisputable,  at least with respect to movement induced motion sickness, as animals 
and  humans  who  have  no  functional  vestibular  apparatus  do  not  develop  motion 
sickness during rotation or when placed in unusual forced environments associated 
with  the  exploration  of  space  (Crampton,  1990;  Igarashi,  1990;  Money,  1990).  
Movement-induced  motion  (boat/plane/car  travel)  or  visually-induced  perceived 
motion  (optokinetic  stimulation,  wide-screen  movies)  that  is  incompatible  with 
proprioceptive and vestibular cues (Drummond, 2005) stimulates central mechanisms   50 
that induce symptoms of motion sickness.   It may be that motion sickness is warning 
the body of the potential threat to homeostasis.  The conflicting central sensory input 
evokes  physiological  disturbances  and,  as  a  precaution,  nausea/vomiting  occurs  to 
expel potential toxins/poisons from the system; in much the same way as vomiting is 
triggered following absorbed toxins.   This ‘conflict theory of motion sickness’ is 
consistent  with  Treisman’s  theory  of  conflicting  sensory  inputs  leading  to  central 
disturbance (Money, 1990). 
       Migraine and motion sickness share many common symptoms including nausea, 
tiredness, dizziness, body temperature changes and headache (Marcus, Furman and 
Baleban, 2005).   The presence of otoneurologic symptoms indicates activation of 
vestibular pathways.  Dizziness and vertigo often accompany migraine attacks (von 
Brevern,  Zeise,  Neuhauser,  Clarke  and  Lempert,  2005;  Cutrer  and  Baloh,  1992; 
Lance, 2000) and are frequently reported during the headache-free interval (Kuritzy, 
Ziegler and Hassanein, 1981).   A quarter of migraine sufferers experience episodes of 
vertigo.   Additionally, phonophobia, the most common auditory symptom reported 
during attacks, sometimes involves fluctuating or permanent hearing deficits (Baloh, 
1997).        
        Baloh proposed that a possible inherited mechanism, similar to that discovered in 
rare  forms  of  migraine,  may  also  account  for  otoneurologic  symptoms  that  are 
experienced in the more common varieties of migraine, i.e., migraine with/without 
aura.   Defective calcium channel genes and subunits have been isolated in familial 
hemiplegic  migraine  (Baloh,  1997;  Gardner,  1999,  2006;  Larkin,  1997;  Peroutka, 
Wilhoit and Jones, 1997) and in families with episodic vertigo and ataxia (Baloh, 
1997).    In the case of the common varieties of migraine, auditory and vestibular 
symptoms  may  also  be  related  to  a  defective  calcium  (ion)  channel,  primarily 
expressed in the brain and inner ear. This defect could lead to reversible hair cell 
depolarization  (following  calcium/potassium  displacement)  and,  in  turn,  the 
otoneurologic symptoms experienced during, and outside, attacks.   Perhaps genetic 
factors also underlie predisposition to motion sickness.   
        As  motion  sickness  and  migraine  appear  to  share  common  pathways,  the 
initiation  of  one  malady  may  necessarily  trigger  the  other  -  motion  sickness  or 
migraine – as a direct result of closely interconnected neural pathways that express 
either condition. 
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Vascular reactivity during and between attacks 
 
     Signs of intra- and extracranial vascular instability have been observed in migraine 
sufferers  during  and  between  attacks  (Drummond,  1982a).    Headache  sufferers 
reported symptoms of vascular pulsatililty in the temples during stress (excitement or 
emotional  upset)    and  othostatic  symptoms  (dizziness,  flashing  lights,  black  spots 
before the eyes on standing), which increased relative to the number of migrainous 
symptoms associated with headache.  Drummond suggested that othostatic symptoms 
may be related to poor circulatory regulation in the intracranial blood vessels of the 
brainstem  during  changes  of  posture.   The sensation of throbbing of the temples 
during stress (Drummond and Lance, 1981; Drummond, 1982b) and during migraine 
attacks (Drummond, 1983) may be a sign of extracranial vascular distention.  The 
present  study  explored  extracranial  vascular  responses  in  migraine  sufferers 
interictally to a series of stressful stimuli.  It was anticipated that findings may further 
clarify the role that the vasculature plays in those predisposed to migraine. 
         In  a  later  experiment  Drummond  and  Lance  (1984b)  assessed  extracranial 
changes  thermographically  in  relation  to  headache  intensity,  in  response  to  the 
application  of pressure over the superficial temporal and common carotid arteries.  
Heat loss was mostly observed on the affected side during attacks with unilateral pain, 
particularly  in  cases  where  pressure  to  the  temporal  vessel  was  associated  with 
temporary  pain  relief.    Asymmetric  thermographic  differences  subsided  as  the 
headache  improved.      However,  many  migrainous-like  headaches  displayed  no 
vascular component thermographically, or responded to vascular compression.  In fact 
responses to vascular compression were inconsistent  from one headache to the next 
in  the  same  individual.    It  appeared,  at  best,  that  extracranial  vascular  changes 
happened  erratically  depending  on  the  severity  of  pain  and  other  associated 
migrainous features present during an attack.   
        A cerebral vasodilator response was provoked in migraine sufferers in response 
to 5% CO2   inhalation but not in controls (Sakai and Meyer, 1979).  Furthermore, 
cerebral  blood  flow  showed  greater  responsiveness  to  CO2  in  the  hemisphere 
corresponding to the usual side of head pain during an attack than the non-headache   52 
hemisphere.  Sakai and Meyer suggest that the asymmetry of the vascular response 
may  indicate  different  types  of  abnormality  in  cerebrovascular  receptor  sites; 
therefore, one region of the brain may be more disordered than another. 
        Overall,  this  series  of  studies  indicates  that  intra-and  extracranial  vascular 
instability  is  evident  in  migraine  sufferers  during  and  outside  attacks.      Migraine 
headache is attributed to neurovascular mechanisms (Edvinsson and Uddman, 2005; 
Moskowitz, 1993).   Thus, it is conceivable that the increased vascular reactivity also 
observed  outside  attacks  in  migraine  sufferers  (Drummond,  1982)  may  render  the 
susceptible individual vulnerable to recurring attacks.   Perhaps, a low threshold to 
triggers,  such  as  excess  stress  (Drummond,  1981;  Drummond,  1982b;  Hassinger, 
Semenchuk and O’Brien, 1999), potentiates neurovascular mechanisms involved in 
the development of migraine headache. 
 
 
Sensory hyperacuitity 
 
         Symptoms typically experienced during migraine headache, and to some extent 
between  attacks,  such  as  phono/photophobia,  nausea,  hyperalgesia  and  dizziness, 
demonstrate activation of the somatosensory system.  Four different types of sensation 
are encoded by the somatosensory system (Waxman, 2003): 
 
i       superficial - touch, pain 
ii       deep  - muscle/joint position (proprioception), deep muscle pain    
iii      visceral - hunger, thirst, nausea, visceral pain  
iv       special - smell, vision, hearing, taste, and balance  
   
Symptoms of migraine, per se, suggest that each of these sensations is involved in 
attacks.   Sensory irregularities also occur in the headache-free interval.   The present 
study compared symptomatic responses of migraine sufferers interictally to healthy 
controls, in relation to a series of stressful sensory stimuli.  It was anticipated that 
findings  might  further  clarify  the  extent  to  which  sensory  hyperacuity  in  those 
predisposed to migraine may render them vulnerable to attacks.    53 
       Studies  of  evoked  and  event-related  potentials  (visual,  auditory,  cortical, 
olfactory  and  trigeminal)  suggest  interictal  brain  abnormalities  (Gantenbein  and 
Sándor,  2006;  Aurora,  Cao,  Bowyer  and  Welch,  1999;  Auror,  Ahmad,  Welch, 
Bhardhwaj and Ramadan, 1998; Wray, Mijovic-Prelec and  Kosslyn, 1995; Dahlem 
and Podoll, 2007; Evers, Quibeldey, Grotemeyer, Suhr and Husstedt, 1999; Grosser, 
Oelkers, Hummei, Geisslinger, Brune, Kobal and Lıtsch, 2000; Judit, Sándor. and 
Schoenen,  2000;  Schoenen,  1996;  Siniatchkin,  Gerber,  Kropp,  Voznesenskaya  and 
Vein, 2000; Wang and Schoenen, 1998); while somatosensory evoked potentials have 
demonstrated delayed latency and nerve conduction velocity, particularly along the 
arm,  compared  to  tension  headache  sufferers  (Montagna,  Zucconi,  Zappia  and 
Liguori, 1985).   Perhaps the slow nerve conduction detected by somatosensory tests 
is a signal that neurotransmission/ neuromodulation (Firenze, Del Gatto, Mazzotta and 
Gallai,  1988)  is  generally  compromised  in  individuals  prone  to  migraine;  thus, 
increasing  susceptibility  to  migraine.    It  has  been  suggested  that  trigeminal 
somatosensory  evoked  potentials  may  provide  important  information  about  the 
functional integrity of trigeminal sensory pathways from the peripheral nerve up to, 
and  including,  the  sensory  cortex  during  and  outside  attacks  (van  Vliet,  Vein,  le 
Cessie, Ferrari and van Dijk, 2002).    Superficial, deep and visceral sensations in 
migraine sufferers are discussed in detail in the general discussion later in this book.  
The special senses are discussed next.   
       The special senses are conveyed by cranial nerves, and almost all cranial nerve 
nuclei are situated in the brain stem (Waxman, 2003), an area of focal activity  in the 
development of migraine attacks (Weiller, May, Limmroth, Juptner, Schayck, Coenen 
and Diener, 1995).    Migraine sufferers commonly experience exaggerated sensitivity 
to even innocuous sensory stimulation during attacks (Goadsby, 2001).   Heightened 
sensitivity to light, sound, smell (Lance and Goadsby, 2000), balance (Kuritzy et al., 
1981), and to some extent, taste (Debney, 1984) have been documented.   Up to 80% 
of migraineurs find light and sound uncomfortable (Lance and Goadsby, 2000; Kayan 
and  Hood,  1984).    Additionally,  sense  of  smell  is  frequently  sharper  at  this  time 
(Kayan and Hood, 1984; Snyder and Drummond, 1997).   
         During the interictal period hypersensitivity of the special senses may persist.   
Migraine  sufferers  are  more  sensitive  to  light  between  attacks  than  controls 
(Drummond,  1986;  Main,  Dowson  and  Cady,  1997;  Woodhouse  and  Drummond, 
1993; Vanagaite, Pareja, Støren, White, Sanc and Stovner, 1997), particularly to glare   54 
following exposure to dull and bright light (Drummond, 1986).   Headache sufferers 
also  report  that  bright  light  is  painful.  Drummond  concluded  that  glare  probably 
demonstrates a general hypersensitivity of the special senses in migraine sufferers.   
Exposure to bright light seems to exacerbate pain during an attack, possibly due to 
trigeminal pain pathway activation.   The pain of migraine may be more to do with the 
abnormal  perception  of  the  normal  rather  than  the  activation  of  pain  processing 
pathways in the usual way that pain is generated, e.g. photophobia is the exaggeration 
of  normal  light  and  phonophobia  the  exaggeration  of  normal  sound,  by  the  brain 
(Goadsby, 2001).     
        Main  et  al.  (1997)  found  that  phonophobia  also  persisted  interictally.    This 
finding was in contrast to Woodhouse and Drummond (1993), who discovered that 
while the auditory discomfort threshold was lower during headache, interictally it did 
not differ from healthy controls.  Main et al. (1997) suggested that the discrepancy 
between these studies was probably due to the larger sample size in their study.      
         Contradictory findings have similarly been reported in olfaction of migraineurs 
between attacks.  Snyder and Drummond (1997) found that olfactory thresholds to 
vanillin  were  lower  than  in  contols.    This  hyperosmia  also  applied  to  acetone 
thresholds - particularly in the case of migraineurs usually hypersensitive to odours 
during attacks.   In contrast, Hirsch (1992) found that 18% of migraine sufferers, 
when given pyridine odour threshold tests, were hyposmic or anosmic.  In contrast, 
only 1% of the population of the United States is hyposmic or anosmic.  Snyder and 
Drummond  (1997)  suggested  that  the  difference  in  findings  between  these  studies 
may have been due to the lack of standardized controls, adaptation, and the use of a 
trigeminal rather than olfactory stimulus, in Hirsch’s (1992) study.   
     Light, sound and smell have been reported to trigger attacks in some individuals 
(Blau and Solomon, 1985; Debney, 1984; Scharff, Turk and Marcus, 1995).   Indeed, 
provocative  visual  stimuli  during  the  headache-free  interval  induced  subsequent 
headache  in  migraine  sufferers  (Aurora  et  al.,  1999;  Cao,  Welch,  Aurora  and 
Vikingstad, 1999).    
        Collectively, these studies imply that the headache-free interval in migraineurs 
appears to be a vulnerable time.  Hyperacuity of the special senses appears to persist 
between attacks, which may increase susceptibility to migraine.    
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Hyperalgesia 
 
 
       Normal pain vs migraine pain 
 
        Under normal circumstances pain serves a functional purpose.  Primarily, the 
somatosensory  system  guards  against  any  overt  threat  impinging  on  the  body 
(Waxman,  2003).    However,  migraine  pain  is  felt  spontaneously  rather  than 
functionally,  which  suggests  that  the  pain-control  system  is  not  working  as  it 
predictably should (Lance, 2000; Woolf, 2004). 
      Nociceptive  pain  alerts  the  body  to  potentially  damaging  sensory  stimuli.   
Nociception involves the ‘transduction’ of information received from the periphery, in 
the form of electrical activity from primary afferents, to the central nervous system.  
This information is then sent to the central nervous system by a process referred to as 
‘conduction’    (Woolf,  2004).    Electrical  messages  conducted  via  nerve  fibres 
converge  on  nerve  cells,  which  then  chemically  transmit  the  message,  i.e., 
neurotransmission  (Lance,  2000).      Following  this,  information  is  carried  from 
primary  sensory  neurons  to  central  projection  neurons  by  a  process  known  as 
‘transmission’  (Woolf,  2004).    Finally,  information  is  transferred  to  the  cerebral 
cortex, which is responsible for pain perception, and so the sensory experience of pain 
transpires (Lance, 2000; Woolf, 2004).   Impulses then descend from the pain control 
pathways in the midbrain (the periaqueductal grey matter and locus coeruleus), and 
brain stem to the spinal cord.  Pain control pathways regulate the transmission of pain 
via the release of various chemical messengers (Lance, 2000).    
         In cases where early warning nociceptive pain is overwhelmed, such as during 
acute  severe  pain/trauma,  an  inflammatory  response  ensues.    A  feature  of 
inflammatory pain is hypersensitivity to innocuous stimuli due to the production of 
inflammatory  mediators  that  alter  the  properties  of  high-threshold  primary-sensory 
neurons.    Inflammatory  pain  is  associated  with  peripheral  sensitization,  which 
involves changes in the chemical properties and function of neurons in the nervous 
system.   Peripheral sensitization leads to an increase in the excitability of neurons 
within  the  central  nervous  system;  hence,  central  sensitization  results.  Some   56 
pathological conditions, such as rheumatoid arthritis, are associated with severe pain 
and ongoing inflammation   (Woolf, 2004). 
       The  present  study  investigated  vascular  and  symptomatic  responses  associated 
with pain processing in migraine sufferers.   Migraineurs were exposed to painful 
stimulation of the head (trigeminal sensitivity) and limb (general pain processing) in a 
series of experimental conditions.      
        Pain processing in migraine sufferers during and outside attacks are discussed 
next.   Following this pain thresholds in migraine sufferers are considered. 
 
 
       Ictal pain 
 
 
       Woolf (2004) classifies migraine pain as a very distinct category of pain, which 
has  features  that  resemble  inflammatory  pain.  Certainly,  inflammatory  mediators 
(Moskowitz, 1993) within the cortex appear to act on meningeal sensory fibres.   A 
key mechanism operating in the manifestation of migraine pain appears to involve 
changes  in  sensory  terminals  that  innervate  blood  vessels  in  the  meninges 
(Moskowitz, 1993; Woolf, 2004).   It is suggested that migraine headache is initiated 
following  activation  of  peripheral  sensory  fibers  which  appear  to  innervate 
intracranial  blood  vessels  and  the  dura;  activation  of  descending  pathways  that 
facilitate  processing  of  pain  impulses  by  spinal  cord  neurons;  and  restraint  of 
descending pathways that inhibit processing of these pain impulses in the spinal cord  
(Burstein,  2001).  Vasodilatation  and  scalp  muscle  contraction  are  commonly 
associated with migraine headache; these mechanisms do not cause pain in headache-
free controls (Sicuteri, 1981b).   Another process operating in migraine pain appears 
to  be  the  alteration  of  excitability  of  central  pain  processing  neurons  and  the 
development of central sensitization (Burstein, 2001; Woolf, 2004).   
        Woolf distinguishes migraine from functional pain syndromes such as tension-
type headache and fibromyalgia, which similarly have features of inflammatory pain.  
However, functional pain syndromes also have characteristics of neuropathic pain, 
which  have  underlying  physiological  mechanisms  that  generate  pain,  e.g.,  the 
compression  of  the  median  nerve  in  carpal  tunnel  syndrome.    With  respect  to   57 
migraine,  there  is  typically  an  absence  of  organic  lesions  in  pain-affected  areas 
(Sicuteri, 1981b).  
        Despite  the  difference  between  functional  syndromes  and  migraine,  certain 
features are common to both - specifically, the involvement of altered sensitivity of 
the pain system: central sensitization, hyperexcitability of somatosensory pathways, 
and also altered modulation of nociceptive discharge (Woolf, 2004). 
 
 
       Interictal pain 
 
       Hypersensitivity to painful stimuli has also been observed in migraine sufferers 
during  the  headache-free  interval  (Drummond,  2002;  Drummond,  1987;  Kowacs, 
Piovesan, Werneck, Tatsui, Lange, Ribas and da Silva, 2001).   Drummond (1987) 
found  that  migraine  sufferers  who  experienced  frequent  headaches  reported  that 
tenderness of the forehead and temples persisted interictally; raising the question of 
whether  scalp  tenderness  might  somehow  be  linked  to  susceptibility  to  recurring 
attacks.   More recently, Drummond (2002) found that scalp tenderness developed 
during  optokinetic  stimulation-induced  motion  sickness,  particularly  in  the  most 
nauseated subjects.  Furthermore, migraine sufferers were more prone to nausea than 
healthy controls.   Additionally, pain in the fingertips increased more so in migraine 
sufferers  than  controls,  after  optokinetic  stimulation.    Based  on  these  findings 
Drummond proposed that brain stem disturbances responsible for nausea may also 
sensitize central trigeminal nociceptive nuclei.  Alternatively, inhibitory controls on 
the discharge of trigeminal neurons may be lost.   The tendency to develop nausea, 
and  for  sensitization  to  develop  in  pain  pathways,  may  increase  an  individual’s 
susceptibility to migraine (Drummond, 2002).    
        Lance and Goadsby (2000) suggested that hypersensitivity of the face and scalp, 
commonly observed in migraine sufferers, may involve mechanisms similar to those 
responsible for the increased acuity of the special senses.   Kowacs et al. (2001) found 
that  pain  perception  thresholds  in  migraine  sufferers  interictally,  measured  by 
pressure algometries to a series of trigeminal and cervical sites, persistently dropped 
following  exposure  to  progressively  intense  light  stimulation.      Controls  tolerated 
procedures.      Kowacs  et  al.  concluded  that  light  might  influence  trigeminal  and 
cervical pain tolerance thresholds in migraineurs.  Conversely, light pain increased   58 
following  painful  stimulation  of  the  forehead  and  face  in  migraine  sufferers 
interictally  (Drummond,  1997; Drummond and Woodhouse, 1993), suggesting that 
pain  and  visual  pathways  may  be  functionally  interconnected.      Perhaps  then, 
headache  and  photophobia  increase  and  compound  one  another  during  an  attack 
(Drummond, 1997).         
           Elsewhere,  the  association  between  muscle  contraction  and  hyperalgesia  in 
migraine  has  been  explored  during  and  between  headaches  (Bakal  and  Kaganov, 
1977; Tfelt-Hansen, Lous and Olesen, 1981).   Electromyogram activity in frontal and 
neck muscles was greater in migraine sufferers during and outside attacks compared 
to  controls  and  tension  headache  sufferers.    Perhaps  these  findings  indicate  that 
muscle contraction mechanisms are linked to predisposition to migraine (Bakal and 
Kaganov, 1977), at least in part. 
 
 
 
     Altered pain thresholds in migraine sufferers 
 
 
      Trigeminal  pain  pathways  (Goadsby,  Lipton  and  Ferrari,  2002)  and  pericranial 
musculature  (Drummond,  1987;  Giamberardino,  Tafuri,  Savini,  Fabrizio,  Affaitati, 
Lerza,  Di  lanni,  Lapenna  and  Mezzetti,  2007;  Fernández-de-las-Peñas,  Cuadrado, 
Arendt-Nielsen  and  Pareja,  2008)  are  particularly  sensitive  in  migraine  sufferers.    
Migraine  sufferers,  interictally,  were  found  to  have  lower  pain  thresholds  in 
pericranial musculature than controls, in response to mechanical (Drummond, 1987; 
Fernández-de-las-Peñas et al., 2008), heat (Langemark, Jensen, Jensen and Olesen, 
1989)  and  electrical  (Giamberardino  et  al.,  2007)  stimulation.      Pain  perception 
thresholds distant from the head were also observed to be lower in migraine sufferers 
interictally than in controls (Nicloldi, Sicuteri, Coppola, Greco, Pietrini and Sicuteri, 
1994).    Over-distension of the hand-forearm veins following pressure-cuff inflation 
induced  more  local  pain  in  migraine  sufferers  than  controls.    Also,  injection  of 
hypertonic saline into the anticubital vein during restricted circulation (ischemia) from 
pressure-cuff  inflation  to  the  arm,  provoked  moderate  to  unbearable  local  pain  in 
migraineurs but not in controls (Nicloldi et al., 1994).    59 
        Research  elsewhere  (Göbel,  Weigle,  Kropp  and  Soyka,  1992;  Metsahonkala, 
Anttila,  Laimi,  Aromaa,  Helenius,  Mikkelsson,  Jäppilä,  Viander,  Siianpää  and 
Salminen,  2006)  has  not  detected  lowered  pain  perception  in  migraine  sufferers.  
Göbel  et  al.  (1992)  found  that  pericranial  pain  sensitivity  in  migraineurs,  tension 
headache  sufferers  and  healthy  controls,  was  generally  comparable  in  response  to 
mechanical  pressure  -  although  migraine  and  tension-headache  sufferers  tended  to 
have  lower  thresholds  than  controls.      Furthermore,  Göbel  et  al.  found  that 
electromyogenic (EMG) activity increased in all three groups following experimental 
pain.      Scores  were  significantly  higher  in  tension  headache  sufferers  than  in 
migraineurs at high experimental pain levels.  It was suggested that increases in EMG 
scores may have been partly due to facial movement, possibly reflecting an emotional 
reaction  to  pain  induction  procedures.    Indeed,  psychophysiological  stressors  have 
provoked increased muscular activity in both muscle contraction headache sufferers 
and migraineurs (Bakal and Kaganov, 1977;  Feuerstein, Bush and Corbisiero, 1982).  
However, in Göbel’s study, psychological measures did not differ between individuals 
within  groups  with  lower  or  higher  pain  sensitivity  scores,  implying  that  motor 
components  of  pain,  rather  than  affective  components,  were  responsible  for 
differences in EMG scores.       
       Metshonkala et al. (2006) also found that interictal extracephalic pain perception 
thresholds did not differ between children with migraine or episodic tension headache.  
However,  children  with  migraine  reported  more  non-headache  pains  (gastric  and 
limb) than those children with episodic tension headache.  
        Drummond (1986) found that migraine sufferers experienced more light-induced 
pain and glare in the headache-free interval than controls.  Based on these findings 
Drummond suggested that the threshold to stimulation of the special senses is lower 
in  migraineurs,  perhaps  due  to  poor  inhibitory  controls.      In  a  later  experiment 
(Drummond  and  Woodhouse,  1993),  painful  stimulation  of  the  forehead  increased 
glare  and  photophobia  in  migraineurs  between  headaches.    Drummond  and 
Woodhouse (1993) suggested that migraine-related glare may reflect hyperexcitable 
visual afferences, and that migraine-related photophobia may be due to activation of 
trigeminal pathways.   This notion is consistent with Vanagaite, Pareja, Støren, White, 
Sand and Stovner’s (1997) suggestion that visual and trigeminal neural pathways may 
converge at the thalamus.  Alternatively, attenuation of inhibitory mechanisms may 
account for atypical responses (Drummond, 1986).    Furthermore, while migraine   60 
sufferers display lower thresholds to light than controls do, visual discomfort in both 
groups  diminishes  with  repeated  stimulation  -  perhaps  demonstrating  a  general 
adaptation to light or ‘central fatigue’ in response to previous stimuli (Vangaite et al., 
1997).  
       Kowacs, Piovesan, Werneck, Tatsui, Lange, Ribas and da Silva (2001) explored 
the  influence  of  light  on  trigeminal  and  cervical  pain  thresholds.      Pressure 
algometries  were  performed  on  the  supraorbital,  infraorbital,  mental  and  occipital 
nerves,  and  temporal  muscles.    Response  to  progressively  uncomfortable  light 
stimulation was compared  immediately after, then ten minutes following the second 
algometric  procedure.      Pain  perception  thresholds  were  observed  to  consistently 
diminish (similar to Vanagaite’s 1997 findings for visual discomfort) at all sites in 
migraineurs;  however,  a  slight  but  non-significant  increase  in  pain  perception 
thresholds  was  observed  over  muscle  sites  ten  minutes  following  the  second 
algometric procedure.   Kowac’s findings suggest that light influenced both trigeminal 
and  cervical  pain  thresholds  -  further  implying  that  there  is  an  interplay  or 
convergence of visual afferences (sensory circuits) on trigeminal (Vanagaite et al., 
1997), as well as cervical nociception.  
       Interestingly, pain sensitivity of the pericranial musculature was not only found to 
vary over the course of the day in pain-free volunteers, but women were twice as 
sensitive as men to painful stimuli (Göbel and Cordes, 1990).   Göbel and Cordes 
applied  varying  pressure  over  the  superficial  temporal  and  occipital  vessels  of  
participants by inflating a cuff around the head at 0200, 0600, 1000, 1400, 1800 and 
2200 hours.  Diurnal differences in pain sensitivity were not detected at low levels of 
pain intensity.  However, at high levels of pain, sensitivity was greatest at 0200 hours.   
Given  the  female  preponderance  in  migraine  (Rasmussen,  1995),    and  that  many 
migraineurs awaken with headache in the morning (Linde, 2006; Linde et al., 2006),  
Göbel  and  Cordes’  (1990)  findings  may  be  relevant  in  understanding  migraine 
pathophysiology.  
       While hereditary factors have not been conclusively linked with pain sensitivity, 
Norbury,  MacGregor,  Urwin,  Spector  and  McMahon  (2007)  found  that  pain 
sensitivity may indeed have a genetic component.   Ninety-eight healthy pairs of twins 
(51 monozygotic, 47 dizygotic) were exposed to thermal, mechanical and chemical 
pain-producing stimuli.   Sensory scores were then compared using structural equation 
modeling to provide an estimate of heritability between monozygotic and dizygotic   61 
pairs.   Responses to the majority of pain-producing stimuli showed strong genetic 
components  (22  -  55%).    Norbury  et  al.  concluded  that  genetic  factors  may  be 
important, at least in determining human experimental pain sensitivity.   Moreover, as 
pain  sensitivity  has  been  associated  with  pathological  pain,    genetic  factors,  with 
respect to pain sensitivity, may underlie clinical pain states (Norbury et al., 2007) 
including migraine headache. 
         This  research  compared  pain  processing  in  migraine sufferers, interictally, in 
response to painful stimulation of the head and limb.   The aim was to determine the 
extent of sensitivity of pain pathways in this vulnerable group, and to clarify the roles 
of  trigeminal  and  general  pain  mechanisms  in  the  recruitment  of  vascular  and 
symptomatic responses.        
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Precipitating factors  
 
 
 
Triggers in general 
 
        Migraine triggers (or precipitants) are factors alleged to induce headache attacks 
in  predisposed  individuals;  distinct  from  predisposing  factors,  regarded  as 
constitutional, initiating or causal agents (Rasmussen, 1995).   Numerous migraine 
precipitants have been reported (Dowson and Cady, 2002; Lance and Goadsby, 2000; 
MacGregor, 1999; Perkins and Hartje, 1983; Sandler, Li, Jarrett and Glover, 1995; 
Seltzer, 1982; Weiss, Stern and Goldberg, 1991) including:  
 
•  stress/emotional  triggers:  anxiety,  tension,  excitement,  depression,  shock, 
frustration 
•  relaxation after stress 
•  various foods/irregular meals 
•  exposure to vasodilators: alcohol, heat, strenuous exercise 
•  odours, light and noise 
•  weather/temperature changes, barometric pressure 
•  insufficient/excessive sleep 
•  head/neck pain, illness 
•  trauma to the head 
•  hormonal changes   
 
        It has been suggested that crying may be a commonly underrecognised trigger, 
particularly  when  associated  with  emotional  upset    (Blau,  1995;  Evans,  1998).    
Emotional crying would presumably be considered stressful and, indeed, stress is a 
commonly  acknowledged  migraine  precipitant  (Passchier,1994;  Reynolds  and 
Hovanitz, 2000).    Another underrecognised trigger may be water deprivation (Blau, 
2005),  which  is  apparently  not  acknowledged  by  the  medical  profession.    Blau 
pointed  out  that  too  little  or  too  much  of  diverse  stimuli  are  reported  to  provoke 
headache  such  as  insufficient  or  prolonged  sleep,  and  during  or  after  stress.    63 
Additionally, variable body temperature (Blau, 2005) and serum glucose levels (Blau, 
1966, 2005; Lance and Goadsby, 2000; Perkins and Hartje, 1983; Seltzer, 1982)  are 
also implicated in migraine. 
        Ice-cream or cold drink has also been reported to trigger migraine (Raskin and 
Knittle, 1976).   Many  individuals experience ‘ice-cream’ headaches, which typically 
last for twenty to thirty seconds.  The swift onset suggests that the pain results from a 
reflex response triggered by stimulation of the trigeminal nerve (Cheshire and Ott, 
2001).   Raskin and Knittle (1976) found that ice cream or cold drink resulted in 
headache in 93% of migaine sufferers compared with 31% of the general population.   
Drummond and Lance (1984) found that about one-third of migraine sufferers who 
experience ice-cream headache feel the pain on the same side as their usual migraine 
headache,  suggesting  that  involved  pain  pathways  are  very  sensitive  in  migraine 
sufferers.   Migraine sufferers with typically more severe headache were more likely 
to to be prone to ice-cream headache. 
        Dowson and Cady (2002) acknowledge the role that trigger factors play in the 
genesis of some individual’s attacks, but caution that research findings are open to 
debate.  Conclusions are conflicting, particularly regarding diet-induced migraine, and 
are often based on poorly designed studies.   For instance,   investigations related to 
food  allergies  have  been  both  positive  (Egger,  Carter,  Wilson  and  Turner,  1983; 
Garlick, 2004; Monro, Brostoff, Carini and Zilkha, 1980; Peatfield, 1994; Peatfield, 
Littlewood,  Glover,  Sandler  and  Clifford  Rose,  1983;  Speer,  1971;  Schaumburg, 
Byck, Gerstl and Marshman, 1969) and negative (Medina and Diamond, 1976, 1978; 
Moffett,  Swash  and  Scott,  1972,  1974).      Trigger  factors  associated  with  the 
development  of  migraine  headache  were  not  investigated  in  the  present  study; 
therefore, research dealing with migraine triggers will not be further addressed  in this 
book.    The  reader  is  directed  to  the  bracketed  references  (pages  62-63)  for  more 
detailed debate on this somewhat contentious topic.   However, stress, a commonly 
reported migraine trigger, was of interest in this research, so will be discussed next in 
light of the relevant literature.   
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Stress: a commonly reported migraine trigger 
 
       Headache  triggers  are  generally  determined  via  retrospective  self-report 
questionnaires or are monitored prospectively by diary (Passcheir, 1994).   Particular 
triggers are implicated more frequently than others.   Robbins (1994) found that stress 
(62%) was reported most often, followed by weather changes (43%), missing meals 
(40%), and bright sunlight (38%).  Van den Bergh, Amery and Waelkens (1987) also 
found  that  stress  (48.8%)  was  commonly  reported  in  addition  to  alcohol  (51.6%), 
menstruation (48%) and selected foods (44.7%).    Stress is a frequently reported 
potent factor associated with an imminent migraine attack (Passcheir, 1994; Reynolds 
and Hovanitz, 2000).   
      The  stress-response  has  also  been  measured  physiologically  in  the  laboratory 
involving  the  measurement  of  extracranial  vasomotor  responses    in  response  to 
stressful stimuli.   Facial blood flow was found to increase in migraine sufferers in the 
temporal  artery  in  response  to  stress  (Drummond,    1984,  1985b).   
Sympathetic/parasympathetic  activity  such  as  heart  rate,  blood  pressure,  skin 
conductance, and stress hormones have also been measured in response to stressful 
stimuli (Passchier, 1994).    Stress hormones have been observed in the blood stream 
following stressful stimuli (Peroutka et al., 1997).   Passchier (1994) cautioned that 
laboratory data assessing the link between stress and headache may only be relevant 
in those cases where migraine headache follows shortly after provocative testing (up 
to 24 hours).    However, Passchier (1994) acknowledged that data from migraine 
sufferers  who  do  not  develop  headache  after  experimental  conditions  may  still 
provide useful subclinical information about abnormal reactions to stress.      
          Retrospective self-report questionnaire data may not be as useful as prospective 
diarised  data  (Köhler  and  Haimer,  1990;  Passchier,  1994).    Self-report  data  is 
obviously  subjective  and  therefore  possibly  influenced  by  individual  attributional 
tendencies.    Additionally,  as  attacks  tend  to  start  after  the  cessation  of  stress, 
retrospective data may miss these connections because of the passage of time.   An 
attack might have occurred anyway and stress was wrongly held responsible for its 
onset (Kohler and Haimer, 1990). 
       Kohler  and  Haimer  (1990)  analysed  the  diaries  of  migraine  sufferers  who 
recorded  headache  and  stressful  events  over  a  six  month  period.      Headache  was 
found to frequently occur on the day of stressful events or the day after.  Attacks   65 
rarely occurred three or four days after the cessation of stress.   Similarly, Levor, 
Cohen,  Naliboff,  McArthur  and  Heuser  (1986)  analysed  the  diaries  of  migraine 
sufferers kept for a month, and found that stressful events were greater on headache 
days than headache-free days.   However, unlike Kohler and Haimer (1990), Levor et 
al.  also  found  that  the  quality/presence  of  stressful  events  for  three  days before a 
headache  differed  to  corresponding  days  before  headache-free  days.    Migraine 
sufferers in Levor’s study experienced more headaches per month (10.71)  than in 
Kohler  and  Haimer’s  study  (2.4  per  month  of  1  day  duration).        As  clusters  of 
stressful days appeared to be pathogenic for Levor’s  (1986) group, perhaps acute 
stress plays a more prominent role in migraine sufferers with more chronic or frequent 
attacks. 
     Clearly,  emotional  factors,  distress,  or  relaxation  after  stress,  may  precipitate 
migraine attacks.  Van den Bergh et al. (1987)  suggest that this is probably related to 
somatic  factors  associated  with  the  excitation  of  the  autonomic  nervous  system.   
Interestingly,  migraine  sufferers  in  Van  den Bergh’s study reported several trigger 
factors    in  conjunction  with  stress,  which  may  be  relevant  as  they  may  serve  as 
compounding  stressors.    Together  these  triggers  may  tip  the  migraine-threshold 
necessary for an attack to ensue (MacGregor, 1996).  Alternatively, stress may simply 
be  an  early  prodromal  sign  wrongly  blamed  as  being  a  trigger  (Griffen  et  al., 
2003;Van den Berg et al., 1987).    If this is the case, perhaps more subtle prodromal 
signs were overlooked by the more prominent associated anticipatory anxiety in the 
wake of an impending attack. 
 
 
 
 
Personality traits, psychiatric disorders and stress   
 
         Although stress in relation to personality/psychiatric factors were not studied in 
this book, symptomatic and vascular aspects of the stress-response were explored.     
Thus, the degree of reactivity to stress following painful/uncomfortable procedures in 
this  study  may  shed  some  light  on  the  psychological  influences  of  coping/pain 
thresholds in migraine sufferers.    Indeed, psychological factors have been associated 
with atypical reactions to various life stressors, particularly with respect to a given   66 
quantity and quality of stress (Henryk-Gutt and Rees, 1973).    Personality/psychiatric 
characteristics in migraine sufferers in relation to stress, are discussed next.   
       Henryk-Gutt  and  Rees  proposed  that  certain  personality  traits  may  predispose 
migraine  sufferers  to  experience  a  greater  than  average  reaction  to  stressful  life 
events.   Stress indeed appears to be a potent migraine precipitant (Passchier, 1994; 
Reynolds  and  Hovanitz,  2000).    Furthermore,  as  migraine  sufferers  and  controls 
experience comparable emotional stressors over the course of their lives, it appears 
that  autonomic  hyper-reactivity  to  stressors  in  migraineurs  may  be  a  factor  that 
predisposes  them  to  attacks  (Henryk-Gutt  and  Rees,  1977).      Perhaps  atypical 
autonomic wiring is also associated with vulnerability to develop certain personality 
traits.      Henryk-Gutt  and  Rees  identified  several  personality  traits  in  migraine 
sufferers  including  increased  neuroticism  (Eysenck  Personality  Inventory),  anxiety 
and  somatisation  (Minnesota  Multiphasic  Personality  Inventory),  hostility  (Buss 
Scale), and emotionality/psychological symptoms. Certain personality/psychological 
tendencies found in those predisposed to migraine may further indicate that this group 
is  neurally  programmed  to  experience  a  greater  than  average  reaction  to  stressful 
events (Henryk-Gutt and Rees, 1977).     Consistent with these findings, research 
elsewhere  has  found  that  migraine  correlates  positively  with  major  psychiatric 
conditions  such  as  depression  and  anxiety,  often  in  a  reciprocal  manner  (Baskin, 
Lipchik and Smitherman, 2006; Breslau, Davis and Andreski, 1991; Hamelsky and 
Lipton,  2006).    Additionally,  obsessive-compulsive  disorder  (Baskin,  Lipchik  and 
Smitherman,  2006),  borderline  personality  disorder  (Saper  and  Lake,  2002),  and 
personality  traits  including  hostility,  suppressed  anger  and  rigidity  (Bag, 
Hacihasanoglu  and  Tufekci,  2005;  Lanzi,  Zambrino,  Ferrari-Ginevra,  Termine, 
D’Arrigo,  Vercelli,  Silvestri  and  Guglielmino,  2001;  Passchier,  Schouten,  van  der 
Donk and van Romunde, 1991), are associated with migraine.    Attachment problems 
have  also  been  linked  with  migraine  (Rossi,    Di  Lorenzo,  Malpezzi,  Di  Lorenzo, 
Cesarino, Faroni, Siracusano and Troisi, 2005).    Furthermore, there may be a genetic 
link between certain psychological conditions (e.g., borderline personality disorder) 
and  hemiplegic  migraine  (Castro,  Nunes,  de  Vries,  Lemos,  Vanmolkot,  van  den 
Heuvel, Temudo, Barros, Sequeiros, Frants, Koenderink, Pereira-Monteiro and van 
den Maagdenberg, 2008). 
      Abnormalities  of  serotonergic,  noradrenergic  and  dopaminergic  pathways  are 
implicated  in  a  wide  variety  of disorders including anxiety, depression, psychosis,   67 
sexual functioning, sleep, cognition, eating, and migraine (Naughton, Mulrooney and 
Leonard, 2000; Silberstein, 1994).   The Tridimensional Personality Questionnaire, 
designed  to  measure  discrete  traits  associated  with  aminergic  activity,  found  that 
migraine sufferers and tension headache sufferers had higher harm avoidance scores 
(related to serotonergic activity) than controls.   Additionally, migraine sufferers had 
lower novelty seeking scores (dopaminergic-dependent) and higher persistence scores 
(glutamine-dependent)  than  other  groups.    It  was  concluded  that  personality  traits 
associated  with  dysfunction  in  serotonergic  transmission  are  common  to  migraine 
sufferers  and  tension  headache  sufferers.    Dysfunction  of  dopaminergic  and 
glutaminergic  tone  is  specific  to  migraine  (Di  Piero,  Bruti,  Venturi,  Talamonti, 
Biondi,  Di  Legge  and  Lenzi,  2001).      Boz,  Velioglu,  Ozmenoglu,  Sayar,  Alioglu, 
Yalman and Topbas (2004) used a similar  psychometric tool – The Temperament and 
Character Inventory -   but migraine sufferers were not found to deviate from normal 
in relation  to  personality dimensions.   Since migraine is thought to be a disorder 
related to abnormal serotonergic tone, somewhat unexpectedly,  Boz et al. found that 
only tension headache sufferers  demonstrated higher serotonergic activity related to 
increased harm avoidance scores.     
         Other scientists have also found that migraine sufferers have normal personality 
profiles (Cuypers, Altenkirch and Bunge, 1981; Wise, Mann, Jani and Jani, 1994).   
The inconsistent research denotes that the psychological correlates of migraine are 
unclear.    However, it is well recognized that headaches generally occur in relation to 
emotional/psychological stress – albeit that the cause-effect relationship is not certain 
(Bag  et  al.,  2005).      To  illustrate  this,  Merikangas  and  Merikangas  (1993)  draw 
attention  to  two  opposing  explanations  with  regard  to  the  association  between 
migraine and anxiety/depression: either the same etiologic factors are shared in both 
conditions or, alternatively, that migraine causes anxiety/depression (or vice versa). 
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Triggers in perspective  
 
       The conflicting research/lack of substantial findings, challenges the notion of a 
firm role for triggers in migraine (Dowson and Cady, 2002).  Nevertheless, 85% of 
migraine sufferers attribute their attacks to various internal and external triggers (Van 
den Bergh et al., 1987).   Triggers differ between individuals and even across attacks 
in  the  same  individual  (MacGregor,  1999;  Rasmussen,  1995;  Turner,  Molgaard, 
Gardner, Rothrock and and Stang, 1995; Van den Bergh et al., 1987).   Most migraine 
sufferers report that several triggers in unison, rather than in isolation, are linked to 
migraine  onset,  such  as  high  stress  levels  and  alcohol  consumption  during 
menstruation (Robbins, 1994; Van den Bergh et al., 1987).   Perhaps a combination of 
genetic,  internal  and  precipitating  factors  are  needed  to  challenge  the  migraine 
threshold before an attack can ensue (MacGregor, 1996; Van den Bergh et al., 1987).    
        Precipitants generally change over the lifespan, e.g., missed meals and late nights 
when young, neck and dental problems later in life (MacGregor, 1999).   Furthermore, 
Van den Bergh et al. (1987) found that the prevalence of triggers tended to increase 
proportionally to aging and duration of illness.  This trend was attributed to greater 
familiarity with triggers due to increasing exposure to attacks over time.  However, as 
it may be difficult to differentiate suspected triggers from prodromal symptoms, such 
as food cravings or photophobia, suspected triggers may simply be an early migraine 
symptom  (Dowson  and  Cady,  2002;  MacGregor,  1999)  mistakenly  assigned  as  a 
trigger.  Alternatively, the emotional impact of an associated trigger may lead to a 
conditioned response (Lance and Goadsby, 2000).  Hence, the mere sight or thought 
of a supposed trigger, even if harmless, is ascribed an offensive role and declared a 
trigger.  
         The  variability  of  reported  migraine  triggers  -  between  individuals  and  from 
attack to attack in the same individual - suggests that migraine sufferers have varying 
sensitivities  to  environment  changes,  which  may  be  based  on  varying  individual 
responses/neurochemistry.        Specifically,  environmental  changes  may  initiate  a 
‘neural shift’ or neurochemical response which manifests as a key trigger factor in 
vulnerable individuals (Turner et al., 1995).   
          Indeed, migraine frequently occurs spontaneously without any obvious trigger 
(Dowson and Cady, 2002; Lance and Goadsby, 2000).   Additionally, the cyclical 
regularity  and  pattern  of  attacks,  e.g.,  migraine  on  awakening,  has  prompted  the   69 
notion  that  an  internal  mechanism  may  be  involved  akin  to  a  ‘biological’  or 
‘circadian’ clock (Lance and Goadsby, 2000).   Despite the apparent constitutional 
(Rasmussen, 1995) nature of migraine, Lance and Goadsby (2000) recommend that 
trigger factors need to be explored in the patient’s history as their avoidance may 
reduce the frequency and severity of migraine headache.   However, some scientists 
disagree  with  the  concept  of  avoiding  triggers;  instead  insisting  that  avoidance  of 
precipitants may serve to heighten sensitivity to triggers (Martin, 1999, 2001; Martin, 
Reece and Forsyth, 2006).  In this case greater exposure to the offending agent is 
recommended to desensitize the susceptible individual to the trigger in much the same 
way that phobias are treated in anxiety disorders (Andrews, Crino, Hunt, Lampe and 
Page, 1995).     
          Medina and Diamond (1978) suggested that some triggers, at best, may set the 
pace for headaches, but it is doubtful that they produce new ones.  This  notion was 
based on findings that alcohol, chocolate or fasting occasionally triggered headaches, 
whereas  headache  frequency  remained  constant  despite  dietary  manipulations.   
However, Drummond (1985) found that frequency of migraine, tension-vascular, and 
tension  headache,  was  associated  with  certain  precipitating  factors.      Specifically, 
psychological  factors  (social  problems,  depression)  and  symptoms  of  muscular 
contraction (frowning, neck pain) were more often associated with constant headache 
than  episodically-recurring  headache.    Jaw  clenching  or  teeth  grinding  was  only 
reported by migraine patients.   
      Chabriat, Danchot, Michel, Joire and Henry (1999) found that frequently reported 
precipitating  factors,  particularly  fatigue/sleep,  stress,  diet,  menstruation, 
temperature/weather  changes,  and  illness  were  identical  in  migraineurs  and  non-
migraineurs.      However,  all  these  factors,  except  illness,  were  reported  more 
frequently  in  migraine  sufferers,  indicating  that  the  degree  of  sensitivity  to  these 
triggers differed between groups.   Maybe, as Drummond (1985) proposed, there is a 
continuum between migraine and tension headache, and those closer to the migraine 
end of the headache spectrum are more sensitive to certain precipitants. 
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Mechanism of migraine 
 
 
Brain stem involvement 
 
        Brain stem and hypothalamic disturbance often precede migraine, and focal brain 
stem activity develops during attacks (Weiller et al., 1995).   Weiller et al. explored 
neuronal  activity  during  migraine  attacks  using  positron  emission  tomography  to 
examine regional cerebral blood flow as a reference.  Increased blood flow was found 
in brain stem regions corresponding to the dorsal raphe nuclei and locus coeruleus, 
suggesting increased neural activity in this area.   This finding led to the concept that 
the brain stem may in fact be the migraine “generator”.    Specifically, it was proposed 
that in migraine sufferers an abnormality might lead to an imbalance in brain stem 
regulation of the normal control of cerebral blood vessels and pain.   Furthermore, 
brain stem dysregulation seems specific to migraine, since it was not observed during 
cluster  headache  (Bahra,  Matharu,  Buchel,  Frackowiak  and  Goadsby,  2001;  May, 
2003).   
 
 
The trigeminovascular system and migraine 
 
        There  is  considerable  evidence  that  migraine  headache  is  associated  with 
trigeminal nerve activation (Williamson and Hargreaves, 2001).  This nerve contains 
sensory and motor components but the sensory division, in particular, appears to be 
associated with migraine pathophysiology (Borsook, Burstein, Moutlton and Becerra, 
2006).           
        The  trigeminal  nerve,  the  fifth  and  largest  of  the  cranial  nerves,  has  three 
divisions: the ophthalmic, maxillary and mandibular.  The central fibres of all three 
divisions enter the brain stem, and project to the pons or medulla, or enter the spinal 
trigeminal  tract.    Sensory  information  from  the  face  and forehead, including pain, 
thermal and tactile sensations, are conveyed to higher brain centers via this nerve.   
Cerebral blood vessels and dura mater are innervated by branches of the trigeminal 
nerve.  Specifically, the trigeminovascular system - a collection of specific cell bodies   71 
located in the trigeminal ganglion of the trigeminal nerve - regulates vascular activity.   
The trigeminal ganglion houses bipolar nerve cells, as well as synaptic links from the 
periphery to blood vessels including the pain-producing large cranial vessels and dura 
mater.   Centrally projecting fibres synapsing in the caudal brain or upper cervical 
cord (C2, C3) are also contained in the trigeminal ganglion (May and Goadsby, 1999).    
The trigeminal nerve regulates the vasculature of the pia mater (Mayberg, Langer, 
Zervas  and  Moskowitz,  1981),  forebrain  and  the  rostral  basilar  artery  (Arbab, 
Wiklund and Svendgaard, 1986 ).  Additionally, the cerebral (middle cerebral artery) 
and extracerebral (middle meningeal artery) circulation is influenced by the trigeminal 
nerve  (O’Conner and van der Kooy, 1986).  Nerve fibres that project from peripheral 
and  central  arms  of  the  trigeminovascular  system  provide  pathways  for  the 
transmission of pain signals from cranial vessels to brain centers involved in pain 
sensation (Borsook, et al., 2006).    
        Migraine  has  long  been  considered  a  vascular  headache  (Lance,  1993; 
Williamson and Hargreaves, 2006).  Consistent with this notion, elevated levels of the 
vasodilator calcitonin gene-related peptide were identified during the headache phase 
of migraine, which was assumed to be released from activated trigeminal nerve fibres 
(Goadsby  et  al.,  1990).        The  finding  that  calcitonin  gene-related  peptide  has  a 
powerful effect on cranial blood vessels (Edvinsson, Ekman, Jansen, McCulloch and 
Uddman,  1987)  indeed  supported  the  belief  that  migraine  may  be  a  disorder 
characterized by distention of cerebral blood vessels.   Additionally, the throbbing 
quality of migraine headache, the sometimes conspicuous dilatation of extracranial 
vessels, and the recognized pain sensitivity of cranial blood vessels, further implied 
that migraine may be linked to trigeminovascular mechanisms (Lance, 1993).   Lance 
proposed that an unstable trigeminovascular reflex, in conjunction with a fault within 
pain control pathways, may underlie the pathogenesis of migraine. 
          Susceptibility to migraine, in the first place, is presumedly due an underlying 
innate  ‘migrainous  threshold’,  delicately  balanced  depending  on  excitation  or 
inhibition  within  the  nervous  system.    Given  this  vulnerability,  a  number  of  key 
players in the brain are then implicated in the generation of migraine headache.  The 
cerebral cortex responds to stressful stimuli and the thalamus to afferent stimuli such 
as  glare  or  noise.    The  hypothalamus  detects  changes  within  the  body  and  the 
internal/external carotid blood vessels respond to vasodilators.     The nucleus raphe 
dorsalis and the locus coeruleus communicate with the cortex via serotonergic and   72 
noradrenergic neurochemical pathways.  Additionally, the nucleus raphe dorsalis and 
the  locus  coeruleus  regulate  the  internal/external  carotid  circulation  via 
parasympathetic efferent pathways shared by the facial nerve (seventh cranial nerve) 
and  the  trigeminal  nerve,  to  increase  blood  flow  in  both  circulations.      The  pain 
control pathway extends from the periaqueductal gray matter of the mid brain and 
incorporates  the  serotonergic  nucleus  raphe  magnus  in  the  medulla  and  locus 
coeruleus in the pons (Lance, 1999).    Stimulation of the locus coeruleus leads to the 
discharge of norepineprine from the adrenal medulla (Goadsby, 1985), which  may  
be  a  catalyst  for  the  discharge  of  serotonin  systemically  (Lance,  1999).      Lance 
suggests that these mechanisms may explain brain and vascular activity responsible 
for the aura and headache of migraine.   
        Despite  the  appealing  logic  of  increased  cerebral  blood  flow  resulting  in 
migraine  headache,  vasodilatation  does  not  necessarily  equate  to  headache.      For 
example, the headache of migraine with aura frequently begins while blood flow is 
restricted  (Olesen,  Friberg,  Skyhøj  Olsen,  Iversen,  Lassen,  Andersen  and  Karle, 
1990).   Furthermore, severe headache has also been observed during vasoconstriction 
following subarachnoid haemorrhage (Macfarlane, 1993).   Macfarlane suggests that 
vasodilatation  is  more  likely  to  be  an  ‘epiphenomenon’  to  nociceptive  or  sensory 
nerve activation, rather than the cause of it.   Stimulation of  trigeminovascular axons 
evokes  a  neurogenic  inflammatory  response  within  cephalic  tissue  involving  the 
release  of  the  vasoactive  neruopeptides  substance  P,  neurokinin  A,  and  calcitonin 
gene-related  peptide,  from  perivascular  axons.    Vasodilatation,  plasma  protein 
extravasation and pain ensue (Moskowitz, 1993).   Moskowitz points out that triggers 
of  the  trigeminovascular  reflex  are  unclear  but  probably  involve  neurochemicals 
which develop within brain parenchyma.  After the provoking stimulus is removed, 
the sensitization of sensory nerve endings, a result of the inflammatory reponse, may 
perpetuate pain (Macfarlane, 1993).   
 
 
 
Sensory and trigeminal stimuli 
 
       During the aura, sensory and trigeminal stimuli appear to provoke reflexes that 
relay in the brain stem and initiate a brain stem disturbance in migraine sufferers.  In   73 
particular,  sensory  stimuli  increase  intensity  of  headache  and  other  symptoms  of 
migraine during (Linde, 2006) and outside attacks (Kowacs et al., 2001), and also 
trigger attacks (Debney, 1984; Scharff et al., 1995; publication related to this book, 
Granston  and  Drummond,  2005).    Additionally,  head pain increases discomfort to 
sensory stimulation (Drummond and Woodhouse, 1993; Woodhouse and Drummond, 
1993).    Even    seemingly  innocuous  visual  and  auditory  stimulation  is  commonly 
associated  with  migraine  headache  (Goadsby,  2001),  which  supports  further  the 
notion of an underlying brain stem disturbance in migraine sufferers.   Drummond 
(1997)  suggests  that  hypersensitivity  of  the  special  senses  during  migraine  attacks 
may be due to the loss of normal inhibitory controls, resulting in increased sensory 
discomfort and aggravation of headache. 
       It is well documented that migraine headache can be triggered by physiological 
and psychological factors.   The initiation of migraine is thought to involve activation 
of peripheral sensory fibres, which, in turn, initiate changes in cranial blood vessels 
and  dura  mater.    Alternatively,  the  initiation  of  attacks  may  reflect  mechanisms 
involving  the  activation  of  descending  pathways  in  the  brain  that  facilitate  pain 
signals, or the suppression of descending pathways that inhibit pain processing in the 
spinal cord (Edvinsson and Uddman, 2005). 
 
 
 
Influence of the stress-response 
 
         Stress, a commonly recognized trigger of migraine (Passchier,1994; Reynolds 
and Hovanitz, 2000), may also contribute to the quality of the attack once in motion.  
Brain stem mechanisms associated with migraine headache may, in part,   be triggered 
from the cerebral cortex in response to stress (Lance, 1993).   
         The  brain  itself  is  largely  insensitive  to  pain  (Lance,  2000);  therefore, 
intracranial pain is probably generated from intracranial blood vessels.   Blood vessels 
are supplied with nuclei in ganglia that form part of the sympathetic, parasympathetic 
and  the  sensory  nervous  systems  (Edvinsson  and  Uddman,  2005).    This 
neuroanatomy,  particularly  the  presence  of  autonomic  receptors  in  blood  vessels, 
implies that the stress-response in migraine most likely has a role in the disorder - be 
it  in  the  initiation  of  an  attack,  or  its  perpetuation.        For  example,  it  has  been   74 
suggested that intense activation of central pain pathways may involve the superior 
salivatory nucleus leading to parasympathetic activation,  thus resulting in the release 
of  the  parasympathetic  neuropeptide  vasoactive  intestinal  peptide  and  the 
manifestation of facial symptoms such as flushing or lacrimation, observed in cluster 
headache and migraine (Edvinsson and Uddman, 2005; Knight, 2005).  
       Lance (1993) proposed  that an unstable pain control system in migraine sufferers 
may  render  them  vulnerable  to  recurring  attacks.    Stimulation  from  higher  brain 
centers, such as the cortex or hypothalamus during stress or emotion, or excessive 
afferent input from the special senses, or cerebral or extracranial vessels, may provoke 
defective discharge of the pain control system in individuals vulnerable to migraine.    
 
 
 
Characteristics peculiar to those vulnerable to migraine 
 
 
           Atypical hyperexcitable vascular and sensory reactivity has been observed in 
migraine  sufferers  between  attacks,  which  may  underlie  susceptibility  to  recurring 
attacks.    Furthermore, migraine sufferers share several characteristics, which may 
also  render  them  vulnerable  to  the  disorder.    Characteristics  peculiar  to  those 
susceptible to migraine include: 
 
•  motion sick prone - evidence of brain stem disturbance in motion sickness 
•  persistence of photo/phonophobia  
•  persistence of scalp tenderness– hyperalgesia/allodynia 
•  altered pain thresholds  
•  exaggerated stress-response 
 
These characteristics were previously discussed, pages 35-69 of this chapter.  The 
caveat to these findings is that it is not certain what is cause or effect in terms of what 
predisposes one to migraine or whether these features are purely symptoms of the 
migrainous  brain/predisposition.      Either  way  these  factors  may  predispose  the 
susceptible person to repeated attacks.   75 
      Indeed,  painful  stimulation  of  the  face/head  in  migraine  sufferers  interictally, 
increased  photophobia  and  trigemino-parasympathetic  reflexes  such  as  extracranial 
vasodilatation  (Drummond,  1992;  Drummond,  1997;  Drummond  and  Woodhouse, 
1993);  symptoms  typically  observed  during  migraine  attacks.      Sometimes  a  full-
blown  migraine  attack  can  even  follow  provocative  procedures  such  as  painful 
stimulation of the trigeminal nerve (see publication related to this book, Appendix 14, 
pages  445).      Furthermore,  hyperalgesia  and  photophobia  followed  optokinetic 
stimulation-induced motion sickness (Drummond, 2002).   Optokinetic stimulation 
and  painful  stimulation  might  well  be  considered  stressful  events;  therefore,  the 
stress-response  probably  played  a  role  in  evoking  vascular  and  sensory  responses 
observed  during  these  procedures.      It  appears  that  once  the  head  hurts,  other 
symptoms follow, e.g., photophobia or nausea.   On the other hand, the presence of 
motion sickness further challenges responses to sensory stimuli (Drummond, 2002).     
 
 
 
Proposed mechanisms underlying susceptibility to recurring attacks 
of migraine in migraine sufferers 
 
 
       Mechanisms underlying susceptibility to recurring attacks of migraine probably 
involve the following components:    
 
•  Sensitization of brain stem nuclei, or disruption to brain stem mechanisms that 
normally  inhibit  sensations  of  head  pain,  increases  headache  and  sensory 
discomfort.   
•  Sensory stimuli most likely intensify sensitization of brain stem nuclei. 
•   Trigeminovascular  reflexes  probably  aggravate  brain  stem  disturbances 
responsible for some of the symptoms of migraine.   
  
      Whether this reciprocal vascular and neurochemical cascade in the brain stem is 
externally or internally triggered, or is simply a spontaneous discharge based on a 
persistent subclinical or a cyclical brain stem disturbance, is not certain.  However, it   76 
seems  likely  that  the  stress-response  influences  the  initiation  and  development  of 
symptoms of migraine. 
         Neural pathways that generate symptoms of migraine may be shared with those 
responsible for motion sickness.  Migraine headache begins with a disturbance in the 
brain that resembles the effects of motion sickness, and symptoms of migraine and 
motion sickness are remarkably similar.   Therefore, in the susceptible individual, 
activation of these pathways, regardless of the condition, may explain the recruitment 
of analogous symptoms. 
 
 
 
General overview of this book 
 
       This book investigated cause-effect relationships between symptoms of migraine 
and  extracranial  vascular  reactivity  to  various  stimuli  in  one  central  experiment 
comprised  of  six  experimental  conditions.    Migraine  sufferers  were  tested  in  the 
headache-free  interval  and  compared  to  healthy  controls  who  rarely  experience 
headache.  Participants  were  exposed  to  optokinetic  stimulation  and  painful 
stimulation  of  the  temple  or  non-dominant  hand, individually and in combination. 
Each  condition  was  investigated  independently,  and  findings  were  then  compared 
across  conditions.    The  purpose  of  each  condition  and  the  rationale  for  selected 
condition comparisons are presented in the introductory text of the results/discussion 
chapters for each condition (refer to Chapters 5 to 12).   Specific hypotheses and 
expectations are also presented in the introductory section of these chapters.   
      
The key assumptions and hypotheses that underlie this book are as follows: 
 
•  A  cyclical  covert  brainstem  disturbance  between  episodes  of  migraine 
increases sensitivity to recurrent attacks. 
•  Brainstem  disturbances,  sensory  stimulation,  and  inflammation  of  tissue 
surrounding blood vessels, mutually interact to reinforce one another.  This 
interaction may trigger attacks of migraine and might also underlie a vicious-
circle of escalating headache and other migrainous symptoms during attacks.   77 
•  The  physiological  disturbances  that  underlie  motion  sickness  are  similar  to 
those of migraine. 
•  Anticipating stressful stimuli will provoke physiological responses that may 
be accentuated in migraine sufferers.   
•  Pain processing may be compromised in migraine sufferers. 
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CHAPTER 2  
 
METHODOLOGICAL CONSIDERATIONS 
 
Questionnaire 
 
       Participants were asked to complete a questionnaire (‘confidential details form’) 
where they detailed features of their headaches including triggers, and also motion 
sickness susceptibility. Appendix 2 (page 276) has a copy of the questionnaire. 
 
     Headache triggers 
      Participants were asked to consult a checklist about their headache triggers.  The 
compilation of this checklist was based on some key references (Chabriat, Danchot, 
Michel, Joire and Henry, 1999; Debney 1984; Evans 1998; Martin and Seneviratne 
1998; Medina and Diamond 1978; Perkin and Hartje, 1983; Seltzer, 1982). 
 
     Motion sickness items 
       Questions  about  motion  sickness  susceptibility  were  adapted  from  Golding’s 
(1998) Motion Sickness Susceptibility Questionnaire Revised (MSSQ-R).  Golding 
reported  that  the  internal  reliability  of  the  whole  scale  was  high  (Cronbach’s 
standardised item alpha of 0.86) and the split-half reliability was 0.77.  Correlations 
across  several  studies  showed  the  validity  of  the  scale  in  predicting  tolerance  to 
motion sickness exposure averaged r = 0.45 (range, 0.14-0.72).  Only the adult section 
of the MSSQ-R was used in this study, and 3 additional items were added (omni 
theatre, simulators, reading in the car).  The nature and duration of motion sickness 
TT   The nature and duration of motion sickness after exposure was also investigated.   
Symptoms experienced, their intensity (0 = not present, 10 = extremely intense), how 
long symptoms persisted, and frequency of vomiting, was noted.  The participant was 
also asked if they experienced vertigo or dizziness independent of headache.   Cutrer 
and Baloh (1992) found that nearly 50% of migraineurs (with and without aura, and   79 
recurrent aura without headaches) reported that episodes of dizziness would linger for 
more than 24 hours, and that many of these episodes were independent of headache.  
Elsewhere, vertigo not associated with headache was reported more often in migraine 
(in  particular,  with  aura)  patients  than  in  controls  (Kuritzky,  Dewey,  Ziegler  and 
Hassanein,  1981).    These  researchers  also  found  that  motion  sickness  during 
headache-free periods was significantly more frequent in migraine with aura patients 
(42%), and in a high percentage (25%) of those without aura when compared with 
controls (17%).  They concluded that the migraine with aura group probably have an 
especially sensitive vestibular system, while those without aura showed a tendency to 
vestibular impairment.    
 
Subjective measures 
 
        Participants were asked to rate their experience of motion sickness during each 
procedure.  Five symptoms were rated.  These included what Harm (1990) referred to 
as  the  two  cardinal  symptoms  of  the  syndrome,  nausea  and  change  in  body 
temperature.  The other symptoms rated were those Harm called ‘associated’ or more 
variable  in  their  occurrence  and  time  course:  dizziness,  drowsiness  and  headache.   
Participants were also asked to rate how ‘unpleasant’ the symptoms felt.  They also 
rated  the  ‘intensity’  and  ‘unpleasantness’  of  pain  eliciting  tasks  using  ice  as  the 
stimuli.    Physiological  correlates  describing  motion  sickness  (Reason  and  Brand, 
1975) and pain (Melzack and Wall, 1988) are well accepted.   Emotional distress and 
the role this plays in pain perception has also been acknowledged  (Bishop, Holm, 
Borowiak and Wilson, 2001), as have individual characteristics (i.e., level of anxiety, 
previous  experience)  in  mediating  motion  sickness  (Grunfeld  and  Gresty,  1998).  
Hence, the rating scales in the present study included physiological and emotional 
(‘unpleasantness’) indicators for motion sickness and pain. All items on the rating 
scales required a response between 0 (not noticed) to 10 (extreme).  
         Methods used, including time intervals between reports for obtaining subjective 
ratings of pain, vary widely (Loftin, Zeichner and Given, 1998), and the same might 
be  suspected  of  self-report  ratings  generally.    The  present  study  required  the 
participant  report  on  between  8  to  10  items  (nausea,  body  temperature,  dizziness, 
drowsiness, headache, self-motion, visual illusion, unpleasantness, ice intensity, ice   80 
unpleasantness) at one time, depending on the condition being tested.  It was decided, 
based on earlier trials in the laboratory, self-report at 2 minute intervals would allow 
enough time for the person to concentrate on the task at hand and not be distracted by 
too frequent self-reporting.  It was also estimated that this time would be sufficient to 
pick up gradual changes throughout the testing period. 
 
 
Optokinetic Stimulation 
 
       This study involved observing reactions to optokinetic stimulation.  Exposure to 
the  optokinetic  drum  is  a  well-established  way  of  inducing  symptoms  of  motion 
sickness in susceptible individuals (Cheung and Vaitkus, 1998). The neurophysiology 
of motion sickness is extremely complex and has been described in several reviews 
(Crampton, 1990; Harm, 1990; Yates, Miller and Lucot, 1998).  Numerous structures, 
pathways and mechanisms are implicated and the brain stem plays an essential as well 
as coordinating role in the circuitry.   Stern, Koch, Leibowitz, Lindblad, Shupert, and 
Stewart (1985) claim that the optokinetic drum induced symptoms of motion sickness 
in approximately 60% of healthy subjects.  In a later study (Stern, Koch, Stewart and 
Lindblad, 1987) 66% of healthy subjects were affected.  
 
Nociceptive stimuli: ice  
 
        Mechanical  and  electrical  stimuli  have  been  used  effectively  to  evoke  pain 
experimentally.    Additionally,  the  cold  pressor  procedure  has  shown  validity  as  a 
laboratory pain analogue (Melzack, 1983).   In this study, the pain stimulus was ice. 
        To stimulate the trigeminal nerve, ice was applied to the temple.  The trigeminal 
nerve is associated with head pain in migraine and involves reflexes that relay in the 
brain  stem  (Lance,  1993;  Macfarlane,  1993;  Moskowitz,  1993;  Weiller,  May, 
Limmroth, Jǔptner, Kaube, Schayck, Coenen and Diener, 1995).   
         To stimulate nociceptors elsewhere in the body the participant immersed their 
fingers  and  palm  in  ice-water.  These  experiments  involved  observing  reactions  to 
painful stimulation in the body (non-specific pain) away from the trigeminal area.  
Burstein,  Cutrer,  and  Yarnitsky  (2000)  found  cutaneous  allodynia  away  from  the   81 
referred pain area of the head during a migraine attack.  They found that allodynia 
developed gradually and extended from the head to the forearms.  They suggested that 
central sensitisation and cutaneous allodynia developed 1-2 hours after the activation 
of peripheral nociceptors in the trigeminal-vascular pain pathway.  This activation 
was then thought to have resulted in intracranial hypersensitivity, which led to the 
activation of nearby second-order neurons and then third-order neurons.  This state, 
they  hypothesised,  was  the  precursor  to  the  development  of  cutaneous  allodynia.   
Drummond  (2002)  reported  increased  pain  ratings  in  the  fingertips of migraineurs 
during  the  headache-free  interval  compared  to  controls,  directly  after  optokinetic 
stimulation.   Allodynia was not related to the intensity of nausea or headache during 
motion sickness so the mechanism of this non-cranial pain was unclear.  However, 
Drummond speculated that mechanisms to account for allodynia beyond the referred 
pain area in migraineurs could be due to faulty central-pain modulating mechanisms.  
The present study was interested in further observing sensitivity to pain in the body 
away from the trigeminal area during the headache-free interval in migraine sufferers.  
The plan was to compare findings between the trigeminal stimulation tests and the 
non-specific  painful  stimulation  tests,  independently  and  in  relation  to  optokinetic 
stimulation.   
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CHAPTER 3 
 
METHOD  
 
Participants 
 
      A total of 50 individuals, 27 migraineurs and 23 healthy controls of similar age and 
sex  distribution,  participated  after  giving  informed  written  consent.    The  University 
Human  Ethics  Committee  approved  the  study.    The  migraine  group  consisted  of  22 
women and 5 men (mean age 40.7 + 11.2 years; range, 20 to 59 years) who met the 
International  Headache  Society  (I.H.S.)  (1988,  2004)  criteria  for  migraine.    Three 
participants had migraine with aura and 24 had migraine without aura.   Participants were 
screened for absence of other medical problems and were not taking ongoing medication 
for migraine.  Headache frequency was on average 2 per month.  To relieve attacks 5 
individuals  took  imigran  and  2  ergodryl,  but  the  majority  took  analgesic,  anti-
inflammatory,  or  caffeine  based  remedies.    Some  supplemented  with  anti-emetics.  
Twenty-three from this group reported a family history of migraine; the remainder did 
not. The control group consisted of 17 women and 6 men  (mean age 39.7 + 11.8 years; 
range, 18 to 62 years) who reported less than 12 headaches per year that did not meet the 
diagnostic criteria for migraine.  All but 6 controls reported experiencing occasional mild 
headache.  The other 6 controls reported experiencing 1 to 3 more intense headaches per 
year.  These more intense headaches were described as lasting from 20 minutes to an 
hour, predominantly associated with tension or sinusitis and generally resolved without 
treatment.  Analgesics, when used, included paracetamol or aspirin, which relieved the 
headache within 20 minutes.  Only 5 individuals in the control group reported a family 
history of migraine.  Participants were enlisted by public advertisement (local and state 
newspapers), from the Migraine Support Group and the university population.   Each 
participant was invited to take part in 3 separate sessions spaced, on average, a month 
apart.  They were paid in total $35 for their assistance ($10 session 1, $10 session 2, $15 
session 3).   83 
 
         Experiments were carried out when individuals were headache-free for at least 4 
days, and medication and alcohol free for at least 24 hours.  One migraineur, prior to her 
second testing session, commenced a course of celecoxib for an inflamed knee joint, then 
diclofenac for the same problem prior to her last testing session.  Before these sessions 
she  withheld  taking  the  drug  for  72  hours  to  ensure  they  cleared  from  her  system.  
Participants were also required to fast for 2 hours prior to testing and to avoid cigarettes 
for this period.  Females were tested between menstrual periods.  As procedures used in 
this study had the potential to trigger a headache in susceptible individuals, migraineurs 
were advised to bring their medication to testing sessions.  If required, the service of the 
University Health Centre was available: 2 migraineurs made use of this service once.  
Transport home was available for those not well enough to drive but this facility was not 
used.   
        Five participants did not complete the 3 testing sessions (4 migraineurs, 1 control) 
and withdrew after session 1.   Two from the migraine group commenced prophylactic 
anti-migraine  medication,  which  meant  they  no  longer  met  inclusion  criteria.      The 
remaining 2 migraineurs withdrew due to experiencing unabated nausea and headache 
after testing for up to a week.  The control subject discontinued because of time restraints 
from personal and work commitments. 
       Appendix 1 (page 275) has a copy of the consent form given to participants. 
 
 
 
Apparatus 
 
 
     Questionnaire 
 
       Participants were asked to give details about their headaches including triggers, and 
also about motion sickness susceptibility.  The experimenter interviewed and guided each 
participant  through  the  questionnaire.    General  medical  status  including  history  was   84 
 
established.  Migraineurs indicated if their migraine was previously diagnosed but all 
subjects,  including  controls,  were  reviewed  about  the  quality  of  their  headaches 
according to the I.H.S. criteria.  Participants were also questioned on frequency, intensity, 
duration  and  location  of  their  headaches  and  about  family  history  of  migraine.   
Medication  used  to  treat  headache,  and  use  generally,  was  investigated  to  ensure 
individuals met inclusion criteria (no prophylactic medication). 
       All participants were asked about their headache triggers; and migraineurs, whether 
they  observed  a  difference  between  headache  and  migraine  triggers.      Triggers  were 
presented in checklist form, grouped under: ‘psychological’, ‘physiological’, ‘external’, 
and ‘others’ (not mentioned in the checklist).   Responses required either: ‘yes’, ‘no’ or 
‘unsure’; and relevant details were noted against particular triggers.   
      Appendix 2 (page 276) has  a copy of the questionnaire given to participants. 
 
 
 
      Headache Diary 
 
 
       Both groups were instructed to record details of their headaches between each testing 
session, and for 1 week after the final session.  They were supplied with a ‘headache 
diary’ and ‘headache details form’ booklet to fill out daily for this purpose.  Even if they 
were  headache-free  this  was  still  noted  in  the  diary.    The  ‘headache  diary’  asked 
participants  to  note  the  time,  intensity  (0  =  no  headache,  10  =  extremely  intense), 
headache trigger, and treatment for the attack.  If a headache was more than mild (>3) 
they were asked to complete the ‘headache detail forms’ booklet, where they supplied 
more detail about the attack.  In this book they recorded the location of head pain, signs 
and symptoms and the intensity every 8 hours until the headache resolved.  To address 
signs and symptoms they were asked to consult a checklist which included: sensitivity to 
light and sound, nausea, vomiting, sweating or increase in body temperature, dizziness, 
drowsiness, headache, and aura.  Individuals noted any additional signs or symptoms not 
on the list.   85 
 
         Appendix 3 (pages 284-290) has copies of the 2 booklets given to participants for 
recording headache occurrence.   The diaries between sessions covered 32 days to allow 
for the required 3-4 week interim between testing sessions.  The booklets also covered a 
7-day period after the final session.  
 
      Subjective measures 
 
       Participants  were  asked  to  rate  their  experience  of  motion  sickness  during  each 
procedure.   Five symptoms were rated including nausea, body temperature, dizziness, 
drowsiness  and  headache.    Participants  were  also  asked  to  rate  how  ‘unpleasant’  the 
symptoms  were.  Additionally, they rated the ‘intensity’ and ‘unpleasantness’ of pain 
eliciting tasks using ice as the stimuli.  All items on the rating scales required a response 
between 0 (not noticed) to 10 (extreme). 
        Circular  vection  was  assessed  during  optokinetic  stimulation  by  having  the 
participant  report  on  ‘self-motion’  (sensation  of  self-rotation  though  stationary)  and 
‘visual illusion’ (visual change in the stripes inside the drum).  Reponses required either 
‘none’,  ‘some’, or ‘complete’. 
       Subjective ratings were recorded at 2-minute intervals and the researcher recorded 
responses on a series of forms. 
       Appendix 4 (pages 291-295) has a copy of the rating scales given to participants and 
forms used by the researcher to record participant self-ratings during the experiment. 
 
 
      Nociceptive stimuli 
 
       To stimulate the trigeminal nerve, an ice block 3.5 centimetres square held by a short 
stick, was applied to the temple.  To stimulate nociceptors elsewhere in the body the 
participant immersed the fingers and palm of their non-dominant hand in a foam box (24 
cm long, 14 cm wide, and 14 cm high) containing a mixture of 8 cups of crushed ice to 8 
cups of tap water, giving a temperature of 2 degrees Celsius.  The participant alternated 
the placement of this hand between the ice-water and an identical container of water at 32   86 
 
degrees Celsius.  The purpose of placing the hand into the warm water was to standardise 
hand temperature prior to being placed in the ice-water.  The temperature in the second 
container was obtained by mixing 9 cups of tap water with 2 cups of boiling water.  This 
testing session entailed 2 testing blocks of approximately 25 minutes each and over each 
block  the  water  temperature  dropped  gradually  by  about  2  degrees  in  the  second 
container.  In the ice-water container, the temperature remained at 2 degrees Celsius over 
this time.  Both foam boxes, however, were rejuvenated at the commencement of the 
second testing block.  A thermometer remained in each container throughout testing to 
monitor the temperatures. 
 
 
      Optokinetic Drum 
 
       The  drum  consisted  of  a  metal  cylinder  50  centimetres  in  diameter  and  70 
centimetres in height.  The interior was covered with alternate black and white vertical 
stripes  3.3  centimetres  wide.  The  participant  sat  still  on  a  chair  with  their  head  and 
shoulders inside the drum, which rotated 10 times per minute.    
       Appendix  5  (page  296)  illustrates  the  optokinetic  drum  and  positioning  of  the 
participant.  
 
 
       Physiological Equipment 
 
        Pulse  volume  was  detected  via  a  Polygraph  Data  Recording  System  (Grass 
Instrument Model 79E, Quincy, U.S.A.).    Physiological information was transferred to a 
BIOPAC  Systems  Analogue/Digital  Channel  Receptor  and  MacPacq,  MP100,  16  Bit 
(BIOPAC  Systems,  U.S.A.).    Data  was  then  sent  to  a  personal  computer  and  the 
AcqKnowledge (version 3.01, BIOPAC Systems, U.S.A.) computer programme recorded 
input.  The BIOPAC System and the acqKnowledge programme were prepared to obtain 
2 channels (A1 = right pulse volume; A2 = left pulse volume) at 100 samples per second   87 
 
for 45 minutes.  The AcqKnowledge version 3.71 programme was later used to transform 
and analyse output.   
 
Pulse Volume 
 
        Pulse volume was estimated by measuring blood flow close to the surface of the skin 
of the temples via pulse transducers.   Before the transducers were attached, the skin was 
cleaned with an alcohol swab.  A photoelectric pulse transducer (photo plethysmograph, 
Grass Instrument, Quincy, U.S.A.) was attached with a double-stick  
disc  (MEDITEC)  approximately  4.5  centimetres  above  the  top  of  both  ears  and  8.5 
centimetres  forward  of  this  point  over  the  vicinity  of  the  anterior  branches  of  the 
superficial temporal blood vessels (see Figure 3.1).  A black lightproof headband was 
placed over the transducers to ensure light emitted via the transducer reflected back into 
the instrument when blood moved through the skin, and was not affected by outside light.   
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Figure 3.1.  Positioning of pulse transducers on the temples 
 
Testing Area  
 
The participant was tested in a small electrically shielded room (1.6m x 1.5m) to reduce 
the effects of interference from extraneous electrical artifacts on physiological signals.  
The optokinetic drum and the sensors for the pulse transducers were housed in this room.   
The experimenter and remaining physiological recording equipment were positioned next   89 
 
to the participant’s room.  Communication between rooms was via a small earplug and a 
microphone clipped to the collar.  A stopwatch was used to time recordings throughout 
testing.  
 
 
 
Research Design and Analysis 
 
       This was a factorial experiment as the effects of more than 2 independent variables 
were  studied  simultaneously.    Participants  were  exposed  to  6  separate  experimental 
conditions.  Statistical analysis was performed using the Statistical Package for the Social 
Sciences  11.5  for  Windows.    Within-subjects  and  between-subjects  factors  were 
investigated  by  mixed  analyses  of  variance,  the  general  linear  model  for  repeated 
measures  statistic.    Post  hoc  tests  were  performed  using  paired  t-tests  to  compare 
responses within groups and independent t-tests to compare those between groups.  The 
within-subjects  design  minimizes  error  variance  (Grimm,  1993;  Kerlinger,  1986)  and 
strengthens  power  (Grimm,  1993).    To  reduce  adaptation effects  the  3  sessions  were 
spaced 3 to 4 weeks apart.     This break also allowed for the  time  
between menses required for female participants.  To minimize order effects participants 
were equally allocated to 1 of 6 combinations of test orders in the 3 sessions.   Table 3.1 
shows  the  number of  migraine sufferers and controls in each of the 6 testing orders.   
Each session involved 2 testing parts (see figures 3.2, 3.3 and  3.4).  
          Quantifiable  subjective  data  was  collected  at  2-minute  intervals  for  all 
experimental  conditions,  and  physiological  data  was  recorded  continuously.    The 
AcqKnowledge  programme  version  3.71  was  used  to  transform  physiological  data.   
Pulse amplitude was calculated as the mean difference between the peak and trough of 
the pulse wave using acqKnowledge software. 
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                     N  Test Order                         Sessions 
         1                       2                      3   Migraineurs    Controls 
1        1 + 2        3 + 4       5 + 6           4          4 
2        1 + 2        5 + 6       3 + 4           4          5 
3        3 + 4        1 + 2       5 + 6           4          3 
4        3 + 4        5 + 6       1 + 2           5          4 
5        5 + 6        1 + 2       3 + 4           4          4 
6        5 + 6        3 + 4       1 + 2           4          3 
 
Table  3.1.   Number of participants in each testing order 
            Key:   1 = OKS alone  
                       2 = ice to temple after OKS  
                       3 = ice to temple before OKS  
                       4 = OKS + ice to temple  
                       5 = hand ice-water before OKS  
                       6 = OKS + hand ice-water 
 
Procedure 
        At the first testing session the participant was asked to fill out the questionnaire on 
headache  details  including  triggers,  and  motion  sickness  susceptibility.    They  were 
guided  through  this  form  with  the  experimenter.    Following  this  they  were  tested 
according to the session and conditions they were allotted.  After testing, and prior to 
leaving,  they  were  given  the  headache  diary  and  the  headache  details  booklet  and 
instructed how to fill them in.  They were advised that a summary of the instructions 
given in this session was on the inside cover of each booklet.     Subsequent    sessions  
involved  the  researcher  initially  going  through  the returned  diary  with  participants  to 
ensure information was adequately recorded.  The booklets were reissued at the end of  
each of the next 2 sessions, and in the last session a reply paid envelope was given to 
participants not on campus, so they could return the diary.    
         Prior  to  each  testing  condition  the  self-rating  scales  were  explained  to  the 
participant.  Participants with mobile phones were asked to turn them off as they may 
interfere with physiological recording during testing.  The pulse transducers were placed 
on the temples.  Finally, the communication headset was placed on the individual.    
         The same researcher carried out procedures and recordings throughout the study in 
a laboratory maintained at a temperature of 22 degrees Celsius (+ 1.5
o C).   Participants   91 
 
were encouraged to complete all 3 testing sessions although they were free to withdraw at 
any  time.    Testing  sessions  were  3  to  4  weeks  apart,  although  a  few  participants 
(particularly migraineurs) had longer breaks between sessions due to not meeting pre-
testing requirements.   Each session comprised 2 testing conditions of approximately 25 
minutes each.  The gap between the end of the first condition and commencement of the 
next was 8-10 minutes.  This period allowed for preparation of the pending condition (eg. 
moving in or out of drum, setting up pain eliciting apparatus).   
 
Optokinetic stimulation 
 
       The participant was instructed to sit still with their head and shoulders inside the 
optokinetic drum.  They were told that once the drum began revolving to look straight 
ahead and were asked to keep their eyes open.  They were asked to look beyond the 
stripes and to avoid changing focus or tracking the stripes.  They were advised the drum 
would revolve for a maximum of 15 minutes but if they felt they were about to vomit 
they should tell the experimenter and the drum would be turned off.   They were also 
requested  not  to  speak  during  testing,  apart  from  reporting  to  the  experimenter  as 
instructed. 
        For the first 5 minutes a baseline was recorded while the participant sat still in the 
non-revolving  drum.    During  this  period  they  were  asked  to  rate  the  5  symptoms  of 
motion sickness and unpleasantness.  At the completion of baseline recording they were 
reminded that the drum was about to start.   After the drum started, self-ratings continued 
at minutes 2, 4, 6, 8, 10, 12, and 14, and they also rated self-motion and visual illusion.  
The drum was turned off at minute 15.  The participant was advised of this beforehand to 
avoid being startled.  They remained seated inside the drum for a further 5 minutes while 
self-ratings (excluding self-motion and visual illusion) continued for minutes 16, 18, and 
20.  The participant then withdrew from the drum, and the pulse sensors were checked in 
readiness for the following condition. 
        Figure 3.2.A demonstrates the timing of the optokinetic stimulation procedure. 
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A.   Optokinetic stimulation 
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B. Trigeminal stimulation after optokinetic stimulation 
 
 
                                                               ice on temple  
 
                                              ice 1               ice 2               ice 3 
   
                                                         
   Baseline 
                                                 
                                     2         4         6          8        10        12       14        16      18    20             
                                                               Minutes    
                                                  
  
                   
                                                                
                                                                 Ratings 
 
 
Baseline commenced approximately 13-15 minutes after optokinetic stimulation 
         
              
 
Figure 3.2.   Optokinetic   stimulation   (top)   and  trigeminal   stimulation   after  
                     optokinetic stimulation (bottom)   93 
 
 
 
Trigeminal stimulation after optokinetic stimulation 
 
 
        To evoke this stimulation the participant was instructed to apply ice to their temple.  
Migraineurs used the side of the head usually most painful during migraine and controls 
selected either side.  The side selected was used in all testing conditions requiring ice on 
the temple.  Before beginning this condition participants were given the ice block on a 
stick and instructed how to apply the ice when prompted during the test.  When not in use 
the ice block was placed in a nearby cup. To absorb any drips from the ice, a small towel 
was placed on the participant’s shoulder.     
         Initially a 5-minute baseline recording was taken which involved the participant 
sitting  still  and  when  prompted,  they  rated  their  motion  sickness  symptoms  and 
unpleasantness.  Two minutes later they were asked to rate these items again, and then in 
another 2 minutes (minute 4) they were instructed to pick up the ice and place it firmly 
side on to their temple for the first time. The instant they made contact they said ‘on’ and 
the experimenter timed the placement of ice for 30 seconds.  Immediately following this, 
the experimenter said ‘off’ at which the participant removed the ice and placed it back 
into the cup ready for the next placement.  A second application of ice was at minute 8 
and a third placement at minute 12.  The procedure was identical for each ice placement.  
Each time the ice was removed the subject was prompted to recall what their self-ratings 
were at the time the ice was on.   Minutes 4, 8 and 12 were the only times the participant 
was required to recall when giving self-ratings.  All other ratings fell on the timed 2-
minute interval (baseline, then at minutes 2, 6, 10, 14, 16, 18, 20).   Ratings from minute 
4  onwards  included  ice  intensity  and  unpleasantness  in  addition  to  motion  sickness 
symptoms and unpleasantness. 
          Figure 3.2.B demonstrates the timing of the trigeminal stimulation after optokinetic 
stimulation procedure. 
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Trigeminal stimulation before optokinetic stimulation 
 
 
The procedure for this condition was the same as that described for trigeminal stimulation 
after optokinetic stimulation (see figure 3.3.A).  The intention this time was to observe 
effects of trigeminal stimulation independent of optokinetic stimulation.   
A.  Trigeminal stimulation before optokinetic stimulation 
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A.  Trigeminal stimulation before optokinetic stimulation    
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B.  Trigeminal stimulation during optokinetic stimulation 
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Baseline commenced approximately 16-18 minutes after trigeminal stimulation 
 
 
 
Figure 3.3.   Trigeminal   stimulation  before  optokinetic  stimulation  (top)  and,  
                     trigeminal stimulation during optokinetic stimulation (bottom)   96 
 
 
Trigeminal stimulation during optokinetic stimulation 
 
        This test involved observing reactions to trigeminal stimulation during optokinetic 
stimulation.  The participant sat in the optokinetic drum, as described in the optokinetic 
stimulation  condition.  This  time  however,  they  were  given  additional  directions 
concerning the placement of ice on their temple while under the drum.  A cup holding the 
ice apparatus was placed on the participant’s lap.  It was placed on a towel to ensure the 
individual  did  not  sense  coldness,  which  would  be  distracting.    They  were  told  that 
placement of the ice was identical to the previous condition but now the task would be 
performed in the rotating drum.  They were asked to orientate themselves to where the ice 
block was on their lap and that when prompted they should place the ice on their temple.  
They were told that this task would be performed without looking at the ice block or 
without breaking their gaze from the rotating drum. 
        As  in  condition  1,  baseline  recording  involved  the  participant  sitting  still  in  the 
stationary  drum  and  when  prompted  they  rated  motion  sickness  symptoms  and 
unpleasantness.    Ice  was  not  placed  on  their  temple  at  this  stage  but  they  were  still 
prompted to rate ice intensity and unpleasantness.  This particular rating was based on the 
after-effects  from  ice  received  before  optokinetic  stimulation.  All  these  ratings  were 
prompted again 2 minutes into the rotating drum, and they also rated ‘self-motion’ and 
‘visual illusion’.  After 4 minutes in the rotating drum the participant was directed to 
place ice on their temple for the first time.  The second application of ice was at minute 8 
and the third at minute 12.  As in the other ice conditions, each time the ice was removed 
the subject was prompted to recall their self-ratings at the time the ice was on.  Minutes 4, 
8 and 12, as before, were the only times the participant was required to recall when 
giving self-ratings.  All other ratings fell on the timed 2-minute interval (baseline, then at 
minutes 2, 6, 10, 14, 16, 18, 20).  Ratings after the rotating drum until the end of the 
experiment (minutes 16, 18, &20), excluded self-motion and visual illusion. 
        Figure 3.3.B demonstrates the timing of the trigeminal stimulation and optokinetic 
stimulation procedure.   
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    Non-specific painful stimulation 
 
        To evoke non-specific painful stimulation the participant was instructed to immerse 
the fingers and palm (excluding thumb) of their non-dominant hand in ice-water.  The 
same timing was used for the ice-water immersion as application of ice to the temple.  
Items and timing of subjective ratings also matched that used in the application of ice to 
the temple.   Figure 3.4.A demonstrates timing of ice-water placement and self-ratings.  
The foam boxes filled with ice-water and warm water were positioned on a table next to 
the participant’s chair.  The participant was instructed how to place their hand in the 
warm and ice-water.   
      Two minutes after the participant’s self-report at baseline they were asked to rate 
these items again and to place their hand in the warm water.  The instant it was immersed 
they said ‘in’ and the experimenter timed the placement for 2 minutes.  Then they were 
instructed to remove their hand from the warm water and say ‘out’ when it was removed.  
They were then instructed to place it in the ice-water for the first time and say ‘in’, on 
immersion.   The hand, with fingers splayed, was continually swirled while in the ice-
water.   The experimenter timed this placement for 30 seconds and then said ‘out’ at 
which the participant removed their hand and placed it back in the warm water.  Other 
than  when  prompted  for  ice-water  placement,  the  participant’s  hand  remained  in  the 
warm water until the end of the test. 
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A.  Non-specific painful stimulation  
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                                                                Ratings 
 
 
 
B.  Non-specific painful stimulation during optokinetic stimulation 
 
                                                      Optokinetic drum 
                   
 
                         on                                                                                off      
                                                           hand in ice-water 
                                              ice 1               ice 2               ice 3 
   
   Baseline 
                                                 
                                     2         4         6          8        10        12       14        16      18    20             
                                                               Minutes    
                                          
                   
                                                                
                                                                 Ratings 
 
Baseline commenced approximately  16-18 minutes after painful stimulation of the hand 
 
 
Figure 3.4.   Non-specific   painful   stimulation   (top)  and,  non-specific  painful  
                     stimulation during  optokinetic stimulation (bottom) 
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Non-specific painful stimulation during optokinetic stimulation 
 
       This test involved observing reactions during non-specific painful stimulation and 
optokinetic stimulation.  The participant was instructed to sit in the optokinetic drum, as 
described during the optokinetic stimulation condition.  Items and timing of subjective 
ratings  were  the  same  as  those  used  during  trigeminal  stimulation  and  optokinetic 
stimulation.  The participant was given additional directions concerning the placement of 
their hand in the warm and ice-water while in the rotating drum.  They were positioned in 
the  drum  with  the foam  boxes  on the  table  next to their chair.  They were asked to 
orientate themselves to where the foam boxes were and when prompted to alternate their 
hand between the warm and ice-water.  They were instructed that these tasks would be 
performed  without looking  at  the  boxes  or  breaking  their gaze from the drum.  Two 
minutes into the optokinetic stimulation they were told to place their hand in the warm 
water for the first time.  Thereafter, whilst in the rotating drum, they placed their hand 
alternately between the warm and ice-water in the same way as in the previous condition. 
        Figure  3.4.B  demonstrates the  timing  of the non-specific painful stimulation and 
optokinetic stimulation procedure. 
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CHAPTER 4 
 
QUANTIFICATION OF DATA 
 
 
Statistical approach for each condition 
 
 
 
Symptom ratings  
     Migrainous symptoms were analyzed in a 2  (group: migraineurs, controls) x 11 (time: 
every  2  minutes  from  baseline  to  minute  20)  repeated-measures  analysis  of  variance 
(ANOVA) with simple contrasts between baseline and each subsequent point.   Self-
motion and visual-illusion were analyzed in a 2 (group: migraineurs, controls) x 7 (time: 
every 2 minutes during OKS) repeated-measures ANOVA and ice-induced pain intensity 
and unpleasantness in a 2  (group: migraineurs, controls) x 9 (time: every 2 minutes from 
the  first  application  of  ice)  repeated-measures  ANOVA.      Where  appropriate,  simple 
contrast analyses were used to explore each time point in relation to baseline within each 
group.  The multivariate solution is reported for Time and the Time x Group interaction.  
ANOVA  results  (main  effects,  interactions)  are  presented  in  tables  in  the  following 
chapters.    Means,  standard  deviations  and  simple  contrasts  are  presented  in 
supplementary tables in Appendix 6 to 11. 
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Pulse Amplitude 
     As condition 1 (OKS) did not involve painful stimulation, responses were analyzed in 
a 2  (group: migraineurs, controls) x 2 (side: left, right) x 11 (time: 30 second sample 
increments from baseline, at minutes 3 ½, 4, 4 ½, 7 ½, 8, 8 ½, 11 ½, 12, 12 ½, 14 ½, 19 
½)  repeated-measures  ANOVA.     Time points were selected to correspond with data 
points in conditions involving painful stimulation.   The other five conditions all involved 
painful stimulation so were analyzed in a 2  (group: migraineurs, controls) x 2 (side: 
ipsilateral, contralateral to stimulation) x 11 (time: 30 second samples, before {trial 1, 2 
& 3}, during {trial 1, 2 & 3} and after {trial 1, 2 & 3} painful stimulation, and 3 and 8 
mins  after  the  3
rd  trial)  repeated-measures  ANOVA.    Where  appropriate,  significant 
interactions were investigated in a series of 2 (group: migraineurs, controls) x 2 (side: 
ipsilateral, contralateral to stimulation) repeated-measures ANOVA’s at each time point.  
Condition 1 was investigated in 2 (group: migraineurs, controls) x 2 (side: left, right) 
repeated-measures ANOVA’s at each time point.   Pulse amplitude was expressed as the 
percent change from baseline recorded 4 minutes before the first data point. ANOVA 
results  (main  effects,  interactions)  are  presented  in  tables  in  the  following  chapters.  
Means, standard deviations and simple contrasts are presented in supplementary tables in 
Appendix 6 to11. 
 
 
Condition comparisons 
 
 
            Symptom ratings and pulse amplitude were compared across conditions using a 
series of repeated measures ANOVAs.   The following contrasts were explored: 
 
•  Response during OKS 
          Conditions: 1 (OKS alone), 4 (ice on temple during OKS) and 6 (hand in ice-water    
           during OKS).  Mean ratings across the full period of OKS were calculated.  As       102 
 
           preliminary analyses indicated that pulse amplitude increased following painful    
           stimulation with ice (temple, hand), mean pulse amplitude (30 second samples)   
           after ice stimulation was calculated. 
 
 
•  Response independent of OKS  
    
           Conditions 2 (Ice on temple after OKS), 3 (Ice on temple before OKS) and              
           5 (Hand in ice-water before OKS).  Mean scores were calculated, as listed above. 
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                   CHAPTERS FIVE to TWELVE  
 
 
 
RESULTS/DISCUSSION  PREAMBLE 
 
 
 
       Results for each of the six testing conditions are presented and discussed individually 
in Chapters 5 to 10, and later compared in chapters 11 and 12.    Specific findings with 
respect  to  pain  processing  in  response  to  cranial  pain  and  non-specific  painful 
stimulation,  independently  and  in  relation  to  OKS  are  explored  in  these  chapters.   
Findings are then discussed in more detail in the general discussion at the end of the book 
(i.e.,  Chapter  13),  in  relation  to  the  literature  of  the  existing  models  of  the migraine 
mechanism, and the overall outcomes of the entire experiment. 
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CHAPTER 5  
             
 
RESULTS and DISCUSSION 
 
 
Condition 1 
Optokinetic stimulation (OKS) alone  
 
 
 
     The  purpose  of  this  condition  was  to  investigate  whether  symptomatic  responses 
evoked  during  OKS  would  differ  between  migraine  sufferers  and  controls.      Since 
migraine  sufferers  are  prone  to  motion  sickness  (Golding,  1998;  Kuritzky,  Ziegler  & 
Hassanein, 1981), it was hypothesized that ratings would be greater in migraine sufferers 
than in controls during OKS.    
        Motion  sickness  is  commonly  associated  with  facial  pallor  and  cold  sweating 
(Marcus, Furman and Balaban, 2005) but increases in skin oxygen and flushing, an index 
of blood flow, have also been observed.  In people who do not develop motion sickness 
skin oxygen decreases (Harm, Beatty and Reschke, 1987).  Kolev, Moller, Nilsson and 
Tibbling (1997) similarly observed increased blood flow in the forehead during motion 
sickness measured by laser doppler flowmeter.   Additionally, sympathetic activation is 
greater in insusceptible individuals, resulting in cutaneous vasoconstriction throughout 
motion tests (Harm, 1990).    
          Blood appears to be diverted away from facial capillaries to deeper blood vessels, 
as the individual visibly appears pale (Marcus et al., 2005) while blood flow through 
deeper dermal vessels is heightened (Kolev et al., 1997).    This same mechanism may 
occur in migraine and so explain the characteristic facial pallor observed during attacks 
(Marcus et al., 2005) while deeper cephalic vessels dilate (Moskowitz, 1993).   
       Since  migraineurs  are  predisposed  to  motion  sickness,  it  was  hypothesized  that 
extracranial  skin  blood  flow  in  deeper  dermal  vessels  as  measured  by   105 
 
photophlethysmography to OKS would be greater in the migraine group than in controls 
in the current test.   
 
 
RESULTS 
Symptom ratings  
 
     Overall,  symptomatic  responses  were  greater  in  migraine  sufferers  than  controls 
throughout testing: nausea (mean + S.E. = 1.721 + .298 vs .466 + .298; F (1,40) = 8.866, 
p < .01), body temperature (2.110 + .303 vs .344 + .303; F (1,40) = 16.957, p < .001), 
dizziness (1.749 + .334 vs .686 + .334; F (1,40) = 5.048, p < .05), drowsiness (1.357 + 
.269 vs .361 + .269; F (1,40) = 6.840, p < .05), and headache (1.167 + .225 vs .068 + 
.225; F (1,40) = 11.910, p < .001).  Closer inspection indicated that apart from headache, 
differences between groups developed early into OKS.  Headache, however, was greater 
in the migraine group the entire time, even prior to OKS (see Figure 5.1.E and Appendix 
6.1.5, page 301).  Both groups experienced more nausea (main effect for Time: F (10, 31) 
= 2.599, p < .05), dizziness (main effect for Time: F (10, 31) = 2.353, p < .05) and 
elevation in body temperature (main effect for Time: F (10, 31) = 4.460, p < .01) during 
OKS than at baseline.  Simple contrast analyses indicated that increases in nausea and 
body  temperature  in migraineurs  persisted  after  OKS but dizziness subsided within 5 
minutes.    In  contrast,  experience  of  nausea  and  dizziness  in  controls  was  slight  and 
stabilized quickly mid OKS, and body temperature remained stable throughout.   
     Unpleasant sensations developed in both groups during OKS (main effect for Time: F 
(10, 31) = 3.836, p < .01).  Contrast analyses indicated that in migraineurs unpleasantness 
was constant, even following OKS.  However, controls only reported unpleasantness mid 
OKS.  The extent of unpleasantness overall was greater in migraine sufferers than in 
controls  (2.626  +  .371 vs .714  + .371; F (1,40) = 13.291, p < .01).  The difference 
between groups was evident from 4 minutes into OKS (see Figure 5.1.E and Appendix 
6.1.6, page 302). 
      Self-motion and visual-illusion developed in both groups during OKS (main effect for 
Time: Self-motion, F (6, 35) = 3.262, p < .05; Visual-illusion, F (6, 35) = 4.131, p < .01).    106 
 
Self-motion was greatest mid OKS for both groups while visual-illusion increased further 
into OKS.  The experience however, was greater in migraine sufferers than in controls 
(main effect for Group: Self-motion, F (1, 40) = 5.472, p < .05; Visual-illusion, F (1, 40) 
= 6.997, p < .05).   Refer to Figure 5.1.G, 5.1.H, Table 5.1 and Appendix 6.1.7, 6.1.8 
(pages 303, 304, respectively) .    
     Sixteen  percent  of  migraine  sufferers  withdrew  from  OKS  compared  with  only  5 
percent of controls.  This difference however, did not reach significant levels (refer to 
Appendix 13, page 363). 
      Figure 5.1. A to F demonstrates change in symptom ratings over time.  Table 5.1 lists 
main effects and interactions for each symptom. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   107 
 
A.                                                                                               B. 
                       Nausea                                     Body temperature 
 
                         OKS                                                OKS 
      Baseline                                             Recovery    
0
1
2
3
4
5
  
*
*
*
*
*
*
*
*
*
R
a
t
i
n
g
 
(
0
-
1
0
)
  Baseline R ecovery
-1
0
1
2
3
4
5
*
*
*
*
*
*
*
*
*
w
a
r
m
e
r
 
(
0
-
1
0
)
C.                                                                             D.  
                   Dizziness                                             Drowsiness 
 
                      OKS                                                       OKS 
  Baseline      Recovery
0
1
2
3
4
5
 
*
*
*
*
* *
*
R
a
t
i
n
g
s
 
(
0
-
1
0
)
  Baseline Recovery
0
1
2
3
4
5
  
*
*
*
* *
* * *
R
a
t
i
n
g
s
 
(
0
-
1
0
)
                                                                                                                       
                                                                                                                        Migraineurs 
                                                                                                                                                 Controls 
 
        Figure 5.1.A-D.  Symptom ratings (+ SEM) for migraineurs (n = 21) and controls (n 
= 21) over 11 time points (every 2 minutes from baseline to minute 20).                 
 OKS = optokinetic stimulation                      *  statistically significant group difference (* p < .05)  
                                                                                                                      P.T.O for additional ratings                                          108 
 
E.                                                                                F. 
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G.                                                                              H. 
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     Figure 5.1.E– H.  Symptom ratings (+ SEM) for migraineurs (n = 21) and controls (n 
= 21) over 11 time points (every 2 minutes from baseline to minute 20 for Figs E and F) 
and over 7 time points (every 2 minutes from commencement of OKS for Figs G and H).   
OKS = optokinetic stimulation                       *  statistically significant group difference (* p < .05)                                         
Note:  Different rating scales for self-motion and visual-illusion  (0-2)   109 
 
 
      Table  5.1.    Main  effect  and  interaction  F,  p,  and  df  values  from  a  2  (group: 
migraineurs, controls) x 11 (time: every 2 minutes from baseline to minute 20) repeated-
measures ANOVA for each rating.  Values for Self-motion and Visual-illusion obtained 
from a 2 (group: migraineurs, controls) x 7 (time: every 2 minutes during OKS) repeated-
measures ANOVA. 
 
                                                                                   F ratios (df) 
  Group   Time   Time x Group 
Nausea     8.866 (1, 40) **    2.599 (10, 31) *  1.569 (10, 31)  
Body temperature  16.957 (1, 40) ***    4.460 (10, 31) **  3.016 (10, 31) ** 
Dizziness     5.048 (1, 40) *    2.353 (10, 31) *  1.378 (10, 31)  
Drowsiness     6.840 (1, 40) *    2.129 (10, 31)  1.282 (10, 31) 
Headache   11.910 (1, 40) **    1.906 (10, 31)   1.321 (10, 31) 
Unpleasantness   13.291 (1, 40) **    3.836 (10, 31) **  2.830 (10, 31) * 
Self-motion    5.472 (1, 40) *    3.262 (6, 35)   *    .985 (6, 35) 
Visual-illusion    6.997 (1, 40) *    4.131 (6, 35)   **    .745 (6, 35) 
* difference between migraine sufferers and controls statistically significant (* p < .05,** p < .01,*** p < .001) 
   degrees of freedom differ across the dependent variables because of empty cells 
 
 
 
 
 
Pulse Amplitude 
 
 
     Facial blood flow increased bilaterally during OKS for both groups (main effect for 
Time: F (10,31) = 7.001, p < .001) and responses between sides were comparable (see 
Table  5.2).      Overall,  pulse  amplitude  increased  more  in  migraine  sufferers  than  in 
controls throughout the experiment (34% + 4% vs 9% + 4%; F (1,40) = 16.635, p <  
.001).   Figure 5.2 and Appendix 6.2.1 (page  305) illustrate these trends.  
        Pulse  amplitude  increased  in  the  migraine  group  throughout  the  procedure.  
Vasodilatation in the control group was observed during OKS but returned to baseline 
levels 5 minutes later (Time x Group interaction: F (10,31) = 2.792, p < .05).  Appendix 
Tables 6.2.1 and 6.2.2 (pages 305, 306, respectively) illustrate change over time for each 
group.   As previously described, changes were greater in migraineurs than in controls.    110 
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                                                                                                                        Migraineurs 
                                                                                                                                                 Controls 
 
            Figure 5.2.   Pulse amplitude change (+ SEM) for migraineurs (n = 21) and controls 
(n = 21) over 11 time points (30 second sample increments from baseline, at minutes 3 ½, 
4, 4 ½, 7 ½, 8, 8 ½, 11 ½, 12, 12 ½, 14 ½, 19 ½).                OKS = optokinetic stimulation                      
*  statistically significant group difference (* p < .05)  111 
 
 
 
 
 
 
 
 
 
     Table  5.2.  Main  effect  and  interaction  F,  p,  and  df  values  from  a  2    (group: 
migraineurs, controls) x 2 (side: left, right) x 11 (time: 30 second sample increments from 
baseline, at minutes 3 ½, 4, 4 ½, 7 ½, 8, 8 ½, 11 ½, 12, 12 ½, 14 ½, 19 ½) repeated-
measures ANOVA for pulse amplitude change.   
 
Main effect                    df                        F                                     P 
Group                            1, 40                16.635                                .000 
Side                               1, 40                  1.296                                .262               
Time                            10, 31                  7.001                                .000  
Interaction  
Side x Time                10, 31                     .455                                .906 
Side x Group              10, 40                     .233                                .632 
Time x Group             10, 31                   2.792                                .014 
Side x Time x Group  10, 31                     .494                                .881  
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DISCUSSION 
 
Effects on symptomatic responses 
 
 
Summary of major findings 
 
      Key findings to emerge from exploring the effects of optokinetic stimulation were: 
 
•  Overall, symptomatic ratings were greater in migraine sufferers than in controls.  
Controls experienced slight nausea, dizziness, self–motion, visual-illusion and 
associated  unpleasantness  during  OKS.    Body  temperature  did  not  appear  to 
change, and drowsiness and headache did not develop. 
 
 
Discussion of effects on symptomatic responses 
 
 
     It was expected that symptomatic ratings would be greater in migraine sufferers than 
in controls during OKS.   In support of the hypotheses, and consistent with the literature, 
symptoms  of  motion  sickness  (nausea,  headache,  dizziness, drowsiness and perceived 
increases in body temperature) were greater in migraineurs than in controls throughout 
the procedure.  Visual-illusion, self-motion and, not surprisingly, overall unpleasantness 
were also greater in migraine sufferers.   
         As  symptoms  of  motion  sickness  and  migraine  are  similar,  the  enhanced 
symptomatic responses observed in migraine sufferers may reflect activation of neural 
pathways that produce either motion sickness or migraine.   If so, the same neural events 
may be involved in both conditions.  Specifically, brainstem and associated nuclei usually   113 
 
 
involved  during  attacks  of  migraine  (Weiller  et  al.,  1995)  might  reciprocally  initiate 
headache and other symptoms during OKS.   
 
 
 
Effects on pulse amplitude 
 
 
Summary of major findings 
 
•  Increases in pulse amplitude were greater in migraine sufferers than in controls 
throughout.    In  controls,  vasodilatation  was  observed  during  OKS  but  this 
response had subsided 5 minutes later. 
 
 
Discussion of effects on pulse amplitude   
 
       As anticipated changes in pulse amplitude were greater in migraine sufferers than in 
controls  during  OKS.      Increased  extracranial  blood  flow  has  been  observed  during 
motion sickness (Kolev, Moller, Nilsson and Tibbling, 1997) and at the onset of threat 
(Carrive and Bandler, 1991).   It may be that the enhanced vasodilatation observed in 
migraineurs  in  the  present  study  represents  a  stress  response  to  the  unpleasant  (and 
familiar  in  terms  of  the  migraine  experience)  symptoms  of  OKS-induced  motion 
sickness.  The  midbrain  PAG  is  involved  in  the  mediation  of  defensive  behaviour, 
including  modulating  fear  and  anxiety  and  autonomic  and  cardiovascular  responses 
(Behbehani, 1995).   Therefore, it is tempting to speculate that the enhanced vascular 
responses  observed  in  migraineurs  in  this  study  may  indicate  disrupted  PAG  control 
(hyperexcitable neural responses or weak inhibitory mechanisms).   
         However, the PAG is part of a circuit involving other areas of the brain in the 
regulation of fear, anxiety, and autonomic and cardiovascular responses. Specifically, the   114 
 
 
hypothalamus, amygdala, cortical, basal ganglia and brainstem nuclei (Venes, 2001; Bray 
et al., 1999) are also involved in regulation of these reactions.  It may be that all, or any, 
of these areas are faulty in those with a migraine predisposition.    
         Whatever  the  mechanism,  the  continued  vasodilatation  observed  in  this  group 
during recovery may demonstrate a neural or vascular hypersensitivity/ “wind-up” (Bray, 
Cragg, MacKnight and Mills, 1999) that amplifies neurovascular responses. 
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CHAPTER 6              
 
 
RESULTS & DISCUSSION 
 
 
 
  Condition 2 
                              
                  Ice on temple after optokinetic stimulation (OKS) 
    
 
 
 
     This  condition  investigated  whether  symptomatic  responses  following  painful 
stimulation of the temple with ice after OKS would differ between migraine sufferers and 
controls.  Since the ice probably stimulated the trigeminal nerve it was hypothesized that 
headache  would  develop  more  readily  in  the  migraine  group  than  controls.    
Additionally, if transmission of trigeminal impulses impinges on neurons responsible for 
symptoms  other  than  headache  in  migraineurs,  symptomatic  responses  other  than 
headache  might  develop  in  migraine  sufferers  more  readily  than  in  controls.  
Furthermore,  the  superficial  temporal  artery  dilates  during  some  attacks  of  migraine 
(Lance and Goadsby, 2002) and forehead blood flow increases readily in migraineurs 
following painful stimulation of the face and neck (Drummond, 1997).  Therefore, it was 
hypothesized that vascular responses to temple pain would be greater in the migraine 
group than in controls.  As migraine sufferers are prone to motion sickness (Golding, 
1998; Kuritzky, Ziegler & Hassanein, 1981) it was anticipated that residual effects from 
OKS would augment the development of vascular and symptomatic responses.   
 
   116 
 
 
RESULTS 
Symptom ratings 
 
     Procedures provoked more nausea (mean + S.E. = 1.127 + .254 vs  .037 + .270; F 
(1,45) = 8.649, p < .01) and headache (1.810 + .326 vs .333 + .347; F (1,45) = 9.635, p < 
.01) in migraine sufferers than controls throughout testing (see Figure 6.1.A, 6.1.E and 
Appendix 7.1.1, 7.1.5, pages 307, 311, respectively).  Simple contrast analyses indicated 
that low–grade nausea (awareness) persisted after OKS in migraineurs and then increased 
over  successive  applications  of  ice.    In  contrast,  nausea  was  negligible  in  controls 
throughout testing.  Low-grade headache also persisted after OKS in migraineurs and 
increased following the initial ice trial.  Controls were vaguely aware of headache during 
the course of the test but it did not develop further.  Generally, migraine sufferers were 
aware of dizziness, even prior to the application of ice, whereas controls reported none 
(.462  +  .125  vs  0  +  0;  F  (1,45)  =  6.424,  p  <  .05).    Apart  from  during  the  first  2 
applications of ice, dizziness was greater in migraine sufferers the whole time (see Figure 
6.1.C and Appendix 7.1.3, page 309).  Both groups became slightly less drowsy during 
early applications of ice (main effect for Time: F (9, 37) = 2.206, p < .05) but contrast 
analyses indicated that this effect was significant only in  migraine sufferers. 
     Both  groups  reported  experiencing  increased  levels  of  symptom  unpleasantness  in 
general, particularly during the application of ice to the temple (main effect for Time: F 
(9, 37) = 5.180, p < .001).  Simple contrast analyses indicated that unpleasantness was 
restricted  to  when  ice  was  applied  in  the  control  group  but  was  more  persistent  in 
migraine sufferers.  The extent of unpleasantness was greater for migraine sufferers than 
controls  (2.522  + .343  vs  .612,  +  .366;  F  (1,45)  = 14.479,  p  <  .001)  throughout  the 
procedure (see Figure 6.1.F and Appendix 7.1.6, page 312). 
Pain peaked in intensity and unpleasantness for both groups when ice was applied to 
the  temple  (main  effect  for  Time:  Pain  Intensity,  F  (8,38)  =  21.578,  p  <  .001;  Pain 
Unpleasantness, F (8,38) = 15.559, p < .001).  Ratings were greater in migraine sufferers 
than controls until just following the final ice application (see Figures 6.1.G, 6.1.H and 
Appendix 7.1.7, 7.1.8, pages 313, 314, respectively).   
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      Figure  6..1.A  to  H  demonstrate  change  in  symptom  ratings  over  time.  Table  6..1 
demonstrates main effects and interactions for each symptom. 
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       Figure 6.1.A-B.  Symptom ratings (+ SEM) for migraineurs (n = 25) and controls (n 
= 22) over 11 time points (every 2 minutes from baseline to minute 20).  
* statistically significant group difference (* p < .05)                                P.T.O for additional ratings 
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       Figure 6.1.C-F.  Symptom ratings (+ SEM) for migraineurs (n = 25) and controls (n 
= 22) over 11 time points (every 2 minutes from baseline to minute 20).  
* statistically significant group difference (* p < .05)                                    
Note: Y axis has different rating scales for unpleasantness 
                                                                                                  P.T.O for additional ratings    119 
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       Figure 6.1.G-H.:  Symptom ratings (+ SEM) for migraineurs (n = 25) and controls 
(n = 22) over 9 time points (every 2 minutes from ice 1).   
* statistically significant group difference (* p < .05)    
 
 
Note: Y axis has different rating scales unpleasantness (previous page), ice-induded 
intensity and ice-induced unpleasantness 
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    Table 6.1.  Main effect and interaction F, p, and df values from from a 2 (group: 
migraineurs, controls) x 11 (time: every 2 minutes from baseline to minute 20) repeated-
measures ANOVA for each rating.  Ice-induced pain intensity and unpleasantness  values 
obtained from a 2  (group: migraineurs, controls) x 9 (time: every 2 minutes from the first 
application of ice) repeated-measures ANOVA 
 
                                                                F ratios (df) 
  Group   Time   Time x Group 
Nausea     8.649 (1, 45) **    1.563 (9, 37)  1.911 (9, 37) 
Body temperature    2.633 (1, 45)    1.662 (9, 37)  1.220 (9, 37) 
Dizziness     6.424 (1, 45) *    1.082 (9, 37)  1.082 (9, 37) 
Drowsiness     1.311 (1, 45)    2.206 (9, 37) *  2.197 (9, 37) * 
Headache     9.635 (1, 45) **    2.016 (9, 37)  1.766 (9, 37) 
Unpleasantness   14.479 (1, 45) ***    5.180 (9, 37) ***  1.357 (9, 37) 
Ice-induced intensity  11.398 (1, 45) **  21.578 (8, 38) ***    .800 (8, 38) 
Ice-induced unpleasantness  15.745 (1, 45) ***  15.559 (8, 38) ***  1.783 (8, 38) 
* difference between migraine sufferers and controls statistically significant (* p < .05,** p < .01,*** p < .001)  
 
    degrees of freedom differ across the dependent variables because of empty cells 
 
 
 
Pulse Amplitude 
 
     Pulse  amplitude  remained  unchanged  throughout  procedures  for  both  groups  and 
responses between sides were comparable (see Figure 6.2, Tables 6..2, and Appendix 
7.2.1 and 7.2.2, pages 315, 316, respectively).   
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    Figure  6.2.      Pulse  amplitude  change  (+  SEM)  for  migraineurs  (n  =  25)  and 
controls (n = 22) over 11 time points (30 second samples: before, during and after ice 
application {3 trials}, and after 3 and 8 minutes of recovery {R}).  The first arrow in each 
trial represents pulse amplitude before the immersion, and the second arrow represents 
pulse amplitude after the immersion.        * statistically significant group difference (* p < .05)122 
 
 
 
 
 
 
     Table  6.2.  Main  effect  and  interaction  F,  p,  and  df  values  from  a  2    (group: 
migraineurs, controls) x 2 (side: ipsilateral, contralateral to stimulation) x 11 (time: 30 
second samples, before {trial 1, 2 & 3}, during {trial 1, 2 & 3} and after {trial 1, 2 & 3} 
ice application to temple, and 3 and 8 mins after the 3
rd application) repeated-measures 
ANOVA for pulse amplitude change.   
 
Main effect                    df                        F                                     P 
Group                            1, 45                    .007                                .936 
Side                               1, 45                    .567                                .455               
Time                            10, 36                 1.326                                .254                                     
Interaction  
Side x Time                10, 36                   1.012                                .452 
Side x Group                1, 45                   3.059                                .087 
Time x Group             10, 36                   1.088                                .397 
Side x Time x Group  10, 36                     .742                                .681  
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DISCUSSION 
 
Effects on symptomatic responses 
 
Summary of major findings 
 
     Key findings to emerge from exploring the effects of ice to the temple after OKS 
were: 
•  Symptomatic ratings, apart from body temperature and drowsiness, were greater 
in  migraineurs  than  in  controls.    A  slight  awareness  of  increase  in  body 
temperature  and  drowsiness  persisted  throughout  testing  for  both  groups.  As 
these  symptoms  were  evident  even  prior  to  procedures,  they  were  probably 
carry-over  effects  from  the  earlier  OKS.    Residual  nausea,  headache  and 
dizziness  prior  to  the  ice  application  were  also  evident  in  migraineurs.  
Headache and nausea subsequently increased from the initial application of ice.  
Dizziness  remained  low-grade  (an  awareness)  the  entire  time.    On  the  other 
hand, controls remained virtually asymptomatic throughout.    
•  Overall unpleasantness and pain ratings were greater in migraine sufferers than 
in  controls.  In  migraine  sufferers,  unpleasantness  to  symptomatic  changes 
increased from the initial application of ice and subsided by 6 minutes after the 
third trial.  In controls, overall unpleasantness increased only during the first 2 
applications of ice. For both groups, ice-induced intensity and unpleasantness 
increased during each application of ice to the temple.   
 
 
Discussion of effects on symptomatic responses  
 
     Findings,  in  part,  supported  the  hypotheses  that  headache  and  other  symptomatic 
responses would develop more readily in the migraine group than controls.  Apart from 124 
 
 
body temperature and drowsiness, symptomatic ratings were greater in migraine sufferers 
than in controls.   Prior to painful stimulation of the temple, migraineurs showed signs of 
residual effects from the preceding OKS.   They commenced testing with a low-grade 
awareness  of  nausea,  dizziness,  drowsiness  and  a  perception  of  increased  body 
temperature.  Additionally, low-grade headache was reported which increased following 
the initial application of ice.  Nausea increased over successive applications of ice and an 
awareness  of  increases  in  body  temperature,  dizziness  and  drowsiness  persisted 
throughout.   Controls remained practically asymptomatic the entire time.  
     Application  of ice  to  the temple most likely stimulated branches of the trigeminal 
nerve.    Migraineurs, between attacks of migraine, were more sensitive than controls to 
painfully cold stimulation of the temple in the presence of residual motion sickness.   Not 
surprisingly, as symptomatic changes were mostly greater in migraine sufferers, overall 
unpleasantness was enhanced for this group.  Activation of the trigeminal sensory system 
and neurogenic inflammation has been linked to head pain (Moskowitz, 1995) and nausea 
during migraine attacks (Knight, 2005; Dalhlof and Hargreaves, 1998).  The development 
of these particular symptoms, and the heightened pain reported in the present test by 
migraineurs,  suggests  that  the  trigeminal  nerve  is  also  hypersensitive  in  the  interictal 
period.   
       However,  hypersensitivity  of  trigeminal  afferents  between  migraine  sufferers  and 
controls has not been established.  It could be that hypersensitivity may occur at any point 
anatomically  from  activation  of  the  somatosensory  to  the  cortex.    Furthermore,  to 
conclude “trigeminal hypersensitivity” in migraine sufferers compared to controls based 
on heightened pain responses may also be problematic.   The brain may indeed process 
pain differently in migraine sufferers, or it may be that this group simply use different 
criteria in their reported experience of pain.    Given that pain is a subjective experience it 
may have been more appropriate to have compared responses of migraine sufferers with 
themselves, i.e., pain perception ictally to interictally, rather than to a pain-free control 
group, as done in this study.    However, exposure to the provocative procedures used in 
this study probably would not have been tolerated during a migraine attack, making data 
collection impossible, or at best insufficient at that time for meaningful analyses. 125 
 
 
       Whether symptomatic changes intensified in migraine sufferers in the presence of 
any residual symptoms following OKS, will be addressed in later sections.  In particular, 
the  effects  of  painfully  cold  stimulation  of  the  temple  independent  of  OKS  will  be 
compared  to painfully cold stimulation of the temple after OKS (see chapter 12, page 
192-208)  
 
 
 
Effects on pulse amplitude 
 
 
Summary of major findings 
 
 
•  Overall,  pulse  amplitude  remained  stable,  and  reactions  between  sides  were 
comparable  for  both  groups.    Slight  vasoconstriction  was  observed  in  both 
groups but did not reach significant levels.         
 
 
Discussion of effects on pulse amplitude   
 
 
           The lack of extracranial vasodilatation during painful stimulation of the temple in 
the presence of residual effects of motion sickness is surprising, as it was anticipated that 
residual effects from OKS would augment the development of vascular responses. The 
application of ice to the temple was painful and no doubt excited the sympathetic nervous 
system.    This  may,  in  turn,  help  account  for  the  slight  extracranial  vasoconstriction 
observed in both groups.   As previously suggested, it may be that the headache observed 
in migraine sufferers in the present study is symptomatic of the neurogenic inflammatory 
response.    Plasma  extravasation  and  vasodilatation,  i.e.  neurogenic  inflammation,  has 126 
 
 
been  attributed  to  antidromic  activation  of  afferent  C-fibres.        In  the  present  case, 
vasodilatation associated with headache may have occurred in deeper cephalic tissue, e.g. 
meningeal vasculature, as the trigeminal nerve transmits nociceptive signals from dilated 
blood vessels of the pia- and dura mater (Frickle, 2001; Frickle, Andres and Von Düring, 
2001; Moskowitz, 1993).    
        As  pulse  amplitude  did  not  appear  to  recover  in  migraine  sufferers  during  the 
previous procedure (i.e., OKS alone), data was re-analysed using the baseline from the 
previous condition (see Appendix 12, page 361-362).  This analysis indicated that pulse 
amplitude  increased  during  OKS  and  remained  increased  when  ice  was  applied  after 
OKS,  particularly    in  migraine  sufferers.  Occasional  vasoconstriction  was  evident  in 
controls  only.     Overall, pulse  amplitude  was comparable between groups.   If some 
aspect  of  motion  sickness  disrupted  vasomotor  activity  at  a  neural  level  this  should 
become clearer in light of the vascular response to cold stimulation of the temple: in the 
absence  of  motion  sickness  (see  results  condition  3,  page  127-137)  and  during  OKS 
induced motion sickness (see results condition 4, page 138-149).    
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CHAPTER 7              
 
 
RESULTS and DISCUSSION 
 
 
  Condition 3 
                              
                  Ice on temple before optokinetic stimulation (OKS) 
    
   
 
     The  purpose  of  this  condition  was  to  determine  whether  symptomatic  responses 
following  painful  stimulation  of  the  temple  with  ice  would  differ  between  migraine 
sufferers and controls.  As the application of ice could stimulate the trigeminal nerve, it 
was hypothesized that headache would develop more readily in the migraine group than 
in controls.   Also, if conduction of trigeminal impulses converges centrally on neurons 
responsible for symptoms other than headache, painful stimulation of the temple might 
evoke these responses in migraine sufferers more readily than in controls.  Enhanced 
extracranial responses during head pain have been observed (Lance and Goadsby, 2002; 
Drummond, 1997) so it was hypothesized that vascular responses to temple pain in this 
test might be greater in the migraine group than in controls.  128 
 
 
 
 
RESULTS 
 
Symptom ratings  
     Throughout the procedure changes in symptom ratings were minimal for both groups.  
Migraine  sufferers  experienced  low-grade  headache  (head  awareness),  which  built  up 
over the procedure whereas controls were barely aware of headache (mean + S.E. = .910 
+  .163  vs  028  +  .170;  F  (1,46)  =  14.033,  p  <  .001).    While  slight  headache  (head 
awareness)  was  observed  in  migraine  sufferers  prior  to  testing,  contrast  analyses 
indicated headache increased from the second placement of ice and recovered 6 minutes 
after the final application.  Further contrast analyses indicated that both groups became 
slightly less drowsy during early applications of ice, but no other symptoms developed.  
Both  groups  reported  increased  levels  of  unpleasantness  to  symptoms  in  general, 
particularly during application of ice to the temple (main effect for Time: F (9, 38) = 
6.599, p < .001).  Simple contrast analyses indicated that unpleasantness was restricted to 
when ice was applied in the control group but persisted in migraine sufferers.  The extent 
of unpleasantness overall was greater for migraineurs than controls (1.358 + .211 vs .370 
+ .220; F (1,46) = 10.487, p < .01) particularly during ice applications and following the 
third trial  (see figure 7.1.F and Appendix 8.1.6, page 322).      
       Understandably, ice-induced pain increased in intensity and unpleasantness for both 
groups when ice was applied to the temple (main effect for Time: Pain Intensity, F (8,39) 
=  27.560,  p  <  .001;  Pain  Unpleasantness,  F  (8,39)  =  19.362,  p  <  .001).      Migraine 
sufferers generally rated the experience as more intense and unpleasant than controls (see 
Figure 7.1.G and H and Appendix 8.1.7, 8.2.8, pages 323, 324, respectively). 
        Figure 7.1.A to H demonstrate change in symptom ratings over time.  Table 7.1 
demonstrates main effects and interactions for each symptom. 
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       Figure 7.1.A-B.  Symptom ratings (+ SEM) for migraineurs (n = 25) and controls (n 
= 23) over 11 time points (every 2 minutes from baseline to minute 20).  
* statistically significant group difference (* p < .05)                                P.T.O for additional ratings 
  
 
 
 
 130 
 
 
C.                                                                               D. 
                           Dizziness                                          Drowsiness 
  B aseline   1   2   3     R ecovery    
0
1
2
 
R
a
t
i
n
g
 
(
1
-
1
0
)
  B aseline   1   2   3     R ecovery    
0
1
2
 
R
a
t
i
n
g
 
(
1
-
1
0
)
                         ↑___ ice ___↑                                                                ↑___ ice ___↑ 
E.                                                                               F. 
                     Headache                                           Unpleasantness  
  Baseline   1   2   3      Recovery    
0
1
2
 
* *
*
*
*
*
*
* * *
R
a
t
i
n
g
 
(
1
-
1
0
)
  Baseline   1   2   3     Recovery    
0
1
2
3
4
 
*
*
*
*
* *
R
a
t
i
n
g
 
(
1
-
1
0
)
                        ↑___ ice ___↑                                                                   ↑___ice ___↑ 
 
                                                                                                                        Migraineurs 
                                                                                                                                                Controls 
 
       Figure 7.1.C-F.  Symptom ratings (+ SEM) for migraineurs (n = 25) and controls (n 
= 23) over 11 time points (every 2 minutes from baseline to minute 20).  
* statistically significant group difference (* p < .05)                                 
Note: Y axis has different rating scales for unpleasantness          
                                                                                                 P.T.O for additional ratings                                        131 
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       Figure 7.1.G-.H.  Symptom ratings (+ SEM) for migraineurs (n = 25) and controls 
(n = 23) over 9 time points (every 2 minutes from ice 1)  
* statistically significant group difference (* p < .05)    
 
Note:  Y  axis  has  different  rating  scales  for  unpleasantness  (previous  page)  ice-
induded intensity and ice-induced unpleasantness  
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      Table  7.1.    Main  effect  and  interaction  F,  p,  and  df  values  from  a  2  (group: 
migraineurs, controls) x 11 (time: every 2 minutes from baseline to minute 20) repeated-
measures ANOVA for each rating.  Ice-induced pain intensity and unpleasantness values 
obtained from a 2  (group: migraineurs, controls) x 9 (time: every 2 minutes from the first 
application of ice) repeated-measures ANOVA 
 
                                                                F ratios (df) 
  Group   Time   Time x Group 
Nausea    3.964 (1, 46)    1.244 (9, 38)  1.361 (9, 38) 
Body temperature     .618 (1, 46)    1.489 (9, 38)    .584 (9, 38) 
Dizziness    2.012 (1, 46)    1.034 (6, 41)  1.034 (6, 41) 
Drowsiness       .453 (1, 46)     1.732 (9, 38)    .924 (9, 38) 
Headache   14.033 (1, 46) ***    1.631 (9, 38)  1.381 (9, 38)  
Unpleasantness   10.487 (1, 46) **    6.599 (9, 38) ***  2.839 (9, 38) * 
Ice-induced intensity  20.545 (1, 46) ***  27.560 (8, 39) ***  2.745 (8, 39) * 
Ice-induced unpleasantness  21.781 (1, 46) ***  19.362 (8, 39) ***  3.364 (8, 39) ** 
* difference between migraine sufferers and controls statistically significant (* p < .05,** p < .01,*** p < .001)  
 
   degrees of freedom differ across the dependent variables because of empty cells 
 
 
 
 
 
 Pulse Amplitude 
 
     Pulse amplitude increased bilaterally and progressively in both groups over time (main 
effect for Time: F (10,37) = 3.403, p < .01) but overall increases were greater in migraine 
sufferers than in controls throughout the condition (25% + 4% vs 7%  + 4%; F (1,46) = 
11.461, p <  .001).   Figure 7.2, Table 7.2 and Appendix 8.2.1 and 8.2.2 (pages 325, 326, 
respectively) demonstrate these observations.   
     Vasodilatation was evident in migraine sufferers throughout testing, even before the 
initial application of ice to the temple.  However, vasodilatation in the control group 
developed as the procedure progressed.   Refer to Appendix 8.2.1 and 8.2.2 (pages 325, 
326, respectively). 133 
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 Figure 7.2.   Pulse amplitude change (+ SEM) for migraineurs (n = 25) and controls 
(n = 23) over 11 time points (30 second samples: before, during and after ice application 
{3  trials},  and  after  3  and  8 minutes  of recovery  {R}).  The  first  arrow  in each trial 
represents pulse amplitude before the immersion, and the second arrow represents pulse 
amplitude after the immersion.             *  statistically significant group difference (* p < .05)  134
 
 
 
 
 
     Table  7.2.    Main  effect  and  interaction  F,  p,  and  df  values  from  a  2    (group: 
migraineurs, controls) x 2 (side: ipsilateral, contralateral to stimulation) x 11 (time: 30 
second samples, before {trial 1, 2 & 3}, during {trial 1, 2 & 3} and after {trial 1, 2 & 3} 
ice application to temple, and 3 and 8 mins after the 3
rd application) repeated-measures 
ANOVA for pulse amplitude change.   
 
Main effect                    df                        F                                     P 
Group                            1, 46                11.461                                .001 
Side                               1, 46                    .295                                .590               
Time                            10, 37                  3.403                                .003                                     
Interaction  
Side x Time                10, 37                     .892                                .549 
Side x Group              10, 46                     .146                                .705 
Time x Group             10, 37                   1.050                                .423 
Side x Time x Group  10, 37                     .542                                .849  
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DISCUSSION 
 
Effects on symptomatic responses 
 
Summary of major findings 
 
     Key findings to emerge from exploring the effects of ice to the temple before OKS 
were: 
•  Overall, ratings of nausea, body temperature, dizziness and drowsiness remained 
virtually unchanged and comparable for both groups throughout.  However, in a 
different analysis of these responses (refer to publications related to this study, 
Drummond  and  Granston,  2005),  it  was  demonstrated  that  by  the  third 
application  of  ice  nausea  increased  more  so  in  migraine  sufferers  than  in 
controls.    Headache,  overall  unpleasantness  and  ice-induced  intensity  and 
unpleasantness, were greater in migraineurs than in controls.    
 
 
Discussion of effects on symptomatic responses 
 
       Results  were  consistent  with  the  hypothesis  that  headache  would  develop  more 
readily in migraine sufferers than in controls.  Migraine sufferers were aware of low-
grade  headache  even  prior  to  the  procedures,  which  increased  following  the  second 
application of ice to the temple.  Six minutes after the third ice application, headache 
gradually subsided to baseline levels of head-awareness.  Low-grade nausea (awareness) 
developed in the migraine group before and during the final application of ice, which at 
least partly supported the hypothesis that symptoms other than headache might be evoked   136
in migraine sufferers more readily than in controls.   Controls remained asymptomatic 
throughout. 
        Thermal  nociceptors  were  excited,  apparently  more  so  in migraineurs interictally 
than  in  controls  to  extremely  cold  sensory  provocation.    Specifically,  ice-induced 
intensity and upleasantness, headache and not surprisingly, overall unpleasantness were 
enhanced  in  the  migraine  group.    Migraine  sufferers  were  more  sensitive  to  painful 
stimulation  of  the  temple  with  ice  than  were  controls,  and  more  readily  developed 
headache.    It is plausible that headache may have developed following activation of 
neuronal  structures  and  pathways  normally  involved  in the transmission of head pain 
(Pietrobon,  2005;  Knight,  2005;  Silberstein,  2004,  2003;  Moskowitz  and  Macfarlane, 
1993).    As pointed out, in addition to the development of headache, migraine sufferers 
experienced nausea by the third application of ice to the temple.  Head pain appeared to 
trigger nausea, suggesting gastrointestinal disturbance in this group, which may similarly 
occur in a migraine attack.    
 
 
 
Effects on pulse amplitude 
 
 
Summary of major findings   
 
•  Pulse amplitude increased bilaterally for both groups over time but more so in 
migraineurs.    In migraine sufferers vasodilatation was evident even before the 
initial application of ice, but developed in controls as the procedure progressed.  
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Discussion of effects on pulse amplitude   
 
           Increases  in  pulse  amplitude  were  observed  in  both  groups  in  response  to 
trigeminal stimulation.  However, consistent with hypotheses responses were greater in 
the  migraine  group  than  in  controls.      The  enhanced  vascular  reactivity  observed  in 
migraine  sufferers  was  evident  before  the  application  of  ice,  suggesting  a  possible 
defense response in this group in anticipation of the painful stimuli.   
      Vasodilatation developed in migraineurs even before the initial application of ice, but 
in controls gradually developed as the procedure progressed.   Extracranial blood vessels 
dilate more readily in migraine sufferers than in controls during exposure to stressful 
stimulation  (Drummond,  1984).    Stress  is  also  a  commonly  sited  precipitating  and 
aggravating factor of migraine headache (Spierings, Ranke and Honkoop, 2001; Holm, 
Lokken and Myers, 1997).  It is conceivable that migraineurs in the present study were 
primed in anticipation of the pending painful stimulus, perhaps because of an association 
with  the  all  too  familiar  pain  of migraine.      Hence,  the vasodilator defense response 
probably accounted for vasodilatation prior to the ice application and also contributed to 
enhanced reactions when the ice was applied. 
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CHAPTER 8  
 
RESULTS and DISCUSSION 
 
 
 
  Condition 4 
                              
                  Ice on temple during optokinetic stimulation (OKS) 
    
 
 
 
      This  condition  investigated  whether  symptomatic  responses  following  painful 
stimulation of the temple with ice during OKS would differ between migraine sufferers 
and controls.  As migraineurs are prone to motion sickness (Golding, 1998; Kuritzky, 
Ziegler  &  Hassanein,  1981)  it  was  hypothesized  that  symptomatic  ratings  would  be 
greater in migraine sufferers than in controls during OKS.  Also, as ice on the temple 
probably  stimulated  the  trigeminal  nerve,  it  was  hypothesized  that  headache  would 
intensify more readily during OKS in the migraine group than in controls.    Similarly, if 
conduction of trigeminal impulses converges on neurons responsible for symptoms other 
than headache, these symptoms might be enhanced in migraine sufferers during painful 
stimulation.  Also, as facial blood flow increases during motion sickness in susceptible 
individuals (Harm, 1990; Kolev et al., 1997) and during head pain in migraineurs (Lance 
and Goadsby, 2002; Drummond, 1997), it was hypothesized that vascular reactions in 
response  to  temple  pain  during  OKS would be greater in the migraine group than in 
controls.     139
 
RESULTS 
 
Symptom ratings       
 
      Overall, symptomatic responses increased during OKS for both groups (main effect 
for Time for each response, p < .05).  Procedures evoked more nausea (mean + S.E. = 
2.116 + .353 vs .473 + .319; F (1,38) = 11.910, p < .001), dizziness (2.239 + .392 vs .578 
+ .354; F (1,38) = 9.892, p < .01) and headache (1.968 + .351 vs .014 + .318; F (1,38) = 
17.012,  p  <  .001)  in migraine  sufferers than  in controls.    Investigation  of  significant 
Group by Time Simple Contrast interactions indicated that nausea and dizziness ratings 
were greater in migraine sufferers than in controls once OKS commenced, before the first 
application of ice (see Figure 8.1.A, 8.1.C and Appendix 9.1.1, 9.1.3, pages 327, 329, 
respectively).  Headache was greater in migraineurs even before OKS (see Figure 8.1.E 
and  Appendix  9.1.5,  page  331).    While  both  groups  developed  nausea  and  dizziness 
during OKS, controls recovered sooner.  Headache increased in migraineurs following 
the first application of ice, but was minimal in controls throughout the procedures (Time 
x Group interaction, F (10,29) = 3.977, p < .01).    Body temperature and drowsiness 
increased during the procedure in migraine sufferers but remained stable in controls (see 
Appendix 9.1.2, 9.1.4,  page 328, 330, respectively).   
      Unpleasantness overall was greater for migraine sufferers than for controls (3.081 + 
.445 vs .886 + .403; F (1,38) = 13.361, p < .001).  Inspection of significant Group by 
Time Simple Contrast interactions indicated that these ratings were greater in migraine 
sufferers than in controls throughout the test (see Figure 8.1.F and Appendix 9.1.6, page 
332).    Otherwise,  both  groups  reported  experiencing  increased  levels  of  symptom 
unpleasantness  in  general,  particularly  during  application  of  ice  to  the  temple   (main 
effect  for  Time:  F  (10,29)  =  5.477,  p  <  .001).    Migraine  sufferers  experienced 
unpleasantness throughout testing.  Controls however, experienced unpleasantness during 
the first application of ice and recovered soon after OKS (Time x Group interaction: F 
(10,29) = 2.498, p < .05).   140
   Pain peaked in intensity and unpleasantness for both groups during ice application to 
the temple (main effect for Time: Pain Intensity, F (10,29) = 11.179, p < .001; Pain 
Unpleasantness,  F  (9,30) =  8.751,  p  <  .001).   Perceptions increased from the initial 
application of ice in both groups, and while controls recovered after OKS, pain intensity 
persisted  in  migraineurs.    Investigation  of  significant  Group  by  Time  interactions 
indicated that ratings were greater in migraine sufferers than in controls throughout the 
procedures  (see  Figures  8.1.G,  8.1.H  and  Appendix  9.1.7,  9.1.8,  pages  333,  334, 
respectively).   
        Apart from during and after the second application of ice, self-motion was greater in 
migraine sufferers than in controls (main effect for Group: F (1, 38) = 8.136, p < .01).  
Visual-illusion developed more in migraineurs than in controls following the second ice 
trial (main effect for Group: F (1, 38) = 5.741, p < .05).  Refer to Figure 8.1.I, 8.1.J and 
Appendix 9.1.9, 9.1.10 (pages  335, 336, respectively). 
        Twenty-eight  percent  of  migraine  sufferers  withdrew  from  OKS  and  painful 
stimulation  of  the  temple  compared  to  only  four  percent  of  controls  (p<0.05,  see 
Appendix 13, page 363). 
      Figure  8.1.A  to  H  demonstrate  change  in  symptom  ratings  over  time.    Table  8.1 
demonstrates main effects and interactions for each symptom. 
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      Figure 8.1.A-D.   Symptom ratings (+ SEM) for migraineurs (n = 18) and controls (n 
= 22) over 11 time points (every 2 minutes from baseline to minute 20).  
OKS = optokinetic stimulation                       *  statistically significant group difference (* p < .05)                                  
                                                                                                                      P.T.O for additional ratings   142
E.                                                                               F. 
                        Headache                                      Unpleasantness 
OKS
    Baseline       1       2       3         Recovery        
0
1
2
3
4
5
 
* *
* *
* * * * * * *
R
a
t
i
n
g
 
(
1
-
1
0
)
OKS
    Baseline       1       2       3         Recovery        
0
1
2
3
4
5
 
*
*
*
*
*
*
* *
*
*
*
R
a
t
i
n
g
 
(
1
-
1
0
)
                           ↑___  ice ___↑                                                          ↑___  ice ___↑ 
 
  G.                                                                               H. 
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      Figure 8.1.E-H.  Symptom ratings (+ SEM) for migraineurs (n = 18) and controls (n 
= 22) over 11 time points (every 2 minutes from baseline to minute 20 {E, F}) and over 9 
time points (every 2 minutes from ice 1 {G, H}).    
OKS = optokinetic stimulation                       *  statistically significant group difference (* p < .05)                                 
Note:  Y  axis  has  different  rating  scales  for  ice-induced  intensity  and  ice-induced 
unpleasantness.                                                                       P.T.O for additional ratings                 143
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      Figure 8.1.I-J.  Symptom ratings (+ SEM) for migraineurs (n = 18) and controls (n = 
22) over 7 time points (every 2 minutes from commencement of OKS).    
OKS = optokinetic stimulation        *  statistically significant group difference (* p < .05)  
 
Note:  Different rating scales for self-motion and visual-illusion  (0-2) 
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      Table 8.1.  Main effect and interaction F, p, and df values from from a 2 (group: 
migraineurs, controls) x 11 (time: every 2 minutes from baseline to minute 20) repeated-
measures ANOVA for each rating.  Values for Self-motion and Visual-illusion obtained 
from a 2 (group: migraineurs, controls) x 7 (time: every 2 minutes during OKS) repeated-
measures ANOVA, and ice-induced pain intensity and unpleasantness from a 2  (group: 
migraineurs,  controls)  x  9  (time:  every  2  minutes  from  the  first  application  of  ice) 
repeated-measures ANOVA.    
 
                                                                F ratios (df) 
  Group   Time   Time x Group 
Nausea   11.910 (1, 38) ***    3.573 (10, 29) **  1.951 (10, 29) 
Body temperature    4.034 (1, 38)    2.369 (10, 29) *  1.481 (10, 29) 
Dizziness     9.892 (1, 38) **    2.835 (10, 29) *  1.357 (10, 29) 
Drowsiness     3.396 (1, 38)     2.604 (10, 29) *  1.630 (10, 29) 
Headache   17.012 (1, 38) ***    4.217 (10, 29) ***  3.977 (10, 29) ** 
Unpleasantness   13.361 (1, 38) ***    5.477 (10, 29) ***  2.498 (10, 29) * 
Ice-induced intensity  10.833 (1, 38) **  11.179 (10, 29) ***  2.897 (10, 29) * 
Ice-induced unpleasantness  11.079 (1, 38) **    8.751 (9, 30)   ***  3.386 (9, 30)   ** 
Self-motion    8.136 (1, 38) **    1.313 (6, 33)  1.528 (6, 33) 
Visual-illusion    5.741 (1, 38) *    1.522 (6, 33)  1.124 (6, 33) 
* difference between migraine sufferers and controls statistically significant (* p < .05,** p < .01,*** p < .001)  
 
   degrees of freedom differ across the dependent variables because of empty cells 
 
 
 
 
 
Pulse Amplitude 
 
      Pulse  amplitude  increased  bilaterally  in  both  groups during  OKS  (main effect  for 
Time: F (10,29) = 3.740, p < .01).  Refer to Figure 8.2 and Table 8.2.  Closer inspection 
indicated that vasodilatation was greater in migraine sufferers than in controls during the 
second ice trial (see Figure 8.2).  Intercept analyses indicated that vasodilatation persisted 
throughout OKS in both groups and returned to baseline in migraineurs by 5 minutes 
after OKS but fell below baseline in controls (Time x Group interaction: F (10,29) = 
2.878, p < .05).  Table 8.2 and Appendix  9.2.1 and 9.2.2 (pages 337, 338, respectively) 
illustrate this observation.     
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 Figure 8.2.   Pulse amplitude change (+ SEM) for migraineurs (n = 18) and controls 
(n = 22) over 11 time points (30 second samples: before, during and after ice application 
to temple {3 trials}, and after 3 and 8 minutes {recovery - R}). The first arrow in each 
trial represents pulse amplitude before the application, and the second arrow represents 
pulse amplitude after the application.   
OKS = optokinetic stimulation                       * statistically significant group difference (* p < .05)   146
 
 
 
     Table  8.2.  Main  effect  and  interaction  F,  p,  and  df  values  from  a  2    (group: 
migraineurs, controls) x 2 (side: ipsilateral, contralateral to stimulation) x 11 (time: 30 
second samples, before {trial 1, 2 & 3}, during {trial 1, 2 & 3} and after {trial 1, 2 & 3} 
hand  immersion  in  ice-water,  and  3  and  8  mins  after  the  3
rd  immersion)  repeated-
measures ANOVA for pulse amplitude change.  
  
Main effect                    df                        F                                     P 
Group                          1, 38                     2.969                              .093 
Side                             1, 38                       .055                              .816                           
Time                          10, 29                    3.740                              .003 
Interaction  
Side x Time               10, 29                        .923                              .526 
Side x Group               1, 38                        .073                              .789  
Time x Group            10, 29                      2.878                              .013 
Side x Time x Group 10, 29                        .577                              .819  
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DISCUSSION 
 
Effects on symptomatic responses 
 
Summary of major findings 
     Key findings to emerge from exploring the effects of ice to the temple during OKS 
were: 
•  Overall, ratings of headache, nausea, dizziness, self-motion and visual illusion 
were  greater  in  migraine  sufferers  than  in  controls.    Drowsiness  and  body 
temperature also increased, more so in migraineurs, but group differences only 
became  evident  as  the  procedure  progressed.      Apart  from  slight  nausea, 
dizziness, self-motion and visual illusion, symptomatic ratings barely developed 
in controls.   Migraineurs found the experience generally more unpleasant, and 
ice-induced pain more intense and unpleasant, than controls.   
 
Discussion of effects on symptomatic responses 
 
         As hypothesized, symptomatic ratings were greater in the migraine sufferers than in 
controls  when  ice  was  applied  to  the  temple  during  OKS.      In  addition,  a  greater 
proportion of migraine sufferers than controls withdrew from OKS, indicating that they 
were unable to tolerate procedures.  Ratings of overall unpleasantness and ice-induced 
pain were also heightened in migraineurs, probably because symptoms developed more 
readily in this group.   It may also be that migraine sufferers use different criteria in their 
reported  experience  of  pain  and  have  a  lower  tolerance  threshold  in  terms  of 
unpleasantness.   Ideally, it may have been better to have compared the responses of 
migraine  sufferers  with  themselves  during  an  attack,  than  to  responses of  a  normally 
pain-free group, as done in this study.   However, it was methodologically considered 
impractical to test migraine sufferers during a migraine attack in this study (see comment 
in Discussion of Results Condition 2, page 124).    148
       OKS most likely triggered visually-induced motion sickness (Takeda, Morita, Horii, 
Nishiike and Uno, 2001) as symptomatic responses developed in both groups, albeit more 
so in migraineurs.   In addition, trigeminal nociceptors were stimulated by the application 
of ice to the temple.  Migraine sufferers were more sensitive to painful stimulation than 
controls, and developed headache during the procedure.  While vestibular structures are 
required  for  the  generation  of  motion  sickness  (Yates,  Miller  and  Lucot,  1998), 
trigeminal nuclei are probably involved in the development of symptoms including head 
pain, during a migraine attack (Moskowitz, 1993).   Both of these pathways have been 
associated  with  activation  of  the  “vomiting  center”  (Dahlof  and  Hargreaves,  1998; 
Mitchelson, 1992).  The enhanced symptomatic responses in migraineurs in this study 
may be because hypersensitivity persists in these neural pathways in the interictal period.    
Closely  connected  and  overlapping  pathways  that  typically  generate  either  motion 
sickness or migraine perhaps interact and augment one another during a migraine attack.   
         Symptomatic  ratings  were  greater  in  migraine  sufferers  than  in  controls  in  the 
presence, or absence (see results condition 1, page 104-114), of painful stimulation of the 
temple  during  OKS.    Collectively,  these  findings  further  suggest  trigeminal  and 
brainstem  nuclei  are  hyperexcitable  in  migraineurs  between  headaches.      Whether 
symptoms were exacerbated when ice was applied during OKS will be discussed later 
(see results, comparison of OKS in the presence and absence of painful stimulation of the 
temple, Chapter 11, pages 175-191).    
 
Effects on pulse amplitude 
 
Summary of major findings 
 
•  Pulse  amplitude  increased  bilaterally  in  both  groups  during  OKS.    
Vasodilatation subsided in migraineurs by 5 minutes after OKS, but fell below 
baseline in controls. 
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Discussion of effects on pulse amplitude  
  
         It was hypothesized that vascular reactions in response to temple pain during OKS 
would  be  greater  in  the  migraine  group  than  in  controls.    Contrary  to  expectations, 
vascular  reactions  in  response  to  temple  pain  during  OKS  generally  did  not  differ 
between  groups.    However,  vasodilatation  was  greater  in  migraine  sufferers  than  in 
controls during the second ice trial, indicating vessels were at least more reactive in the 
migraine group during this period.   
          Clearly, excessive motion (Kohl, 1985; Eversmann et al, 1978) and painfully cold 
stimulation,  particularly  in  migraine  sufferers  (Peroutka,  2004;  Hassinger, Semenchuk 
and  O’Brien,  1999),  are  stressful  stimuli.  OKS  does  not  involve  excessive  motion; 
nevertheless, the disconcerting nature of OKS was possibly a stressful experience for 
participants  in  the  present  study.    Facial  flushing,  an  index  of  blood  flow,  has  been 
observed  during  motion  sickness  (Harm,  Beatty  and  Reschke,  1987),  and  migraine 
sufferers  are  prone  to  motion  sickness  (Drummond,  2005;  Golding,  2006,  1998; 
Kuritzky, Ziegler & Hassanein, 1981).   Cardiac output increased more so in migraineurs 
than  controls  during  painfully  cold  stimulation  and  cognitive  stress  (Hassinger  et  al, 
1999).    Similarly,  extracranial  vasodilatation  developed  more  readily  in  migraine 
sufferers  than  in  controls  during  exposure  to physical and mental  stress  (Drummond, 
1984).   However, in the present test, contrary to these findings, extracranial vascular 
responses generally did not differ between groups following painfully cold stimulation of 
the  temple  during  OKS  (two  stressors).    An  explanation  for  these  findings  is  not 
immediately obvious.   OKS in the absence of painful stimulation of the temple, and 
painful stimulation of the temple in the presence of OKS, are compared respectively with 
OKS in the presence of painful stimulation of the temple in later sections (see chapter 11, 
pages 175-191).   In light of these findings, physiological mechanisms responsible for the 
present findings may become more apparent. 
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CHAPTER 9  
 
 
RESULTS and DISCUSSION 
 
 
 
  Condition 5 
 
                              
                                         Hand in ice-water  
    
 
 
The purpose of this condition was to act as a comparison with other conditions that 
explored pain processing in response to cranial pain.  In particular, if pain processing is 
compromised in migraine sufferers, symptomatic ratings to limb pain as well as head pain 
might be greater in migraine sufferers than in controls. Facial blood flow increases in 
response to head pain (Lance and Goadsby, 2002; Drummond, 1997), but extracranial 
vascular responses to limb pain have not previously been investigated.  If pain processing 
is  compromised or if defense responses are greater in migraine sufferers, extracranial 
vascular responses to limb pain might be greater in migraine sufferers than in controls. 
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RESULTS 
 
Symptom ratings  
 
     Symptom  ratings  remained  unchanged  during  ice-water  immersion for both groups 
(see Appendix 10, pages 339-346).  Migraine sufferers experienced a low-grade headache 
(head awareness) throughout the procedure while controls remained headache-free the 
entire time (mean + S.E. = .237 + .078 vs 0 + 0; F (1,43) = 4.539, p < .05).   Simple 
contrast analyses indicated that headache did not increase in migraine sufferers during the 
course  of  the  test,  and  that  the  small  difference  between  groups  was  only  evident 
following the first and third immersions (see Figure 9.1.E and Appendix 10.1.5, page 
343).      In  general,  unpleasantness  ratings  were  greater  in  migraine  sufferers  than  in 
controls  (1.741  +  .262  vs  .921  +  .268;  F  (1,43)  =  4.790,  p  <  .05).    Both  groups 
experienced increased levels of unpleasantness during the procedure, particularly during 
immersion of the hand in ice-water (main effect for Time, F (9, 35) = 6.247, p < .001).  
Furthermore, ratings of unpleasantness differed between migraine sufferers and controls 
after the third immersion (Group by Time Simple Contrast interaction, F (1, 43) = 5.532, 
p < .05).  Investigation of this interaction indicated that ratings were greater in migraine 
sufferers  than  in  controls  after  the  third  immersion    (see  Figure  9.1.F  and  Appendix 
10.1.6, page 344).  
Ice induced pain, not surprisingly, peaked in intensity and unpleasantness for both 
groups during immersion of the hand in ice-water (main effect for Time: Pain Intensity; F 
(8,36)  =  62.972,  p  <  .001;  Pain  Unpleasantness;  F  (8,36)  =  40.688,  p  <  .001). 
Investigation of significant Group by Time Simple Contrast interactions indicated that 
ratings were greater in migraine sufferers than in controls during immersions but did not 
differ between groups during any of the recovery periods following the immersions (see 
Figures 9.1.G, 9.1.H and Appendix 10.1.7, 10.1.8, pages 345, 346, respectively).   
       Figure  9.1.A-H  illustrates  change  in  symptom  ratings  over  time.    Table  9.1 
demonstrates main effects and interactions for each symptom. 
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      Figure 9.1.A-B.  Symptom ratings (+ SEM) for migraineurs (n = 23) and controls 
(n = 22) over 11 time points (every 2 minutes from baseline to minute 20). 
                                                                                                  P.T.O for additional ratings     
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           Figure 9.1.C-F.  Symptom ratings (+ SEM) for migraineurs (n = 23) and controls   
(n = 22) over 11 time points (every 2 minutes from baseline to minute 20). 
* statistically significant group difference (* p < .05) 
Note: Y axis has different rating scales for unpleasantness 
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                                                                                                                         Migraineurs 
                                                                                                                                                 Controls 
        
  
      Figure  9.1.G-H.      Symptom  ratings  (+  SEM)  for  migraineurs  (n  =  23)  and 
controls (n = 22) over 11 time points (every 2 minutes from baseline to minute 20{E, F}) 
and over 9 time points (every 2 minutes from ice 1{G, H}).  
* statistically significant group difference (* p < .05) 
 
Note:  Y  axis  has  different  rating  scales  for  unpleasantness  (previous  page),  ice-
induced intensity and ice-induced unpleasantness.      
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      Table 9.1.  Main effect and interaction F, p, and df values from from a 2 (group: 
migraineurs, controls) x 11 (time: every 2 minutes from baseline to minute 20) repeated-
measures ANOVA for each rating.  Ice-induced pain intensity and unpleasantness  values 
obtained from a 2  (group: migraineurs, controls) x 9 (time: every 2 minutes from the first 
application of ice) repeated-measures ANOVA 
 
                                                                F ratios (df) 
  Group   Time   Time x Group 
Nausea   .859 (1, 43)     .955 (7, 37)  1.109 (7, 37) 
Body temperature  .014 (1, 43)      .841 (9, 35)  1.093 (9, 35) 
Dizziness   2.347 (1, 43)    1.002 (3, 41)  1.002 (3, 41) 
Drowsiness   1.445 (1, 43)    1.461 (8, 36)  1.144 (8, 36) 
Headache   4.539 (1, 43) *    1.173 (8, 36)  1.173 (8, 36) 
Unpleasantness   4.790 (1, 43) *    6.247 (9, 35) ***  1.281 (9, 35) 
Ice-induced intensity  5.585 (1, 43) *  62.927 (8, 36) ***  1.279 (8, 36) 
Ice-induced unpleasantness  8.551 (1, 43) **  40.688 (8, 36) ***  2.210 (8, 36) 
* difference between migraine sufferers and controls statistically significant (* p < .05,** p < .01,*** p < .001)  
 
   degrees of freedom differ across the dependent variables because of empty cells 
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Pulse Amplitude 
 
 
Overall,  increases  in  pulse  amplitude  were  greater  for  migraine sufferers  than  for 
controls throughout the experiment (26% + 4% vs 12% + 4%; F (1,43) = 5.860, p <  .05).  
A main effect for Side of stimulation (F (1,43) = 7.117, p < .05) indicated that increases 
for both groups were greater ipsilaterally (migraineurs: 29%, + 4%; controls: 20%, + 4%) 
than  contralaterally  (migraineurs:  24%  +  6%;  controls:  4%  +  6%).    Pulse  amplitude 
increased bilaterally in both groups after the hand was withdrawn from ice-water (main 
effect for Time: F (10,34) = 7.722, p < .001).  Furthermore, increases persisted during 
recovery.  Figure 9.2, Table 9.2 and Appendix 10.2.1 (page 347) illustrate these trends.   
      Pulse amplitude had increased in migraine sufferers, but not controls, even before the 
first cold water immersion.   The vasodilator response developed in controls during the 
first cold water immersion, and persisted in both groups throughout the remainder of the 
experiment.  However, as previously described, changes were greater in migraineurs than 
controls.    During  immersions  differences  were  not  evident  (see  Appendix  10.2.1  and 
10.2.2, pages 347, 348, respectively). 
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 Figure 9.2.   Pulse amplitude change (+ SEM) for migraineurs (n = 23) and controls 
(n = 22) over 11 time points (30 second samples: before, during and after hand immersion 
in ice-water {3 trials}, and after 3 and 8 minutes of recovery {R}).  The first arrow in 
each  trial  represents  pulse  amplitude  before  the  immersion,  and  the  second  arrow 
represents pulse amplitude after the immersion. 
* statistically significant group difference (* p < .05)   158
 
 
 
 
     Table  9.2.    Main  effect  and  interaction  F,  p,  and  df  values  from  a  2    (group: 
migraineurs, controls) x 2 (side: ipsilateral, contralateral to stimulation) x 11 (time: 30 
second samples, before {trial 1, 2 & 3}, during {trial 1, 2 & 3} and after {trial 1, 2 & 3} 
hand  immersion  in  ice-water,  and  3  and  8  mins  after  the  3
rd  immersion)  repeated-
measures ANOVA for pulse amplitude change.   
 
Main effect                    df                        F                                     P 
Group                            1, 43                  5.860                                .020 
Side                               1, 43                  7.117                                .011               
Time                            10, 34                  7.722                                .000 
Interaction  
Side x Time                10, 34                   2.710                                .015 
Side x Group                1, 43                   1.875                                .178 
Time x Group             10, 34                     .978                                .480 
Side x Time x Group  10, 34                     .668                                .745  
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DISCUSSION  
 
Effects on symptomatic responses 
 
Summary of major findings 
 
      Key findings to emerge from exploring the effects of immersing the hand in ice-water 
were:    
•  Immersing  the hand  in  ice-water did not induce nausea, headache, dizziness, 
drowsiness  or  change  in  perceived  body  temperature,  either  in  migraine 
sufferers or controls, although overall unpleasantness was enhanced when the 
hand  was  actually  immersed  in  ice-water.    However,  ratings  specific  to  ice-
induced pain were greater in migraine sufferers. 
 
 
Discussion of effects on symptomatic responses 
 
          The investigation of limb pain was intended to act as a control condition for painful 
stimulation  of  the  temple  and  was  essentially  exploratory;  therefore,  no  specific 
hypotheses could be generated.   However, it was anticipated that if pain processing is 
compromised in migraine sufferers, symptomatic ratings to limb pain as well as head pain 
might be greater in migraine sufferers than in controls.  
          It was found that symptomatic responses during immersion of the hand in ice-water 
were  negligible  for  both  groups.      However,  participants  reported  moderate  levels  of 
overall unpleasantness.   This enhanced response in the absense of symptom development 
may be because immersion of the hand was perceived as overwhelmingly painful.    
        Pain  attributed  directly  to  the  ice-water  was  greater  in  migraine  sufferers  than 
controls.   Pain is both a sensory and affective experience (Venes, 2001).  It involves not 
only  the  physical  perception  of  a  painful  stimulus  (usually  triggered  by  activation  of   160
peripheral nerves) but also the emotional response to that perception (Silberstein, 2003).   
It  may  be  that  fear  of  pain  and  anxiety  (defense  response)  influenced  nociceptive 
intensity in the present study in response to painful stimulation of the limb. 
        Hyperalgesia  (Silberstein,  2003)  and  cutaneous  allodynia  (Levy,  Jakubowski  and 
Burstein, 2004; Burstein, Cutrer, and Yarnitsky, 2000; Burstein and Jakubowski, 2004; 
Bustein, Collins and Jakubowski, 2004; Yarnitsky, Goor-Aryeh, Bajwa, Ransil, Cutre, 
Sottile  and  Burnstein,  2003)  have  been  observed  in  migraine  sufferers  beyond  the 
referred pain area of the head, particularly during a migraine attack.  Cutaneous allodynia 
has also been observed interictally (Ashkenazi, LoPinto and Young, 2005; Kitaj, 2005).   
Ashkenazi et al. suggested that the cutaneous allodynia observed in their study might be 
constant as they found it to occur in an individual between attacks.    The enhanced 
reactions to limb pain observed in migraineurs in the interictal period in this study may 
also be because of persistent hypersensitive nociception, or this group may simply use 
different criteria in their reported experience of pain. 
 
 
 
Effects on pulse amplitude 
 
 
Summary of major findings 
 
•  Increases in temporal pulse amplitude during hand immersion were greater 
ipsilaterally  than  contralaterally  in  both  groups  but,  overall,  pulse 
amplitude increased more in migraineurs than in controls.  The vasodilator 
response was apparent in migraine sufferers even before the first ice-water 
immersion,  but  developed  in  controls  during  the  first  immersion.  
Vasodilatation  peaked  bilaterally  in  both  groups  after  the  hand  was 
withdrawn from ice-water.    The response persisted during recovery. 
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Discussion of effects on pulse amplitude   
 
      If pain processing is compromised in migraine sufferers, or the defense response is 
greater, vascular responses to limb pain should be greater in migraine sufferers than in 
controls.   In support of these hypotheses, vasodilatation was greater in migraineurs than 
in controls, even prior to painful stimulation.   
      Ipsilateral vasodilatation developed in controls during the initial immersion, whereas 
blood vessels dilated on both sides in migraine sufferers.    The overall enhanced bilateral 
response  in  migraineurs  may,  in  part,  reflect  enhanced  fear  and  anxiety  (defense 
response) triggered even in anticipation of the procedure, as migraine sufferers reported 
more pain (intensity and unpleasantness) during painful stimulation than controls.  In 
addition,  atypical  autonomic  reactivity  may  also  partly  account  for  the  augmented 
vascular responses in migraineurs.   The source of the atypical reaction may involve the 
periaqueductal grey region of the brainstem, which has an integrative function including 
modulating pain transmission, fear and anxiety, autonomic and cardiovascular responses 
(Knight and Goadsby, 2001; Behbehani, 1995).    
       Greater ipsilateral than contralateral extracranial vasodilatation was observed during 
immersion  of  the  hand  in  extremely  cold  water  in  both  groups,  which  implies  that 
ipsilateral  vasodilatation  is  a  normal  systemic  vasomotor  reaction  to  painfully  cold 
stimulation of the limb.   
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CHAPTER 10  
 
 
RESULTS and DISCUSSION 
 
 
 
  Condition 6 
                              
                  Hand in ice-water during optokinetic stimulation (OKS) 
    
 
 
     This condition investigated the impact of painful stimulation of the hand during OKS 
on symptom ratings of motion sickness in migraine sufferers and controls. The intention 
was to compare outcomes alongside conditions that explored pain processing in response 
to cranial pain during OKS, as well as OKS alone.  As migraine sufferers are prone to 
motion  sickness  (Golding,  1998;  Kuritzky,  Ziegler  &  Hassanein,  1981)  it  was 
hypothesized  that  symptomatic  ratings would be  greater  in  migraine sufferers  than  in 
controls during OKS.  Also, as vasodilatation has been observed during motion sickness 
(Harm, 1990; Kolev et al., 1997), it was hypothesized that vascular reactions would be 
greater  in  the  migraine  group  than  in  controls  during  OKS.    Furthermore,  if  pain 
processing  is  compromised  in  migraineurs,  it  was  anticipated  that  symptomatic  and 
vascular responses would intensify during limb pain in the migraine group.  
 
 
RESULTS 
 
Symptom ratings  
 
      Procedures provoked more nausea (mean + S.E. = 1.543 +  .293 vs  .155 + .286; F (1, 
37) = 11.505, p < .01), headache (1.474 + .324 vs .124 + .316; F (1, 37) = 8.902, p < .01)   163
and dizziness (1.775 + .368 vs .400 + .358; F (1, 37) = 7.172, p < .05) in migraineurs than 
in controls.  Overall, migraine sufferers experienced mild nausea while controls felt only 
marginally nauseated.  Apart from baseline and during the second immersion, differences 
were  evident  throughout  testing  (see  Figure  10.1.A  and  Appendix  11.1.1,  page  349).    
Low-grade nausea was evident in both groups prior to immersion of the hand in ice-
water,  and  simple  contrast  analyses  indicated  nausea  increased  in  migraine  sufferers 
following  the  initial  ice-water  trial.    In  contrast, nausea  in  the  control group  did not 
change from baseline, apart from during the second ice-water trial (nausea awareness 
increased).   Overall, mild headache developed in migraineurs but was negligible in the 
control  group.    Group  differences  were  evident  throughout  the  procedure (see  Figure 
10.1.E and Appendix 11.1.5, page 353).  Slight headache (head awareness) was observed 
in migraine sufferers at baseline.  Furthermore, contrast analyses indicated increases were 
evident following each hand immersion trial and during the recovery period.  Generally, 
dizziness  in  migraine  sufferers  was  mild  while  controls  reported  awareness.    Group 
differences were apparent in the first half of OKS and after OKS (see Figure 10.1.C and 
Appendix 11.1.3, page 351).  Assessment of individual groups indicated that migraineurs 
experienced lightheadedness (awareness of dizziness) prior to OKS.  Once procedures 
commenced,  mild  dizziness  developed  and  participants  remained  aware  of  dizziness 
during recovery.  Controls became aware of dizziness after the first ice-water trial but 
recovered soon after OKS. 
      Overall,  migraineurs  were  aware  of  body  temperature  increases  but  change  was 
negligible in controls (.702 + .157 vs .067 + .153; F (1,37) = 8.400, p < .01).  Group 
differences  were  evident  throughout  testing  (see  Figure  10.1.B  and  Appendix  11.1.2, 
page 350).  Closer inspection indicated that body temperature in migraine sufferers, apart 
from during the initial ice-water trial, increased throughout OKS and gradually recovered 
after OKS. 
      Prior to testing both groups were slightly aware of unpleasantness.  Contrast analyses 
indicated levels increased during OKS.    Increased levels of unpleasantness to symptoms 
in general were experienced during immersion of the hand in ice-water (main effect for 
Time: F (10, 28) = 8.325, p < .001).   In migraine sufferers unpleasantness lingered after 
OKS whereas controls eventually recovered.  The extent of unpleasantness overall was   164
greater for migraine sufferers than for controls (3.285 + .433 vs 1.361 + .422; F (1,37) = 
10.136, p < .01) and apart from during the initial immersion, differences were evident 
throughout testing (see Figure 10.1.F and Appendix 11.1.6, page 354).    
Ice-induced pain  increased in  intensity  and  unpleasantness  for both groups during 
immersion of the hand in ice-water (main effect: Pain Intensity; F (1, 37) = 16.723, p < 
.001; Pain Unpleasantness; F (1, 37) = 15.741, p < .001).  Investigation of significant 
Group by Time interactions indicated that ratings were greater in migraine sufferers than 
in controls during immersions and following the third immersion (see Figures 10.1.G, 
10.1.H and Appendix 11.1.7, 11.1.8, pages 355, 356, respectively).   Perceptions were 
elevated throughout procedures in the migraine group though unpleasantness gradually 
settled.   In controls pain intensity was notable from the initial immersion in ice-water 
until just after OKS but unpleasantness was primarily only reported during immersions.  
Self-motion developed in both groups during OKS (main effect for Time: F (6, 32) = 
2.623, p < .05).  The sensation was greater in migraine sufferers than in controls (main 
effect for Group: F (1, 37) = 4.778, p < .05), particularly following the third immersion in 
ice-water (see Figure 10.1.I and Appendix 11.1.9, page 357).  Visual-illusion was greater 
in the migraine group than in controls (main effect for Group: F (1, 37) = 6.541, p < .05) 
during  the  first  immersion  and  following  the  third  (see  Figure  10.1.J  and  Appendix 
11.1.10, page 358).   The experience persisted throughout OKS in both groups but closer 
inspection of a simple contrast interaction indicated controls reported dramatically less 
visual-illusion  during  the  first ice  immersion  (Time  x Group interaction:  F (6, 32)  = 
2.460, p < .05).  See Appendix 11.1.10, page 358.    
     Seventeen percent of migraine sufferers withdrew from OKS compared with only 9 
percent of controls.  This difference however, did not reach significant levels (refer to 
Appendix 13, page 363). 
Figure 10.1.A to H demonstrate change in symptom ratings over time.  Table 10.1 
demonstrates main effects and interactions for each symptom. 
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      Figure 10.1.A-D.   Symptom ratings (+ SEM) for migraineurs (n = 19) and controls 
(n = 20) over 11 time points (every 2 minutes from baseline to minute 20).  
OKS = optokinetic stimulation                        * statistically significant group difference (* p < .05)                                  
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      Figure 10.1.E-H..   Symptom ratings (+ SEM) for migraineurs (n = 19) and controls 
(n = 20) over 11 time points (every 2 minutes from baseline to minute 20) {E, F}) and 
over 9 time points (every 2 minutes from ice 1 {G, H}). 
OKS = optokinetic stimulation                        * statistically significant group difference (* p < .05)                                 
Note: Y axis has different rating scales for unpleasantness, ice-induced intensity and 
ice-induced  unpleasantness.                                                  P.T.O for additional ratings   167
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      Figure 10.1.I-J.  Symptom ratings (+ SEM) for migraineurs (n = 19) and controls (n 
= 20) over 7 time points (every 2 minutes from commencement of OKS).    
OKS = optokinetic stimulation         *  statistically significant group difference (* p < .05)  
 
Note:  Different rating scales for self-motion and visual-illusion  (0-2) 
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      Table 10.1.  Main effect and interaction F, p, and df values from from a 2 (group: 
migraineurs, controls) x 11 (time: every 2 minutes from baseline to minute 20) repeated-
measures ANOVA for each rating.  Values for Self-motion and Visual-illusion obtained 
from a 2 (group: migraineurs, controls) x 7 (time: every 2 minutes during OKS) repeated-
measures ANOVA, and ice-induced pain intensity and unpleasantness from a 2  (group: 
migraineurs,  controls)  x  9  (time:  every  2  minutes  from  the  first  application  of  ice) 
repeated-measures ANOVA.    
 
 
                                                                F ratios (df) 
  Group   Time   Time x Group 
Nausea   11.505 (1, 37) **    2.007 (10, 28)  2.234 (10, 28) 
Body temperature    8.400 (1, 37) **    1.660 (10, 28)  1.494 (10, 28) 
Dizziness     7.172 (1, 37) *    1.933 (10, 28)  1.176 (10, 28) 
Drowsiness     1.607 (1, 37)     1.545 (10, 28)  1.908 (10, 28) 
Headache     8.902 (1, 37) **    1.689 (10, 28)  1.626 (10, 28) 
Unpleasantness   10.136 (1, 37) **    8.325 (10, 28) ***  2.230 (10, 28) 
Ice-induced intensity  16.723 (1, 37) ***  45.077 (8, 30)   ***  2.496 (8, 30)   * 
Ice-induced unpleasantness  15.741 (1, 37) ***  43.452 (8, 30)   ***  3.474 (8, 30)   ** 
Self-motion     4.778 (1, 37) *    2.623 (6, 32)   *   1.122 (6, 32) 
Visual-illusion    6.541 (1, 37) *    1.330 (6, 32)  2.460 (6, 32)   * 
* difference between migraine sufferers and controls statistically significant (* p < .05,** p < .01,*** p < .001)  
  degrees of freedom differ across the dependent variables because of empty cells 
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Pulse Amplitude 
 
 
      Pulse amplitude was comparable for both groups throughout the procedures.  A main 
effect for Side of stimulation (F (1, 37) = 14.025, p < .001) indicated that increases for 
both groups were greater ipsilaterally (migraineurs: 26% + 10%; controls: 31% + 10%) 
than contralaterally to painful stimulation (migraineurs:  11% + 6%; controls: 14% + 
6%).   Pulse amplitude peaked bilaterally in both groups after the hand was withdrawn 
from  ice-water  (main  effect  for  Time:  F  (10,  28)  =  2.755,  p  <  .05).    Pulse  volume 
decreased for both groups and side differences were no longer evident following OKS 
(Side x Time interaction: F (10,28) = 2.452, p < .05).   Figure 10.2, Table 10.2 and 
Appendix 11.2.1 and 11.2.2 (pages 359, 360, respectively) illustrate these trends.   
      Intercept  analyses  indicated  vasodilatation  in  both  groups  during  OKS  before  the 
initial ice-water trial.  In the migraine group further vasodilatation followed each ice-
water  trial  but  when  the  hand  was  immersed  pulse  amplitude  did  not  differ  from 
preceding levels.  Vasodilatation in the control group persisted throughout OKS and both 
groups recovered soon after OKS (see Appendix 11.2.2, page 360).  
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       Figure 10.2.   Pulse amplitude change (+ SEM) for migraineurs (n = 19) and controls 
(n = 20) over 11 time points (30 second samples: before, during and after hand immersion 
in ice-water {3 trials}, and after 3 and 8 minutes {recovery - R}). The first arrow in each 
trial represents pulse amplitude before the immersion, and the second arrow represents 
pulse  amplitude  after  the  immersion.                OKS  =  optokinetic  stimulation  171
 
 
 
 
     Table  10.2.      Main  effect  and  interaction  F,  p,  and  df  values  from  a  2    (group: 
migraineurs, controls) x 2 (side: ipsilateral, contralateral to stimulation) x 11 (time: 30 
second samples, before {trial 1, 2 & 3}, during {trial 1, 2 & 3} and after {trial 1, 2 & 3} 
hand immersion in ice-water during OKS, and 3 and 8 mins after the 3
rd immersion) 
repeated-measures ANOVA for pulse amplitude change.   
 
Main effect                    df                        F                                     P 
Group                           1, 37                       .165                              .687 
Side                             1, 37                    14.025                              .001                           
Time                          10, 28                      2.755                              .017 
Interaction  
Side x Time               10, 28                      2.452                              .030 
Side x Group               1, 37                        .051                              .823  
Time x Group            10, 28                        .940                              .514 
Side x Time x Group 10, 28                        .576                              .820  
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DISCUSSION 
 
Effects on symptomatic responses 
Summary of major findings 
 
     Key findings to emerge from exploring the effects of immersion of the hand in ice-
water during OKS were: 
 
•  In general, ratings of headache, nausea and dizziness were greater in migraine 
sufferers  than  in  controls.    Additionally,  increases  in  body  temperature  and 
ratings of self-motion and visual illusion were greater in migraineurs than in 
controls.  Overall, both groups experienced comparable drowsiness.  However, 
before  and  during  the  third  hand  immersion,  drowsiness  increased  in 
migraineurs.      Apart  from  slight  dizziness,  visual  illusion  and  self-motion, 
symptomatic ratings barely developed in controls.    
•  The  procedure  was  more  unpleasant  for  migraine  sufferers  than  controls.  
Furthermore, pain ratings were also greater in migraineurs, particularly during 
immersions.   
 
Discussion of effects on symptomatic responses 
 
        The investigation of limb pain during OKS was purely exploratory.  In the present 
study, nausea, headache, dizziness, perceived body temperature increases, visual illusion 
and self-motion developed more so in migraine sufferers than in controls when the hand 
was immersed in ice-water during OKS.   Furthermore, migraine sufferers reported low-
grade headache and drowsiness even prior to the procedures, which may have carried 
over from the previous procedure involving immersion of the hand in ice-water in the 
absence  of  OKS.       Throughout the  procedures  headache  increased  progressively but 
drowsiness did not develop further.  In contrast, controls remained virtually symptom free   173
throughout, apart from slight dizziness, visual illusion and self-motion.    These findings 
may simply reflect OKS-induced motion sickness.   Whether immersion of the hand in 
painfully cold water modified symptoms induced by OKS is not clear but the possibility 
is explored in the next chapter (comparison of conditions involving OKS, Chapter 11, 
pages 175-191).    
        OKS  probably  induced  motion  sickness,  at  least  in  migraine  sufferers  (Golding, 
2006, 1998; Kuritzky, Ziegler & Hassanein, 1981), as symptomatic responses developed 
during and persisted, largely, after the procedures in this group.   Headache, in particular, 
increased  progressively  throughout  the  recovery  period.      It  may  be  that  the  gradual 
worsening of headache in the present study reflected a neural “wind-up” phenomenon 
(Bray, Cragg, MacKnight and Mills, 1999; Dallel et al, 1999), which was initiated during 
OKS.          
         Both groups reported that the procedure was unpleasant.   However, this rating was 
greater  in  migraine  sufferers  than  in  controls.    After  the  procedures  migraineurs 
continued to experience unpleasantness, probably because they remained symptomatic.   
Conversely,  in  controls,  symptomatic  responses,  which  were  minimal,  and  associated 
unpleasantness, subsided quickly.   Both groups found the ice-water painful.  However, 
pain was greater in migraine sufferers, which may reflect hyperexcitable nociception in 
this group interictally.   
 
 
Effects on pulse amplitude 
 
Summary of major findings 
 
•  Increases in pulse amplitude were greater ipsilaterally than contralaterally 
in  both  groups,  and  blood  flow  peaked  bilaterally  after  the  hand  was 
withdrawn  from  ice-water.      However,  in  migraine  sufferers,  a  weak 
bilateral vasoconstrictor response occurred during immersion of the hand.    
Vascular responses recovered soon after OKS in both groups.   
   174
       
Discussion of effects on pulse amplitude   
 
       It  was  anticipated  that  vascular  responses  would  intensify  during  limb  pain  in 
migraine sufferers if pain processing is compromised in this group.   Change in pulse 
amplitude evoked by procedures generally did not differ between groups, suggesting a 
normal response to immersion of the hand in ice-water.  The increased facial blood flow 
may reflect a stress response triggered in reaction to two consecutive, and tandem, novel 
stressors - OKS followed by cold stimulation during OKS.    As pointed out above, blood 
flow peaked bilaterally after the hand was withdrawn from ice-water in both groups.  In 
addition,  a  weak  bilateral  vasoconstriction  occurred  during  hand  immersion  in 
migraineurs, consistent with greater reactivity in the extracranial vasculature of this group 
than in controls.   
        Symptomatic responses were enhanced in migraineurs interictally, suggesting that 
neural pathways were excitable.   In particular, the development of headache suggests 
that the trigeminovascular system was activated in this group.   If nociceptive pathways 
are hypersensitive in migraineurs, it is conceivable that stimulation of the hand may have 
contributed  to  the  development  of  headache  and,  by  implication,  to  activation  of  the 
trigeminovascular vasodilatatory reflex.                  
        The asymmetry of the vascular response to painfully cold stimulation of the hand, 
observed in both groups, implies that ipsilateral vasodilatation is a normal vasomotor 
reaction to immersion of the hand in ice-water.   Curiously, asymmetry preceded the first 
immersion during OKS.   Perhaps the mechanism that induced assymmetry during the 
previous procedure involving hand immersion before OKS (see Appendix 10.2.1, page 
347) persisted, or a conditioned response developed. 
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CHAPTER 11              
 
 
RESULTS and DISCUSSION 
 
Comparison of Conditions 
 
 1 (OKS alone), 4 (Ice on temple during OKS) and  
 
6 (Hand in ice-water during OKS) 
 
 
 
      The aim was to explore whether trigeminal nerve activity following stimulation of the 
temple  with  ice  during  OKS  would  intensify  symptomatic  and  vascular  responses  in 
migraineurs  compared  to  controls.    To  investigate  this  association  OKS  alone  was 
compared with ice on the temple during OKS to explore the impact of painful stimulation 
of the temple during OKS.   Ice on the temple during OKS was compared with the hand 
in  ice-water  during  OKS  to  investigate  the  effect  of  painful  cranial  stimulation  as 
opposed to elsewhere.   The following hypotheses were investigated:       
 
1.  As migraineurs are prone to motion sickness (Golding, 1998; Kuritzky, Ziegler & 
Hassanein,  1981)  and  show  signs  of  trigeminal nerve sensitivity  (Lance,  1993, 
2002;  Macfarlane,  1993;  Moskowitz,  1993;  Weiller  et  al.,  1995),  it  was 
hypothesized that headache would intensify more readily in migraineurs than in 
controls when ice was applied to the temple during OKS compared to OKS alone, 
or combined with hand immersion in ice-water.    
 
2.   If trigeminal impulses converge on neurons responsible for symptoms other than 
headache, these symptoms might be enhanced in migraine sufferers during painful 
stimulation of the temple.   
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3.  As facial blood flow increases during motion sickness in susceptible individuals 
(Harm, 1990; Kolev et al, 1997) and during head pain in migraineurs (Lance and 
Goadsby, 2002; Drummond, 1997), it was hypothesized that vascular reactions in 
response to temple pain during OKS would be greater, particularly in comparison 
to OKS alone, in migraine sufferers than in controls.   
 
4.   If  pain  processing  is  compromised  following  painful  stimulation  of  the  hand 
during OKS, symptomatic and vascular responses should intensify in the migraine 
group, particularly in comparison with OKS alone.   
 
 
 
 
RESULTS 
 
Symptom ratings 
 
 
     Ratings  during  OKS  and  ice  stimulation  (temple,  hand),  and  OKS  alone  (time 
equivalents), were analyzed in a series of 2 (group: migraineurs, controls) x 3 (condition: 
OKS alone {condition 1}, ice to temple during OKS {condition 4}, hand in ice-water 
during OKS {condition 6}) repeated-measures ANOVAs for nausea, body temperature, 
dizziness, drowsiness, headache, unpleasantness, self-motion and visual-illusion.   Simple 
planned contrasts were used to compare the mean of painful stimulation of the temple 
during OKS with the mean of OKS alone and immersion of the hand in ice-water during 
OKS.   Ice-induced intensity and ice-induced unpleasantness were analyzed in 2 (group: 
migraineurs, controls) x 2 (condition: 4 and 6) repeated-measures ANOVAs. Figure 11.1 
demonstrates comparative change in symptom ratings across conditions. 
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      Figure 11.1.A-D.   Means + SEM for migraineurs (n = 23) and controls (n = 22) for 
OKS alone, ice to the temple during OKS, hand in ice-water during OKS.  Mean time 
during OKS was explored.   OKS = optokinetic stimulation                                                           
                                                                                                  P.T.O for additional ratings   178
                     ICE APPLICATION DURING OKS AND OKS ALONE 
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Figure 11.1.E-H..   Means + SEM for migraineurs (n = 23) and controls (n = 22) for 
OKS alone, ice to the temple during OKS, hand in ice-water during OKS.  Mean time 
during OKS was explored.    OKS = optokinetic stimulation 
*  statistically significant difference between conditions for migraineurs (P<.05)  
Note:  Y-axis  has  different  rating  scales  for  unpleasantness,  and self-motion  and          
            visual-illusion  (0-2)                                                     P.T.O for additional ratings                                             179
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Figure 11.I and  J.   Means + SEM for migraineurs (n = 23) and controls (n = 22) for ice 
to the temple during OKS (mean  ice applications), hand in ice-water during OKS (mean 
ice-water immersions).   OKS = optokinetic stimulation    
                                                                                                           
Note:  Y-axis has different rating scales for ice-induced intensity and unpleasantness 
 
 
 
 
     As observed in preliminary analyses, each symptom was greater in migraine sufferers 
than controls across all three conditions (see table 11.1).  Nausea was greater in both 
groups when ice was applied to the temple during OKS than during OKS alone or when 
the hand was immersed in ice-water during OKS (main effect for Condition: OKS vs 
OKS ice temple, F (1, 43) = 7.017, p < .05; OKS ice temple vs OKS hand ice-water, F (1, 
43) = 4.936, p < .05).   Refer to Figure 11.1.A.  While headache developed during each 
condition in migraineurs, it was greatest when ice was applied to the temple during OKS.  
Controls,  as  observed  in  preliminary  analyses,  remained  headache-free  over  the  three   180
conditions (Condition x Group contrast interaction: OKS vs OKS ice temple, F (1, 43) = 
4.891, p < .05).  Refer to Figure 11.1.E.   Ratings of body temperature were greater in 
both groups when ice was applied to the temple during OKS than when the hand was 
immersed in ice-water during OKS (main effect for Condition: F (1, 43) = 4.609, p < 
.05).   See Figure 11.1.B.   Unpleasantness ratings were greater in both groups during 
OKS  with  ice  stimulation  to  the  temple  than  during  OKS  alone  (main  effect  for 
Condition: OKS vs OKS ice temple, F (1, 43) = 14.539, p < .001), and during immersion 
of the hand in ice-water during OKS than ice application to the temple during OKS (main 
effect for Condition: OKS ice temple vs OKS hand ice-water, F (1, 43) = 10.557, p < 
.01).    See Figure 11.1.F.   Pain was greater in intensity and unpleasantness when the 
hand was immersed in ice-water than when ice was applied to the temple during OKS 
(main  effect  for  Condition:  Pain  Intensity,  F  (1,  43)  =  19.432,  p  <  .001;  Pain 
Unpleasantness, F (1, 43) = 26.541, p < .001).   Figures 11.1.I and 11.1.J illustrate this 
effect.  
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     Table 11.1.  Main effect and interaction F, p, and df values from a 2 (group: migraineurs, 
controls) x 3 (condition: OKS alone {condition 1}, ice to temple during OKS {condition 4}, hand 
in  ice-water  during  OKS  {condition  6})  repeated-measures  ANOVA  for  nausea,  body 
temperature, dizziness, drowsiness, headache, unpleasantness, self-motion and visual-illusion. 
Mean rating during OKS was explored.       OKS = optokinetic stimulation 
 *  statistically significant (* p < .05,** p < .01,*** p < .001)                         
 
 
 
      Table  11.2.    Main  effect  and  interaction  F,  p,  and  df  values  from  a  2  (group: 
migraineurs, controls) x 2 (condition: ice to temple during OKS, hand in ice-water during 
OKS)  repeated-measures  ANOVA  for  ice-induced  intensity  and  ice-induced 
unpleasantness. Mean for ice applications were explored.   OKS = optokinetic stimulation 
 
                                                                                               F ratios (df = 1, 43) 
  Group   Condition   Condition x Group  
Ice-induced intensity 
          
10.452 **  19.432 ***    .008  
Ice-induced unpleasantness 
          
16.244 ***  26.541 ***    .001  
*  statistically significant (** p < .01,*** p < .001) 
                                                                                                         F ratios (df = 1, 43) 
  Group   Condition   Condition x Group  
Nausea 
         OKS vs OKS ice temple 
         OKS ice temple vs OKS hand ice-water 
10.342 **    
  7.017 * 
  4.936 *  
 
  .971 
  .998 
Body temperature 
         OKS vs OKS ice temple 
         OKS ice temple vs OKS hand ice-water 
10.595 **     
    .014 
  4.609 * 
  
  .501 
1.567 
Dizziness  
         OKS vs OKS ice temple 
         OKS ice temple vs OKS hand ice-water 
  9.031 **   
    .000 
    .010 
 
  .012 
  .063 
Drowsiness 
         OKS vs OKS ice temple 
         OKS ice temple vs OKS hand ice-water 
  4.382 *   
  1.890 
  1.055 
 
  .477 
  .112 
Headache 
         OKS vs OKS ice temple 
         OKS ice temple vs OKS hand ice-water 
20.337 ***   
  3.914 
    .464 
 
4.891 * 
  .773 
Unpleasantness  
         OKS vs OKS ice temple 
         OKS ice temple vs OKS hand ice-water 
12.311 ***   
14.539 *** 
10.557 ** 
 
  .404 
  .870 
Self-motion 
         OKS vs OKS ice temple 
         OKS ice temple vs OKS hand ice-water 
  8.845 **   
    .010 
    .026 
 
  .001 
2.615 
Visual-illusion 
         OKS vs OKS ice temple 
         OKS ice temple vs OKS hand ice-water 
  9.117 **   
    .939 
  1.174 
 
  .396 
  .007   182
Pulse amplitude 
 
          Data was analysed in a 2 (group: migraineurs, controls) x 3 (condition: OKS alone 
{condition 1}, ice to temple during OKS {condition 4}, hand in ice-water during OKS 
{condition 6}) x 2 (side: average of left, right {condition 1}; Ipsilateral, contralateral 
{conditions 4, 6}) repeated-measures ANOVA.  Simple planned contrasts were used to 
compare the mean of painful stimulation of the temple during OKS with the mean of 
OKS  alone  and  immersion  of  the  hand  in  ice-water  during  OKS.      Figure  11.2 
demonstrates comparative change in pulse amplitude across conditions. 
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     Figure  11.2.      Mean  ipsilateral  and  contralateral  pulse  amplitude  change  to  ice 
stimulation (temple, hand), and average of left and right sides for OKS alone.  Pulse 
amplitude change (+ SEM) for migraineurs (n = 23) and controls (n = 22) 30 seconds 
after ice stimulation and time equivalents for OKS alone.   OKS = optokinetic stimulation                        
* statistically significant within group difference (* p < .01)  
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     Vascular responses were comparable across conditions for both groups (Table 11.3).   
Closer inspection indicated that responses were greater ipsilaterally for both groups after 
immersion of the hand in ice-water during OKS than after ice was applied to the temple 
during  OKS  (main  effect  for  Side:  F  (1,  43)  =  16.319,  p  <  .001;  Condition  x  Side 
interaction:  OKS  ice  temple  vs  OKS  hand  ice-water,  F  (1,  43)  =  5.862,  p  <  .05).    
Bilateral responses were comparable for both groups during OKS alone and after ice was 
applied to the temple during OKS.  Table 11.3 and Figure 11.2 illustrate these trends. 
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     Table 11.3.  Main effect, interaction and simple contrast F, p, and df values from a 2 
(group: migraineurs, controls) x 3 (condition: OKS alone {condition 1}, ice to temple 
during  OKS{conditions  4},  hand  in  ice-water  during  OKS{conditions  6})  x  2  (side: 
average left, right {condition 1}; Ipsilateral, contralateral {conditions 4, 6}) repeated-
measures ANOVA of mean pulse amplitude 30 seconds after ice stimulation (temple, 
hand) during OKS and time equivalents for OKS alone.   OKS = optokinetic stimulation 
   
Main effect                                                    df= 1, 43                      F                           P 
Group                                                                                              3.930                       .054 
Condition                                                            
      OKS vs OKS ice temple                                                             .182                        .672 
      OKS ice temple vs OKS hand ice-water                                  1.305                        .260 
Side                                                                                               16.319                       .000 
Interaction  
Condition x Group                                             
      OKS vs OKS ice temple                                                          2.645                         .111 
      OKS ice temple  vs OKS hand ice-water                                1.174                         .285 
Side x Group                                                                                   .141                         .709 
Condition x Side                                                 
      OKS vs OKS ice temple                                                            .209                         .650 
      OKS ice temple  vs OKS hand ice-water                                 5.862                        .020 
Condition x Side x Group                                   
      OKS vs OKS ice temple                                                            .099                         .754 
      OKS ice temple vs OKS hand ice-water                                   .453                         .504 
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      Table 11.4.   Means and standard deviations during OKS alone, ice to the temple 
during OKS, and hand in ice-water during OKS, of pulse amplitude 30 seconds after ice 
stimulation (temple, hand) during OKS and time equivalents for OKS alone.    
OKS = optokinetic stimulation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                     Means + SD 
                                                 Migraineurs (n = 23)              Controls (n = 22) 
                                                                                     Average 
OKS alone                  34.3 + 27.8                       9.2 + 8.6 
  Ipsilateral           Contralateral         Ipsilateral             Contralateral 
OKS ice temple  26.5 + 29.9  23.0 + 33.6  15.0 + 36.8  14.4 + 16.0 
OKS hand ice-water  33.2 + 45.8  16.9 + 35.9   38.6 + 43.8  15.3 + 17.8   186
DISCUSSION   
 
 
Effects on symptomatic responses 
 
Summary of major findings 
 
Ice on temple during OKS vs OKS alone (Condition 4 vs 1, respectively) 
 
•  Nausea  and  unpleasantness  were  greater  when  ice  was  applied  to  the  temple 
during OKS than during OKS alone for both groups. 
•  Headache was greater in migraine sufferers when ice was applied to the temple 
during OKS but controls remained headache-free over both conditions. 
•  Ratings of dizziness, drowsiness, increases in body temperature, visual illusion 
and self-motion, were comparable over both conditions for both groups. 
•   
 
Ice on temple during OKS vs Hand in ice-water during OKS (Condition 4 vs 6, 
respectively) 
 
•  Headache in migraine sufferers was comparable for both conditions.  Controls 
remained headache-free. 
•  Nausea and increases in body temperature were greater when ice was applied to 
the temple than when the hand was immersed in ice-water during OKS for both 
groups. 
•  For  groups,  dizziness,  drowsiness,  visual  illusion  and  self-motion,  were 
comparable for both conditions. 
•  Overall  unpleasantness,  and  ice-induced  intensity  and  unpleasantness,  were 
greater when the hand was immersed in ice-water than when ice was applied to 
the temple during OKS for both groups.   187
 
 
Discussion of effects on symptomatic responses 
 
        It  was  hypothesized  that  symptomatic  ratings  would  intensify  more  readily  in 
migraineurs than in controls when ice was applied to the temple during OKS compared to 
OKS alone, or combined with hand immersion in ice-water.   As observed in preliminary 
analyses,  each  symptomatic rating  was  generally  greater  in  migraine sufferers than in 
controls for all three conditions (see Table 11.1 ).   
 
 
 Ice on temple during OKS vs OKS alone (Condition 4 vs 1, respectively) 
 
        Both  groups  experienced  more  nausea  when  the  temple  was  stimulated  with  ice 
during OKS than during OKS alone.  Additionally, overall unpleasantness was greater 
during this condition probably because of the increased nausea.  As expected, migraine 
sufferers  experienced  increased  headache  when  the  temple  was  painfully  stimulated 
during OKS than during OKS alone.  In contrast, controls remained headache-free during 
both conditions. Remaining ratings were comparable across conditions for both groups. 
       The cranial sensory anatomy involves convergence of visceral (blood vessels) and 
somatic  (head/facial  musculature)  nerve  fibres  on  to  the  same  central  interneurons.  
Central projections include the trigeminal nucleus caudalis (TNC), which mediates pain 
responses, and the nucleus tractus solitarius (NTS) which mediates autonomic responses, 
e.g.,  vomiting  (see  Macfarlane  for  a  review  of  the  literature,  1993).      A  functional 
connection is believed to exist between the TNC and the NTS.  It is conceivable that 
trigeminal  nerve  stimulation  during  the  application  of  ice  to  the  temple  provoked 
headache  in  migraine  sufferers.    Nausea  increased  in  both  groups  but  more  so  in 
migraineurs.    Remaining  symptomatic  ratings  were  not  altered  following  temple  pain 
during OKS, which suggests a specific association between nausea and head pain.  The 
increased nausea coupled with increased headache observed in migraine sufferers when 
the temple was painfully stimulated during OKS implies a mutual interaction between the   188
TNC and NTS.   If so, it may be that these cardinal symptoms compound one another 
during a migraine attack.    
 
 Ice on temple during OKS vs hand in ice-water during OKS (Condition 4 vs 6, 
respectively) 
 
      Headache did not depend on whether the temple or hand was painfully stimulated 
during OKS.  Neuronal events mediating the headache phase of migraine are believed to 
involve the trigeminovascular system and its central projections (Welch, 2003).  In the 
present study it may be that this circuitry was somehow activated in migraineurs during 
OKS  in  the  absence  of  painful  stimulation,  and  painful  stimulation  facilitated  this 
response (Ashkenazi et al., 2005).   In contrast, controls remained headache-free in all 
three conditions.   
      Both groups experienced more nausea and increases in body temperature during OKS 
when  ice  was applied to  the  temple  than when the hand was immersed in ice-water.    
However,  despite  the  enhanced  responses,  overall  unpleasantness,  and  ice-induced 
intensity and unpleasantness, were greater when the hand, not the temple, was stimulated 
during  OKS.    Migraine  sufferers  were  more  sensitive  than  controls  to  painfully  cold 
stimulation.  However, both groups found the ice-water painful and immersion of the 
hand appeared to modify the effects of OKS.  As pointed out, nausea and increases in 
body temperature were greater when ice was applied to the temple than when the hand 
was  immersed  in  ice-water  during  OKS.    Nevertheless,  responses  were  greater  in 
migraine sufferers than in controls for both conditions.   
         Nociceptive stimulation of the hand possibly triggered DNIC (Bouhassira, Chollet, 
Coffin, Lemann, Le Bars, Willer and Jian 1994; Dallel et al., 1999) in migraine sufferers, 
thereby inhibiting the less intense symptoms of motion sickness, in this case nausea and 
body  temperature.    Nausea  and  perceived  changes  in  body  temperature  are  not 
nociceptive sensations.  However, nausea is a noxious sensation so may be nociceptive 
linked.      It  is  believed  that  the  analgesia,  which  follows  exposure  to  a  stressor,  is 
mediated  by  opioid  or  non-opioid  systems  and  the  activation  of  descending  pain 
inhibitory  pathways  (Malan,  2005).      Alternatively,  the  intense  pain  during  hand   189
immersion  may  have  simply  distracted  participants’  attention  away  from  other  less 
intense sensations, such as nausea and body temperature.   Whatever the mechanism, it is 
certainly conceivable that the extremely cold stimulus overpowered the usual sensation of 
warmth reported during motion sickness (Harm, 1990).  Remaining symptomatic ratings 
including  headache,  dizziness,  drowsiness,  visual  illusion  and  self-motion  were 
comparable, irrespective of  whether the temple or hand was painfully stimulated during 
OKS, for both groups.   
 
 
 
Effects on pulse amplitude 
 
 
Summary of major findings 
 
Ice on temple during OKS vs OKS alone (Condition 4 vs 1, respectively) 
 
•  Vascular changes were comparable over both conditions for both groups. 
 
 
Ice on temple during OKS vs Hand in ice-water during OKS (Condition 4 vs 6, 
respectively) 
 
•  Overall vascular responses were comparable in both groups.  Furthermore, the 
ipsilateral response was greater than the contralateral response when the hand was 
immersed in ice-water during OKS. 
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Discussion of effects on pulse amplitude   
 
 
Ice on temple during OKS vs. OKS alone (Condition 4 vs. 1, respectively) 
 
 
       It was anticipated that facial blood flow would be greater in migraine sufferers than 
in  controls  when  the  temple  was  stimulated  during  OKS  than  during  OKS  alone.  
Contrary to expectations, vascular responses were comparable across conditions for both 
groups.  Preliminary findings demonstrated that pulse amplitude increased more so in 
migraine sufferers than in controls during OKS alone.  However, vascular reactivity to 
painful stimulation of the temple during OKS did not differ between groups.   It appears 
that  the  additional  component  of  painfully  cold  stimulation  during  OKS  augmented 
extracranial vasodilatation in controls to resemble that observed in migraine sufferers.  
Extracranial vasodilatation may form part of a defense response to noxious or threatening 
stimuli (Carrive and Bandler, 1991; Kolev et al., 1997; Bandler and Shipley, 1994).  The 
midbrain periaqueductal gray (PAG) is involved in the mediation of defensive behaviour 
including  modulating  fear  and  anxiety  and  autonomic  and  cardiovascular  responses 
(Behbehani, 1995), so may have been activated in both groups when pain was combined 
with  OKS.    The  enhanced  response  in  migraineurs  during  OKS  alone  may  indicate 
disrupted PAG control – hyperexcitable neural responses or weak inhibitory mechanisms 
in this group.  Vascular changes across conditions, regardless of whether the temple was 
painfully  stimulated  during  OKS,  were  equivalent  for  both  groups.        Nevertheless, 
headache was greater in migraine sufferers than controls, suggesting that a mechanism 
other than extracranial vasodilatation was responsible for headache.  
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Ice  on  temple  during  OKS  vs  hand  in  ice-water  during OKS  (Condition  4  vs  6, 
respectively) 
 
   
     Overall, vascular responses were comparable in both groups, though the ipsilateral 
response was greater than the contralateral response when the hand was immersed in ice-
water during OKS.   As discussed previously (chapters 9, 10), this asymmetrical reaction 
to  painfully  cold  stimulation  of  the  limb  in  both  groups  suggests  that  ipsilateral 
vasodilatation is a normal response. 
        Extracranial blood vessels usually dilate more readily in migraine sufferers than in 
controls  during  exposure  to  stressful  stimuli  (Drummond,  1984)  and  cardiac  output 
increases more so in migraineurs in response to cold- and cognitive-stress (Hassinger, 
Semenchuk and Obrien, 1999).     In view of this it was expected that vasodilatation 
would be greater in migraineurs than in controls in the present study during stressful 
procedures (temple pain during OKS, hand pain during OKS), yet it developed equally in 
both groups.  It seems that the added stress of painfully cold stimulation during OKS 
boosted  vascular  responses  in  controls  to  resemble  those  of  migraine  sufferers.   
Therefore,  for  both  groups  the  vasodilator  stress  response  was  activated  comparably 
across both conditions.  
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CHAPTER 12              
 
 
RESULTS and DISCUSSION 
 
Comparison of Conditions 
 
 2 (ice on temple after OKS), 3 (Ice on temple) and  
 
5 (Hand in ice-water) 
 
 
 
          The intention was to determine whether painful stimulation of the temple would 
promote symptoms of discomfort and intensify vascular responses in migraine sufferers 
compared to controls.   Ice was applied to the temple after OKS and independent of OKS 
to explore the impact of painful stimulation in the presence of residual effects from OKS.   
Ice to the temple (independent of OKS) was compared with immersing the hand in ice-
water (independent of OKS) to gauge the effect of painful stimulation to the head as 
opposed to elsewhere (the control condition).   
         Bearing in mind the migraine sufferer’s susceptibility to motion sickness (Golding, 
1998; Kuritzky, Ziegler & Hassanein, 1981), sensitive trigeminal system (Lance, 1993, 
2002;  Macfarlane,  1993;  Moskowitz,  1993;  Weiller  et  al.,  1995),  and  vasodilatation 
during  motion  sickness  (Harm,  1990;  Kolev  et  al.,  1997)  and  head  pain  (Lance  and 
Goadsby, 2002; Drummond, 1997); the following hypotheses were investigated:  
 
1.  Headache would develop more readily in migraineurs than in controls when ice 
was  applied  to  the  temple,  particularly  after  OKS  (in  the  presence  of  residual 
motion sickness) compared to immersion of the hand in ice-water, independent of 
OKS.     193
 
2.  If trigeminal impulses converge on neurons responsible for symptoms other than 
headache in migraineurs, these symptoms would develop more readily in migraine 
sufferers than in controls during painful stimulation of the temple than the hand.  
Additionally,  symptomatic  responses  might  intensify  in  the  presence  of  any 
residual symptoms following OKS to a greater extent in migraine sufferers than in 
controls.   
 
3.  Facial blood flow would be greater in migraine sufferers than in controls when ice 
was applied to the temple, particularly during stimulation of the temple after OKS 
(in the presence of residual motion sickness).      
 
 
 
 
 
 
RESULTS 
 
 
Symptom ratings 
 
     Ratings were analyzed in a series of 2 (group: migraineurs, controls) x 3 (condition:  
ice  to temple  before  and  after  OKS,  hand in  ice-water) repeated-measures ANOVAs.  
Simple planned contrasts were used to compare the mean of painful stimulation of the 
temple with painful stimulation of the temple after OKS, and immersion of the hand in 
ice-water.    Figure 12.1 demonstrates comparative change in symptom ratings across 
conditions.   
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ICE APPLICATION AFTER AND INDEPENDENT OF OKS 
 
A.                                                     B.        
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      Figure 12.1.A-B   Means + SEM for migraineurs (n = 23) and controls (n = 22) for 
ice to the temple after OKS, ice to the temple and hand in ice-water.  Mean rating from 
minutes 2-14 was explored.  OKS = optokinetic stimulation                                                           
* statistically significant difference between conditions for migraineurs (*P<.05)                                                                                                    
                                                                                                 P.T.O for additional ratings 
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 ICE APPLICATION AFTER AND INDEPENDENT OF OKS   
C.                                                     D.    
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 Figure 12.1C-F.   Means + SEM for migraineurs (n = 23) and controls (n = 22) for ice to 
the temple after OKS, ice to the temple and hand in ice-water.  Mean rating from minutes 2-
14 was explored.   OKS = optokinetic stimulation                                                           
*  statistically significant difference between conditions for migraineurs (*P<.05)  
Note:  Y-axis has different rating scales for unpleasantness                                                                                      
                                                                                    P.T.O for additional ratings   196
ICE APPLICATION AFTER AND INDEPENDENT OF OKS 
 
G.                                                       H.    
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Figure 12.1.G-H.   Means + SEM for migraineurs (n = 23) and controls (n = 22) for ice 
to the temple after OKS, ice to the temple and hand in ice-water.  Mean rating from minutes 
2-14 was explored.   OKS = optokinetic stimulation                                                           
 
Note:  Y-axis has different rating scales for unpleasantness (previous page), and ice-
induced intensity and ice-induced unpleasantness. 
 
 
 
 
Ice on temple before vs after OKS (Condition 3 vs 2, respectively): 
 
     The pattern of findings indicates that nausea and headache were greater when ice was 
applied to the temple after OKS than during ice to the temple independent of OKS (main 
effect for Condition, ice to temple after OKS vs ice temple: Nausea, F (1, 43) = 6.529, p < 
.05; Headache, F (1, 43) = 7.457, p < .01).  Closer inspection indicated that this only 
applied to migraineurs, particularly for nausea  (Condition x Group contrast interaction, 
ice  to  temple  after  OKS  vs  ice  temple,  Nausea:  F  (1,  43)  =  6.263,  p  <  .05).     197
Unpleasantness ratings were greater when the temple was stimulated with ice after OKS 
than independent of OKS (main effect for Condition, ice to temple after OKS vs ice 
temple,  Unpleasantness:  F  (1,  43)  =  17.476,  p  <  .001),  particularly  for  migraineurs 
(Condition  x  Group  contrast  interaction,  ice  to  temple  after  OKS  vs  ice  to  temple, 
Unpleasantness:  F (1, 43) = 4.322, p < .05).  See Figure 12.1.F.    
 
Temple pain vs limb pain (Condition 3 vs 5, respectively) : 
 
     Nausea was minimal during both conditions in migraine sufferers, and when the hand 
was immersed in ice-water headache was negligible in comparison to when the temple 
was stimulated with ice.    In controls ratings of nausea and headache were minimal in all 
three conditions (main effect for Condition, ice to temple vs hand in ice-water, Headache: 
F (1, 43) = 11.176, p < .01; Condition x Group contrast interaction, F (1, 43) = 8.722, p < 
.01).   Refer to Figures 12.1.A and 12.1.E.   Ratings of body temperature were lower in 
both groups when the hand was immersed in ice-water than when ice was applied to the 
temple (main effect for Condition, ice to temple vs hand ice-water, Body temperature: F 
(1, 43) = 4.553, p < .05).   See Figure 12.1.B.  When the hand was immersed in ice-water 
ratings  of  overall  unpleasantness,  and  ice-induced  intensity  and  unpleasantness,  were 
greater than when ice was applied to the temple independent of OKS (main effect for 
Condition, ice temple vs hand ice-water: Unpleasantness, F (1, 43) = 8.650, p < .01; Pain 
Intensity, F (1, 43) = 35.513, p < .001; Pain Unpleasantness, F (1, 43) = 29.557, p < 
.001), and as observed in preliminary analyes, were greater in migraine sufferers than in 
controls.   Figures 12.1.F, 12.1.G and 12.1.H illustrate this effect.  
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     Table 12.1.  Main effect and interaction F, p, and df values from a 2 (group: migraineurs, 
controls) x 3 (condition: ice to temple after OKS, ice to temple, hand in ice-water) repeated-
measures  ANOVA  for  nausea,  body  temperature,  dizziness,  drowsiness,  headache  and 
unpleasantness.  Mean rating from minutes 2-14 for migraineurs (n = 23) and controls (n = 
22) was explored.   OKS = optokinetic stimulation  
 
 *  statistically significant (* p < .05,** p < .01,*** p < .001)                         
 
 
 
 
 
 
      Table  12.2.    Main  effect  and  interaction  F,  p,  and  df  values  from  a  2  (group: 
migraineurs, controls) x 3 (condition: ice to temple after OKS, ice to temple, hand in ice-water) 
repeated-measures  ANOVA  for  ice-induced  intensity  and  ice-induced  unpleasantness. 
Mean rating for ice applications for migraineurs (n = 23) and controls (n = 22) were 
explored.  OKS = optokinetic stimulation 
 
*  statistically significant (** p < .01,*** p < .001) 
     
                                                                                                         F ratios (df = 1, 43) 
  Group   Condition   Condition x Group  
Nausea 
         Ice temple after OKS vs Ice temple 
         Ice temple vs Hand ice-water 
6.659 *    
  6.529 * 
    .787  
 
6.263 * 
2.374 
Body temperature 
         Ice temple after OKS vs Ice temple 
         Ice temple vs Hand ice-water 
  .379   
    .446 
  4.553 * 
 
3.417 
  .858 
Dizziness  
         Ice temple after OKS vs Ice temple 
         Ice temple vs Hand ice-water 
6.527 *   
  3.870 
  1.567  
 
3.870 
1.567 
Drowsiness 
         Ice temple after OKS vs Ice temple 
         Ice temple vs Hand ice-water 
  .727   
  2.047 
    .837 
 
  .157 
  .146 
Headache 
         Ice temple after OKS vs Ice temple 
         Ice temple vs Hand ice-water 
15.641 ***   
  7.457 ** 
11.176 ** 
 
2.584 
8.772 ** 
Unpleasantness  
         Ice temple after OKS vs Ice temple 
         Ice temple vs Hand ice-water 
12.785 ***   
17.476 *** 
  8.650 ** 
  
4.322 * 
  .107 
                                                                                               F ratios (df = 1, 43) 
  Group   Condition   Condition x Group  
Ice-induced intensity 
         Ice temple after OKS vs Ice temple 
         Ice temple vs Hand ice-water 
10.283 **   
  3.419 
35.515 *** 
   
.473 
.899 
Ice-induced unpleasantness 
        Ice temple after OKS vs Ice temple 
         Ice temple vs Hand ice-water 
16.285 ***       
    .792 
29.557 *** 
   
.274 
.796   199
Pulse amplitude 
 
          Responses were analysed in a 2 (group: migraineurs, controls) x 3 (condition: ice to 
the temple before and after OKS, hand in ice-water) x 2 (side: Ipsilateral, contralateral) 
repeated-measures ANOVA.    Simple planned contrasts were used to compare the mean 
of painful stimulation of the temple with painful stimulation of the temple after OKS, and 
immersion of the hand in ice-water.   Figure 12.2 demonstrates comparative change in 
pulse amplitude across conditions. 
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     Figure 12.2.   Mean ipsilateral and contralateral pulse amplitude change (+ SEM) to 
ice stimulation (temple, hand) for migraineurs (n = 23) and controls (n = 22) 30 seconds 
after ice stimulation.   OKS = optokinetic stimulation                        
Between group difference:   
Between condition side difference for both groups:  …:… (ipsilateral) 
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       Vascular  responses  were  greater  when  the  temple  was  stimulated  with  ice 
independent of OKS, than during stimulation after OKS (main effect for Condition, ice to 
temple after OKS vs ice temple: F (1, 43) = 12.192, p < .001).   However, as observed in 
preliminary  analyses,  this  effect  was  greater  in  migraine  sufferers  than  in  controls 
(Condition x Group interaction,  ice temple after OKS vs ice to temple: F (1, 43) = 4.213, 
p < .05).  Vascular responses were greater still when the hand was immersed in ice-water 
compared to when the temple was stimulated with ice independent of OKS (main effect 
for Condition, ice to temple vs hand ice-water: F (1, 43) = 5.079, p < .05).   Closer 
inspection indicated that responses were greater ipsilaterally  after immersion of the hand 
in ice-water than when ice was applied to the temple independent of OKS (Condition x 
Side interaction, ice temple vs hand ice-water: F (1, 43) = 5.595, p < .05).     Tables 12.3 
and 12.4, and Figure 12.2 illustrate these trends. 
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    Table 12.3.  Main effect, interaction and simple contrast F, p, and df values from a 2 
(group: migraineurs, controls) x 3 (condition: ice to temple after OKS, ice to temple, 
hand in ice-water) x 2 (side: Ipsilateral, contralateral) repeated-measures ANOVA, of 
mean pulse amplitude 30 seconds after ice stimulation (temple, hand).  
OKS = optokinetic stimulation 
 
 
Main effect                                                    df = 1, 43                   F                              P 
Group                                                                                            11.405                       .002 
Condition                                                            
      Ice temple after OKS vs Ice temple                                       12.192                        .001 
      Ice temple vs Hand ice-water                                                   5.079                       .029 
Side                                                                                                 3.862                       .056 
Interaction  
Condition x Group                                             
      Ice temple after OKS vs Ice temple                                        4.213                         .046 
      Ice temple vs Hand ice-water                                                    .002                         .964 
Side x Group                                                                                 2.137                         .151 
Condition x Side                                                 
      Ice temple after OKS vs Ice temple                                          .948                         .336 
      Ice temple vs Hand ice-water                                                   5.595                        .023 
Condition x Side x Group                                   
       Ice temple after OKS vs Ice temple                                       1.057                         .310 
       Ice temple vs Hand ice-water                                                   .604                         .441 
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     Table 12.4.   Means and standard deviations during OKS alone, ice to the temple 
during OKS, and hand in ice-water during OKS, of pulse amplitude 30 seconds after ice 
stimulation (temple, hand).   OKS = optokinetic stimulation 
 
 
 
 
                            
 
 
 
 
DISCUSSION:  
 
Effects on symptomatic responses 
 
Summary of major findings  
 
Ice on temple before vs after OKS (Condition 3 vs 2, respectively): 
 
•  Headache and nausea (particularly in migraine sufferers), was rated higher when 
ice was applied to the temple after OKS than when ice was applied independent 
of  OKS.      However,  in  controls  all  symptomatic  ratings  were  negligible 
regardless  of  condition.    During  painful  stimulation  before  OKS,  symptoms 
barely developed in migraine sufferers apart from mild headache and low-grade 
nausea.   
                                                     Means + SD 
                                                 Migraineurs (n = 23)              Controls (n = 22) 
  Ipsilateral           Contralateral         Ipsilateral             Contralateral 
Ice temple after OKS    0.7 + 25.1    8.3 + 21.4    0.1 + 13.5  -0.7 + 7.1  
Ice temple  28.6 + 31.9  27.5 + 39.5    6.1 + 14.1    5.5 + 16.5  
Hand ice-water  42.4 + 32.9   33.3 + 43.4  23.5 + 21.1    7.0 + 18.2    203
•   Unpleasantness in response to the development of symptoms was greater when 
ice  was  applied  to  the  temple  after  OKS  than  before  OKS,  particularly  for 
migraine  sufferers.      In  addition,  ratings  of  unpleasantness  were  greater  in 
migraineurs than in controls regardless of the procedure. 
•  Ice-induced pain ratings were comparable across conditions.   However, ratings 
were greater in migraineurs than in controls throughout both procedures. 
 
 
Temple pain vs limb pain (Condition 3 vs 5, respectively) : 
 
•  Headache was greater in migraine sufferers when the temple was stimulated with 
ice than when the hand was immersed in ice-water.  Controls remained headache-
free. 
•  Ratings of nausea, dizziness and drowsiness were minimal regardless of condition 
for both groups.  
•  Perceived increases in body temperature were lower in both groups when the hand 
was immersed in ice-water than when ice was applied to the temple. 
•  Overall  unpleasantness,  and  ice-induced  intensity  and  unpleasantness,  were 
greater during painful stimulation of the limb than during painful stimulation of 
the temple.   However, ratings were greater in migraine sufferers than in controls, 
for both procedures.   
 
 
Discussion of effects on symptomatic responses 
 
 
Ice on temple before vs after OKS (Condition 3 vs 2, respectively): 
 
        For  both  groups,  headache,  and  nausea  (particularly  in  migraine  sufferers),  were 
rated higher during painful stimulation of the temple after than before OKS.   Closer 
inspection  indicated  that  in  controls,  regardless  of  condition,  overall  symptomatic   204
responses were negligible.    It appeared that some aspect of OKS intensified head pain 
and nausea in migraineurs.   Therefore, these cardinal responses developed more readily 
in  migraineurs  than  in  controls  during  painful  stimulation  in  the presence of residual 
motion sickness. 
       OKS can excite vestibular structures and, in turn, the vomiting centre (Drummond, 
2005, 2002; Mitchelson, 1992).    The vomiting centre in the NTS is also activated during 
migraine headache.   As migraine headache is associated with activation of the trigeminal 
nerve it may be that the TNC communicates with the NTS during the migraine crisis 
(Knight,  2005).      Indeed,  it  appears  that  during  migraine  and  motion  sickness  these 
centres  have  a  functional  connection.    Since  nausea  and  headache  developed  in  the 
present study in migraineurs more so during painful stimulation of the temple after rather 
than before OKS, it is feasible that OKS may have excited vestibular pathways, and that 
painful  stimulation  of  the  temple  after  OKS  may  have  excited  trigeminal  pathways.   
Nausea, in particular, was greater when the trigeminal nerve was stimulated after OKS 
than before OKS.   During OKS, signals from the vestibular system may have converged 
on the NTS.   Subsequent signals from the TNC following painful stimulation of the 
temple after OKS may have simultaneously converged on NTS nuclei, thus heightening 
sensitivity in the “vomiting center” in migraine sufferers.   
          It is also possible that trigeminal stimulation boosted vestibular activity directly, as 
Marano, Marcelli, Di Stasio, Bonuso, Vacca, Manganelli, Marciano and Perretti (2005) 
observed  that  painful  trigeminal  stimulation  increased  spontaneous  nystagmus  in 
migraineurs.   Provocation of spontaneous nystagmus is probably a reasonable marker of 
vestibular  involvement  as  it  has  been  demonstrated  that  spontaneous  nystagmus  has 
vestibular  origins  (Cutrer  and  Baloh,  1992;  Kuritzsky,  Toglia  and  Thomas,  1981; 
Savundra, Carroll, Davies and Luxon, 1997).   Migraine certainly is more common in 
those who experience dizziness (Neuhaser, Leopold, von Brevern, Arnold and Lempert, 
2001),  which  may  further  suggest  that  trigeminal  and  vestibular  pathways  are 
functionally linked.  In the present study migraineurs experienced slightly more dizziness 
after than before OKS.    Therefore, it may be that painful trigeminal signals boosted 
vestibular activity and, in turn, the emetic circuit.  Alternatively, the enhanced dizziness 
may merely reflect residual effects of motion sickness.   205
         Nausea increased gradually from the commencement of the procedure when ice was 
applied to the temple after OKS (see Figure 6.1.A, page 117), whereas nausea did not 
develop until the final painful application during ice to the temple in the absence of OKS 
(see  Figure  7.1.A,  page  129).      Residual  activity  in  emetic,  trigeminal  or  vestibular 
circuits may have enhanced the nauseating effect of head pain after OKS.   OKS clearly 
seemed  to  influence  the  development  of  headache,  nausea  and  dizziness  in  migraine 
sufferers, as these symptoms did not develop as readily during the application of ice to 
the temple in the absence of OKS.   
        Ratings of drowsiness and perceived increases in body temperature were also greater 
when  the  temple  was  painfully  stimulated  after  OKS  than  before  OKS,  in  migraine 
sufferers, probably due to the residual effects of OKS.   However, differences between 
conditions did not reach significant levels.   
      For  both  groups,  and  particularly  for  migraineurs,  the  development  of  symptoms 
following  the  application  of  ice  to  the  temple  after  OKS  was  perceived  as  more 
unpleasant than before OKS.   This, no doubt, was because symptoms developed more 
readily during painful stimulation after OKS.  
     Ice-induced pain ratings were comparable for each condition in both groups.    Apart 
from  mild  headache,  reported  in  migraine  sufferers  during  painful  stimulation  of  the 
temple after OKS, symptoms were generally minimal in both conditions for both groups.  
Therefore,  participants  were  probably  equally  focused  on  the  painfully  cold  stimulus 
whether  applied  before  or  after  OKS.   Migraine sufferers, however, reported that the 
application of ice to the temple was more painful than controls, suggesting hyperexcitable 
nociception in this group. 
 
Temple pain vs limb pain (Condition 3 vs 5, respectively): 
 
           In migraine sufferers headache was more intense when the temple was stimulated 
with ice than when the hand was immersed in ice-water.    Headache did not develop at 
all when the hand was immersed in ice water.     It appeared that temple pain initiated 
headache  in  migraineurs,  suggesting  that  trigeminal  nerve  impulses  generated  the   206
enhanced nociception.   In contrast, controls remained headache-free throughout all three 
procedures.           
       Ratings  of  nausea,  dizziness,  drowsiness  and  perceived  increases  in  body 
temperature  were  generally  minimal  regardless  of  condition  for  both  groups.  
Furthermore, perceived increases in body temperature were lower in both groups when 
the hand was immersed in ice-water than when ice was applied to the temple.  Noxious 
stimulation of the limb was certainly more painful than noxious stimulation of the temple, 
for both groups.   Immersion of the hand in ice-water was probably more extreme than 
applying an ice block to the temple as it involved exposure of a greater surface area of 
skin.   
        Interestingly, for both groups overall unpleasantness in response to the development 
of  symptoms  was  greater  during  painful  stimulation  of  the  hand  than  during  painful 
stimulation of the temple, even though body temperature, and nausea and headache, in 
migraineurs, were generally greater during temple pain.   Perhaps because limb pain was 
overwhelmingly more painful than head pain, it was perceived as the more unpleasant 
condition overall. 
 
 
 
Effects on pulse amplitude 
 
Summary of major findings   
 
Ice on temple before vs after OKS (Condition 3 vs 2, respectively): 
 
•  Vascular  responses  were  greater  when  the  temple  was  stimulated  with  ice 
independent of OKS than after OKS, in both groups.  This effect was greater in 
migraine sufferers than in controls. 
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Temple pain vs limb pain (Condition 3 vs 5, respectively): 
 
•   Pulse amplitude was generally greater when the hand was immersed in ice-water 
than when ice was applied to the temple in both groups.  Responses were greater 
ipsilaterally after immersion of the hand in ice-water than when ice was applied to 
the temple independent of OKS.    
 
 
Discussion of effects on pulse amplitude   
 
Ice on temple before vs after OKS (Condition 3 vs 2, respectively): 
 
      Vascular  responses  were  greater  when  the  temple  was  stimulated  with  ice 
independent of OKS than after OKS, in both groups.   However, it was expected that 
facial blood flow would be greater in migraine sufferers than in controls when ice was 
applied to the temple after (in the presence of residual motion sickness) than before OKS.      
         Preliminary  analyses  (see  chapter  6,  page  126)  indicated  that  extracranial 
vasodilatation  persisted  after  OKS  in  migraine  sufferers,  hence  data  was  re  analysed 
using the baseline before OKS (see Appendix 12, pages 361-362).   When analysed with 
a different baseline it appeared that pulse amplitude increased during OKS and remained 
so when ice was applied to the temple after OKS, particularly in migraine sufferers.   In 
addition, vascular responses were found to be comparable in each condition, for both 
groups.  This effect was greater in migraine sufferers than in controls.   
 
Temple pain vs limb pain(Condition 3 vs 5, respectively): 
 
      Overall, extracranial vascular increases were greater during limb pain than head pain, 
for  both  groups,  suggesting  that  vascular  reactivity  was  not  entirely  mediated  by 
trigeminal nerve activity.   208
      Facial blood flow increased more readily in migraine sufferers than in controls during 
temple  pain.    During  limb  pain,  overall  increases  in  pulse  amplitude  were  greater 
ipsilateral than contralateral to stimulation, and were greater in migraine sufferers than 
controls contralaterally.  The defense response was assumed to at least partly account for 
the enhanced vascular response observed in migraineurs during temple pain.  Atypical 
autonomic reactivity may have also influenced facial blood flow during limb pain and 
will be discussed next.    
      Drummond (1999) found that anger and embarrassment provoked increases in facial 
blood flow but decreases in the hand.  He suggested that this might represent a defense 
response mediated in the periaqueductal gray matter in areas that link pain and emotional 
processing centres in the cerebral cortex and the brain stem (Bandler and Shipley, 1994).  
      The asymmetry of the response appeared to be a normal reaction to hand immersion 
in both groups, implying that mechanisms other than a general widespread sympathetic 
response (Strandring, 2005) to painful stimulation was responsible.    In contrast, side 
differences were not apparent during painful stimulation of the temple.  
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CHAPTER 13  
 
GENERAL DISCUSSION 
 
   
      In this chapter key findings are summarized and then discussed in light of the relevant 
literature/models of the migraine mechanism, for symptomatic and vascular responses, 
respectively.  Following this, general methodological issues associated with the project 
are addressed, followed by directions for further research, and conclusions. 
 
 
 
 
 
13.1.  SYMPTOMATIC RESPONSES 
 
Discussion of findings 
 
        In this major section, aspects of OKS, trigeminal stimulation, and  hyperexcitability 
in trigeminal and brain stem nuclei in migraine sufferers are discussed.   In light of this 
review,  the  relationship  between  head  pain  and  nausea,  two  cardinal  symptoms  of 
migraine,  is  examined  in  depth.    Observations  during  limb  pain  and  psychophysical 
factors in relation to pain are then discussed. 
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Symptoms  generally  develop more  readily  in migraine  sufferers  than    
in controls during OKS 
 
      Symptomatic  responses  generally  developed  more  readily  in  migraineurs  than  in 
controls, particularly during the three procedures involving OKS and during temple pain 
after OKS in the presence of residual motion sickness.   
      This section focuses on aspects of motion sickness.  First, the neurophysiology of 
nausea,  and  nociceptive  and  non-nociceptive  pathways  that  may  converge  on  emetic 
circuits, is introduced.   The focus is then directed to OKS-induced motion sickness and 
its impact on pain processing.   Nausea is explored next in relation to both maladies - 
migraine and motion sickness.   Following this, motion sickness in migraine sufferers, 
with respect to interconnected neural pathways, particularly vestibular and emetic, are 
considered.    Whether  symptoms  of  motion  sickness  are  a  defense  response  is  also 
discussed.   This section concludes with a summary of key points related to OKS-induced 
symptoms. 
    
      Mechanism of nausea 
 
       Although  many  different  maladies  cause  nausea  and  vomiting  (motion  sickness, 
migraine,  morning  sickness,  toxin  ingestion) the  same central circuitry (the ‘vomiting 
center’) in the brainstem is thought to coordinate emesis (Dahlof and Hargreaves, 1998; 
Mitchelson,  1992).    Vomiting  is  frequently,  but  not  always,  heralded  by  nausea.   
Furthermore, nausea - an unpleasant wave-like sensation in the throat, epigastrium or 
abdomen - does not always culminate in vomiting (Venes, 2001).     Nausea, a cardinal 
symptom  of  migraine,  was  of  particular  interest  in  the  present  study.    Plausibly,  an 
association exists between the sensation of nausea and activation of the ‘vomiting centre’,  
which    comprises  part  of  the  nucleus  tractus  solitarius  (NTS)  and  the  dorsal  motor 
nucleus of the vagus (Dahlof and Hargreaves, 1998; Mitchelson, 1992).    
      Three  different  afferent  pathways  converge  on  the  ‘vomiting  centre’:  the 
chemoreceptor trigger zone (CTZ), gastrointestinal visceral afferents, and the labyrinth 
(Noriaki et al., 1993).   Visceral (via: vagal and sympathetic nerves) and labyrinth (via   211
vestibular(via  vestibular  nuclei)  input  has  direct  synaptic  contact  with  the  “vomiting 
centre” but the CTZ, located in the area postrema at the floor of the fourth ventricle on 
the upper surface of the medulla, detects emetic signals via circulating chemical stimuli 
in plasma and cerebral spinal fluid (Borison, 1989; Leslie, 1986; Yates, Gr÷lot, Kermon, 
Balaban, Jakuš and Miller, 1994).      
        Perhaps  the  so-called  “vomiting  center”  also  receives  indirect  input  via  the 
cerebellum  as  cerebellovestibular  connections  project  to  superior,  medial  and  inferior 
vestibular nuclei (Standring, 2004).   Vestibular inputs to the nucleus tractus solitarius 
were demonstrated to come directly from medial and inferior vestibular nuclei in the cat 
(Yates et al., 1994) and rabbit (Balaban and Beryozkin, 1994).            
         The vagal nucleus, also known as the dorsal motor nucleus of the vagus, is a general 
efferent  nucleus  and  the  largest  parasympathetic  nucleus  in  the  brain  stem.  
Approximately 80% of its neurones give rise to the preganglionic pararsympathetic fibres 
of the vagus nerve. Also, sparse vagal afferents that supply the gastrointestinal system 
project directly to the NTS (Helke, 2001).   The muscular contractions associated with 
vomiting are coordinated by efferent motor fibres in the vagus. 
 
 
 
       Multiple neural pathways including nociceptive may converge on the NTS 
 
        Multiple  pathways  may  mediate  nociceptive  inputs  to  the  NTS,  which  perhaps 
explains  why  symptoms  such  as  headache  developed  during  OKS  in  this  study, 
particularly in migraine sufferers.   In a review of the literature, Boscan, Kasparov and 
Paton  (2002)  illustrate  the  potential  for  integration  of  visceral  and  somatic  afferents 
within the NTS.   They site evidence that cardio-respiratory afferent regions in the NTS 
receive direct projections from the spinal cord and express c-fos immuno-reactivity in 
response  to  noxious  stimulation  of  the  limb,  cornea  and  stomach.      The  immediate 
response gene c-fos plays a role in the alteration of cellular responses to pain signals 
(Moskowitz, 1993).  Boscan et al. (2002) studied the interaction between nociceptive and 
baroreceptive activity in the NTS in rats involving mechanical stimulation of the paw,   212
electrical  stimulation  of  the  brachial  nerve,  and  paced  microinjections  of  GABA  A 
antagonist - bicuculline methiodide, substance P, and the NK1 receptor antagonist –CP-
99,994 into the NTS.   They concluded that somatic nociceptive afferents activate NK1 
receptors,  which  in  turn  enhance  the  release  of  GABA  in  the  NTS.    This  activation 
inhibits  the  baroreceptor  cardiac  reflex.    These  researchers  claim  this  inhibition  may 
facilitate and maintain the tachycardia and pressor response that is associated with pain.   
Based  on  their electrophysiological  findings  they  suggest  that  multiple  pathways  may 
mediate nociceptive inputs to the NTS.   Consistent with the literature they point out that 
nociceptive  information  may  be relayed directly  via the dorsal horn, or indirectly via 
lamina  1  neurons  and  the  lateral  cervical  nucleus  in  the  spinal  cord,  to  the  NTS.   
Additionally, other brainstem and midbrain regions may forward nociceptive information 
to  the  NTS,  e.g.  the  rostal  ventrolateral  medulla,  parabrachial  complex  and 
periaqueductal grey matter.    Spinal, brainstem and midbrain structures per se were not 
directly  investigated  in  the  present  study,  but  as  symptoms  including  headache  and 
nausea developed, particularly in migraine sufferers exposed to OKS, it is plausible that a 
number of these pathways were activated. 
          Consistent with the notion that multiple pathways impact on the NTS, in a series of 
studies involving stimulation of vagal and sympathetic abdominal and cardiac visceral 
afferents, Longhurst, Tjen-A-Looi and Fu (2001) observed an interaction of sympathetic 
and vagal parasympathetic afferents in the NTS.  In particular, myocardial ischemia is a 
condition  where  both  vagal  and  sympathetic  cardiac  afferent  reflexes  are  activated.  
Nausea,  vomiting,  inhibitory  responses  (e.g.,  bradycardia,  hypotension)  and  excitatory 
responses (e.g., tachycardia, hypertension) have all been observed during this state.  It is 
thought that nausea (and vomiting), and inhibitory cardiovascular responses are mainly 
facilitated by vagal efferents while excitatory cardiovascular responses are a function of 
sympathetic  efferents.  During  the  vomiting  process  outputs  initiated  by  the  medulla 
include: sweating and increased heart rate, a SNS response; increased salivation, a PNS 
response;  and motor responses involving abdominal muscles.  This collective activity 
may demonstrate central integration of opposing reflexes (vagal/PNS and SNS) in the 
NTS as Longhurst et al. (2001) suggest.  Some pathways from the viscera and pharynx 
(gagging:  glossopharyngeal,  trigeminal  afferents)  are  thought  to  bypass  the  CTZ  and   213
input  directly  into  the  NTS.    Perhaps  the  central  integration  of  opposing  reflexes, 
believed  to  occur  during  emesis,  to  some  extent  underlie  nausea,  which  commonly 
precedes vomiting.  Sensory and emotional (pain, sight, smell, anticipation) inputs to the 
‘vomiting centre’ are mediated via higher brain centres but motion sickness is thought to 
have input through the cerebellum/vestibular apparatus (Dahlof and Hargreaves, 1998; 
Mitchelson, 1992).  A number of these pathways could conceivably be activated in a 
migraine attack.    
  
           
        OKS-induced motion sickness and impact on nociception  
 
        OKS most likely triggered visually-induced motion sickness (Takeda, Morita, Horii, 
Nishiike and Uno, 2001) as symptomatic responses developed in both groups, albeit more 
so in migraineurs.    Migraine sufferers were more sensitive to painful stimulation than 
controls, and developed headache during the procedure.   Drummond (2002) found that 
migraine sufferers were more sensitive than controls in terms of nausea and headache, 
after  OKS,  and  scalp  tenderness  increased  in  the  most  nauseated  subjects.      Scalp 
tenderness was assessed using an algometer to each side of the forehead.  Drummond 
proposed that the disturbance responsible for nausea also sensitized primary or secondary 
trigeminal nociceptors or released inhibitory controls on their discharge. 
 
 
      Nausea in migraine and motion sickness 
                
       Nausea  and  vomiting  in  migraine  (Dahlof  and  Hargreaves,  1998)  and  in  motion 
sickness (Takeda et al., 2001; Cass et al., 1997) is presumed to start within the central 
nervous system.   In further support of central generation of nausea in motion sickness, 
Levine, Chillas, Stern and Knox (2000) found that while gastric tachyarrythmia resolved 
following  administration  of  serotonin  (5-HT)  receptor-antagonist  antiemetics  during 
OKS, nausea (and other symptoms of motion sickness) still developed.  These researchers 
concluded that nausea (associated with motion sickness) was not purely dependent on the   214
presence  of  tachyarrhythmia/stomach-discomfort.  They  suggested  that  activity  in 
multiple pathways contributes to the sensation of nausea.   Peripheral pathways, however, 
mediate the actual vomiting process (Lang, 1999; McMillin, Richards, Mein and Nelson, 
1999).   
 
        Motion sickness in migraine sufferers  
 
         Enhanced symptomatic responses in migraine sufferers observed during OKS in the 
present  study  may  reflect  activation  of  neural  pathways  that  mediate  symptoms  of  
motion  sickness  and  migraine.      Signals  from  the  vestibular  system  are  required  for 
triggering motion sickness (Yates, Miller and Lucot, 1998).  Visually-induced motion 
sickness from OKS does not involve direct vestibular stimulation but, instead, involves 
converging sensory inputs (vestibular, visual, somatosensory) that are at variance with 
sensory  integration  from  the  ‘neural  store’  (memory,  past  experience)  (Takedo  et  al., 
2001).       This neural mismatch results in motion sickness.  As symptoms of motion 
sickness  and  migraine  are  similar,  the  same  neural  events  may  be  involved  in  both 
conditions.  Specifically, brainstem nuclei usually involved during attacks of migraine 
(Weiller et al., 1995) might reciprocally initiate headache and other symptoms during 
OKS.  
 
       Convergent neural pathways 
 
       Anatomical pathways involved in the generation of symptoms (e.g., nausea/vomiting, 
dizziness) of motion sickness and migraine, may be shared.   Activation of “the vomiting 
centre”  nuclei  could  conceivably  lead  to  nausea/vomiting,  which  in  turn  because  of 
neural interconnections, may activate vestibular nuclei and so initiate the sensation of 
dizziness.  As previously pointed out, the vestibular apparatus is also involved in motion 
sickness.  In this case, impulses from the vestibular apparatus travel to the vestibular 
nucleus, then through the cerebellum to the ‘vomiting centre’ (Mitchelson, 1992).            
       Takedo et al. (2001) propose that a hypersensitive ‘emetic center’ (low threshold for 
the emetic response) underlies susceptibility to motion sickness.  As the same central   215
mechanisms  orchestrate  emesis,  regardless  of  the  triggering  condition,  and  migraine 
sufferers  are  prone  to  motion  sickness,    ‘vomiting  centre’  hypersensitivity could also 
explain the recruitment of nausea in a migraine attack.   
 
 
      Dizziness/vertigo in migraine 
 
       The  experience  of  dizziness  or  vertigo  is  frequently  reported  during  attacks  of 
migraine as well as in the headache free interval (Marano, Marcelli, Di Stasio, Bonuso, 
Vacca, Manganelli, Marciano and Perretti, 2005; Baloh, 1997; Cutrer and Baloh, 1992), 
and nausea is often coupled with dizziness/vertigo during an attack (Baloh, Foster, Yue 
and Nelson, 1996; Harris, 1999).  This may reflect an interaction between the trigeminal 
and vestibular systems.   Consistent with this interaction, Marano et al. (2005) found that 
spontaneous nystagmus developed more readily in migraineurs than in controls following 
unilateral  electrical  stimulation  of  the  supraorbital  region  of  the  forehead.    Lesions 
associated  with  vestibular  structures  commonly  produce  rhythmic  eye  movements  or 
nystagmus (Venes, 2001).  The findings of Marano et al. (2005) may indicate dysfunction 
of  the  vestibular  system  in  migraineurs  and  a  functional  connection  between  the 
vestibular and trigeminal systems.  In the case of motion sickness, impulses are relayed 
from vestibular nuclei to the cerebellum, and then to the “vomiting center” (Mitchelson, 
1992).        Motion  sickness  symptoms  develop  readily  in  most  migraine  sufferers  but 
motion sickness is not comorbid with common peripheral vestibular disorders, such as 
Meniere’s disease, benign paroxysmal positional vertigo or vestibular neuritis (Marcus, 
Furman annd Balaban, 2005).  The reciprocal relationship between motion sickness and 
migraine lends further support to the notion that anatomical pathways involved in their 
generation may be shared. 
  
 
        Symptoms of motion sickness as a possible defense response 
 
        In the case of motion sickness, Triesman (1977) suggests that symptoms represent a 
defense  response,  similar  to  the  protective  reflex  of  vomiting  that  follows  gastric   216
irritation in response to ingestion of a toxin.   The sensory conflict generated in motion 
sickness may trigger nausea, but in the instance of motion sickness this is due to a false 
perception that a neurotoxin is involved.    
         Interestingly,  Rohleder,  Otto,  Wolf,  Klose,  Kirschbaum,  Enck  and  Klosterhalfen 
(2006)  demonstrated  gender  specific patterns during nauseogenic body rotation in the 
production  of  pro-inflammatory  cytokine  production  and  the  sensitivity  of  stimulated 
cytokine production to glucocorticoid suppression.   In healthy males, stress responses 
during  body  rotation  stimulated  pro-inflammatory  cytokine  production,  and  the 
sensitivity of stimulated cytokine production was linked to glucocorticoid suppression.  
In females, however, glucocorticoid sensitivity increased and changes in inflammatory 
responses were minimal.   In the present study, perhaps the threat to homeostasis during 
motion sickness triggered neurogenic inflammation to defend the brain of the susceptible 
individual, in addition to nausea/emesis.   
       Inflammation is an immunological defense against injury, infection or allergy (Bray 
et al., 1999; Davis, 2001; Kemper, Meijler, Korf and Ter Horst, 2001).  When tissue is 
traumatised  or  threatened  the  immune  system  is  activated  and  a  local  inflammatory 
response begins as the first line of defense.  Numerous proteins including cytokines are 
released that signal a cascade of chemical events to regulate inflammation and immune 
responses.  Cytokines are able to alter cells that produce them (autoendocrine effect), 
change  neighbouring  cells  (paracrine  effect),  or  affect  cells  systemically  (endocrine 
effect).   Systemic inflammatory responses occur when foreign proteins are detected in 
the blood stream and immune responses or cytotoxic T-cells are activated.    
      In their review of the literature, Kemper et al. (2001) reported that changes of serum 
levels of complement and immunoglobulins, histamine, cytokines and immune cells were 
sometimes  observed  in  migraine  sufferers,  suggesting  that  immune  function  in 
migraineurs might be altered.   However, Kemper et al. point out that these findings were 
not replicated in the majority of studies.   Hence, in light of the available evidence, it was 
concluded that there is no definitive evidence of an immune dysfunction in migraineurs. 
       However, it is well recognized that a local neurogenic inflammatory response of the 
meningeal vasculature is specifically associated with migraine pathogenesis (Moskowitz, 
1993).   As migraine sufferers developed headache during OKS in the present study, it is   217
tempting to speculate that an immunological inflammatory defense reaction occurred in 
deeper structures of the brain, initiated in response to stressful procedures.   On the other 
hand, it appears that meningeal neurogenic inflammation may simply be a process that 
occurs in the period before the headache phase of a migraine attack rather than being a 
force  for  the  headache,  as  the  anti-migraine  drug  Bosentan  blocks  plasma  protein 
extravasation but has no vasoconstrictive effects, and does not alleviate head pain during 
the headache phase of the attack (May, Gijsman, Wallnofer, Jones, Diener and Ferrari, 
1996). 
        In  the  present  study,  the  stress  of  OKS-induced  motion  sickness  may  well  have 
provoked activity in the hypothalamic-pituitary-adrenal axis and the autonomic nervous 
system (Kajantie and Phillips, 2006).   In Rohleder’s study (2006) increases in endocrine  
responses  (adrenocorticotrophic  hormone,  cortisol  and  antidiuretic  hormone)  were 
observed  in  both  sexes  during  rotation-induced  motion  sickness.      All  endocrine 
responses  habituated  over  time  except  for  the  cortisol  response  in  males.      Gender 
specific patterns in the production of stress hormones are also seen in response to various 
other stressors including physical, mental and psychosocial tasks (Kajantie and Phillips, 
2006).  
       Furthermore, perhaps the stress/defense response to the disconcerting state of motion 
sickness (Drummer, Stromeyer, Reipl, König, Strollo, Lang, Maass, Rocker and Gerzer, 
1990; Otto, Riepl, Otto, Klose, Enck and Klosterhalfen, 2005; Reichardt, Üngörgil, Reipl, 
Schedlowski, Lehnert and Enck, 1997; Rohleder, Otto, Wolf, Klose, Kirschbaum, Enck 
and  Klosterhalfen,  2006)  added  to  or  facilitated  vascular  and  symptomatic  responses 
during OKS. 
 
 
     Key points: OKS-induced symptoms 
 
       Migraine  sufferers  were  more  sensitive  to  OKS-induced  motion  sickness  than 
controls.  The similarity of symptoms during motion sickness and migraine imply that 
neural pathways in their manifestation are shared.  It is also plausible that the stress-
response augmented symptomatic responses during OKS.   218
Trigeminal stimulation increases nausea and headache more readily in 
migraine sufferers than in controls 
 
       In  the  present  study,  headache  and  nausea  increased  progressively  in  migraine 
sufferers but not in controls following painful stimulation of the temple.  Among other 
possibilities, this may indicate dysfunction of the trigeminal brainstem nuclear complex 
in migraine.   
       This section discusses the trigeminal nerve in relation to head pain and nausea.  The 
structure and function of the trigeminal nerve is described.   Activation of  the trigeminal 
sensory system during migraine is discussed next with respect to head pain and nausea 
during an attack.  The neurophysiology of nociception in general is described, followed 
by a more specific discussion related to the mechanism of head pain during a migraine 
attack.    The  neurogenic  inflammatory  response  and  hyperexcitable  nociception  in 
migraine sufferers are considered.   This section concludes with a summary of key points 
related to the role of the trigeminal nerve in the development of symptoms in migraine 
sufferers. 
 
   
    Anatomy of the trigeminal nerve 
 
      Application of ice to the temple most likely stimulated the ophthalmic branch of the 
trigeminal nerve and possibly the maxillary and mandibular nerves as all three divisions 
converge in the temple.   The  trigeminal  nerve  is  the  largest  of  the  cranial  nerves.  It  
transmits sensory information from most of the scalp, face, oral and nasal cavities and 
relays motor signals to the muscles of mastication.  Three branches of the trigeminal 
nerve converge to form the trigeminal or gasserian ganglion: the mandibular (sensory and 
motor), ophthalmic and maxillary (sensory).     The main sensory root of the trigeminal 
nerve  is  situated  within  the  pons  (Silberstein,  2003;  Waxman,  2003;  Woolfall  and 
Coulthard,  2001).      The  ophthalmic  branch  of  the  trigeminal  nerve  carries  sensory 
information from the nose, paranasal sinuses and upper face.   Deeper brain structures 
including  the  large  cerebral  vessels,  venous  sinuses  and  dura  mater,  are  supplied  by   219
afferent sensory fibres which project through the ophthalmic division.  Theses fibres then 
converge  in  the  brainstem  with  primary  afferents  from  the  ophthalmic  and  occipital 
structures onto second order neurons in the caudal trigeminal nucleus (TNC) (Knight, 
2005).   
         The  TNC  receives  input  from  the  trigeminal  nerve  and  contains  neurons  that 
discharge when the meninges are stimulated (Moskowitz, 1993).     Pain and temperature 
fibres in the trigeminal nerve enter the brain stem and descend within the spinal tract.   
Pathways  then  pass  to  the  thalamus.      Subnuclei  for  proprioception  project  to  the 
mesencephalon, and reflex connections pass to the cerebellum and motor nuclei of cranial 
nerves V, VII and IX (Waxman, 2003).  Trigeminal nerve afferents convey pain, thermal 
and tactile information from the face, cerebral vessels and dura mater, to higher brain 
centres.    Also,  pressure  and  kinesthetic  sensations  from  teeth,  gums  and  the 
temporomandibular joint are conveyed to higher brain centers (Carpenter, 1985). 
 
 
        Trigeminal nerve stimulation in relation to migraine headache 
 
 
         Knight (2005), in a review of the literature, points out that trigeminal brainstem 
structures form an intricate and complex system of converging projections, a “nociceptive 
loop”.   Imaging studies also confirm that neural activity/brainstem structures (medulla, 
pons, midbrain) play a role in the generation of migraine headache (Borsook, Burstein, 
Moulton  and  Becerra,  2006;  Weiller,  May,  Limmroth,  Juptner,  Kaube,  Schayck  and 
Diener, 1995).  Clearly, activation of the trigeminal sensory system is linked to head pain 
and nausea during attacks (Knight, 2005; Dalhlof and Hargreaves, 1998).   
       The trigeminal nerve innervates the meninges and may contribute to the development 
of a migraine attack (Bolay, Rueter, Dunn, Huang, Boas and Moskowitz, 2002).  While 
the brain itself is generally insensate (Strandring, 2005), headache pain is generated from 
trigeminovascular input presumably from the meningeal and extracranial blood vessels 
(Silberstein, 2003; Moskowitz, 1993).   Trigeminovascular activation may also trigger   220
nausea  and  vomiting  because  of  potential  functional  connections  between  the 
trigeminovascular system and the Nucleus Tractus Solitarius (Knight, 2005).   
        Direct stimulation of the trigeminal nerve is a useful and convenient diagnostic and 
research  tool  that  has  helped clarify  the  neurophysiology  of the  trigeminal  nerve  and 
closely associated brain structures (e.g., Grosser, Oelkers, Hummel, Gesslinger, Brune, 
Kobal  and  Lotsch,  2000;  Honey,  Bland-Ward,  Connor,  Feniuk  and  Humphrey,  2002; 
Valls-Solé, 2005).  In the present study trigeminal nociception was stimulated thermally 
with the application of ice to the temple.  
 
 
            Effects of trigeminal stimulation on nausea  
 
             It is conceivable that trigeminal nerve stimulation during the application of ice to 
the temple provoked headache in migraine sufferers in the present study.  As previously 
pointed out, the cranial sensory anatomy involves convergence of visceral (blood vessels) 
and somatic (head/facial musculature) nerve fibres on to the same central interneurons.  
Central projections include the trigeminal nucleus caudalis (TNC), which mediates pain 
responses, and the nucleus tractus solitarius (NTS) which mediates autonomic responses, 
e.g.,  vomiting  (see  Macfarlane  for  a  review  of  the  literature,  1993).      A  functional 
connection is believed to exist between the TNC and the NTS.   
         Knight  (2005)  suggested  that  trigeminovascular  activation  triggers  the  emetic 
response as these symptoms are alleviated by antimigraine medication targeting the 5-
HT1B/1D  receptors in the NTS.  In support of this, remarkable levels of 5-HT1D  and 5-HT1F  
binding-site  areas  were  found  in  the  TNC  and  NTS  during  analyses  of  brain  tissue 
(Pascual, del Arco, Romon, del Olmo, Castro and Pazos, 1996).  An action of triptans on 
these brain nuclei may contribute to the anti-emetic and analgesic therapeutic effects of 
this group of drugs.  It is also likely that the NTS modulates trigeminal nociception in the 
TNC since visceral nociception requires an intact NTS (Wietelak, Roemer and Maier, 
1997).   
        In the present study nausea increased in both groups when ice was applied to the 
temple, but more so in migraineurs.  The other symptomatic ratings generally did not   221
change following temple pain during OKS, which suggests a specific association between 
nausea and head pain.  The increased nausea, coupled with increased headache observed 
in migraine sufferers when the temple was painfully stimulated after and during OKS, 
implies  a  mutual  interaction  between  the  TNC  and  NTS.      If  so,  it  may  be that  the 
cardinal  symptoms of nausea and headache compound one another during a migraine 
attack. 
 
 
        Neurophysiology of nociception 
 
         Pain occurs when stimulation is intense enough to threaten or to cause tissue injury 
(Bray et al., 1999).  Free nerve endings in peripheral and cranial nerves are believed to be 
the  specific  nociceptors  for  pain  and  also  serve  as  thermo-  and  mechanoreceptors 
(Slaughter,  2002).      Painful  mechanical,  chemical  or  thermal stimulation  can activate 
nociceptors.   Nociceptive pain fibres consist of rapid firing thinly myelinated A-delta 
fibres  and  slower  conducting  unmyelinated  C  fibres  (including  polymodal  C  fibres) 
(Waxman,  2003).      A-delta  fibres  are  sensitive  to  high  intensity  mechanical  or  cold 
thermal stimuli while C fibres signal high intensity mechanical, thermal (cold and hot) 
and noxious chemical stimuli (Bray, Cragg, MacKnight and Mills, 1999; FitzGerald and 
Folan-Curran,  2002).    Nociceptive  axons  arise  from,  and  transmit,  information to the 
dorsal  root  ganglia  of  the  spinal  cord  and  the  trigeminal  ganglia  (Barker  and Barasi, 
2001; Waxman, 2003).  The brain stem spinal trigeminal nucleus and the dorsal horn of 
the spinal cord are the initial sites of synapse in the central nervous system (Silberstein, 
2003). 
         Mechanical and thermal stimuli to the skin evoke specific painful sensations (Ochoa 
and Yarnitsky, 1994).  Mechanical stimuli usually activate myelinated A-delta fibres and 
unmyelinated  C  polymodal  nociceptors  and  induce  a  sharp  or  dull  pain  without  any 
thermal  quality.      During  high  noxious  temperatures  unmyelinated  C  polymodal 
nociceptors  mediate  the  characteristic  burning  pain  sensation  (Ochoa  and  Torebjörk, 
1989).        Low  temperature stimuli  activate  small myelinated fibres  and  cold  specific 
channels at the primary afferent level (Adriaensen, Handwerker and van Hees, 1983).    222
Noxious  low  temperature  stimuli  co-activate  unmyelinated  C  polymodal  nociceptors, 
which is thought to evoke the typical painful cold sensation rather than burning pain 
(LaMotte and Thalhammer, 1982).   Interestingly, when myelinated fibres are blocked 
leaving only the C fibres to transmit the afferent message, low temperature stimuli no 
longer induce the cold pain sensation.  Instead, an unexpected sensation of burning is 
perceived (Yarnitsky and Ochoa, 1990).   To explain this paradox, Ochoa and Yarnitsky 
(1994)  suggest  that  the  cold  pain  afferent  message  involves  participation  of  both 
myelinated A-delta fibres and unmyelinated C fibres to override the perceived burning 
quality observed during blockade of myelinated fibres.    The quality of pain was not 
formally measured in the present study but anecdotally both groups reported a dull aching 
cold pain consistent with the concept of Ochoa and Yarnitsky, of dual activation of A and 
C fibres in the sensation of cold pain.   The experience of pain was more intense and 
unpleasant  in  migraine  sufferers,  consistent  with    hypersensitive  nociception  in  this 
group. 
 
 
      Neurophysiology of migraine 
 
       In  a  review  of  the  literature,  Burstein  (2001)  outlined  several  theories  that  may 
explain the initiation of pain in a migraine attack.  Activation of peripheral sensory fibers 
that innervate intracranial blood vessels and the dura has been proposed.  It has also been 
proposed  that  pain  activates  descending  pathways  that  facilitate  processing  of  pain 
signals by spinal cord neurons.  Alternatively, suppression of descending pathways that 
inhibit  such  processing  of  pain  signals  in  the  spinal  cord  has  been  implicated  in  the 
initiation of migraine pain.    
       The periaqueductal gray (PAG), the locus coeruleus (LC) and the raphe nuclei (RN) 
are  probably  major  components  of  descending  modulatory  brainstem  pain  pathways. 
Weiller,  May,  Limmroth,  Juptner,  Kaube,  Schayck,  Coenen  and  Diener  (1995)  found 
rCBF values in the distribution of the PAG, LC and RN were higher during migraine, 
even after pain-relieving treatment, than during the headache-free interval.     223
       Earlier  studies  demonstrated  that  headache  resulted  from stimulation  of  the PAG 
(Hass, Kent and Friedman, 1993; Raskin, Hosobuchi and Lamb, 1987) and to a lesser 
degree  the  thalamus  (Raskin,  et  al.,  1987).  Raskin  et  al.  studied  175  pain  patients 
implanted with stimulating electrodes in the PAG and/or thalamus for pain relief from 
1977 to 1982.    Headache was observed in 13, previously headache-free, individuals 
immediately, or soon after they underwent implantation, particularly in the PAG, and to a 
lesser  extent  (2  patients)  in  the  thalamus.    Some  patients  experienced  migrainous 
headache (pounding headache with nausea and visual disturbance).   The remaining 160 
individuals in Raskin’s study experienced pain relief for their original pain problem and 
did not develop headache.    Elsewhere, a solitary lesion of multiple sclerosis in the PAG 
region  led  to  severe  headache  (the  worst  of  her  life)  in  a  patient  with  a  virtually 
unremarkable medical history (Hass et al., 1993).   
       Consistent with Weiller’s (1995) imaging studies which isolated the PAG as a major 
component of modulating pain pathways, these earlier studies (Hass et al., 1993; Raskin 
et  al., 1987)  indicated  that  disruption  to  the  PAG,  a  specific  region  of  the  midbrain, 
generated headache in otherwise headache-free individuals.   
          Despite the appealing logic that the PAG may somehow be linked to the generation 
of  headache,  more  rigorous  research  is  required,  involving  larger  sample  sizes  than 
provided by those early studies of Hass et al. and Raskin et al.   Neuroimaging (Weiller et 
al., 1995) indeed implicates the involvement of brainstem structures during attacks of 
migraine.   The challenge is to establish whether activation of this area was a cause or 
consequence of the headache.   It may be that brainstem activation during attacks is due 
to neuronal discharge when the meninges are stimulated (Moskowitz, 1993) rather than 
from activation of trigeminal afferents.   In any case, the brainstem appears to be part of a 
neural circuit; the abnormality in those with migraine may feasibly extend beyond the 
brainstem. 
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        Neurogenic inflammation 
   
         During a migraine attack an inflammatory process (neurogenic inflammation) may 
occur at the site of trigeminal nerve terminals.   Neurotransmitters within nociceptive 
pain fibres, glutamate and the neuropeptides substance P, calcitonin gene-related peptide 
(CGRP), and neurokinin A, are released from trigeminal nerve sensory terminals.  These 
neuropeptides  may  activate  mast  cells,  endothelial  cells,  and  platelets.    In  turn, other 
extracellular chemical mediators (e.g., amines, metabolites) are released.  This chemical 
cascade  of  activated  cells  and  injured  tissue  leads  to  hyperalgesia  and  pain,  and 
stimulation of an early immediate response gene c-fos in the trigeminal nucleus caudalis 
of the brain stem (Moskowitz, 1993; Silberstein, 2003).   The central convergence of the 
ophthalmic branch of the trigeminal nerve and branches of C2 nerve roots in the brain 
stem possibly explains why head pain is typically located over the frontal and temporal 
regions  of  the  head,  and  referred  pain  is  experienced  in parietal, occipital  and  upper 
cervical  areas  (Angus-Leppan,  Lambert  and  Michalicek,  1997;  Goadsby,  Lipton  and 
Ferrari, 2002).    
        In the present study, migraine sufferers were more sensitive to painful stimulation of 
the temple with ice than were controls, and more readily developed headache.     As the 
trigeminal  sensory  system and neurogenic inflammation has been linked to head pain 
(Moskowitz, 1995), perhaps this inflammatory response played some part in eliciting the 
headache and hyperalgesia observed in migraine sufferers in the present study.   In any 
case, painful stimulation of the temple may have led to activation of afferent fibres of the 
trigeminal  ganglion.    Subsequently,  second-order  neurons  in  the  trigeminal  nucleus 
caudalis (TNC), and regions involved in the processing and perception of pain (thalamus, 
PAG and cortex), may have been activated.  Findings may also indicate that descending 
pathways  that  facilitate  pain  are  dysfunctional  in  migraineurs,  and  may  provoke 
trigeminal neuronal hyperexcitability (Pietrobon and Striessnig, 2003), or pathways that 
suppress pain may fail (Burstein, 2001).    
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     Hyperexcitable nociception in migraine sufferers 
 
 
       Hyperalgesia  has  been  observed  during  migraine  headache  (Burstein,  Cutrer,  and 
Yarnitsky,  2000;  Burstein,  Collins  and  Jakubowski,  2004;  Burstein  and  Jakubowski, 
2004;  Levy,  Jakubowski  and  Burstein,  2004;  Yarnitsky,  Goor-Aryeh,  Bajwa,  Ransil, 
Cutre, Sottile and Burnstein, 2003) and interictally (Kitaj and Klink, 2005).   Consistent 
with the notion of constant nociceptive sensitivity, Caputi and Firetto (1997) suggested 
that mechanical hyperalgesia, seen in the interictal period, of the emergence points of the 
supraorbital and greater occipital nerves in migraine sufferers, is a sign that extracranial 
perivascular nociception is constantly sensitive with consequent central hypersensitivity.  
They found that the frequency and intensity of headache attacks in migraine sufferers was 
alleviated  following  analgesic  blockade  of  these  epicranial  nerves,  particularly  in 
individuals sensitive to pressure at these points.  They considered that this constantly 
sensitized state  might  be the basis of the trigger for the migraine crisis.  Mechanical 
hyperalgesia in remote areas of the skin has also been relieved following the control of 
similarly  focused  nociceptor  discharge  (Penfield,  1932).    Caputi  and  Firetto  (1997) 
proposed  that  the  analgesic  nerve  block  reduced  peripheral  sympathetic  activity 
(perivascular)  and  that  this  response  represented  a  normalization  of  the  excitability 
threshold  to  endogenous  and/or  exogenous  migraine  triggers.    Consistent  with  this 
premise, Goadsby (2001) suggests that the source of pain in migraine is probably more to 
do  with  the  “abnormal  perception  of  the  normal”  than  the  activation  of  nocieptive 
pathways  in  the  usual  way  that  pain  is  generated,  e.g.,  photophobia  is  normal  light 
exaggerated, phonophobia is normal sound amplified.      
         In  the  present  study  symptomatic  responses  were  enhanced  in  migraineurs 
interictally, suggesting that neural pathways were excitable.    
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       Key points:  role of the trigeminal nerve in the development of symptoms in 
migraine sufferers 
 
 
        This study demonstrated that migraine sufferers were particularly sensitive to ice-
induced  stimulation.      Headache  and  nausea  developed  in  migraineurs  during  this 
procedure but not in controls.  The findings suggest that nociceptive pathways were more 
reactive  in  migraine  sufferers,  while  the  concurrent  development  of  nausea  implies  a 
specific link with head pain.   
 
 
 
 
Hyperexcitablity  in   trigeminal  and  other brain  stem  nuclei  in  
migraine  sufferers interictally 
 
 
         In  the  present  study,  symptomatic  responses  including  head  pain,  nausea  and 
dizziness were enhanced in migraine sufferers in the headache-free interval, during OKS 
and  temple  pain.      It  appeared  that  particularly  in  migraine  sufferers,  temple  pain 
activated trigeminal nuclei (leading to head pain) and OKS activated vestibular nuclei 
(leading  to  dizziness)  and,  in  turn,  the  “vomiting  center”  (leading  to  nausea).   
Symptomatic  ratings  were  also  greater  in  migraine  sufferers  than  in  controls  in  the 
absence of painful stimulation of the temple during OKS (OKS alone).  Collectively, 
these findings suggest that trigeminal and other brainstem nuclei are hyperexcitable in 
migraineurs between headaches.    
         For  both  groups,  symptomatic  responses  tended  to  be  greater  during  OKS  and 
painful stimulation of the temple, than painful stimulation of the limb during OKS or 
OKS  alone.      Also,  responses  tended  to  be  greater  when  the  temple  was  painfully   227
stimulated    after  OKS  than  before  OKS,  which  probably  reflected  residual  motion 
sickness from the preceding OKS. 
         The development of symptoms during trigeminal nerve stimulation in the presence 
of OKS, and in the presence of residual motion sickness, are discussed next.  Sensory 
hyperacuity  in  migraine  sufferers,  and  possible  mechanisms  accounting  for 
hypersensitivity,  such  as  neural  wind-up  and  hypersensitive  thermoregulation  are also 
considered.  Finally, this section of the discussion concludes with an overview of key 
points relevant to brain stem hyperexcitability in migraine sufferers.   
 
 
        Symptoms  developed  more  readily   in   migraine  sufferers  than  in   controls  
when  the trigeminal nerve was painfully stimulated  during OKS 
 
       As hypothesized, symptomatic ratings generally were greater in migraine sufferers 
than  in  controls  when  the  temple  was  painfully  stimulated  during  OKS.     Headache, 
particularly, was greater in migraine sufferers when ice was applied to the temple during  
OKS than during OKS alone.  Neuronal events mediating the headache phase of migraine 
are believed to involve the trigeminovascular system and its central projections (Welch, 
2003).    In  the  present  study  it  may  be  that  this  circuitry  was  somehow  activated  in 
migraineurs during OKS in the absence of painful stimulation, and painful stimulation 
facilitated this response (Ashkenazi et al., 2005).     
          Headache developed comparably during OKS + painful stimulation in migraineurs, 
regardless of the source of pain (temple or hand), suggesting that pain processing may be 
generally  compromised  in  this  group.      Saito  et  al.  (2006)  investigated  limb  pain  in 
childhood  in  a  family  of  migraine  sufferers  and  observed  that  limb  pain  was  often 
provoked by cold conditions.  During limb pain levels of the neuropeptides calcitonin 
gene-related peptide (CGRP) and substance P (SP) were elevated.  They suggested that 
an abnormal release of these transmitters in vascular walls in the extremities might be 
crucial in the pathophysiology of limb pain, similar to the case of the trigeminovascular 
explanation for migraine.  These findings imply that pain perception may be generally 
compromised  in  migraine  sufferers.      Neuropeptide  release  in  response  to  cold   228
stimulation was not measured in the current study.  Nevertheless, the enhanced limb pain 
observed in migraine sufferers may reflect hyperexcitable nociception in the interictal 
period.    
        Ratings  of  overall  unpleasantness  were  also  heightened  in  migraineurs,  probably 
because symptoms developed more readily in this group.  
 
 
        Symptoms develop more readily in migraine sufferers than in controls  during    
trigeminal stimulation in the presence of residual motion  sickness  
 
       As discussed, activation of the trigeminal sensory system has been linked to head 
pain  and  nausea  during  attacks  of  migraine  (Dalhlof  and  Hargreaves,  1998;  Knight, 
2005).   In the present study, headache and nausea increased progressively in migraine 
sufferers following painful stimulation of the temple in the presence of residual motion 
sickness, but not in controls.  This may indicate dysfunction of control of nociception in 
the trigeminal brainstem nuclear complex in migraine.   
    Clearly, migraineurs, between attacks of migraine, were more sensitive than controls to 
painfully cold stimulation of the temple in the presence of residual motion sickness.   Not 
surprisingly,  as  symptomatic  changes  generally  were  greater  in  migraine  sufferers, 
overall unpleasantness was enhanced for this group.  Activation of the trigeminal sensory 
system and neurogenic inflammation has been linked to head pain (Moskowitz, 1995) 
and nausea during migraine attacks (Dalhlof and Hargreaves, 1998; Knight, 2005).  The 
development  of  these  particular  symptoms,  and  the  heightened  pain  reported  in  the 
present test by migraineurs, suggest that the trigeminal system remains hyperexcitable in 
the interictal period.    
        Drummond  (2002) similarly found that nausea increased and headache persisted 
after OKS more so in migraine sufferers, interictally, than in controls.   Furthermore, pain 
in the fingertips, assessed using a pressure algometer, increased more in migraineurs after 
OKS.  However, contrary to the present study, scalp tenderness, also assessed using an 
algometer, but applied to the forehead, was comparable between groups after OKS.  In an 
earlier  study,  Drummond  (1987)  found  that  scalp  tissue  was  tender  in  migraine  and   229
tension  headache  patients  during  headache  and  this  persisted  for  several  days  after 
headache had subsided.  During the headache-free interval scalp sensitivity did not differ 
from controls.   Drummond proposed that a disruption in central pain processing in the 
trigeminal system might account for scalp tenderness during headache.   Hyperalgesia in 
the  fingertips  of  migraine  sufferers  in  the  presence  of  residual  motion  sickness  may 
indicate a spread of sensitization from trigeminal nuclei (Drummond, 2002), in the same 
way that sensitization spreads during a migraine attack (Burstein, 2000).  Drummond’s 
earlier findings, similar to findings in the present study, suggest that a dysfunction of 
processing nociception in the trigeminal brainstem nuclear complex may contribute to the 
migraine predisposition.   
         Headache  and  nausea  generally  were  greater  when  the  temple  was  painfully 
stimulated  after OKS than before OKS, particularly in migraine sufferers,    most  likely 
due to residual motion sickness from the preceding OKS. 
 
         Sensory hyperacuity in migraine  
 
         Drummond (1986) found that light- induced glare and pain ratings were greater in 
migraineurs  and  tension  headache  sufferers  during  the  headache-free  interval  than  in 
controls.    In  addition,  photophobia  increased  in  migraine  sufferers  during  painful 
stimulation of the forehead with ice (Drummond and Woodhouse, 1993) and mechanical 
stimulation of the nose and neck (Drummond, 1997).  Interestingly, he found in an earlier 
study  (Drummond,  1987)  that  tenderness  in  the  forehead  and  temples  in  response  to 
algometer pressure was greatest in migraine and tension headache sufferers who reported 
most  light-induced  pain.      He  suggested  that  hyperexcitability  of  trigeminal  pain 
pathways  persists  subclinically  in  migraine  sufferers  between  episodes  of  headache.  
Trigeminal nerve discharge probably contributes to photophobia in migraine; and during 
headache,  visual  and  trigeminal  input  could  interact  to  exacerbate  pain  (Drummond, 
1986, 1997).      Similarly, Main, Dowson and Gross (1997) found that migraineurs were 
more sensitive to light and also sound in the headache-free interval than were controls.  
They  proposed  that  a  central-processing  mechanism  might  make  migraineurs  more 
sensitive to light, sound and possibly other sensory stimuli.       230
         In the present study trigeminal thermal nociceptors appeared to be  more sensitive 
in  migraineurs  interictally  than  in  controls  to  extremely  cold  sensory  provocation.  
Specifically,  ice-induced  intensity  and  upleasantness,  headache  and  overall 
unpleasantness were enhanced in the migraine group.  However, enhanced responses in 
migraine sufferers may also reflect a difference in reporting style.   This possibility is 
discussed later in this chapter (“psychophysical report of pain”, pages 338-339). 
 
 
       Neural wind-up 
 
        In migraineurs symptomatic responses developed during and persisted, largely, after 
the procedures.  Headache, in particular, increased progressively throughout the recovery 
period.   The gradual amplification of headache in the present study may reflect a neural 
“wind-up” phenomenon (Bray, Cragg, MacKnight and Mills, 1999; Dallel et al., 1999), 
which was initiated during OKS.     
       Dallel,  Duale,  Luccarini and Molat  (1999)  demonstrated  a  progressive  “wind-up” 
response  of  spinal  trigeminal  nucleus  oralis  convergent  neurons  during  repetitive 
supramaximal percutaneous electrical stimulation.   Elsewhere (Katsarava et al., 2004) 
central  antinociceptive  mechanisms  were  investigated  using  the  “nociceptive”  blink 
reflex  (nBR)  following  administration  of  acetylsalicylic  acid  and  zolmitriptan  in 
migraineurs and healthy controls.  Katsarava found nBR responses were not blocked in 
controls, or migraineurs interictally.  However, responses were suppressed in migraine 
sufferers  during  an  attack,  suggesting  that  antinociceptive  effects  of  migraine-specific 
drugs on trigeminal pain processing are different during and outside of headache.   
 
 
        Hypersensitive thermoregulation in migraine sufferers  
 
        Facial pallor (decreased blood flow) and cold sweating is typically associated with 
motion sickness and migraine (Marcus et al., 2005).    In this study, perceived increases 
in  body  temperature,  coupled  with  enhanced  vasodilatation,  were  greater  in  migraine   231
sufferers  than  controls,  particularly  during  OKS  alone.    On  the  other  hand,  although 
vasodilatation  was  observed  in  controls,  body  temperature  remained  at  a  comfortable 
level  throughout  testing.    Kolev  et  al.  (1997)  suggest  that  feelings  of  warmth 
(accompanying vasodilatation) reported during motion sickness, may reflect passage of 
blood through arterio-venous anastomoses (part of the infrastructure of microcirculatory 
blood  flow),  which  play  a  role  in  thermoregulation.      This  association 
(microcirculation/thermoregulation)  may  explain  the  perception  of  elevated  body 
temperature  observed  in  migraine  sufferers.    It  may  be  that  migraineurs  are 
hypersensitive to changes in blood flow, particularly through cranial vessels. 
     
 
       Key  points:  hyperexcitability  in  trigeminal  brain  stem  nuclei  in  migraine 
sufferers 
        
        Symptomatic responses generally were enhanced in migraine sufferers interictally 
during temple pain in the presence of OKS, and during temple pain in the presence of 
residual motion sickness.   Perhaps atypical responses in this group are an indication that 
sensory  processing  in  the  trigeminal  brain  stem  nuclear  complex  is  compromised  in 
migraineurs. 
 
 
 
 
Interaction between head pain and nausea 
 
        Symptoms associated with migraine headache, other than head pain, include nausea, 
photophobia,  phonophobia,  osmophobia,  fatigue  and  numerous  disturbances  in 
autonomic, mental, sensory and motor functions (Burstein, 2001).  In the present study, in 
addition  to  the  development  of  headache,  migraine  sufferers  experienced  nausea  in 
response to painful stimulation  of the temple.    232
       Specifically,  migraine  sufferers  developed  nausea  in  the  presence  of  head  pain, 
suggesting a susceptibility to gastrointestinal sensations in this group.  However, controls 
remained asymptomatic.  Abdominal migraine is associated with nausea and vomiting 
and typically occurs in infancy, childhood, and adolescence (IHS classification, 2004), 
then apparently evolves into more typical migraine during puberty and early adulthood 
(Blau and MacGregor, 1995; d’Onofrio, Cologno, Buzzi, Petretta, Caltagirone, Casucci 
and Bussone, 2006).  Recently, d’Onofrio et al. (2006) described a rare case of an adult 
woman  who  fulfilled  the  diagnostic  criteria  for  late  onset  abdominal  migraine.  
Abdominal pain attacks began in her adolescence and persisted until age 21.  Thereafter 
she  experienced  migraine  head  pain  accompanied  by  nausea,  photophobia  and 
phonophobia.      However,  the  transition  of  childhood  abdominal  migraine  to  adult 
migraine and abdominal migraine as a feature of adult migraine has been challenged.  
Blau and MacGregor (1995) claim that in the majority of migraine sufferers there is an 
absence of abdominal discomfort during a migraine attack, which led them to conclude 
that abdominal pain is not a feature in adult migraineurs.    Despite these contrary views, 
the link between gastrointestinal disturbance and head pain in migraine is certainly well 
documented (Blau, 1993; Botney, 1981; Olesen, 1978; Rasmussen, Jensen and Olesen, 
1991).    
      An association between head pain and nausea was observed in children with a history 
of migraine (Jan, Camfield, Gordon and Camfield, 1997).   After mild head injury these 
children were more likely to vomit than children without a history of migraine.    The 
experience  of  visceral  pain  has  also  been  associated  with  nausea.    There  is  a  higher 
incidence  of  postoperative  nausea  and  vomiting  following  intra-abdominal  operations 
(Andrew,  1992;  Mitchelson,  1992)  and  during  radiation  therapy  if  the  abdomen  is 
irradiated (Gerstner, 1960).  This is possibly because afferent pathways to the vomiting 
centre are activated following the handling of viscera during operative procedures, or 
because  of  tissue  damage  to  viscera  following  radiation  therapy  (Mitchelson,  1992).  
Additionally,  head  irradiation  may  raise  intracranial  pressure  from  local  oedema  and 
inflammation (tissue damage), which then appears to stimulate nausea and vomiting.  The 
administration of  glycerol  following  head  irradiation  reduced  intracranial oedema  and 
controlled the emetic response (Tourtellotte, Reinglass and Newkirk, 1972).  Specifically,   233
the pathway involved in visceral nociceptor-induced nausea and vomiting may include 
activation  of  visceral  afferents,  which  subsequently  activate  the  nucleus  tractus 
solitarious  (NTS) (Barber and Yuan, 1989) and reticular formation (Blair, 1985) of the 
brain stem.  Neural information from these areas is relayed to the cerebral cortex for 
conscious perception.     
          It is believed that nausea and vomiting develop in migraine headache because of  
close reciprocal functional interconnections between the trigeminovascular system and 
the NTS (Knight, 2005).   In the present study, migraine sufferers initially developed 
headache following painful stimulation of the temple before OKS.   Nausea gradually 
developed as the procedure progressed.    It is conceivable that painful stimulation in the 
interictal period may  have triggered nausea via trigeminovascular activation, as could 
occur in a migraine attack.  Since 5-HT specific antimigraine compounds alleviate nausea 
and headache, this may indicate an action via the 5-HT1B/1D receptors in the NTS (Hoskin, 
Lambert and Donaldson, 2004).  
 
 
 
Observations during limb pain: 
   
 
       This section initially explores enhanced symptomatic responses in migraine sufferers 
during limb pain + OKS.   The discussion then focuses on heightened pain perception 
reported by this group compared to controls in relation to aspects of nociception and 
central pain modulation involved in the experience of pain. 
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Symptoms   generally   developed   more  readily  in   migraine  sufferers than  in  
controls when the hand was painfully stimulated during OKS 
  
      Nausea, headache,  dizziness,  perceived body  temperature increases, visual illusion 
and self-motion developed more so in migraine sufferers than in controls when the hand 
was  immersed  in  ice-water  during  OKS.      Migraine  sufferers  reported  low-grade 
headache and drowsiness even prior to the procedures.    Throughout the procedures 
headache increased progressively but drowsiness did not develop further.  In contrast, 
controls remained virtually symptom free throughout, apart from slight dizziness, visual 
illusion  and  self-motion.    It  appears  that  OKS  induced  motion  sickness,  at  least  in 
migraine sufferers.   
  
 
    Pain perception was greater in migraine sufferers than in controls 
 
      For both groups symptomatic responses barely developed throughout testing when the 
hand  was  immersed  in  ice-water.    However,  participants  reported  moderate  overall 
unpleasantness, particularly during actual immersions.  Pain attributed directly to the ice-
water, however, was greater in migraine sufferers than controls.  
        When  immersion  of  the  hand  was  combined  with  OKS,  similarly,  both  groups 
reported the experience was unpleasant.   However, this was greater in migraine sufferers 
than  in  controls.    After  the  procedures  migraineurs  continued  to  experience 
unpleasantness, probably because they remained symptomatic.   Conversely, in controls, 
symptomatic  responses, which were minimal, and associated unpleasantness, subsided 
quickly.      Both  groups  found  the  ice-water  painful.    However,  pain  was  greater  in 
migraine  sufferers,  which  may  reflect  hyperexcitable  nociception  in  this  group 
interictally.   
        Consistent with this possiblity, cutaneous allodynia has been observed distant from 
the  referred  pain  area  of  the  head  during  migraine  headache  (Burstein,  Collins  and 
Jakubowski,  2004;  Burstein,  Cutrer,  and  Yarnitsky,  2000;  Burstein  and  Jakubowski,   235
2004;  Levy,  Jakubowski  and  Burstein,  2004;  Yarnitsky,  Goor-Aryeh,  Bajwa,  Ransil, 
Cutre, Sottile and Burstein, 2003) and interictally (Kitaj and Klink 2005).   
 
 
    Nociception 
 
     It is possible that neural mechanisms that generate pain perception are hypersensitive 
in  migraine  sufferers  (Woolf,  2003)  even  if,  as  Rachman  and  Eyrl  (1989)  propose, 
migraine  sufferers  magnify  the  real  extent  of  pain  qualities  on  recall.      Hyperalgesia 
(Silberstein, 2003) and cutaneous allodynia (Burstein et al., 2004; Burstein et al., 2000; 
Burstein  and  Jakubowski, 2004;  Levy  et al.,  2004; Yarnitsky et al., 2003) have been 
observed in migraine sufferers beyond the referred pain area of the head, particularly 
during a migraine attack.  The Burstein group rationalize that during a migraine attack the 
intense  volley  of  sensory  impulses  on  second-order  sensory  neurons  in  the brainstem 
causes them to become sensitized and to facilitate pain transmission from the periphery to 
the  central  nervous  system.    Cutaneous  allodynia  has  also  been  observed  interictally 
(Kitaj and Klink, 2005) and, recently, dynamic (brush) and static (pressure) mechanical 
stimulation  of  the  posterior  neck  and  inner  forearm  evoked  cutaneous  allodynia  and 
referred pain to the usual side of migraine headache was detected in a woman between 
attacks of migraine (Ashkenazi, LoPinto and Young, 2005).   Ashkenazi et al. suggested 
that the cutaneous allodynia in this individual might be constant as they found it to occur 
between attacks.  Hence, it is conceivable that the enhanced reactions to limb pain in 
migraineurs  observed  in  the  interictal  period  in  this  study  may  also  be  because  of 
persistent hypersensitive nociception. 
 
 
  
        Central pain modulation 
 
         Migraine sufferers were more sensitive than controls to painfully cold stimulation.       
It is likely that cold stimulation stimulated A-delta and unmyelinated C fibres (Bray et al.,   236
1999;  FitzGerald  and  Folan-Curran,  2002).    Melzack  and  Wall  (1965)  originally 
proposed  that  pain  (A-delta, C fibres)  and  pressure    (A-beta)  fibres  interact to either 
inhibit  or  excite  neurons  in  the  anterolateral  system,  leading  to  the  suppression  or 
production  of  pain.      However,  evidence  for  this  theory  has  been  disputed,  even  by 
Melzack  himself  (see  Schneider  and  Tardis,  1986  for  a  review  of  the  literature).   
Nevertheless,  Schneider  and  Tardis  point  out  that  one  of  the  main  premises  of  the 
Melzack-Wall theory, the capability of the nervous system to either augment or inhibit 
the  perception  of  pain,  has  been  demonstrated  with  therapeutic  techniques  –  e.g., 
distracting music in a dentist’s chair lessens the pain intensity of the dentist’s drill, or 
pain relief via acupuncture needles.  Melzack and Wall (1965) explain that this kind of 
stimulation activates areas of the brain including those involved in audition, emotion and 
memory.  The reticular formation receives this information which then triggers impulses 
that travel down the spinal cord to the substantia gelatinosa.  Neuronal activity in the 
anterolateral system is then suppressed, thereby closing a spinal “gate”, shutting off the 
perception of pain.     Barker and Barasi (2001) point out that while Melzack and Walls’ 
“gate  theory”  demonstrates  how  segmental  counter  irritation  with  non-painful  stimuli 
“gates out” painful stimuli, supraspinal input can also “gate out” noxious stimuli.   
       More recent research has further demonstrated that there is a central descending pain 
suppression  circuit  which  explains  the  action  of  analgesic  agents,  e.g.,  drugs, 
acupuncture,  and  placebos  (Schneider  and  Tardis,  1986).    Also,  Diffuse  Noxious 
Inhibitory  Controls  (DNIC)  have  been  demonstrated  to  alter  the  expression  of  pain 
(Dallel et al., 1999).  These are potent and enduring inhibitory controls that modulate the 
activity  of  convergent  neurons.    They  can  be  triggered  via  conditioning  nociceptive 
stimuli applied distant from the vicinity of the excited neuron.  DNIC are mediated by a 
supraspinal  loop  (Morton,  Maisch  and  Zimmerman,  1987)  and  play  a  role  in  pain 
modulation in humans and animals (Villaneuva and Le Bars, 1995).  Chemical mediators 
involved in DNIC are opioid peptides and serotonin (Chitour, Dickenson and LeBars, 
1982; Le Bars, Chitour, Kraus, Dickenson and Besson, 1981).    
           Dallel  et  al.  (1999)  found  that  activity  of  the  spinal  trigeminal  nucleus  oralis 
convergent neurons can be suppressed by noxious heat stimulation of the tail in rats, and 
that  enduring  post-stimulus  effects  follow  this.      These  neurons  have  similar   237
characteristics to those of the spinal trigeminal nucleus caudalis and the spinal dorsal 
horn.  The convergent neurons of these structures are indirectly activated by cutaneous C 
fibre discharge.  Interestingly, Bouhassira, Chollet, Coffin, Lemann, Le Bars, Willer and 
Jian (1994) found that painful visceral stimuli involving distention of the stomach via an 
inflated  balloon,  inhibited  the  spinal  nociceptive  RIII  reflex,  a  somatic  nociceptive 
flexion  reflex  obtained  via  painful  stimulation  of  the  sural  nerve.    Bouhassira  et  al. 
suggest that painful visceral stimulation activated DNIC in the same way that nociceptive 
somatic stimulation activates DNIC.  
          Alternatively, the “gate theory” (Melzack and Wall, 1965; Venes, 2001), a system 
analogous to DNIC, suggests that pain is hindered from reaching higher levels of the 
central  nervous  system  by  the  stimulation  of  larger  sensory  nerves  (Venes,  2001; 
Waxman, 2003).   For instance, as spinal nerves are composed of a higher proportion of 
unmyelinated  C  fibres  than  the  trigeminal  nerve  (Young,  1977),  C-fibre  input  would 
probably dominate in spinal nerves.  The neural pathway for pain suppression comprises 
the periaqueductal gray, nucleus raphe magnus, dorsolateral column, spinal cord and the 
anterolateral system.   The intense pain provoked by painful stimulation of the hand in 
this study, may well have excited a greater ratio of C-fibres than did the trigeminal nerve 
during painful stimulation.  This bias perhaps inhibited more minor symptoms of motion 
sickness  such  as  perceived  increases  in  body  temperature.      This  notion  may  be 
worthwhile exploring further, and is discussed later in this chapter (Further research, page 
265).  
 
 
       Key  points:  effects  of  painful  stimulation  of  the  limb  in  the  development  of 
symptoms in migraine sufferers 
 
      Migraine sufferers more readily developed symptoms during limb pain + OKS, than 
controls.    The  enhanced  pain  perception  reported  by  this  group  during  limb  pain, 
irrespective  of  OKS,  suggested  that  nociception  may  generally  be  compromised  in 
migraine sufferers. 
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Psychophysical report of pain  
 
        Whether heightened ratings of discomfort were an accurate account of the sensory 
experience of migraine sufferers or an effect of response bias is uncertain.  However, 
Rachman and Eyrl (1989) found that chronic headache sufferers tend to magnify the real 
extent of pain as they recalled episodes as more painful than they had reported at the time 
of the pain.   Other researchers (Ferguson and Ahles, 1997) found that pain-patients, 
including  chronic  headache  sufferers  who  reported  high  levels  of  “private  body 
consciousness”, e.g., “I can feel my heart beating”, “I know immediately when my mouth 
gets dry”, reported more imagined pain than those reporting low levels of “private body 
consciousness”.   Asmundson, Norton and Veloso (1999) similarly found that patients 
with recurring headache who were high in “anxiety sensitivity” reported greater levels of 
distress in response to pain.  Ferguson and Ahles (1997) suggested that “private body 
consciousness”  and  “anxiety  sensitivity”  might  be  similar  constructs.      Individuals 
reporting high levels of these characteristics may, in turn, have heightened sensitivity to 
noxious stimulation and so report higher levels of pain.    
         Fear of pain in patients with recurrent headaches has also been found to play a role 
in psychological distress and disruption of lifestyle activities (Hursey and Jacks, 1992).   
It may be that migraine sufferers tend to over report discomfort due to fear of developing 
symptoms associated with a migraine attack.   Fear or anxiety regarding the onset of pain 
and other symptoms may have influenced migraine sufferers’ self-report in the present 
study.     Therefore,  fear of  pain  needs  to  be  considered when interpreting differences 
between groups.   On the other hand, Ferguson and Ahles (1997) found that controls did 
not differ from pain patients on “private body consciousness”, suggesting that “private 
body  consciousness”  is  a  dispositional  variable  and  not  necessarily  a  condition  that 
develops after chronic pain onset.  Perhaps then, the enhanced symptomatic ratings seen 
in migraine sufferers in the present study may reflect a real sensory experience.       
      Pain is both a sensory and affective experience (Venes, 2001).   It involves not only 
the physical perception of a painful stimulus (usually triggered by activation of peripheral 
nerves) but also the emotional response to that perception (Silberstein, 2003).  Hursey 
and Jacks (1992) investigated the influence of fear of pain on nociceptive intensity of the   239
pain stimulus.  They found that chronic tension headache sufferers displayed greater fear 
of (imagined) severe and medical pain and lower fear of minor pain; and that fear of pain 
was related to impact on life (disruption of activities) rather than to frequency, duration 
and/or  severity  of  headache.    Non-headache  controls  made  less  sharp  distinctions 
between  types  of  potentially  painful  situations.    Rachman  and  Eyrl  (1989)  studied 
individuals suffering recurrent painful episodes (headache or menstrual) and cautioned 
there is a tendency for sufferers to recall episodes as more painful than they had reported 
at the time of the pain.  They suggested that  this may serve a protective function.   In 
regard to Hursey and Jacks’ study, the magnification of the real extent of pain needs to be 
considered in interpreting differences between groups.    
         On  the  other  hand,  Bishop,  Jeffrey,  Borowiak  and  Wilson  (2001)  compared 
migraine  sufferers  with  tension  headache  sufferers  and  headache-free  controls  by 
correlating anxiety/fear of pain with pain thresholds and tolerance levels to a cold pressor 
task.    They  found,  somewhat  contrary  to  Hursey  and  Jacks’  (1992)  findings,  no 
differences  between  groups  on  pain  related  anxiety  (escape  and  avoidance,  fearful 
appraisals of pain, and physiological anxiety symptoms associated with pain).    Despite 
these contradictory reports, it may be that in the present study the enhanced reaction to 
ice-water pain in migraineurs was because the stimulus was severe enough to instill fear 
of the pain (as predicted by Hursey and Jacks) that was greater than, or boosted the actual 
intensity of the painful stimulus (as proposed by Rachman and Eyrl, 1989).  Participants 
in this study, unlike the tension headache sufferers in Hursey and Jacks’ study, may be a 
more sensitive group due to their migraine experience, so fear may also be related to 
frequency,  duration  and  severity  of  headache  as  well  as  to  the  disruptive  impact  of 
headaches on normal activities.   
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13.2.     PULSE AMPLITUDE 
 
 
Discussion of findings 
       
      Vascular responses may have been mediated by the following mechanisms: 
 
1.  Defense response 
2.  Frontotemporal vascular response to  ice applied to the temple  
3.  Faulty pain processing in migraine sufferers may have affected pulse amplitude  
            generally 
 
These mechanisms are discussed next. 
 
 
Defense response 
 
 
       Facial  pallor  is  usually  associated  with  motion  sickness  (Marcus  et  al.,  2005), 
suggesting  decreased  blood  flow.    However,  blood  flow  in  deeper  dermal  vessels 
increased during procedures in the present study including OKS induced motion sickness.       
Pulse amplitude increased for both groups during OKS alone but more so in migraineurs 
than in controls.     Kolev, Moller, Nilsson and Tibbling (1997) also observed an increase 
in  blood  flow  in  the  forehead  during  motion  sickness,  measured  by  laser  doppler 
flowmetry.  Elsewhere, motion sickness provocation led to increases in skin oxygen and 
flushing, an index of blood flow, in susceptible individuals (Harm, Beatty and Reschke’s 
study cited in Harm, 1990).   However, decreases in flow were observed in the fingertips 
(Cheung  and  Hofer,  2001;  Cowing  et  al.,  1986;  Kolev  et  al.,  1997).      Kolev  and 
colleagues  suggested  that  different  densities  of  sympathetic  innervation  and  skin 
vasculature in the fingertip and forehead may account for this variation.  Carrive and   241
Bandler (1991) observed that blood flow redistributed between head and limbs at the 
onset of defensive reactions in cats provoked by injection of an excitatory amino acid into 
the  lateral  periaqueductal  gray  (PAG).    Extracranial  vasodilatation  was  evoked at the 
onset of threat displays (presumably to assist muscle tone in the face) but increases were 
not observed in the hindlimbs until flight behaviour developed (to assist muscle tone in 
the limbs/body).   
       A similar vascular defense response may occur in humans when exposed to noxious 
and stressful motion sickness provocation procedures: i.e., confrontation with the ‘threat’ 
component of the defense response.  The blood flow variations between forehead and 
finger during rotation, observed by Kolev et al. (1997) may reflect this ‘threat’ response.  
This reaction may also account for the extracranial vasodilatation observed in the present 
study.      In  Kolev  and  colleagues’  study,  pulse  volume  returned  to  baseline  levels 
following  rotation  (as  did  other  autonomic  responses:  heart/respiration  rate).    In  the 
present  study  pulse volume did not recover in migraine sufferers after termination of 
OKS,  particularly  during  OKS  alone.      However,  procedural  differences  between  the 
present  study  and  Kolev’s  study  make  a  direct  comparison  of  findings  difficult.    In 
Kolev’s study participants were exposed to eccentric vertical axis rotation and blood flow 
was measured by laser Doppler flowmetry.  In contrast, in the present study participants 
were  exposured  to  OKS,  and  pulse  amplitude  was  assessed  via  photoelectric 
plethysmography.  
         The midbrain PAG is involved in the mediation of defensive behaviour, including 
modulating fear and anxiety and autonomic and cardiovascular responses (Behbehani, 
1995).      Therefore,  the  enhanced  vascular  responses  observed  in  migraineurs  in  the 
present study during OKS in the absence of painful stimulation (OKS alone) and during 
painful stimulation before OKS, regardless of the source of pain, may indicate disrupted 
PAG control (hyperexcitable neural responses or weak inhibitory mechanisms). 
          To follow, the discussion explores the potentially stressful effects of  procedures 
used in the present study.  Specifically, the defense response is discussed in relation to 
the trigeminovascular reflex, and vascular responses during OKS and stressful procedures 
generally. 
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      Trigeminovascular response as a possible defense response 
 
 
      Just as nausea and vomiting is believed to be an instinctive defense response to a 
possible  toxin  (Endo  et  al.,  2000;  Mitchelson,  1992),  the  trigeminovascular  response 
(with associated neurogenic inflammation) has been suggested as a defense mechanism 
(Lewis,  1937;  Moskowitz,  1991).    Disturbances  in  the  brain  or  its  blood  supply 
(metabolic changes or circulating factors) may be responsible for triggering neurogenic 
inflammation  (Buzzi,  Bonamini  and  Moskowitz,  1995).        Neurogenic  inflammation 
involves a surge of vasoactive neurotransmitters (substance P, neurokinin A, calcitonin 
gene-related peptide) causing vasodilatation and tissue edema, extra- and intracranially, 
which  leads  to  vasodilatation,  the  development  of  hyperalgesia  and  possibly  the 
prolonged pain associated with a migraine attack (Moskowitz, 1993).   In this regard, 
Buzzi  and  others  (1995)  suggest  that  headache  may  be  considered  a  consequence  of 
threatened injury to the brain.  It is also possible that symptoms typical of a migraine 
attack  develop  because  of  anatomical  connections  between  the trigeminal system  and 
autonomic structures in the brainstem.    
 
 
 
 
        Defense response during OKS 
 
        In  the  present  study  the  enhanced  vasodilatation  observed  in  migraineurs  during 
OKS alone may, indeed, serve a protective function in response to the unpleasant (and 
familiar in terms of the migraine experience) symptoms of motion sickness.  Whatever 
the  mechanism,  the  continued vasodilatation  observed in  migraineurs during  recovery   243
may  demonstrate  a  neural  or  vascular  hypersensitivity/  “wind-up”  (Bray,  Cragg, 
MacKnight and Mills, 1999) that amplifies neurovascular responses. 
        Contrary  to  expectations,  vascular  reactions  in  response  to  painful  stimulation 
during  OKS  did  not  differ  between  groups,  irrespective  of  the  source  of  pain.  
Vasodilatation developed bilaterally in both groups during OKS.   It seems that the added 
stress of painfully cold stimulation during OKS boosted vascular responses in controls to 
come in line with migraine sufferers.   Apparently the vasodilator stress response was 
activated comparably across both conditions (temple pain during OKS, hand pain during 
OKS),  for  both  groups.      When  the  temple  was  painfully  stimulated  during  OKS, 
responses subsided in migraineurs by 5 minutes after OKS but fell below baseline in 
controls.  When the hand was immersed in ice-water during OKS, responses recovered 
soon after OKS, in both groups. 
          Motion sickness has been found to influence the facial microcirculation (Harm, 
1990;  Kolev,  Möller,  Nilsson  and  Tibbling,  1997).      Interestingly,  in  Kolev’s  study 
involving eccentric vertical axis rotation, the vasodilator effect immediately peaked at the 
commencement  of  rotation  (during  vestibular  stimulation),  even  before  the  onset  of 
motion sickness.  The authors suggest that this may have been a stress response induced 
from excessive motion.   Kohl (1985) points out that the stress of excess motion induces 
changes  in  circulatory  hormones,  including  plasma  levels  of  cortisol,  ACTH,  growth 
hormone, prolactin, vasopressin, norepinephrine and epinephrine (Eversmann, Gottsman, 
Ulbrecht and von Werder, 1978; Kohl, 1985).    
        One  of  the  antidiuretic  hormones,  plasma  argenine  vasopressin  (pAVP)  is 
sometimes used to explore the effects of physical and psychological stress.   pAVP levels 
have been found to increase during physical stress (Nettles et al., 2000), including after 
motion  sickness  induced-rotary  stimulation  (Xia,  Zheng-Lin,  Gho-Hua  and  Ji-Wei, 
2005).      Increased  levels  in  antidiuretic  hormone  have  also  been  observed  following 
rotation around a vertical axis in both nauseated and unaffected subjects (Otto et al., 
2005).  Conversely, AVP inhibition has been observed following psychological stress 
(Nettles  et  al.,  2000).        It  has  been  suggested  that  AVP  inhibition  following 
psychological stress may serve a protective function in anticipation of the need for AVP 
with physical stress (Becker, Grecksch, Bernstein, Hollt and Bogerts, 1999).    Clearly,   244
physical and emotional aspects of the stress response, and how they may impact on one 
another, are intricate.  
          OKS involves physical (e.g., perceptual changes and the development of symptoms 
of  motion  sickness)  and  psychological  (e.g.,  emotional reactions  to physical changes) 
components  of  the  stress  response.      Kohl  (1985)  reported  that  epinephrine  and 
norepiniephrine  levels  were  elevated  during  motion sickness  and  that non susceptible 
subjects  displayed  a  more  pronounced  increase.    In  the  present  study  the  vasodilator 
stress  response  was  activated  comparably  during  OKS  in  the  presence  of  painful 
stimulation,  for  both  groups.      Symptoms  of  motion  sickness  developed  in  migraine 
sufferers yet barely developed in controls.   Thus, these findings also suggest that motion 
sickness  provoking  conditions  might  be  considered  stressful  regardless  of  whether 
symptoms of motion sickness develop.   
       Specific  brain  structures  appear  to  play  an  important  role  in  the  stress  response 
including the hippocampal complex in the limbic system.  Nettles et al. (2000) explored 
the  plasma  argenine  vasopressin,  hypothalamic-pituitary-adrenal-axis  response  to 
psychologically stressful stimuli using novel acoustic stress.  In one study responses to 
novel acoustic stress were assessed in rats with bilateral excitotoxic lesions of the ventral 
subiculum and the ventral hippocampus.  In another study responses were observed in 
relation to small lesions in the ventral hippocampal formation, which included projections 
to the neuroendocrine hypothalamus and other fields.  These lesions blocked inhibitory 
AVP  responses  to  psychologically  stressful  stimuli  compared  to  healthy  control  rats, 
implying that hippocampal areas of the limbic system also play a role in the argenine 
vasopressin,  hypothalamic-pituitary-adrenal-axis  response  to  stressful  stimuli.      It  is 
accepted that the limbic system plays an integral role in processing sensory information 
from  the  association  cortices  necessary  for  perception  and  movement,  and  also  in 
mediating emotional responsiveness to a stimulus (Barker and Barasi, 2001).   Indeed, 
this neural area was most likely activated during OKS in the present study.   Perhaps, the 
various  neural  pathways  involved  in  the  defense  response,  in  some  combined  way, 
contributed to the changes in facial blood flow, observed during stressful procedures in 
this study.   245
          Furthermore, it is well accepted that the periaqueductal grey (PAG) is involved in 
the stress response and autonomic regulation (Behbehani, 1995).  Bandler and Carrive 
(1988) administered microinjections of D.L. homocysteic acid (DLH) in the pretentorial 
PAG, a specific site they observed evoked a “threat display” (hisses, howls, retraction of 
the corners of the mouth and ears) in the freely moving cat.  In a follow-up study Carrive 
and Bandler (1991) administered DLH into a restricted portion of the lateral pretentorial 
PAG  in  unanesthetized  and  paralyzed  decerebrate  cats  and  observed  extracranial 
vasodilatation.      The  vasodilatation  observed  in  the  present  study  may  have  been 
influenced,  at  least  in  part,  by  the  release  of  stress-related  hormones  (Eversmann, 
Gottsman, Ulbrecht and Werder, 1978; Kohl, 1985) triggered during the disconcerting 
and unpleasant OKS experience.  This may reflect a defense response involving the PAG, 
similar to that observed by Carrive and Bandler (1991).  
 
 
     Stressful procedures and the defense response 
 
      Extracranial blood vessels dilate more readily in migraine sufferers than in controls 
during exposure to stressful stimulation (Drummond, 1984).   Consistent with the notion 
of  a  general  vascular  dysfunction  in  migraineurs,  Hassinger,  Semenchuk  and  Obrien 
(1999) found that cardiac output increased more in migraine sufferers than in controls in 
response to pain-stress (cold pressor task) and cognitive-stress (arithmetic task).   In the 
present study vasodilatation was evident in migraine sufferers even before the stressfully 
cold stimulus (an ice block on the temple or immersion of the hand in cold water) was 
applied  before  OKS,  thereby  suggesting  that  anticipatory  anxiety  provoked  a  defense 
response in this group.   
       Anticipation of pain and fear-avoidance has been documented in chronic back pain 
sufferers  (Pfingsten,  Leibing,Harter,  Kroner-Herwig,  Hempel,  Kronshage  and 
Hildebrandt,  2001),  as  well  as  in  chronic  headache  sufferers,  including  those  with 
migraine   (Asmundson, Norton and Veloso, 1999; Hursey and Jacks, 1992).   Stress is 
also a commonly sited precipitating and aggravating factor of migraine headache (Holm, 
Lokken and Myers, 1997; Spierings, Ranke and Honkoop, 2001).  It is conceivable that   246
migraineurs  in  the  present  study  were  primed  in  anticipation  of  the  pending  painful 
stimulus,  perhaps  raising  an  association  with  the  all  too  familiar  pain  of  migraine.   
Hence, the vasodilator defense response probably accounted for vascular increases prior 
to procedures and also contributed to enhanced reactions during painful and unpleasant  
procedures.      Conversely,  in  controls  vasodilatation  became  evident  from  the 
commencement  of  painful  procedures.      The  defense  response  perhaps  influenced 
vascular  reactions  in  both  groups.    However,  the  early  increase  in  facial  blood  flow 
observed in migraine sufferers implies hyperexcitable vascular responses in this group. 
 
 
 
       Key points relevant to the defense response and pulse amplitude change  
 
 
       Vasodilatation was observed in both groups throughout procedures in the present 
study.   Findings suggest, at least in part, that the defense response contributed to vascular 
changes. 
 
 
 
Frontotemporal vascular response to  ice applied to the temple  
 
      This section of the discussion considers trigeminovascular mechanisms, which may 
be responsible for changes in facial blood flow observed during painful stimulation of the 
temple in this study.   The link between vascular changes and headache is discussed.  
Extracranial blood flow fluctuations normally observed in the skin are described next 
with respect to stressful procedures (cold stimulation and OKS) used in the present study.  
Sympathetic nerve activity and findings that facial blood flow is particularly reactive in 
migraine sufferers  is  explored.     Whether  or  not  motion sickness somehow disrupted 
vasomotor activity in migraine sufferers in the present study is also considered.   Finally,   247
the  observation  that  head  pain  does  not  seem  to  be  associated  with  extracranial 
vasodilatation is made. 
 
 
     Trigeminovascular response in migraine sufferers 
 
      For  both  groups  extracranial  pulse  amplitude  increased  bilaterally  when  ice  was 
applied  to  the  temple  independent  of  OKS,  but  more  so  in  migraine  sufferers.   
Vasodilatation was evident in migraineurs even before the initial application of ice, but 
gradually developed in controls as the procedure progressed.  
        Vasodilatation of cranial vessels (extra- and intracranial) has been observed during 
migraine headache (Baloh, 1997; Lance, 1993; Lance and Goadsby, 2002) and has long 
been regarded as important in the pathophysiology of migraine symptoms (Wolff, 1972; 
Botney, 1981; Moskowitz, 1993).  It is generally agreed that migraine is the result of 
brain-related  changes  or  dysfunction  within  the  sensory  centres  of  the  brain  (Knight, 
2005; Larkin, 1997).  Borsook, Burstein, Moulton and Becerra (2006) describe migraine 
as  a  neurovascular  disorder  involving  dysfunction  of  the  trigeminovascular  system.  
Cerebral blood vessels innervated by sensory fibres of the trigeminal nerve may dilate in 
response to activation of brainstem centres that regulate vascular tone and pain sensations 
(Buzzi and Moskowitz, 2005).  The trigeminovascular system is believed to provoke a 
neurogenic  inflammatory  reaction  that  causes  pain  (Larkin,  1997;  Moskowitz,  1993).  
Larkin  (1997)  and  MacFarlane  (1993)  point  out  that  although  blood  vessels  become 
involved, the pain actually results in the release of pain-related chemicals (e.g., substance 
P, calcitonin gene-related peptide, and neurokinin A) via trigeminal neurons into areas 
surrounding  the  blood  vessels.      In  the  present  study  vasodilatation  was  observed  in 
migraineurs and controls in response to trigeminal stimulation.  The enhanced vascular 
reactivity  observed  in  migraine  sufferers  suggests  hyperexcitable  trigeminal  vascular 
reflexes in this group between headaches.     
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       Link between vascular changes and headache 
 
        Headache developed more readily in migraine sufferers than in controls during all 
testing sessions, apart from during limb immersion in the absense of OKS.   In contrast, 
controls remained headache-free throughout all procedures.  As previously suggested, the 
headache observed in migraine sufferers in the present study may be due to a neurogenic 
inflammatory  response  and  the  release  of  neuropeptides,  including  CGRP.    Plasma 
extravasation  and  vasodilatation,  i.e.,  neurogenic  inflammation, has  been  attributed  to 
antidromic discharge of afferent C-fibres.    In the present case, vasodilatation may have 
occurred in deeper cephalic tissue, e.g. meningeal vasculature, as the trigeminal nerve 
transmits  nociceptive  signals  from  dilated  blood  vessels  of  the  pia-  and  dura  mater 
(Frickle, 2001; Frickle, Andres and Von Düring, 2001; Moskowitz, 1993).    
         Mechanisms  regulating  central  sensitization  are  thought  to  underlie  migraine 
susceptiblity (Edvinsson and Uddman, 2005).   Changes in environmental, physiological 
or  psychological  states  are  believed  to  trigger  migraine  headache  in  susceptible 
individuals.     Edvinsson and Uddman outline theories that explain how a migraine attack 
is initiated.    It may be that peripheral sensory fibres innervating the dura and cranial 
blood vessels are activated.  Alternatively, descending pathways that process pain signals 
may  be  activated,  or  descending  pathways  that  inhibit  pain-processing  signals  in  the 
trigeminal  nuclei  and  spinal  cord  are  suppressed.    Buzzi,  Bonamini  and  Moskowitz 
(1995) suggest that any stimulus which activates trigeminal sensory fibres activates the 
trigeminovascular  system  and  leads  to  extra/intracranial  changes  in  the  cephalic 
circulation.    In  turn,  headache  and  various  autonomic  responses  occur,  most  likely 
because  of  close  anatomical  connections  between  the  trigeminovascular  system  and 
autonomic structures in the brainstem.  A local inflammatory response probably occurred 
following  painful  stimulation  in  the  present  study.      However,  as  migraine  sufferers 
developed  headache,  it  appeared  that  trigemino  sensory  fibres  may  have  activated 
brainstem nuclei responsible for head pain.       
         Edvinsson  and  Uddman  (2005)  explain  that  the  trigeminovascular  vasodilatory 
reflex,  in  part,  is  generated  via  CGRP  and  VIP,  probably  to  offset  cerebrovascular 
constriction.    Walters,  Gillespie  and  Moskowitz  (1986)  suggest  that  the  trigemino-  249
parasympathetic vasodilator reflex in intracranial vessels may serve to defend the blood 
supply to the brain during inflammatory responses, or may assist in thermoregulation.   
Painful stimulation of the eye has evoked the trigemino-parasympathic reflex leading to 
extracranial  vasodilatation  in  migraine  sufferers  and  normal  controls  (Avnon,  Nitzan, 
Sprecher, Rogowski and Yarnistsky, 2003, 2004; Drummond, 1992, 1993; Drummond 
and Lance, 1992).   
        In  the  present  study,  exposure  to  stressful  procedures  may  have  induced  a 
vasodilatory  stress-induced  response  in  both  groups.    Migraine  sufferers,  however, 
developed  headache,  suggesting  that  the  trigeminovascular  system  was  activated,  
perhaps due to hyperexcitable trigeminovascular reflexes in this group.  
  
 
         Extracranial blood flow fluctuations 
 
          Painfully cold stimuli activate pain and temperature receptors that pass through the 
spinothalamic tracts to the reticular formation; consequently the descending sympathetic 
nervous system (SNS) is activated (Peroutka, 2004).    The vasculature of the skin is 
under sympathetic control (Harm, 1990) and vasoconstriction is attributed to sympathetic 
nerve activity (Honey, Bland-Ward, Connor, Feniuk and Humphrey, 2002).   The initial 
defense response and related blood flow increases (Carrive and Bandler, 1991) observed 
in  the  present  test  when  the  temple  and  hand  were  painfully  stimulated  during  OKS 
generally  appeared  to  subside  soon  after  the  procedures,  for  both  groups.    The 
disappearance of a vasodilatation response in both groups in the recovery period, and the 
extracranial  vasoconstriction  observed  in  controls,  particularly,  after  the  temple  was 
painfully stimulated during OKS, may have been due to sustained activation of the SNS.   
       In the present study blood flow peaked bilaterally after the hand was withdrawn from 
ice-water in both groups.  In addition, a weak bilateral vasoconstriction occurred during 
hand immersion in migraineurs.      
       Furthermore, Kolev et al. (1997) reported that blood flow in deeper dermal vessels 
fluctuated as motion sickness developed, i.e., peaked at vestibular stimulation, subsided, 
then gradually increased during epigastric awareness, epigastric discomfort and nausea,   250
and  peaked  again  at  retching.      Kolev  et  al.  suggested  that  an  autonomic  response 
resembling an unspecific stress reaction to unfamiliar sensory cues probably triggered 
orienting (Siniatchkin, Gerber, Kropp, Voznesenskaya and Vein, 2000; Sokolov, 1963) or 
startle reflexes (Sokolov, 1963).   The increased facial blood flow observed in the present 
study  at  the  onset  of OKS  may  also  reflect  a stress response triggered in reaction to 
unusual sensory cues.   However, vasodilatation did not peak at the onset of OKS as 
occurred  in  Kolev’s  study,  regardless of whether or not cold stimulation was applied 
shortly  following  the commencement of  OKS.    Given  the  disparate  findings  between 
these  studies,  the  mechanism  responsible  for  the  vasodilatatory  peak  at  the  onset  of 
vestibular stimulation observed in Kolev’s study is not clear. 
 
 
 
      Extracranial vasculature more reactive in migraine sufferers 
 
       Extracranial blood flow was generally more reactive in migraine sufferers than in 
controls  to  a  range  of  stimuli in  the  present  study.      Specifically, vasodilatation  was 
greater  in  migraine  sufferers  than  in  controls  during  OKS  alone  and  during  painful 
stimulation in the absence of OKS.    However, during painful stimulation in the presence 
of  OKS,  vasodilatation  was  comparable  for  both  groups.    For  both  groups  pulse 
amplitude  remained  unchanged  when  ice  was  applied  to  the  temple  after  OKS.  
Curiously,  slight  vasoconstriction  was  observed  but  did  not  reach  significant  levels.   
During limb pain, blood flow peaked bilaterally after the hand was withdrawn from ice-
water,  for  both  groups,  and  a  weak  bilateral  vasoconstriction  occurred  for  migraine 
sufferers when the hand was immersed.    
       The vasculature of the skin is under sympathetic control.  In the face, pallor is the 
result of vasoconstriction, and vasodilatation produces flushing.  Increased sympathetic 
activity  causes  vasoconstriction,  and  sympathetic  withdrawal  or  inhibition  leads  to 
vasodilatation  (Harm,  1990).  At  high  body  temperatures,  active  sympathetic 
vasodilatation also augments facial flushing (Drummond and Finch, 1989).   251
       Honey, Bland-Ward, Connor, Feniuk and Humphrey (2002) considered the role of 
neurochemical  messengers  linked  to  sympathetic  nerve  activity,  which  may  have 
accounted  for  fluctuation  in  vasculature  observed  in  their  study.    A  transient 
vasoconstriction was observed in dural blood vessels following electrical stimulation of 
perivascular  trigeminal  nerves  in  anaesthetized  rats  (Honey  et  al.,  2002).    This 
vasoconstriction  was  similarly  attributed  to  sympathetic  nerve  activity:  the  release  of 
catecholamine  neurotransmitters  from  sympathetic  nerve  stimulation.    Vasodilatation 
followed vasoconstriction and was attributed to CGRP release from activated afferent A-
delta  fibres  in  the  dura  mater.    The  vasodilator  response  was  not  observed  when 
Substance P was applied.   Williamson, Hargreaves, Hill and Shepheard (1997) found the 
CGRP antagonist, human αCGRP inhibited the vasodilator response, further suggestive 
that CGRP mediates vasodilatation.   
         A  peripheral  cold  stimulus  activates  pain  and  temperature  receptors  that  pass 
through the spinothalmic tracts to the reticular formation, and activates the descending 
sympathetic nervous system (Peroutka, 2004).  In the present study there was a lack of 
extracranial vasodilatation during painful stimulation of the temple in the presence of 
residual effects of motion sickness.  The reason why the response was absent is uncertain, 
because  the  application  of  ice  to  the  temple  was  painful  and  no  doubt  excited  the 
sympathetic nervous system.     As pointed out in an earlier chapter (chapter 12, page 
239), pulse amplitude did not appear to recover in migraine sufferers during the previous 
procedure  (i.e.,  OKS  alone),  hence  data  was  re  analysed  using  the  baseline  from  the 
previous  condition  (see  Appendix  12,  page  362).    When  analysed  with  a  different 
baseline it appeared that pulse amplitude increased during OKS and remained so when 
ice was applied to the temple after OKS, particularly  in migraine sufferers.  Whether or 
not  some  aspect  of  motion  sickness disrupted vasomotor  activity  at  a neural level  in 
migraine sufferers is discussed next.  
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         Headache does not appear to be related to extracranial vasodilatation 
 
          Headache developed more readily during temple pain after than before OKS in 
migraine  sufferers  but  was  not  obviously  related  to  extracranial  blood  flow  changes.  
Clearly, headache intensified when the temple was painfully stimulated during or after 
OKS  but  vascular  responses  did  not  intensify,  as  might  be  presumed  would  occur  if 
headache is indeed caused by swollen cranial blood vessels in migraine sufferers (Larkin, 
1997).    
          Indeed,  Drummond  and  Lance  (1983)  found  that  headache  is  not  necessarily 
related  to  extracranial  vasodilatation.      Drummond  and  Lance  compared  the  pulse 
amplitude  of  extracranial  blood  vessels  with  the  intensity  of  pain  during  unilateral 
migraine  headache.    Pulse  amplitude  of  the  superficial  temporal  artery  and  its  main 
frontotemporal  branch  were  recorded  with  pulse  transducers.      They  found  that  pain 
appeared to be of extracranial vascular origin in approximately one-third of patients, was 
of  intracranial  origin  in  one-third,  and  had  no  obvious  vascular  component  in  the 
remaining  one-third.   It appeared that extracranial vessels contributed to the pain of 
migraine headache in only a minority of cases.     
         While  blood  vessels  are  clearly  involved  in  head  pain,  they  appear  to  play  a 
secondary role.  Hence they are probably part of a more complex process that originates 
not  in  vessels,  but  in  the  brain  (Larkin,  1997).      As  Macfarlane  (1993)  proposes, 
vasodilatation  may  therefore  be  more  an  epiphenomenon  to  sensory  nerve  activation, 
rather than the cause of it, or the subsequently observed sustained headache during an 
attack. 
 
     Key points:  trigeminovascular reflex and pulse amplitude change 
 
     Extracranial  vasculature  was  indeed  more  reactive  in  migraine  sufferers  than  in 
controls in the present study.  The development of headache in migraineurs suggested 
that trigeminovascular reflexes may be hyperexcitable in this group.    However, head 
pain did not appear to be related to vascular responses as, while headache intensified, 
vascular responses did not.     253
Faulty pain processing in migraine sufferers may have affected pulse 
amplitude generally 
 
      The possibility that autonomic responses in migraine sufferers may be compromised, 
in turn, effecting vascular reactivity in this group, is discussed.  Mechanisms thought to 
regulate cutaneous blood flow are also considered.   Finally, the asymmetrical vascular 
response observed during limb pain is discussed.  
 
 
 
      Possible sympathetic and parasympathetic dysfunction in migraine 
        
      Possible autonomic dysfunction in migraine 
 
       Autonomic  activation  such  as  lacrimation,  conjunctival  injection  and  nasal 
congestion commonly observed during cluster headache, has also been observed during 
severe unilateral migraine headache (Frese, Evers and May, 2003).   Interestingly, Frese 
and colleagues found that experimental head pain (subcutaneous injection of capsaicin to 
the forehead) also evoked autonomic symptoms in healthy controls, suggesting a normal 
response to trigeminal pain.   This response was specific to painful stimulation of the 
ophthalmic branch of the trigeminal nerve.   Perhaps then, autonomic signs are not an 
exclusive feature of some primary headache syndromes but appear secondary to painful 
stimulation of the opthalamic branch of the trigeminal nerve (Frese et al., 2003). 
      Human  studies  have  suggested  sympathetic-  and  parasympathetic  hypofunction  in 
migraine  (Pogacnik,  Sega,  Pecnik, and  Klauta, 1993;  Havanka-Kanniaininen, Tolonen  
and  Mylyla,  1988).      Peroutka  (2004)  proposed  chronic  sympathetic  dysfunction  in 
migraine  sufferers  (an  imbalance  of  sympathetic  co-transmitters).      Specifically,  he 
proposed  that  a  migraine  attack  involves  depletion  of  norepinephrine  (leading  to 
vasodilatation)  and  increases  in  dopamine  (related  to nausea, vomiting and yawning), 
prostaglandins (related to increases in pain sensitivity) and adenosine (associated with 
sedation).    Consistent  with  the  notion  of  atypical  sympathetic  involvement  in   254
migraineurs, increases in plasma norepinephrine levels during the cold pressor test were 
found  to  be  significantly  less  in  migraineurs  than  in  controls  (Takeshima,  Takao, 
Urakami, Nishikawa and Takahashi, 1989). 
      Failure  of  descending  pain  control  mechanisms  involving  vascular  and  autonomic 
control  (Hass,  Kent  and  Friedman,  1993;  Weiller,  May,  Limmroth,  Jǔptner,  Kaube, 
Schayck,  Coenen  and  Diener,  1995),  and  connections  between  pain  control-  and 
parasympathetic  nuclei  in  the  brainstem,  might  also  contribute  to  migraine  (Lance, 
Lambert,  Goadsby  and  Duckworth,  1983;  Matharu  and  Goadsby,  2002).    Cranial 
parasympathetic outflow and dysfunctional pain modulation within the brainstem have 
been posited to intensify head pain and be responsible for extracranial vasodilator and 
other  autonomic  disturbances  during  attacks  (Avnon, Nitzan, Sprecher, Rogowski  and  
Yarnitsky,  2003;  Drummond,  1997).      Avnon  et  al.  (2003)  observed  forehead 
vasodilatation  in  response  to  instillation  of  soapy  water  into  the  eye  in  migraineurs 
between attacks, which appears to be a normal response.    Also, increased  cranial  blood  
levels of vasoactive intestinal polypeptide (a parasympathetic neurotransmitter) has been 
observed  in  migraine  attacks  associated  with  lacrimation  and  rhinorrhoea,  a  further  
indicator  of  parasympathetic  involvement  in  the  disorder  (Goadsby,  Edvinsson  and 
Ekman, 1990).   
       The present findings suggest that limb pain evoked an autonomic (defense response) 
extracranial vasodilatation, more so in migraineurs.   Furthermore, vasodilatation was 
greater  ipsilaterally  than  contralaterally  to  painful  limb  stimulation  in  this  study.    
Asymmetry  was  also  observed  by  Drummond  and  Lance  (1984)  during  migrainous 
attacks as heat loss was greater for unilateral headaches (on the affected side) during 
throbbing headache.  However, the enhanced ipsilateral response seen in both groups in 
this  study  (also observed by Drummond, 2006) implies a normal systemic vasomotor 
reaction to immersion of the hand in ice-water.  The overall enhanced response seen in 
migraineurs  suggests  a  possible  dysfunction  originating  in  the midbrain  or  brainstem.  
Specifically,  as  the  periaqueductal  grey  region  of  the  brainstem  has  an  integrative 
function  including  modulating  pain  transmission,  fear  and  anxiety,  autonomic  and 
cardiovascular responses (Behbehani, 1995; Knight and Goadsby, 2001), it is tempting to 
speculate  that  this  is  the  source  of  the  atypical  reaction  observed  in  migraineurs.     255
Consistent with a hyperexcitable defense response or greater fear in migraine sufferers, 
the contralateral response was greater in migraineurs than controls when the hand was 
painfully stimulated in the absence of OKS.   The ipsilateral response was similar in both 
groups during this procedure.   
 
 
      Mechanisms regulating cutaneous blood flow 
 
       In the present study, given the vasoconstrictor response during hand immersion + 
OKS  in  migraineurs,  it  appears  that  the  extracranial  vasculature  is  more  reactive  to 
stimuli in this group than in controls.   It may be that low blood flow was mediated via a 
sympathetic  noradrenergic  vasoconstrictor  response  (for  a review  of  the  literature see 
Kolev et al., 1997) possibly triggered from the shock of the painfully cold immersion or it 
could be a specific constrictor response to cold hand immersion. 
 
 
     Asymmetric vascular response during limb pain 
 
       During limb pain ipsilateral responses were greater than contralateral responses, for 
both  groups.    However,  application of ice to the temple did not provoke a unilateral 
response. 
        Sympathetic reactions are generally assumed to be widespread mass responses to a 
wide variety of stimuli (e.g., response to fear) involving simultaneous discrete activation 
of  systems  within  the  organism  (cutaneous  vasoconstriction;  vasodilatation  to  heart, 
muscles  and  brain;  sphincter  contraction;  peristalsis  depression)  (Standring,  2005).  
However, recent research (Drummond, 2006) challenges the concept of the sympathetic 
nervous  system  as  a  “mass  action”  system.    Greater  ipsilateral  than  contralateral 
extracranial vasodilatation was observed during immersion of the hand in extremely cold 
water.    This  asymmetric  response  was  then  blocked  following  pretreatment  with 
guanethidine  (a  sympathetic  noradrenergic  neurotransmission  blocker).      Thus,   256
Drummond  proposed  that  the  sympathetic  nervous  system  exerts  separate  control  of 
distinct reflex pathways on either side of the body.   These observations may help explain 
the mechanism of the asymmetric response observed in the present study (an ipsilateral 
release of sympathetic vasoconstrictor tone in extracranial vessels). 
         Pulse  amplitude  generally  was  comparable  in  both  groups  when  the  limb  was 
painfully stimulated during OKS, though a constrictor response was evident in migraine 
sufferers during ice-water immersions.   Furthermore, pulse amplitude  was greater in 
migraine sufferers than in controls during painful stimulation of the limb before OKS, 
suggesting atypical autonomic vascular activity in this group.  
 
 
 
      Key points:  faulty pain processing may have effected pulse amplitude  
 
       Findings suggest that limb pain evoked an autonomic (defense response) extracranial 
vasodilatation, particularly in migraine sufferers.  Furthermore, blood flow was greater 
ipsilaterally  than  contralaterally  for  both  groups,  which  may  have  been  due  to  an 
ipsilateral release of sympathetic vasoconstrictor tone in extracranial vessels (Drummond, 
2006).    
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13.3.   General    methodological   issues   associated   with    the     
            project:   strengths  and  limitations 
 
 
Pre testing criteria 
 
      Participants needed to be 4 days headache-free, between periods of menstruation, and 
alcohol, nicotine and medication-free.  They were also required to fast for 2 hours prior to 
testing.    In  addition  to  strict  pre-testing  criteria  each  session  involved  exposure  to 
particularly uncomfortable procedures.  Most participants returned and completed all 3 
sessions despite the unpleasant nature of procedures and strict pre testing requirements.    
For some migraine sufferers, however, completion of the sessions was protracted due to 
their inability to meet testing criteria (e.g., 4 days headache-free).     Additionally, some 
migraine sufferers developed a migraine attack post testing (refer to publications related 
to this book, Granston and Drummond, 2005).   Consequently, for a number of these 
reasons  some  participants,  particularly  migraine  sufferers,  required  considerable 
encouragement from the experimenter to return to complete the 3 sessions.  
 
 
Extraneous procedural effects 
 
       Preliminary  pilot  research  in  the  laboratory  demonstrated  that  participants 
desensitized to OKS and painful procedures when the interval between repeated testing 
was too close.   Therefore, the 3 sessions in the present study were spaced 3 to 4 weeks 
apart to reduce adaptation effects.     This break also allowed for the time between menses 
required for female participants.    
      A  shortcoming  of  the  long  interval  between  testing  was  that  two  subjects  had  to 
withdraw from the experiment as they commenced prophylactic anti-migraine medication 
between sessions (for participant details see Method,  page 82-83). 
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Selection of procedures 
 
      Procedures used during testing were harmless and effects were transitory.  To induce 
motion sickness OKS was selected, since exposure to the optokinetic drum is a well-
established  way  of  inducing  symptoms  of  motion  sickness  in  susceptible  individuals 
(Cheung and Vaitkus, 1998).   Participants were exposed to OKS for 15 minutes, a period 
found  adequate  to  induce  motion  sickness  during  preliminary  pilot  research  in  the 
laboratory.    
       Ice was selected as a pain stimulus as it is harmless and also a vascular stimulus.  
Participants were exposed to ice for 30 seconds.  This period was arbitrarily chosen as it 
appeared to be sufficient to induce pain.   If exposure to the cold stimulus was longer or 
the pain stimulus was changed (e.g., heat or pressure) responses may have been different.   
This possibility may be useful to explore further, and is discussed shortly in section 13.4.,  
Further research: Painful stimulation: procedural alternatives, pages 264-265. 
 
 
 
Measurement of pulse amplitude 
 
        Recording procedures  used  to  assess  vasodilatation  and constriction in the temple 
involved  photoelectric  plethysmography.  This  instrument  measures  the pumping 
action  of  the  heart,  and  the  recorded signal is commonly referred to as pulse volume  
or   pulse  amplitude  (Stern,  Ray  and  Davis, 1980).      Absolute  comparisons between   
subjects   are  not  possible   because  of   wide  individual   variations  in   skin 
characteristics.    In addition, within individual variations make comparisons only relative 
(e.g.,  precise  placement  of  the  transducer  from  session to session may vary).  Hence, 
changes  in  blood   flow  are  commonly  estimated  from  a  baseline  period,  which   is 
compared to a  treatment period and  is generally expressed  as a percentage change from   259
baseline.   Unfortunately,  because of  the  relative nature of  this  measure,  it  cannot  be 
ascertained  whether  or  not  blood  vessel caliber of migraine sufferers and controls was 
equivalent  at the  commencement  of  the  experiment.    A lightproof headband was 
placeA lightproof headband was placed over the photoelectric pulse transducers to ensure 
that  light  transmitted  from  the  instrument  was  not  influenced  by outside light.   This 
covering could  have  influenced  skin  temperature  from  day to day depending on room 
temperature  variations  and  individual  responses.    To  minimize  this  possibility  room 
temperature    was  maintained  at  a  constant  22  degrees  Celsius  (+  1.5
o  C).      Another 
limitation was that the precise  placement  of  the  transducers  and  headband  may  have 
varied from session to session,  in  turn  influencing  recordings.    However, preparation  
of   participants  for  testing   was standard  as  the   same   researcher   carried   out   
procedures   and  recordings throughout  the  study.         
                                                                                                                              
Self-report issues 
 
      Migraine sufferers generally experienced more discomfort than controls in response 
to the procedures.   However, due to the subjective nature of self-report data it is not 
certain if migraine sufferers tended to over report discomfort due to fear of developing 
symptoms associated with a migraine attack.    It may be that there was a response bias in 
migraineurs; nevertheless the scales were explicit and well defined, including an option 
of  “awareness” of symptom development.   Headache developed during most procedures 
in migraine sufferers, apart from during limb pain before OKS, and also developed in 
some  migraine  sufferers  post  testing.    As  headache  developed  in  response  to  painful 
cranial stimulation but not to painful limb stimulation, it did not appear to be a non-
specific  response  to  discomfort.    Together,  these  findings  suggest  that  headache 
experienced during the procedures was most likely a real account.  In contrast, at no stage 
did headache, or even a head-awareness, develop in controls.   Clearly, with regard to 
headache,  migraine  sufferers  described  a  sensation  that  was  not  reported  at  all  by 
controls.     260
 
Quantification of data 
 
       This  research  involved  investigating  many  dependent  variables  that  required  the 
same measurements being taken several times on each subject.   As a large number of 
statistical analyses were required, the General Linear Model (GLM) Repeated Measures 
procedure  was  selected  using  SPSS  for  Windows  11.5.0.  Software.      This  statistic 
involves analysis of variance, and both univariate and multivariate analyses for repeated 
measures  data.    Between- and within-subjects factors demonstrated main effects and 
interactions of variables.  The within-subjects design minimizes error variance (Grimm, 
1993;  Kerlinger,  1986)  and  strengthens  power  (Grimm,  1993).      To  minimize  the 
possibility of chance findings, simple planned contrasts were used to investigate the mean 
of  each  level  compared  to  the  mean  of  the  first  or  last  category  as  the  reference.    
Nevertheless, because of the large number  of comparisons in the present study, some of 
the  findings  may  still  be  chance  effects.    Therefore,  important  findings  need  to  be 
confirmed in replication studies. 
 
Organisation of sessions and conditions  
    
       The present project explored 6 experimental conditions over 3 sessions, 2 conditions 
per session.  Condition 2, the application of ice to the temple after OKS, which explored 
painful stimulation in the presence of residual motion sickness, necessarily required the 
preceding  procedure,  OKS  alone  (Condition  1),  to  induce  motion  sickness.    The 
remaining  conditions  did  not  necessarily  require  a  preceding  condition.      OKS  alone 
(Condition 1), ice to the temple before OKS (Condition 3) and hand immersion in ice-  261
water before OKS (Condition 5) were the first of 2 conditions conducted in separate 
sessions so were not preceded by another condition.  The application of ice to the temple 
during  OKS  (condition  4)  and  the  immersion  of  the  hand  in  ice-water  during  OKS 
(condition 6) were preceded by a condition - ice to the temple before OKS (conditions 3) 
and hand immersion in ice-water before OKS (condition 5), respectively.   It may be 
worthwhile  exploring  the  2  conditions  involving  painful  stimulation  during  OKS 
independently,  to  minimize  any  possible  carry-over  effects  from  the  preceding 
procedures.  This would involve 2 further sessions on separate days which would extend 
the overall testing period for the entire experiment from 3 to 5 sessions. 
 
 
 
 
13.4.    Further research 
 
 
 
Fear of pain 
 
 
        The present study provided insight into the effects of stress and pain on symptomatic 
and vascular responses in migraine sufferers and healthy controls.  Anxiety and fear have 
been linked to the stress response but the relationship between anxiety sensitivity and fear 
of pain in determining somatic, affective and behavioural responses in recurrent headache 
sufferers, is poorly understood.  Knowledge, specifically related to migraine sufferers, is 
even more limited (Asmundson, Norton and Veloso, 1999).   Determining the impact of 
fear  of  pain  on  headache  and  lifestyle  may  be  helpful  in  targeting  treatment  (e.g. 
cognitive-behavioural,  medication  management).    Therefore,  more  research  into  the 
modulation of pain by fear in subgroups of headache sufferers is required.   262
The stress response 
 
       The stress response was not physiologically confirmed in this study.   In order to 
validate the impact of stress in relation to the development of symptoms, it may be useful 
to measure the stress response in future research.    Two possible measures might include 
monitioring galvanic skin responses, or respiration, possibly using techniques resembling 
those previously discussed employed by Yen Pik Sang, Billar, Golding and Gresty (2003) 
or  Jokerst, Gatto, Fazio, Stern and Koch (1999).  
        Skin  conductance  activity  during  motion  sickness  appears  to  involve 
thermoregulatory mechanisms rather than emotional/arousal (Golding, 1992; Golding and 
Stott,  1997).        It  may  be  worthwhile  exploring  further  these  two  types  of  skin 
conductance responses in relation to motion sickness in future research.     
        In the present study it may have been that stress associated with OKS exposure led 
to  increased  breathing  and  increased  sympathetic  nervous  system  activity,  thereby 
contributing to the development of symptoms of motion sickness (as suggested by Jokerst 
et  al.,  1999).    Alternatively,  increased  sympathetic  nervous  system  activity  might  be 
determined by measuring the release of stress hormones, as Koch, Stern, Vasey, Seaton, 
Demers and Harrison (1990) found that levels of norepinephrine, epinephrine, cortisol 
and β-endorphin were elevated during OKS.   
 
 
 
Neuropeptide release 
 
        In  the  present  study  headache  developed  comparably  in  migraine  sufferers 
irrespective  of  whether  the  temple  or  hand  was  painfully  stimulated  during  OKS.  
Neuronal events mediating the headache phase of migraine are believed to involve the 
trigeminovascular  system  and  its  central  projections  (Welch,  2003).    As  previously 
discussed, it may be that in the present study this circuitry was somehow activated in 
migraineurs during OKS in the absence of painful stimulation, and painful stimulation 
facilitated this response (Ashkenazi et al., 2005).       263
         In  addition  to  headache,  vasodilatation  was  experienced  in  migraineurs  in  the 
present study.  The vasoactive parasympathetic messenger vasoactive intestinal peptide 
(VIP) and the sensory trigeminal messenger CGRP have been detected during migraine 
headache  and  also  during  chronic  paroxysmal  hemicrania  and  cluster  headache 
(Edvinsson and Goadsby, 1995; Edvinsson and Uddman, 2005; Goadsby and Edvinsson, 
1996).      However,  while  these  peptides  appear  to  be  a  marker for  migraine  activity, 
without a blood assay  it cannot be be determined whether their release contributed to 
vasodilatation in the sub group of  migraineurs in the present study.  
       Saito  et  al.  (2006)  found  that  levels  of  the  neuropeptides  calcitonin  gene-related 
peptide (CGRP) and substance P (SP) were elevated during limb pain in childhood in a 
family  of  migraine  sufferers.    They  suggested  that  an  abnormal  release  of  these 
transmitters in vascular walls in extremities might be crucial in the pathophysiology of 
limb pain, similar to the case of the trigeminovascular explanation for migraine.  
          Neuropeptide  release  in  response  to  cold  stimulation  was  not  measured  in  this 
study.  Nevertheless, the enhanced limb pain observed in migraine sufferers may reflect 
hyperexcitable nociception in the interictal period as Ashkenazi et al. (2005) observed.  
In addition, as headache ratings were greater during temple pain than during limb pain, it 
may be that neuropeptide release associated with the development of migraine headache 
was greater when the temple was painfully stimulated in migraine sufferers.  In contrast, 
controls remained headache-free over all three conditions.   It may be helpful to measure 
neuropeptide release in response to cold stimulation in future research to determine if 
indeed  neuropeptide  release  associated  with  the  development  of  migraine  headache 
differs during both types of painful stimuli. 
 
 
Quality of pain 
 
        In  the  present  study,  both  groups  anecdotally  reported  a  dull  aching  cold  pain 
consistent with the concept of Ochoa and Yarnitsky (1994), of dual activation of A and C 
fibres  in the  sensation  of cold  pain.      The  experience  of pain  was  more  intense  and 
unpleasant in migraine sufferers, indicating hypersensitive nociception in this group but   264
the quality of pain was not formally measured.   It may be worthwhile measuring pain 
quality in future research to determine if dual activation of A and C fibres in the sensation 
of cold pain (Ochoa and Yarnitsky, 1994) occurred, or if blocking A fibres left C-fibre 
activity unopposed.   In turn, this may shed light on understanding the hypersensitive 
response to painfully cold stimuli observed in migraineurs in the present study, and the 
neural mechanisms involved in pain processing.  
 
 
Painful stimulation: procedural alternatives 
 
       In  the  present  study  participants  were  exposed  to  painfully  cold  stimulation  for 
periods of 30 seconds.  A lengthier exposure time to painfully cold stimuli, or a different 
(e.g., mechanical, chemical, electrical, heat) or more intense painful stimulus, may have 
elicited  a  different  response.      For  instance,  if  early  warning  nociceptive  pain  is 
overwhelmed,  instead  of  a  defense  response  (e.g.,  Carrive  and  Bandler,  1991)  or  a 
withdrawal response to prevent tissue damage, severe trauma may occur (Woolf, 2003).   
In this case, a retreat response to recover from injury is more probable.    
       Stress induced analgesia appears to be associated with intense and extended noxious 
stimuli.  This response may lessen the impact of the stressor so that the organism  may 
defend  itself against potentially life threatening events.   Bandura, Cioffi, Taylor and 
Brouillard (1988) found that individuals became more distressed and opioid activation 
increased when they perceived pain could not be managed effectively in response to a 
cold pressor task.    
     There are 2 kinds of pain, visceral and somatic, and 2 kinds of sensations, painful and 
non-painful (Bray et al., 1999; Nicolodi, Sicuteri, Coppola, Greco, Pietrini and Sicuteri, 
1994).      The  present  study  involved  painful  stimulation  of  nociceptors  in  the  skin  - 
somatic pain.   Nicolodi et al. injected hypertonic saline into the antecubital vein of the 
arm – visceral pain, which produced considerable, and in some cases unbearable, pain in 
migraine sufferers but not in controls.  Based on these findings Nicolodi et al. suggested 
that  migraine  might  be  a  visceral  sensory  disorder,  consistent  with  the  theory  that 
migraine pain is due to central derangement of the viscerosensory system.  Migraine is   265
thought, in part, to involve inflammatory pain processes within the cranial vasculature, 
which act on meningeal sensory fibres.  Additional mechanisms involve alterations in the 
sensitivity  of  sensory  terminals  innervating  blood  vessels  in  the  meninges,  and  also 
increased  excitability  of  central  pain  relay,  neurons,  and  central  sensitization  (Woolf, 
2003).   
      Visceral  versus  somatic  pain  mechanisms,  alternative  pain  stimuli,  and  differing 
intensities of exposure to painful stimulation, may be worth exploring in future research, 
in relation to effects of OKS.   If mechanisms of pain are better understood, more rational 
and specific choices for effective therapy are possible.  Consistent with this premise, 
Woolf proposed that a mechanism-based diagnosis of pain, rather than a disease-based 
focus, would help increase the understanding of how pain is generated and, in turn, more 
appropriate treatment could then be identified.  
 
 
Diffuse noxious inhibitoy controls (DNIC) 
 
          Nociceptive stimulation of the hand possibly triggered DNIC in migraine sufferers 
in  this  study,    thereby  inhibiting  certain  symptoms  of  motion  sickness,  e.g.,  body 
temperature.   It might be interesting to further explore specific symptoms of motion 
sickness in relation to DNIC and the implications in respect to the migrainous brain.  
Furthermore, investigating the simultaneous effect of painful stimulation of the temple 
and hand during OKS in relation to specific pain sources (temple or hand alone) during 
OKS,  may  help  to  more  conclusively  determine  whether  DNIC  influence  the 
development  of  symptoms  of  motion  sickness.    If  DNIC  are  involved,  simultaneous 
painful stimulation during OKS may inhibit the enhanced nausea, and possibly headache, 
observed in this study during painful stimulation of the temple during OKS.   This of 
course would be an exploratory exercise, as hand pain did not generally inhibit motion 
sickness in the present study. 
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Loss of appetite 
 
 
       It is generally assumed that migraine sufferers are unable to eat or drink during an 
attack (Blau, 1993).  Blau asked 109 sufferers if they could tolerate food or fluid during 
migraine.  The number of migraineurs able to eat (particularly selected foods) in spite of 
nausea during migraine was unexpected (50 could, 59 could not).  Furthermore, food 
consumption reduced nausea, headache and improved general wellbeing.  Blau pointed 
out that cravings for sweet foods is a well documented prodrome of migraine and that 
delayed  meals  can  precipitate  an  attack.    He  suggested  that  the  hypothalamus  or  the 
brainstem could play a role in nausea but that cravings are more likely to originate from 
the hypothalamus.  Therefore, it may be that simultaneous nausea and cravings derive 
from the hypothalamus, which would also account for tiredness and yawning during the 
premonitory  and  headache  phase  as  well  as  after  attacks  (Blau,  1991).    Blau  (1993) 
proposed  that  the  generation  of  migraine  is  not  only  dependent  on  the  activation  of  
neurotransmitters, but may also be a central neuronal metabolic disturbance.   
      The ability to eat or drink during migraine may be worth investigating further.  So too 
might the loss of appetite in relation to head pain and nausea during migraine.  Loss of 
appetite during a migraine attack has been associated with the development of head pain, 
often  before  the  experience  of  nausea,  or  even  in  the  absence  of  nausea  (Malick, 
Jakubowske,  Elmquist,  Saper  and  Burstein,  2001),  suggesting  that  loss  of  appetite  is 
independent of nausea.  Instead nausea appears to be driven by pain.  Consistent with this 
association, Malik et al. (2001) also found that brief noxious stimulation of the dura in 
conscious rats suppressed food intake.  Mapping of neuronal activation in rats indicated 
that  certain  hypothalamic  neurons  mediated  the  suppression  of  food  intake  by  pain 
signals.   Further study aimed at determining the progression of  loss of appetite and 
nausea in relation to head pain may help to identify neural structures/processes involved 
in the development of a migraine attack. 
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Hyperventilation in relation to motion sickness and migraine 
 
        Breathing style in relation to motion sickness and migraine was not explored in the 
present  study  but  may  be  worthy  of  further  investigation.    Research  indicates  that 
breathing style may determine whether nausea and other symptoms of motion sickness 
develop during OKS (Yen Pik Sang, Billar, Golding and Gresty, 2003; Jokerst, Gatto, 
Fazio,  Stern  and  Koch,  1999).    Before  surgery  anxious  patients  may  involuntarily 
swallow large amounts of air which may contribute to distention/discomfort of the upper 
gastrointestinal  tract  and  post-operative  nausea  and  vomiting  (Andrews,  1992).      In 
regards to motion sickness, slow deep breathing (8 breaths per minute) was found to 
reduce  the  development  of  tachygastria  and  decrease  symptoms  of  motion  sickness.  
Jokerst and others point out that this breathing style is known to increase parasympathetic 
nervous system activity and may stimulate reflexes that control the autonomic nervous 
system  (ANS)  (particularly,  the  baroreflex  system)  leading  to  more  efficient  ANS 
control.  Certainly, slow breathing (‘respiratory training’) has been used successfully to 
treat anxiety (Andrews, Crino, Hunt, Lampe and Page, 1995).   
        Koch, Stern, Vasey, Seaton, Demers and Harrison (1990) found that that the stress 
associated  with  OKS  exposure  led  to  increased  breathing  and  increased  sympathetic 
nervous  system  activity:  norepinephrine  and  epinephrine  (evidence  of  sympathetic 
activity)  levels  were  raised  during  OKS  in  motion  sick  subjects.    During  recovery, 
epinephrine, cortisol and β-endorphin responses were elevated: further indication of the 
stress response.  However, neuroendocrine levels did not change from baseline levels in 
asymptomatic subjects, indicating that the stress response was not triggered.    
        Sympathetic activation of the ANS (increased respiration, heart rate) has also been 
observed  during  rotating  chair-induced  motion  sickness  (Cowings,  Suter,  Toskcan, 
Kamiya and Naifeh, 1986; Cramptom, 1990).  Cowings et al. (1986) observed a rapid 
return to pretest levels during post test recovery and put this down to a reduction in 
sympathetic  tone  or  to  a  parasympathetic  rebound,  on  cessation  of  the  stimulus.  
Similarly, Sakai and Meyer (1978) suggest that nausea and vomiting during a migraine 
attack may be a parasympathetic reaction to prolonged sympathetic activity.     268
       Respiration  was  not  measured  in  the  present  study  but  it  may  be  that  the  stress 
associated  with  OKS  exposure  led  to  increased  breathing  and  increased  sympathetic 
nervous system activity, thereby contributing to the development of symptoms of motion 
sickness (as suggested by Jokerst et al., 1999), particularly in migraine sufferers.    This 
notion requires further investigation.  
 
 
Serotonin and migraine  
 
 
          Serotonergic activity has been linked to migraine, during (Hasler, 1999; Ladabaum 
and  Hasler, 1999; Silberstein, 1994) and outside (Afra, Proietti Cecchini, Sandor and 
Schoenen,  2000) attacks.    However, the precise role of serotonin is not clear (Evers, 
Quibeldey, Grotemeyer, Suhr and Husstedt, 1999; Ferrari et al., 1993; Fontes Ribeiro et 
al., 1990).   During a migraine attack the trigeminal sensory system presumably activates 
central  nociceptive  neurons  within  the  brainstem,  which  relay  signals  to  autonomic 
brainstem nuclei and higher cortical pain processing centres.  These afferent impulses, in 
turn, lead to head pain and nausea while activation of efferent autonomic pathways are 
thought  to  trigger  stomach  disturbance  and  vomiting  (Dahlof  and  Hargreaves,  1998).  
Nausea,  headache,  fatigue  and  thermoregulation  have  been  linked  with  5-HT  release 
(Hasler,  1999;  Ladabaum  and  Hasler,  1999;  Silberstein,  1994).    Silberstein  (1994) 
explains  that  5-HT  modulates  rather  than  mediates  sensory  responsiveness,  and 
serotonergic  receptors  are  distributed  widely  throughout the  brain (Pascual, del  Arco, 
Romon,  del  Olmo,  Castro  and  Pazos,  1996;  Waxman,  2003).    Serotonergic  neurons 
originating in the raphe nuclei of the brainstem have extensive projections to widespread 
areas  of  the  brain  including  the  cortex,  hippocampus,  basal  ganglia,  thalamus, 
cerebellum, and spinal cord.  These neurons play a role in controlling levels of arousal 
and  sleep.    In  addition  they  modulate  sensory  input,  particularly  for  pain  (Waxman, 
2003).   Serotonergic input to vestibular nuclei has been found to affect the firing rate of 
vestibular nucleus neurones (Kishimoto, Sasa and Takaori, 1991, 1994).  In particular, in   269
experiments on cats, 5-HT inhibited the transmission of neural impulses in the lateral 
vestibular nuclei.   
        Furthermore, evidence exists for vestibular regulation of sympathetic activity (Ray, 
2001).  Ray found that muscle sympathetic nerve activity, arterial pressure and heart rate 
increased during head down rotation, which engages the vestibulosympathetic reflex in 
healthy  volunteers.    Cass  et al. (1997) suggested that autonomic and somatic activity 
during  a  migraine  attack  may,  in  part,  be  generated  from  the  interaction  between 
vestibular and sympathetic junctions.   Just as depleted 5-HT is believed to play a role in 
vasodilatation and pain observed during migraine (Supornsilpchai, Sanguanrangsirikul, 
Maneesre  and  Srikiatkhachorn,  2006;  Silberstein,  1994),  a  decrease  in  serotonergic 
transmission  during  an  attack  might  also  contribute  to  the  development  of  other 
symptoms  of  migraine.    However,  low  serotonergic  transmission  during  the  migraine 
attack is somewhat controversial as there is evidence 5-HT levels increase ictally (Fontes 
Ribeiro, Cotrim, Morgadinho, Ramos, Seabra Santos and Macedo, 1990).   Clearly, the 
exact role of 5-HT in the pathogenesis of migraine is under discussion (Evers et al., 1999; 
Ferrari et al., 1993;  Fontes Ribeiro et al, 1990).    
          Pharmacological studies indicate that serotonin may be involved in migraine and 
also  motion  sickness.      Pascual  et  al.  (1996)    suggest  that  triptans  evoke  analgesic 
antimigraine activity in the TNC and antiemetic effects in the NTS, by acting on the 
numerous 5-HT receptor sites in these locations.   5-HT agonists and antagonists have 
also successfully treated motion sickness (Yates, Miller and Lucot, 1998).   Additionally, 
serotonin has been found to prevent motion-induced emesis in animals (Javid and Naylor, 
2002; Okada, Saito and Matsuki, 1996).   Baloh (1997) pointed out that antimigraine 
treatments, e.g., ergotamines or sumatriptan, are probably of little help for the treatment 
of  migraine-associated  vertigo,  though  he  did  anecdotally  report  that  several  patients 
found sumatriptan, if taken early in an attack, aborted vertigo (Evans and Baloh, 2001).    
Consistent with this observation, more recently Zolmitriptan was used successfully to 
treat migrainous vertigo in a small group of sufferers (Neuhauser, Radtke, Breven and 
Lempert, 2003).   
        Atypical sertonergic activity may persist interically in migraine sufferers (Afra et al., 
2000).   Afra et al. suggested that low interictal activity of brain stem nuclei projecting to   270
the  cortex,  e.g.,  the  raphe-cortical  serontonergic  pathway,  may  be  responsible  for 
electrophysiological  abnormalities  observed  in  migraine  sufferers.      Afra  et  al. 
demonstrated  lack  of  habituation  of  visual  evoked  potentials  and  a  marked  intensity 
dependence of auditory evoked cortical potentials in both migraine with or without aura 
between  attacks  compared  to  healthy  controls.      Deficient  habituation  of  the  P3a 
component  of  the  passive  “oddball”  auditory  event-related  potential  was  also 
demonstrated in migraineurs between attacks of migraine (Wang and Schoenen, 1998).    
          Interestingly, Schoenen et al. (2003) observed ictal normalisation of evoked and 
event-related  potentials  amplitudes  and  habituation,  implying  there  is  an  increase  in 
cortical preactivation level.   The understanding of the sequence of activation of cortical 
and  brain stem structures, e.g., raphe cortical serotonergic pathways, remains open to 
much debate.  However, Afra et al. (2000) speculated that the normalisation observed in 
their study might be due to a rise in activity of raphe-cortical serotonergic pathways, 
particularly in close proximity to the migraine attack.     
         Serotonergic activity was not assessed in the present study, though fluctuations in 5-
HT may have played a role, at least partly, in the development of symptoms observed in 
migraine  sufferers.    Assay  of  serum  or  urine  5-HT  levels  in  migraine  sufferers  in 
response to procedures used in this study, may be worthwhile exploring.  Findings may 
shed  further  light  on  the  role  of  this  neurotransmitter  in  those  with  a  migraine 
predisposition.  
 
 
 
 
13.4.    Conclusions 
 
   Consistent with the literature (Golding, 1998; Kuritzky, Ziegler & Hassanein, 1981), 
migraine sufferers in this study developed motion sickness more readily than controls.  
Symptomatic responses were enhanced during the three procedures involving OKS and 
during temple pain after OKS, in the presence of residual motion sickness.     271
      During  trigeminal  stimulation  independent  of  OKS,  headache  initially  developed 
followed by nausea as the procedure progressed, implying that activation of the TNC 
triggered  the  NTS.    This  close  functional  relationship  between  the  trigeminovascular 
system and NTS in the brainstem of migraine sufferers has been described elsewhere 
(Knight, 2005).   Symptoms barely developed in controls during any of the six procedures 
except for slight dizziness, self-motion and visual-illusion during conditions involving 
OKS, and slight nausea when the temple was painfully stimulated during OKS and during 
OKS  alone.    Trigeminal  stimulation  during  OKS  intensified  nausea  and  headache  in 
migraine sufferers compared to during OKS alone or limb pain during OKS.  However, 
the remaining symptomatic ratings were not altered following temple pain during OKS, 
suggesting a specific association between nausea and head pain.  These findings further 
imply  a mutual  interaction  between  the  TNC  and  NTS.      If so, it may be that these 
cardinal  symptoms  compound  one  another  during  a  migraine  attack.  Enhanced 
symptomatic  responses  in  migraine  sufferers  may  reflect  activation  of  hypersensitive 
neural pathways that mediate symptoms of motion sickness or migraine. Furthermore, 
migraineurs found procedures generally more unpleasant, and ice-induced pain ratings 
more intense and unpleasant, than controls, which may further indicate hyperexcitable 
nociception in this group, or a difference in their criterion of discomfort. 
        Vascular responses, particularly during OKS alone, and during painful stimulation 
independent of OKS, were greater in migraine sufferers than in controls.   The stress of 
painful stimulation during OKS (two tandem stressors) appeared to boost facial blood 
flow in controls to approach levels obtained in migraine sufferers.   The stress response 
also probably contributed to the enhanced vasodilatation observed in migraineurs, even 
prior to painful stimulation before OKS.   In addition, as headache was experienced in 
migraine sufferers in conjunction with vasodilatation, activation of the TNC may have 
been involved.  Therefore, it may be that increased blood flow in migraineurs was also 
mediated  by  the  release  of  vasoactive  polypeptides  (Edvinsson  and  Goadsby,  1995; 
Edvinsson and Uddman, 2005; Goadsby and Edvinsson, 1996).   
      For  both  groups,  ipsilateral  vascular  responses  were  greater  than  contralateral 
responses when the hand was painfully stimulated, but side differences were not apparent 
during painful stimulation of the temple.  This asymmetrical vascular response to limb   272
pain has also been observed by Drummond (2006) in healthy controls, which implies a 
normal reaction to immersion of the hand in ice-water.   In the present study, asymmetry 
was greater during limb pain before OKS than during OKS, in migraine sufferers but 
responses were comparable in controls.  It may be that atypical autonomic reactivity may 
partly account for the augmented vascular responses observed in migraineurs.  During 
limb pain before OKS asymmetry was marginal in migraine sufferers but more apparent 
in controls.  An enhanced stress response in migraineurs may have drawn ipsilateral and 
contralateral responses closer together. 
 
 
 
 
13.5.   Concluding Comments:   findings  of  the  present  study  
            in relation to contemporary understanding  of  migraine 
  
 
         Migraine is a widespread, chronic, sometimes progressive, and often incapacitating, 
neurovascular disorder (Goadsby, 2003; Lipton and Bigal, 2005; Silberstein, 2003).  The 
personal  burden  of  the  disease  and  the  socioeconomic  costs  of  migraine  are  well 
documented (Lipton and Bigal, 2005).     Knight (2005) pointed out that the present 
challenge  regarding  what  causes  migraine  is  long-standing  and  gradually  evolving.  
Migraine is a complex neurological disorder characterized by headache and associated 
symptoms,  including  nausea.      The  neural  events  involved  in  the  link  between  the 
initiation of a migraine attack and the associated trigger factors are poorly understood 
(Williamson and Hargreaves, 2001).    Interestingly, in the present study migraine-like 
attacks  were  triggered  in  migraine  sufferers  following  procedures,  particularly  after 
sessions that involved painful stimulation of the temple during or after OKS (refer to 
publications related to this book, Granston and Drummond, 2005).   Migraine symptoms 
are  remarkably similar  to  symptoms  of  motion sickness,  so  it may be that symptoms 
evoked during the procedures of the present study simulated a migraine attack in the   273
interictal period.  As migraine-like attacks were triggered in migraineurs, and persisted, it 
may  be  that  symptoms  built  upon  each  other  in  a  vicious  circle.    The  build  up  of 
symptoms  may  demonstrate  a  neural  hypersensitivity/“wind-up”  (Bray,  Cragg, 
MacKnight  and  Mills,  1999)  that  amplifies  responses.    Migraine-like  attacks  did  not 
develop in controls.  
        The  development  of  symptoms  during  the  procedures  of  this  study  provide  an 
insight into how symptoms might develop sequentially in a migraine attack.  Perhaps, 
once the headache is in motion, nausea and headache mutually exacerbate one another.  
In turn, trigeminovascular responses and stress appear to be linked to the migraine crisis.  
Thus,  it  may  be  more  effective  to  target  multiple  symptoms  rather  than  individual 
symptoms in prophylactic or immediate chemical and psychological interventions.  This 
approach may help relieve the burden of migraine, not only for the sufferer but also for 
the community. 
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APPENDIX 1 
 
School of Psychology                                          
Division of Health Sciences                                                Consent form                                                                                                                                            
                                                             Ethics Permit No:  144/2000     
Project Title:       
           Motion sickness, head pain and non-specific pain in the origin of migraine  
 
I am a Doctor of Psychology student at Murdoch University investigating the relationship between 
motion sickness, head pain, and non-specific pain, and how this relates to susceptibility to migraine.  
The  purpose  of  this  study  is  to find out how particular symptoms of migraine contribute to the 
development of a migraine attack; if certain symptoms attenuate or exacerbate the severity of other 
symptoms or predispose the individual to repeated attacks.  Additionally, this study aims to find out 
whether sensitivity to pain elsewhere in the body plays a role in the symptomatology of migraine. This 
information will assist in treatment and research aimed at reducing the likelihood of the individual 
suffering repeated attacks of migraine. 
 
To conduct my study I require people who suffer from migraine and people who do not.  You will be 
required for 3 sessions of approximately 1.5 hours each.  During these sessions an attempt will be 
made to simulate some of the symptoms of migraine including nausea (motion sickness) and head 
pain.  You will be required to sit with your head inside a striped, revolving drum, which may provoke 
nausea.   One session involves you sitting inside the drum and also receiving ice to your temple, which 
may provoke head pain.  To assess the role of pain elsewhere in the body in migraine, another session 
requires drum exposure and immersing your fingers in iced water.  You will be asked to report your 
experience of these stimuli and some of your physiological reactions will be monitored from 
electrodes attached to your skin.  These procedures are harmless if you are in good health, but if you 
have any problems with your heart, lungs, epilepsy or any other serious medical conditions you should 
not participate in this experiment. 
 
If you are willing to participate in this research, please complete the details below.  Any queries about 
this study can be directed to myself, Anna Granston on 93606735, my supervisor, Associate Professor 
Peter Drummond on 93602415, or Murdoch University’s Research Ethics Committee on 93606483. 
 
 
I (the participant) have read the information above.  Any questions I have asked have been clarified to 
my satisfaction.  I agree to take part in this study, however, I know that I may change my mind and 
stop at any time. 
 
I understand that all information provided is treated as confidential and will not be released by the 
investigator unless required to do so by law. 
 
I agree that research data gathered for this study may be published provided my personal identifying 
information is not used. 
 
_________________________________                    __________________________ 
Participant                                                                     Date 
 
_________________________________                    __________________________ 
Investigator      Anna Granston                                     Date   276
APPENDIX 2 
 
CONFIDENTIAL PERSONAL DETAILS 
 
Participant code                         ________________ 
Age                                            ________________ 
Sex                                             ________________ 
Time last ate                              ________________ 
 
•  Medical status 
 
I suffer from a chronic medical condition, eg. neurological (especially   
            epilepsy),  heart disease, gastric ulcer, ear problems   
                                                                                                             Yes/No 
Medical history __________________________________________________ 
 ______________________________________________________________ 
       
       I am uncertain about my medical status and need to visit a General  
       Practitioner for a medical clearance 
                                                                                                                    Yes/No              
             If decided on medical visit, date of visit ______________________________ 
             Result of visit          ______________________________________________ 
              ______________________________________________________________ 
 
•  Headache (including migraine) experience  - Less than 12/year          Yes/No                                         
                                              - More than 12/year         Yes/No 
 
             Frequency of headaches                              ___________________________ 
             How many headaches are severe                 ___________________________ 
             Of  these, how many are migraine               ___________________________ 
             Date most recent headache finished            ___________________________ 
             Was most recent headache a migraine                                                  Yes/No 
 
•  Migraine experience – discuss with the experimenter the following 2 categories of 
migraine below (with & without aura) and circle Yes or No to that which describes your 
experience.                                                                 
    
  1)   Migraine without aura 
     A .  At least 5 attacks fulfilling B – D. 
     B .  Headache attacks lasting 4 – 72 hours (untreated or successfully treated) 
     C  . Headache has at least 2 of the following characteristics: 
1.  Unilateral location 
2.  Pulsating quality 
3.  Moderate or severe intensity 
4.  Aggravation by walking stairs or similar routine physical activity 
      D . During headache at least one of the following: 
1.  Nausea and/or vomiting 
2.   Photophobia and phonophobia 
   277
       2)   Migraine with aura 
      A.   At least 2 attacks fulfilling B. 
                 B.   At least 3 of the following 4 characteristics: 
1.  One or more fully reversible aura symptoms indicating focal cerebral cortical 
and/or brain stem dysfunction 
2.   At least 1 aura symptom develops gradually over more than 4 minutes or, 2 
or more symptoms occur in succession 
3.  No aura symptom lasts more than 60 minutes.  If more than one aura 
symptom is present, duration is proportionally increased 
4.  Headache follows aura with a free interval of less than 60 minutes. (It may 
also begin before or simultaneously with the aura) 
 
          
 
          Migraine without aura                                                                              Yes/No 
          Migraine with aura                                                                                    Yes/No 
 
 
Has a Doctor diagnosed migraine                                                                       Yes/No 
Name and specialty of Doctor                                _____________________________ 
_____________________________________________________________________ 
 
Detail medical investigation(s) of your headache  _____________________________ 
_____________________________________________________________________ 
_____________________________________________________________________ 
 
 
 
 
•  Migraine location (non-migraineurs give headache location):  
 
 
                                                      
                                     
                             
 
 
 
 
 
 
 
 
 
•  Does anyone in your immediate family (parents, siblings, proband relatives) suffer from 
migraine                                                                               Yes/No 
            If yes, give details  _______________________________________________ 
 
 
 
  Yes  No   Approximate number per 10 
headaches 
Left side       
Right side       
Both sides       
Other 
location 
       278
       
                                                
•  Medication 
  
 
       Prophylactic medication for headache relief                                          Yes/No 
       If yes, give details    ______________________________________________ 
 
             Medication as required for immediate headache relief                          Yes/No 
             If yes, give details    ______________________________________________ 
        ______________________________________________________________ 
 
       Medication for another condition, including oral contraceptive             Yes/No                                                                                                  
             If yes, give details     _____________________________________________ 
       ______________________________________________________________ 
 
       Medication over past 7 days                                                                    Yes/No       
       If yes, give details (what, when)    __________________________________ 
       ______________________________________________________________ 
 
 
 
 
•  Menstruating or premenstrual      Yes/No/Not Applicable 
 
 
Date of last menstruation           _____________________________________ 
Days in your cycle                    _____________________________________  
 
 
 
 
 
•  Do you regard yourself as susceptible to motion sickness – circle below 
 
Not at all                     Slightly                 Moderately                 Very much so 
      
 
 
 
 
•  Dizziness or vertigo not associated with headache – circle below  
 
             Never          Once in 6 weeks          More than once in 6 weeks 
           
             Other, give details _____________________________________________   279
•  Regardless of motion sickness, over the last 10 years, how often have you 
travelled/used the following  – tick boxes 
 
 
 
 
 
 
 
 
 
•  Over last 10 years, how often you felt sick or nauseated – tick boxes 
 
 
 
 
 
  Never   Rarely  Sometimes  Frequently  Always 
Cars           
Buses, coaches           
Trains           
Aircraft           
Small boats           
Ships, eg. channel ferries           
Swings           
Roundabouts: playgrounds           
Big dippers, funfair rides           
Omni theatre           
Simulators           
Reading in the car           
 
 
  Never  1- 4 trips   5 - 10 trips  11 or more trips 
Cars         
Buses, coaches         
Trains         
Aircraft         
Small boats         
Ships, eg. channel ferries         
Swings            
Roundabouts: playgrounds         
Big dippers,  funfair rides         
Omni theatre         
Simulators         
Reading in the car           280
 
 
 
•  Over last 10 years, how often you vomited – tick boxes 
 
 
 
 
  Never  Rarely  Sometimes  Frequently  Always 
Cars           
Buses, coaches           
Trains           
Aircraft           
Small boats           
Ships, eg. channel ferries           
Swings           
Roundabouts: playgrounds           
Big dippers, funfair rides           
Omni theatre           
Simulators           
Reading in the car           
 
 
 
 
 
 
•  Nature and duration of motion sickness symptoms after exposure – tick boxes 
 
 
 
 
Duration of symptoms after exposure    Intensity during 
exposure (0-10)  <  1 hour  1 – 6 hours  > 6 hours 
Nausea         
Dizziness          
Sweating          
Drowsiness         
Headache          
Never         
Rarely         
Sometimes         
Frequently         
Vomiting 
Always         
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•  Migraineurs         - tick below Yes, No or Unsure and note relevant details for   
                                     migraine triggers 
                                  `     - asterix headache triggers 
•  Non-migraineurs -  tick below Yes, No or Unsure and note  relevant details for  
                                     headache triggers       
 
 
 
PSYCHOLOGICAL 
Yes  No           Unsure  Relevant details 
             Exposure time 
< 1 hour  1 hour  - 1 day   More than 1 day 
 
Emotional or mental 
stress including anxiety 
   
 
 
 
     
 
Relaxation after stress 
       
           
Depression 
       
 
 
             Exposure time       
< 1 hour   1 hour – 1 day  More than 1 day 
           
           
 
Crying:  
•  when sad 
•  when happy   
•  other, eg. peeling 
onions 
           
 
 
 
 
PHYSIOLOGICAL                                                          
Yes  No  Unsure  Relevant details  
  
Blow to the head (eg. during sport) 
       
Lack of food         
Oral contraceptives         
Other drugs including vitamin 
supplements (particularly Vitamin A) 
      Specify 
Menstruation         
Fatigue         
Excessive exercise         
Insomnia         
Sleeping late         
Allergic reactions (eg. asthma, hay 
fever, dermatitis)  
       
Illness         
High blood pressure         
Head/neck pains           282
 
   
EXTERNAL  Yes  No  Unsure  Relevant details 
                               * tick items                   
Foods:   
wheat, yeast, rice 
      Small taste/ 
bite/sip 
Average 
serve 
More than 
average 
serve 
citrus fruits, apple, pineapple, grapes, coconut, 
tomato 
           
sugar, corn             
tea, coffee             
chocolate, cocoa products             
cola drinks             
eggs, nuts, legumes/broad beans             
fat, milk, sour cream             
Aged, salty or other cheese               
fermented sausages, salted-processed meats (ham, 
salami, frankfurters, bacon,  bologna), beef, pork, 
shellfish, pickled herring 
           
Monosodium glutamate containing foods (some 
Chinese or soya sauce) 
           
Pretzels, potato chips, other salty snacks/fast foods             
                                  * tick items                          
Alcohol: 
red wine, white wine, spirits, beer, other (specify) 
 
 
 
 
 
 
 
 
 
Sip         
 
1 glass 
  More than 1 
glass 
 
  
Taste aversion 
 
 
 
 
 
 
 
 
 
Weather changes/extremes of temperature 
 
 
 
 
 
 
 
 
 
Specify : eg. seasonal (which season), very 
hot days, very cold days,  air conditioned  or  
heated rooms 
 
 
Stuffy atmosphere 
 
 
 
 
 
 
< ½ hour exposure 
 
More than ½ hour 
exposure  
 
 
Fumes/odours  
 
 
 
 
 
 
Specify  
 
 
Travel/motion 
 
 
 
 
 
 
 
 
 
Noise 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Visual stimuli (glare, flicker, sunlight, eye 
strain, television, films, darkness) 
 
 
 
 
 
 
 
Specify 
 
Change in routine  (eg. weekend headaches)           283
  Yes  No  Unsure  Relevant details 
Other triggers  (detail below)         
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APPENDIX 3 
 
 
 
Headache Diary and Headache Detail Forms 
 
 
 
 
 
                                                                                                                                  Pages 
 
 
 
Headache Diary                                                                                                       285- 287 
 
 
 
Headache Detail Forms                                                                                           288- 290 
 
 
 
 
 
 
 
Booklets supplied to participants were A5 size 
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                                                H HE EA AD DA AC CH HE E      
                  
                              D DI IA AR RY Y   
   
 
 
 
 
 
 
                  C Co om mp pl le et te e   d da ai il ly y, ,   e ev ve en n   i if f   h he ea ad da ac ch he e   f fr re ee e      
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                        FILLOUT   HEADACHE DIARY DAILY                         FILLOUT   HEADACHE DIARY DAILY                         FILLOUT   HEADACHE DIARY DAILY                         FILLOUT   HEADACHE DIARY DAILY      
      
                       If y                        If y                        If y                        If you have more than a mild headache also complete the  ou have more than a mild headache also complete the  ou have more than a mild headache also complete the  ou have more than a mild headache also complete the       
                                                                                                                                                                                                                       Headache Details Form Headache Details Form Headache Details Form Headache Details Form                 
                     
 NOTE:   NOTE:   NOTE:   NOTE:       
             
•  Day……Date………..Tick box if a headache free day 
 
•  Time of onset & end of headache 
 
•  Intensity   (0-10)   -  If intensity >3( or mild) complete the  
      Headache Details Form   
 
•  Trigger  (refer to list below) 
  
                           Psychological  (specify eg. arguing)  
 
                           External factor  (specify eg. red wine) 
 
                           Physiological factor  (specify eg. overslept, flu symptom)                                                                     
 
                           No trigger observed    
 
 
•  Treatment – what you did including medication details 
 
                    
 
                                                      
      
      
      
      
      
      
      
        287
 
 
 
 
 
 
 
 
 
 
Remaining pages of diary followed this format.   
 
 
 
 
      
Day   ……..    Date   ………………   Tick box if a Headache free day Day   ……..    Date   ………………   Tick box if a Headache free day Day   ……..    Date   ………………   Tick box if a Headache free day Day   ……..    Date   ………………   Tick box if a Headache free day      
 
Time Time Time Time  Intensity Intensity Intensity Intensity                     Trigger                    Trigger                    Trigger                    Trigger                 Treatment                Treatment                Treatment                Treatment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       288
 
 
 
 
 
 
 
 
 
 
 
            H HE EA AD DA AC CH HE E                              
   
   D DE ET TA AI IL L   F FO OR RM MS S      
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                 HEADACHE  DETAIL  FORMS HEADACHE  DETAIL  FORMS HEADACHE  DETAIL  FORMS HEADACHE  DETAIL  FORMS      
 
 
                                Fill out this form if you have more than a mild headache 
 
NOTE: 
 
•  Date and time Date and time Date and time Date and time      
 
                                  Note start time of headache and record headache details     
                                  
                                  Continue recording details every 8 hours (note time - morning,     
                                   afternoon, evening) until  headache goes  
 
                              * If headache goes within                               * If headache goes within                               * If headache goes within                               * If headache goes within 8 hours, note time and peak rating  hours, note time and peak rating  hours, note time and peak rating  hours, note time and peak rating      
        
•  Location of head pain  
•  Signs and symptoms  (refer to list below)  
 
                                                                                                           Sensitivity to light                                                       Dizziness 
                       Sensitivity to sound                                                     Drowsiness  
                       Nausea                                                                         Headache 
                       Vomiting                                                                       
                       Sweating or increase in body temperature                   
 
                            Aura 
      
                        Note intensity of each sign and  symptom (0-10) 
 
   
        290
   
HEADACHE  DETAILS 
 
Date and time Date and time Date and time Date and time  Location of head pain Location of head pain Location of head pain Location of head pain       Signs and symptoms (intensity of  Signs and symptoms (intensity of  Signs and symptoms (intensity of  Signs and symptoms (intensity of 
each sign and  symptom each sign and  symptom each sign and  symptom each sign and  symptom 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
Remaining pages of booklet followed this format.   
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APPENDIX 4 
 
 
 
 
Rating scales                                                                                                              292 
 
Recording forms 
      
                Optokinetic stimulation alone                                                                    294 
 
                Optokinetic stimulation and/or ice to temple or hand                                295 
 
 
 
Examples of physiological output for pulse amplitude data using Acqknowledge  
programme software, see last page of Appendix 4.   Also, refer to method, pages 86-88. 
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RATING SCALES 
 
During the procedure you will be asked to rate your experience of the following 
sensations: 
 
VISUAL ILLUSION - stripes in the drum appear to be changing shape or are    
                                     distorting 
SELF MOTION         - you feel as though you are moving although you are actually    
                                      still, and the drum appears still 
 
Rating scale                  None                        Some                    Complete  
 
NAUSEA  
 
Rating scale 
    0      1     2      3      4      5      6      7      8      9      10 
     No          Stomach           Mild stomach                      Moderate nausea                Somewhat          Severe nausea            Close to 
 Stomach    awareness            discomfort                                                                      severe                                                vomiting     
Discomfort                                                                              nausea                                                                                                                               
DIZZINESS 
 
Rating scale   
    0      1      2      3      4      5      6      7      8      9      10 
None        Awareness          Mild dizziness                    Moderate dizziness                Somewhat      Severe dizziness       Close to 
              of slight                                                                      severe                                           collapsing 
                 dizziness                                                                                                        dizziness                                                              
BODY TEMPERATURE                            
 
Rating scale     
10  -9  -8  -7  -6  -5  -4  -3  -2  -1  0  1  2  3  4  5  6  7  8  9  10 
Extremely       cold              Moderately              Mildly         Normal         Mildly               Moderately               hot        Extremely  
   cold                                        cold                      cold                                  warm                      hot                                         hot 
DROWSINESS 
 
Rating scale     
    0      1      2      3      4       5      6      7       8      9     10 
None        Awareness                 Mild                                     Moderate                      Somewhat               Severe                Close to  
                       of                                                                                                               severe                                                sleep                 
                 drowsiness                                                                                                                                                         
HEADACHE 
 
Rating scale 
    0      1      2      3      4      5      6      7      8      9     10 
None      Head                 Mild   headache                  Moderate  headache              Somewhat                Severe             Extremely 
                  Awareness                                                                                             severe headache           headache             severe 
                                                                                                                               Headache 
UNPLEASANTNESS – how you feel in relation to any change you may experience 
during this experiment 
 
Rating scale 
    0     1     2     3     4     5     6     7     8     9    10 
Not               Slight           Mildly unpleasant              moderately unpleasant                  severely unpleasant                  Extremely 
Unpleasant   awareness                                                                                                                                                         unpleasant 
                        293
 
 
RESPONSE TO ICE 
 
 
Intensity 
 
Rating scale 
    0      1      2      3      4      5      6      7      8      9     10 
Not              Slight               Mild intensity                     Moderate intensity                             severely intense                  Extremely 
noticeable   awareness                                                                                                                                                              intense 
 
 
 
Unpleasantness 
 
Rating scale 
   0     1     2          3     4     5     6     7     8     9    10 
 Not              Slight           Mildly unpleasant              Moderately unpleasant                        Severely unpleasant             Extremely 
Noticeable    awareness                                                                                                                                                        unpleasant 
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RECORD SHEET 
 
 
 
 
 
 
Participant code: 
 
 
 
 
Date:                  START:  time               temperature                 humidity 
 
                           FINISH:  time              temperature                  humidity 
 
 
Test condition:                                OPD                                      
 
 
   
                                                                                                                                          
                                                                                                                                                    
 
         
                                              
                                                 Start                                                                                                                            End 
                                                 drum                                                                                                                           drum 
Minutes    Pre 
drum   
   2    
 
   4     6    8       10     12   14        15     16  18    20 
Nausea                            
Body 
temperature 
                     
Dizziness                       
Drowsiness                       
headache                 
 
     
   
Self motion               
Visual 
illusion 
 
             
 
 
 
 
Unpleasantness                         
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RECORD SHEET 
Participant code: 
 
 
Date:                 START:  time              temperature                 humidity 
 
                          FINISH:  time              temperature                 humidity 
 
 
Test condition:                             OPD & ICE (temple/fingers) 
 
Time between conditions (ICE, OPD & ICE): 
 
 
                                                                                                                                                                    
Ice placement:                  Right                             Left 
 
 
START: ice-water temperature                             warm water temperature 
 
FINISH: ice-water temperature                             warm water temperature  
 
                                                                                                                                                                                     
                                              
                                                 Start                                                                                                                            End 
                                                 drum                                                                                                                           drum 
Minutes    Pre 
drum 
& ice 
   2    
 
   4  
30sec 
ice 
   6      8 
30sec  
ice 
   10     12  
30sec 
ice 
 14        15     16  18   20 
Nausea                                
Body 
temperature 
                     
Dizziness                       
Drowsiness                       
headache                 
 
     
Self motion                 
Visual 
illusion 
 
             
 
 
 
 
 
Unpleasantness                                
 
Ice Rating 
Intensity                         
Unpleasantness                         Examples of physiological output recorded throughout testing using            
 
  AcqKnowledge programme software  
 
(Refer to Chapter 3, Method, page 86-88)  
 
Baseline recording taken before exposure to optokinetic stimulation and/or ice.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stimulation of right temple with ice during optokinetic stimulation in a migraine 
participant                                   Application of ice 
 
 
R Ri ig gh ht t   p pu ul ls se e   v vo ol lu um me e   
L Le ef ft t   p pu ul ls se e   v vo ol lu um me e   
R Ri ig gh ht t   p pu ul ls se e   v vo ol lu um me e   
L Le ef ft t   p pu ul ls se e   v vo ol lu um me e     296
 
APPENDIX 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
              The optokinetic drum and positioning of the participant 
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APPENDIX 12 
 
 
 
                                            Condition 2 
                              
Ice on temple after OKS 
  
 
Analyses using baseline from condition 1 (OKS alone)  
    
     Table  12.  Main  effect  and  interaction  F,  p,  and  df  values  from  a  2    (group: 
migraineurs, controls) x 2 (side: ipsilateral, contralateral to stimulation) x 11 (time: 30 
second samples, before {trial 1, 2 & 3}, during {trial 1, 2 & 3} and after {trial 1, 2 & 
3} ice application to temple, and 3 and 8 mins after the 3
rd application) repeated-
measures ANOVA.   
 
Main effect                    df                        F                                     P 
Group                           1, 45                  2.771                                .103 
Side                               1, 45                    .115                                .736               
Time                            10, 36                 1.271                                 .283                                     
Interaction  
Side x Time                10, 36                     .654                                .758 
Side x Group                1, 45                     .082                                .776 
Time x Group             10, 36                     .981                                .477 
Side x Time x Group  10, 36                     .995                                .466  
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                           Ipsilateral to ice stimulation 
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                        Contralateral to ice stimulation 
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Figure 12.   Pulse amplitude change (+ SEM) for migraineurs (n = 25) and 
controls (n = 22) over 11 time points (30 second samples: before, during and after ice 
application {3 trials}, and after 3 and 8 minutes of recovery {R}).  The first arrow in 
each trial represents pulse amplitude before the immersion, and the second arrow 
represents pulse amplitude after the immersion.   
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                                   Appendix 13 
 
 
 
 
       Table 13.   Number of subjects who withdrew from each procedure: OKS 
alone, stimulation of the temple with ice during OKS and stimulation of the 
hand in ice-water during OKS  
 
 
 
______________________________________________ 
             Withdrawals from optokinetic stimulation 
 
                                          Migraineurs              Controls           x 
2           p   
                 
 
Drum alone                       4/25 (16%)                1/22 (5%)        1.61      0.20 
 
 
Temple-ice and drum       7/25 (28%)                1/23 (4%)        4.82      0.03 
 
 
Hand-ice and drum           4/23 (17%)                2/22 (9%)         0.67     0.41  
______________________________________________ 
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APPENDIX 14 
 
 
 
 
Slides illustrating the content of PowerPoint platform presentation held at the 14
th 
Migaine Trust international conference in London, United Kingdom. 
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The Association between  The Association between 
nausea, head pain, and  nausea, head pain, and 
vascular changes in migraine  vascular changes in migraine 
sufferers sufferers
Objectives Objectives
Investigate: Investigate:
￿ ￿whether head pain intensifies  whether head pain intensifies 
symptoms of motion sickness symptoms of motion sickness
￿ ￿whether motion sickness intensifies  whether motion sickness intensifies 
head pain head pain
￿ ￿vascular changes during motion  vascular changes during motion 
sickness sickness
Participants Participants
￿ ￿Migraine sufferers Migraine sufferers – – with/without  with/without 
aura, no other serious medical  aura, no other serious medical 
problems, no ongoing drug   problems, no ongoing drug  
treatment.  At least 1 migraine per  treatment.  At least 1 migraine per 
month and headache free during  month and headache free during 
baseline baseline
￿ ￿Controls Controls – – <12 headaches/year  <12 headaches/year 
which did not meet the criteria for  which did not meet the criteria for 
migraine migraine
￿ ￿Age 18 Age 18– – 62 62
Method Method
To investigate whether motion sickness  To investigate whether motion sickness 
intensifies head pain, motion sickness was  intensifies head pain, motion sickness was 
induced by  induced by optokinetic optokinetic stimulation:  stimulation: 
3 separate occasions 3 separate occasions: 23  : 23 migraineurs  migraineurs 
22 controls  22 controls 
1 occasion 1 occasion:                4  :                4 migraineurs  migraineurs 
1 control 1 control2
Optokinetic Optokinetic stimulation stimulation
Sit with head inside striped,  Sit with head inside striped, 
revolving drum 15  revolving drum 15 mins mins
Motion sickness :   mismatch  Motion sickness :   mismatch 
between visual &  between visual & 
propriocecptive propriocecptive messages   messages  
eg eg.  . widescreen widescreen movies movies
Trigeminal Trigeminal stimulation stimulation
Ice applied to  Ice applied to temple.  Three  temple.  Three 
applications 30s every 4mins  applications 30s every 4mins 
Stimulates the Stimulates the trigeminal trigeminal nerve &  nerve & 
provokes head pain provokes head pain
Non Non- -specific painful  specific painful 
stimulation stimulation
Non Non- -dominant hand immersed in  dominant hand immersed in 
iced water.  Three applications 30s  iced water.  Three applications 30s 
every 4mins every 4mins
Used to compare effects of  Used to compare effects of 
trigeminal  trigeminal vs. non vs. non- -specific painful  specific painful 
stimulation elsewhere in the body stimulation elsewhere in the body
To investigate whether nausea  To investigate whether nausea 
intensifies head pain, the intensity  intensifies head pain, the intensity 
of pain induced by ice applied to  of pain induced by ice applied to 
the temple was compared before &  the temple was compared before & 
during  during optokinetic optokinetic stimulation stimulation3
Experimental design Experimental design
Trigeminal stimulation
during optokinetic
stimulation
 Trigeminal stimulation
before optokinetic
stimulation
Non-specific painful
stimulation
during optokinetic
stimulation
Non-specific painful
stimulation
before optokinetic
stimulation
Optokinetic
stimulation
alone
Throughout testing: Throughout testing:
Verbal Verbal ratings         ratings        
10 point scale 10 point scale
Changes in    Changes in   
pulse  pulse 
amplitude amplitude
Stimulation of the right temple with ice during  Stimulation of the right temple with ice during 
optokinetic optokinetic stimulation in a migraine participant stimulation in a migraine participant
Right pulse volume Right pulse volume
Left pulse volume Left pulse volume
Application of ice Application of ice
RESULTS RESULTS Nausea Nausea
0
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1
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3
3.5
drum alone drum & ice on
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drum & hand in
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*
*
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Headache Headache
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0.5
1
1.5
2
2.5
drum drum  & ice on
temple
drum & hand in
ice-water
migraineurs
controls
*      *            *
Headache ratings Headache ratings
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*
Mean pulse amplitude during  Mean pulse amplitude during 
optokinetic optokinetic stimulation alone stimulation alone
100
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M mean pulse
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C mean pulse
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Percentage difference  Percentage difference 
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Summary of ratings Summary of ratings
￿ ￿Migraineurs  Migraineurs were more susceptible  were more susceptible 
to motion sickness induced by  to motion sickness induced by 
optokinetic optokinetic stimulation than  stimulation than 
controls controls
￿ ￿Ice to the temple intensified nausea   Ice to the temple intensified nausea  
during  during optokinetic optokinetic stimulation  stimulation 
￿ ￿However,  However, optokinetic optokinetic stimulation  stimulation 
did not intensify ice induced pain did not intensify ice induced pain
Summary of vascular changes Summary of vascular changes
￿ ￿Before & during  Before & during optokinetic optokinetic
stimulation vascular responses  stimulation vascular responses 
were greater in  were greater in migraineurs  migraineurs than  than 
controls controls
￿ ￿However, painful stimulation and  However, painful stimulation and 
optokinetic optokinetic stimulation reduced  stimulation reduced 
differences between the 2 groups. differences between the 2 groups.
Key points Key points
￿ ￿ Findings have helped clarify the relationship  Findings have helped clarify the relationship 
between head pain & nausea between head pain & nausea
￿ ￿ Confirmed facial blood vessels are more reactive  Confirmed facial blood vessels are more reactive 
in  in migraineurs  migraineurs than controls to a range of stimuli than controls to a range of stimuli
Goals  Goals 
Continue to investigate cause Continue to investigate cause- -effect relationships  effect relationships 
in symptoms of migraine & vascular changes that  in symptoms of migraine & vascular changes that 
accompany them accompany them
Identify new targets for treatment/approaches to  Identify new targets for treatment/approaches to 
reduce susceptibility to recurring attacks of  reduce susceptibility to recurring attacks of 
migraine migraine
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